Thus	O
,	O
EBV	O
binding	O
to	O
its	O
cellular	O
receptor	O
on	O
resting	O
B	O
cells	O
triggers	O
an	O
NF-kappaB-dependent	O
intracellular	O
signaling	O
pathway	O
which	O
is	O
required	O
for	O
infection	O
.	O

Activation	O
of	O
transcription	O
factor	O
NF-kappa	O
B	O
by	O
phagocytic	O
stimuli	O
in	O
human	O
neutrophils	O
.	O

Phagocytosis	O
represents	O
an	O
important	O
physiological	O
trigger	O
for	O
the	O
inducible	O
expression	O
of	O
several	O
genes	O
in	O
human	O
neutrophils	O
.	O

Here	O
,	O
we	O
report	O
that	O
a	O
DNA-binding	O
activity	O
primarily	O
consisting	O
of	O
the	O
classical	O
NF-kappa	O
B	O
heterodimer	O
,	O
p50	O
/	O
RelA	O
,	O
is	O
induced	O
in	O
phagocytosing	O
neutrophils	O
.	O

Under	O
these	O
conditions	O
,	O
NF-kappa	O
B	O
activation	O
was	O
found	O
to	O
be	O
a	O
rapid	O
and	O
transient	O
response	O
,	O
reaching	O
a	O
maximum	O
by	O
10-15	O
min	O
,	O
and	O
returning	O
to	O
near-basal	O
levels	O
by	O
30	O
min	O
.	O

In	O
neutrophils	O
undergoing	O
the	O
phagocytosis	O
of	O
opsonized	O
yeasts	O
,	O
the	O
onset	O
of	O
NF-kappa	O
B	O
activation	O
was	O
paralleled	O
by	O
a	O
decline	O
in	O
immunoreactive	O
I	O
kappa	O
B-alpha	O
protein	O
levels	O
,	O
and	O
the	O
cellular	O
I	O
kappa	O
B-alpha	O
pool	O
was	O
replenished	O
by	O
30	O
min	O
,	O
in	O
agreement	O
with	O
our	O
gel	O
shift	O
data	O
.	O

We	O
conclude	O
that	O
NF-kappa	O
B	O
activation	O
could	B-SPECULATION
constitute	I-SPECULATION
one	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
mechanisms	I-SPECULATION
whereby	I-SPECULATION
the	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
kappa	I-SPECULATION
B-responsive	I-SPECULATION
genes	I-SPECULATION
is	I-SPECULATION
enhanced	I-SPECULATION
in	I-SPECULATION
phagocytosing	I-SPECULATION
neutrophils	I-SPECULATION
.	O

To	O
our	O
knowledge	O
,	O
this	O
represents	O
the	O
first	O
demonstration	O
that	O
phagocytic	O
stimuli	O
can	O
induce	O
NF-kappa	O
B	O
activation	O
in	O
human	O
neutrophils	O
.	O

Surfactant	O
protein	O
A	O
activates	O
NF-kappa	O
B	O
in	O
the	O
THP-1	O
monocytic	O
cell	O
line	O
.	O

The	O
expression	O
of	O
many	O
genes	O
for	O
which	O
products	O
are	O
involved	O
in	O
inflammation	O
is	O
controlled	O
by	O
the	O
transcriptional	O
regulator	O
nuclear	O
factor	O
(	O
NF	O
)-	O
kappa	O
B	O
.	O

Because	O
surfactant	O
protein	O
(	O
SP	O
)	O
A	O
is	O
involved	O
in	O
local	O
host	O
defense	O
in	O
the	O
lung	O
and	O
alters	O
immune	O
cell	O
function	O
by	O
modulating	O
the	O
expression	O
of	O
proinflammatory	O
cytokines	O
as	O
well	O
as	O
surface	O
proteins	O
involved	O
in	O
inflammation	O
,	O
we	O
hypothesized	B-SPECULATION
that	I-SPECULATION
SP-A	I-SPECULATION
exerts	I-SPECULATION
its	I-SPECULATION
action	I-SPECULATION
,	I-SPECULATION
at	I-SPECULATION
least	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
,	I-SPECULATION
via	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
.	O

We	O
used	O
gel	O
shift	O
assays	O
to	O
determine	O
whether	B-SPECULATION
SP-A	I-SPECULATION
activated	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
THP-1	I-SPECULATION
cell	I-SPECULATION
line	I-SPECULATION
,	I-SPECULATION
a	I-SPECULATION
human	I-SPECULATION
monocytic	I-SPECULATION
cell	I-SPECULATION
line	I-SPECULATION
.	O

Activation	O
of	O
NF-kappa	O
B	O
in	O
THP-1	O
cells	O
by	O
SP-A	O
doses	O
as	O
low	O
as	O
1	O
microgram	O
/	O
ml	O
occurred	O
within	O
30	O
min	O
of	O
SP-A	O
treatment	O
,	O
peaked	O
at	O
60	O
min	O
,	O
and	O
then	O
declined	O
.	O

This	O
activation	O
is	O
inhibited	O
by	B-SPECULATION
known	I-SPECULATION
inhibitors	I-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
or	I-SPECULATION
by	I-SPECULATION
simultaneous	I-SPECULATION
treatment	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
cells	I-SPECULATION
with	I-SPECULATION
surfactant	I-SPECULATION
lipids	I-SPECULATION
.	O

Moreover	O
,	O
the	O
NF-kappa	O
B	O
inhibitors	O
blocked	O
SP-A-dependent	O
increases	O
in	O
tumor	O
necrosis	O
factor-alpha	O
mRNA	O
levels	O
.	O

These	O
observations	O
suggest	B-SPECULATION
a	I-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
SP-A	I-SPECULATION
plays	I-SPECULATION
a	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
pathogenesis	I-SPECULATION
of	I-SPECULATION
some	I-SPECULATION
lung	I-SPECULATION
conditions	I-SPECULATION
and	I-SPECULATION
point	I-SPECULATION
to	I-SPECULATION
potential	B-SPECULATION
therapeutic	I-SPECULATION
measures	I-SPECULATION
that	B-SPECULATION
could	I-SPECULATION
be	I-SPECULATION
used	I-SPECULATION
to	I-SPECULATION
prevent	I-SPECULATION
SP-A	I-SPECULATION
induced	I-SPECULATION
inflammation	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
lung	I-SPECULATION
.	O

alpha-Tocopheryl	O
succinate	O
inhibits	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	O
cells	O
by	O
suppressing	O
NF-kappa	O
B	O
mobilization	O
.	O

The	O
adherence	O
of	O
monocytes	O
to	O
activated	O
endothelium	O
is	O
an	O
early	O
event	O
in	O
atherogenesis	O
.	O

Because	O
antioxidants	O
have	O
been	O
considered	O
to	O
be	O
of	O
antiatherosclerotic	O
potential	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
alpha-tocopherol	O
(	O
TCP	O
)	O
and	O
its	O
acetate	O
and	O
succinate	O
esters	O
on	O
monocyte	O
adhesion	O
to	O
cytokine-stimulated	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
.	O

Endothelial	O
cells	O
were	O
treated	O
with	O
TCP	O
,	O
alpha-tocopherol	O
acetate	O
(	O
TCP	O
acetate	O
)	O
,	O
or	O
alpha-tocopheryl	O
succinate	O
(	O
TCP	O
succinate	O
)	O
before	O
stimulation	O
with	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
;	O
10	O
U	O
/	O
ml	O
,	O
6	O
h	O
)	O
or	O
interleukin-1	O
beta	O
(	O
IL-1	O
beta	O
;	O
10	O
U	O
/	O
ml	O
,	O
6	O
h	O
)	O
.	O

Cytokine-stimulated	O
cell	O
surface	O
expression	O
of	O
vascular	O
cell	O
adhesion	O
molecule-1	O
(	O
VCAM-1	O
,	O
CD106	O
)	O
and	O
E-selectin	O
(	O
ELAM-1	O
,	O
CD62E	O
)	O
,	O
but	O
not	B-NEGATION
of	I-NEGATION
intercellular	I-NEGATION
adhesion	I-NEGATION
molecule-1	I-NEGATION
(	I-NEGATION
ICAM-1	I-NEGATION
,	I-NEGATION
CD54	I-NEGATION
)	I-NEGATION
,	O
was	O
time	O
-	O
and	O
dose-dependently	O
inhibited	O
by	O
TCP	O
succinate	O
but	O
not	B-NEGATION
by	I-NEGATION
TCP	I-NEGATION
or	I-NEGATION
TCP	I-NEGATION
acetate	I-NEGATION
.	O

TCP	O
succinate	O
(	O
200	O
microM	O
,	O
24	O
h	O
)	O
reduced	O
TNF-induced	O
VCAM-1	O
and	O
E-selectin	O
expression	O
from	O
a	O
specific	O
mean	O
fluorescence	O
intensity	O
of	O
151	O
±	O
28	O
to	O
12	O
±	O
4	O
channels	O
and	O
from	O
225	O
±	O
38	O
to	O
79	O
±	O
21	O
channels	O
,	O
respectively	O
.	O

Succinate	O
alone	O
had	O
no	B-NEGATION
effect	I-NEGATION
.	O

Decreased	O
adhesion	O
molecule	O
expression	O
was	O
associated	O
with	O
a	O
reduction	O
of	O
monocytic	O
cell	O
adhesion	O
.	O

TCP	O
succinate	O
(	O
20	O
microM	O
,	O
72	O
h	O
)	O
,	O
but	O
not	B-NEGATION
TCP	I-NEGATION
(	I-NEGATION
200	I-NEGATION
microM	I-NEGATION
,	I-NEGATION
72	I-NEGATION
h	I-NEGATION
)	I-NEGATION
,	O
reduced	O
U-937	O
cell	O
adhesion	O
to	O
TNF-alpha-stimulated	O
(	O
10	O
U	O
/	O
ml	O
,	O
6	O
h	O
)	O
HUVEC	O
by	O
30	O
%	O
(	O
P	O
<	O
0.025	O
)	O
and	O
to	O
IL-1	O
beta-stimulated	O
HUVEC	O
by	O
56	O
%	O
(	O
P	O
<	O
0.010	O
)	O
.	O

Electrophoretic	O
mobility-shift	O
assays	O
of	O
HUVEC	O
nuclear	O
proteins	O
revealed	O
a	O
decrease	O
in	O
TNF-alpha-stimulated	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
activation	O
after	O
pretreatment	O
of	O
HUVEC	O
with	O
TCP	O
succinate	O
but	O
not	B-NEGATION
with	I-NEGATION
TCP	I-NEGATION
,	I-NEGATION
TCP	I-NEGATION
acetate	I-NEGATION
,	I-NEGATION
or	I-NEGATION
succinate	I-NEGATION
alone	I-NEGATION
.	O

In	O
conclusion	O
,	O
we	O
demonstrate	O
that	O
the	O
vitamin	O
E	O
derivative	O
TCP	O
succinate	O
prevents	O
monocytic	O
cell	O
adhesion	O
to	O
cytokine-stimulated	O
endothelial	O
cells	O
by	O
inhibiting	O
the	O
activation	O
of	O
NF-kappa	O
B	O
,	O
further	O
emphasizing	O
the	O
antiatherosclerotic	O
potential	O
of	O
lipid	O
soluble	O
antioxidants	O
.	O

Distinct	O
mechanisms	O
for	O
N-acetylcysteine	O
inhibition	O
of	O
cytokine-induced	O
E-selectin	O
and	O
VCAM-1	O
expression	O
.	O

We	O
have	O
examined	O
the	O
effects	O
of	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
,	O
a	O
well-characterized	O
,	O
thiol-containing	O
antioxidant	O
,	O
on	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	O
cells	O
(	O
EC	O
)	O
.	O

NAC	O
inhibited	O
interleukin-1	O
(	O
IL-1	O
beta	O
)-	O
induced	O
,	O
but	O
not	B-NEGATION
basal	I-NEGATION
,	O
adhesion	O
with	O
50	O
%	O
inhibition	O
at	O
approximately	O
20	O
mM	O
.	O

Monocytic	O
cell	O
adhesion	O
to	O
EC	O
in	O
response	O
to	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
alpha-thrombin	O
,	O
or	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
was	O
similarly	O
inhibited	O
by	O
NAC	O
.	O

Unlike	O
published	O
studies	O
with	O
pyrrolidinedithiocarbamate	O
,	O
which	O
specifically	O
inhibited	O
vascular	O
cell	O
adhesion	O
molecule	O
1	O
(	O
VCAM-1	O
)	O
,	O
NAC	O
inhibited	O
IL-1	O
beta-induced	O
mRNA	O
and	O
cell	O
surface	O
expression	O
of	O
both	O
E-selectin	O
and	O
VCAM-1	O
.	O

NAC	O
had	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
the	I-NEGATION
half-life	I-NEGATION
of	I-NEGATION
E-selectin	I-NEGATION
or	I-NEGATION
VCAM-1	I-NEGATION
mRNA	I-NEGATION
.	O

Although	O
NAC	O
reduced	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
activation	O
in	O
EC	O
as	O
measured	O
by	O
gel-shift	O
assays	O
using	O
an	O
oligonucleotide	O
probe	O
corresponding	O
to	O
the	O
consensus	O
NF-kappa	O
B	O
binding	O
sites	O
of	O
the	O
VCAM-1	O
gene	O
(	O
VCAM-NF-kappa	O
B	O
)	O
,	O
the	O
antioxidant	O
had	O
no	B-NEGATION
appreciable	I-NEGATION
effect	I-NEGATION
when	I-NEGATION
an	I-NEGATION
oligomer	I-NEGATION
corresponding	I-NEGATION
to	I-NEGATION
the	I-NEGATION
consensus	I-NEGATION
NF-kappa	I-NEGATION
B	I-NEGATION
binding	I-NEGATION
site	I-NEGATION
of	I-NEGATION
the	I-NEGATION
E-selectin	I-NEGATION
gene	I-NEGATION
(	I-NEGATION
E-selectin-NF-kappa	I-NEGATION
B	I-NEGATION
)	I-NEGATION
was	I-NEGATION
used	I-NEGATION
.	O

Because	O
NF-kappa	O
B	O
has	O
been	O
reported	O
to	O
be	O
redox	O
sensitive	O
,	O
we	O
studied	O
the	O
effects	O
of	O
NAC	O
on	O
the	O
EC	O
redox	O
environment	O
.	O

NAC	O
caused	O
an	O
expected	O
dramatic	O
increase	O
in	O
the	O
reduced	O
glutathione	O
(	O
GSH	O
)	O
levels	O
in	O
EC	O
.	O

In	O
vitro	O
studies	O
demonstrated	O
that	O
whereas	O
the	O
binding	O
affinity	O
of	O
NF-kappa	O
B	O
to	O
the	O
VCAM-NF-kappa	O
B	O
oligomer	O
peaked	O
at	O
a	O
GSH-to-oxidized	O
glutathione	O
(	O
GSSG	O
)	O
ratio	O
of	O
approximately	O
200	O
and	O
decreased	O
at	O
higher	O
ratios	O
,	O
the	B-SPECULATION
binding	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
E-selectin-NF-kappa	I-SPECULATION
B	I-SPECULATION
oligomer	I-SPECULATION
appeared	I-SPECULATION
relatively	I-SPECULATION
unaffected	I-SPECULATION
even	I-SPECULATION
at	I-SPECULATION
ratios	I-SPECULATION
>	I-SPECULATION
400	I-SPECULATION
,	I-SPECULATION
i.e.	I-SPECULATION
,	I-SPECULATION
those	I-SPECULATION
achieved	I-SPECULATION
in	I-SPECULATION
EC	I-SPECULATION
treated	I-SPECULATION
with	I-SPECULATION
40	I-SPECULATION
mM	I-SPECULATION
NAC	I-SPECULATION
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
binding	I-SPECULATION
to	I-SPECULATION
its	I-SPECULATION
consensus	I-SPECULATION
sequences	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
VCAM-1	I-SPECULATION
and	I-SPECULATION
E-selectin	I-SPECULATION
gene	I-SPECULATION
exhibits	I-SPECULATION
marked	I-SPECULATION
differences	I-SPECULATION
in	I-SPECULATION
redox	I-SPECULATION
sensitivity	I-SPECULATION
,	I-SPECULATION
allowing	I-SPECULATION
for	I-SPECULATION
differential	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
regulated	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
same	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
.	O

Our	O
data	O
also	O
demonstrate	O
that	O
NAC	O
increases	O
the	O
GSH-to-GSSG	O
ratio	O
within	O
the	O
EC	O
suggesting	B-SPECULATION
one	I-SPECULATION
possible	B-SPECULATION
mechanism	I-SPECULATION
through	I-SPECULATION
which	I-SPECULATION
this	I-SPECULATION
antioxidant	I-SPECULATION
inhibits	I-SPECULATION
agonist-induced	I-SPECULATION
monocyte	I-SPECULATION
adhesion	I-SPECULATION
to	I-SPECULATION
EC	I-SPECULATION
.	O

Human	O
monocyte	O
binding	O
to	O
fibronectin	O
enhances	O
IFN-gamma-induced	O
early	O
signaling	O
events	O
.	O

Leukocyte	O
integrins	O
are	O
fundamentally	O
important	O
in	O
modulating	O
adhesion	O
to	O
extracellular	O
matrix	O
components	O
and	O
to	O
other	O
cells	O
.	O

This	O
integrin-mediated	O
adhesion	O
controls	O
leukocyte	O
arrest	O
and	O
extravasation	O
during	O
the	O
onset	O
of	O
inflammatory	O
responses	O
.	O

Moreover	O
,	O
integrin-ligand	O
interactions	O
trigger	O
signaling	O
pathways	O
that	O
may	B-SPECULATION
influence	I-SPECULATION
leukocyte	I-SPECULATION
phenotype	I-SPECULATION
and	I-SPECULATION
function	I-SPECULATION
at	I-SPECULATION
sites	I-SPECULATION
of	I-SPECULATION
inflammation	I-SPECULATION
.	O

In	O
the	O
current	O
studies	O
,	O
we	O
evaluated	O
the	O
combinatorial	O
effects	O
of	O
monocyte	O
adhesion	O
and	O
IFN-gamma	O
on	O
intracellular	O
signaling	O
pathways	O
.	O

IFN-gamma	O
triggers	O
a	O
well-defined	O
signal	O
transduction	O
pathway	O
,	O
which	O
although	O
not	O
directly	O
stimulated	O
by	O
monocyte	O
adherence	O
to	O
fibronectin	O
or	O
arginine-glycine-aspartate	O
(	O
RGD	O
)-	O
coated	O
substrata	O
,	O
was	O
enhanced	O
significantly	O
in	O
these	O
matrix-adherent	O
cells	O
.	O

Compared	O
with	O
monocytes	O
in	O
suspension	O
or	O
adherent	O
on	O
plastic	O
surfaces	O
,	O
monocytes	O
adherent	O
to	O
fibronectin	O
or	O
RGD	O
exhibited	O
a	O
greater	O
than	O
threefold	O
increase	O
in	O
steady	O
state	O
levels	O
of	O
IFN-gamma-induced	O
mRNA	O
for	O
the	O
high	O
affinity	O
Fc	O
gammaRI	O
receptor	O
.	O

By	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
this	O
increase	O
in	O
mRNA	O
was	O
associated	O
with	O
a	O
5	O
-	O
to	O
10-fold	O
increase	O
in	O
the	O
STAT1-containing	O
DNA-binding	O
complex	O
that	O
binds	O
to	O
Fc	O
gammaRI	O
promoter	O
elements	O
.	O

Furthermore	O
,	O
the	O
tyrosine	O
phosphorylation	O
of	O
STAT1	O
and	O
the	O
tyrosine	O
kinases	O
JAK1	O
and	O
JAK2	O
was	O
enhanced	O
significantly	O
in	O
RGD-adherent	O
monocytes	O
compared	O
with	O
control	O
cells	O
.	O

These	O
results	O
suggest	B-SPECULATION
a	I-SPECULATION
novel	I-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
integrin-mediated	I-SPECULATION
cell	I-SPECULATION
adhesion	I-SPECULATION
can	I-SPECULATION
modulate	I-SPECULATION
the	I-SPECULATION
magnitude	I-SPECULATION
of	I-SPECULATION
cytokine-induced	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
pathways	I-SPECULATION
,	I-SPECULATION
thereby	I-SPECULATION
amplifying	I-SPECULATION
cellular	I-SPECULATION
events	I-SPECULATION
leading	I-SPECULATION
to	I-SPECULATION
monocyte	I-SPECULATION
activation	I-SPECULATION
and	I-SPECULATION
inflammation	I-SPECULATION
.	O

The	O
carboxyl-terminal	O
cytoplasmic	O
domain	O
of	O
CD36	O
is	O
required	O
for	O
oxidized	O
low-density	O
lipoprotein	O
modulation	O
of	O
NF-kappaB	O
activity	O
by	O
tumor	O
necrosis	O
factor-alpha	O
.	O

The	O
binding	O
of	O
oxidized	O
low-density	O
lipoprotein	O
(	O
Ox	O
LDL	O
)	O
by	O
monocyte-macrophages	O
causes	O
pleiotropic	O
effects	O
,	O
including	O
changes	O
in	O
gene	O
expression	O
,	O
and	O
is	B-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
represent	I-SPECULATION
an	I-SPECULATION
early	I-SPECULATION
event	I-SPECULATION
in	I-SPECULATION
atherogenesis	I-SPECULATION
.	O

The	B-SPECULATION
integral	I-SPECULATION
membrane	I-SPECULATION
glycoprotein	I-SPECULATION
CD36	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
a	I-SPECULATION
physiological	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
binding	I-SPECULATION
and	I-SPECULATION
uptake	I-SPECULATION
of	I-SPECULATION
Ox	I-SPECULATION
LDL	I-SPECULATION
by	I-SPECULATION
monocyte-macrophages	I-SPECULATION
,	O
although	O
the	B-SPECULATION
molecular	I-SPECULATION
events	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
CD36-Ox	I-SPECULATION
LDL	I-SPECULATION
interaction	I-SPECULATION
are	I-SPECULATION
unknown	I-SPECULATION
.	O

To	O
approach	O
this	O
issue	O
,	O
we	O
used	O
CD36	O
transfected	O
Chinese	O
hampster	O
ovary	O
(	O
CHO	O
)	O
cells	O
,	O
exposed	O
them	O
to	O
Ox	O
LDL	O
,	O
and	O
determined	O
changes	O
in	O
the	O
activity	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	O
.	O

We	O
report	O
here	O
that	O
Ox	O
LDL	O
enhanced	O
DNA	O
binding	O
activity	O
of	O
nuclear	O
extracts	O
to	O
an	O
NF-kappaB	O
sequence	O
following	O
activation	O
of	O
CD36-producing	O
CHO	O
cells	O
with	O
the	O
proinflammatory	O
cytokine	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
.	O

This	O
enhanced	O
DNA	O
binding	O
activity	O
was	O
inhibited	O
by	O
coincubation	O
of	O
CD36	O
transfected	O
cells	O
with	O
the	O
human	O
CD36-specific	O
antibody	O
OKM5	O
.	O

We	O
also	O
determined	O
that	O
activation	O
of	O
NF-kappaB	O
DNA	O
binding	O
activity	O
required	O
an	O
intact	O
carboxyl-terminal	O
cytoplasmic	O
segment	O
on	O
CD36	O
.	O

Our	O
results	O
support	O
the	O
idea	B-SPECULATION
that	I-SPECULATION
human	I-SPECULATION
CD36	I-SPECULATION
mediates	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
events	I-SPECULATION
in	I-SPECULATION
response	I-SPECULATION
to	I-SPECULATION
Ox	I-SPECULATION
LDL	I-SPECULATION
.	O

Transcriptional	O
regulation	O
during	O
myelopoiesis	O
.	O

The	O
coordinated	O
production	O
of	O
all	O
blood	O
cells	O
from	O
a	O
common	O
stem	O
cell	O
is	O
a	O
highly	O
regulated	O
process	O
involving	O
successive	O
stages	O
of	O
commitment	O
and	O
differentiation	O
.	O

From	O
analyses	O
of	O
mice	O
deficient	O
in	O
transcription	O
factor	O
genes	O
and	O
from	O
the	O
characterizations	O
of	O
chromosome	O
breakpoints	O
in	O
human	O
leukemias	O
,	O
it	O
has	O
become	O
evident	O
that	O
transcription	O
factors	O
are	O
important	O
regulators	O
of	O
hematopoiesis	O
.	O

During	O
myelopoiesis	O
,	O
which	O
includes	O
the	O
development	O
of	O
granulocytic	O
and	O
monocytic	O
lineages	O
,	O
transcription	O
factors	O
from	O
several	O
families	O
are	O
active	O
,	O
including	O
AML1	O
/	O
CBF	O
beta	O
,	O
C	O
/	O
EBP	O
,	O
Ets	O
,	O
c-Myb	O
,	O
HOX	O
,	O
and	O
MZF-1	O
.	O

Few	O
of	O
these	O
factors	O
are	O
expressed	O
exclusively	O
in	O
myeloid	O
cells	O
;	O
instead	O
it	O
appears	B-SPECULATION
that	I-SPECULATION
they	I-SPECULATION
cooperatively	I-SPECULATION
regulate	I-SPECULATION
transcription	I-SPECULATION
of	I-SPECULATION
myeloid-specific	I-SPECULATION
genes	I-SPECULATION
.	O

Here	O
we	O
discuss	O
recent	O
advances	O
in	O
transcriptional	O
regulation	O
during	O
myelopoiesis	O
.	O

Genomic	O
organization	O
,	O
sequence	O
,	O
and	O
transcriptional	O
regulation	O
of	O
the	O
human	O
eotaxin	O
gene	O
.	O

Eotaxin	O
is	O
an	O
eosinophil	O
specific	O
beta-chemokine	O
assumed	O
to	O
be	O
involved	O
in	O
eosinophilic	O
inflammatory	O
diseases	O
such	O
as	O
atopic	O
dermatitis	O
,	O
allergic	O
rhinitis	O
,	O
asthma	O
and	O
parasitic	O
infections	O
.	O

Its	O
expression	O
is	O
stimulus	O
-	O
and	O
cell-specific	O
.	O

We	O
here	O
describe	O
the	O
genomic	O
organisation	O
(	O
3	O
exons	O
of	O
132	O
,	O
112	O
and	O
542	O
bp	O
and	O
2	O
introns	O
of	O
1211	O
and	O
378	O
bp	O
)	O
and	O
sequence	O
including	O
3	O
kb	O
of	O
DNA	O
from	O
the	O
immediate	O
5	O
'	O
upstream	O
region	O
of	O
the	O
human	O
eotaxin	O
gene	O
.	O

Among	O
the	O
regulatory	O
promoter	O
elements	O
potentially	B-SPECULATION
regulating	I-SPECULATION
eotaxin	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
and	I-SPECULATION
/	I-SPECULATION
or	I-SPECULATION
mediating	I-SPECULATION
the	I-SPECULATION
effects	I-SPECULATION
of	I-SPECULATION
anti-inflammatory	I-SPECULATION
drugs	I-SPECULATION
we	O
identified	O
consensus	O
sequences	O
known	O
to	O
interact	O
with	O
nuclear	O
factors	O
like	O
NF-IL6	O
,	O
AP-1	O
,	O
a	O
NF-kappa-B	O
like	O
consensus	O
sequence	O
and	O
gamma-interferon	O
-	O
as	O
well	O
as	O
glucocorticoid	O
response	O
elements	O
.	O

Rel	O
/	O
NF-kappa	O
B	O
transcription	O
factors	O
and	O
the	O
control	O
of	O
apoptosis	O
.	O

The	O
process	O
of	O
apoptosis	O
is	O
used	O
to	O
eliminate	O
unwanted	O
cells	O
from	O
a	O
wide	O
variety	O
of	O
organisms	O
.	O

Various	O
extracellular	O
signals	O
,	O
often	O
converging	O
in	O
common	O
intracellular	O
pathways	O
,	O
can	O
induce	O
apoptosis	O
in	O
a	O
cell-type-specific	O
fashion	O
.	O

Recent	O
work	O
from	O
several	O
laboratories	O
has	O
demonstrated	O
that	O
Rel	O
/	O
NF-kappa	O
B	O
transcription	O
factors	O
regulate	O
apoptosis	O
in	O
many	O
cell	O
types	O
.	O

In	O
most	O
cells	O
,	O
Rel	B-SPECULATION
/	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
appear	I-SPECULATION
to	I-SPECULATION
mediate	I-SPECULATION
survival	I-SPECULATION
signals	I-SPECULATION
that	I-SPECULATION
protect	I-SPECULATION
cells	I-SPECULATION
from	I-SPECULATION
apoptosis	I-SPECULATION
;	O
however	O
,	O
under	O
some	O
circumstances	O
,	O
activation	O
of	O
these	O
factors	O
may	B-SPECULATION
also	I-SPECULATION
promote	I-SPECULATION
apoptosis	I-SPECULATION
.	O

The	O
role	O
of	O
Rel	O
/	O
NF-kappa	O
B	O
proteins	O
in	O
viral	O
oncogenesis	O
and	O
the	O
regulation	O
of	O
viral	O
transcription	O
.	O

Rel	O
/	O
NF-kappa	O
B	O
is	O
a	O
ubiquitous	O
transcription	O
factor	O
that	O
consists	O
of	O
multiple	O
polypeptide	O
subunits	O
,	O
and	O
is	O
subject	O
to	O
complex	O
regulatory	O
mechanisms	O
that	O
involve	O
protein-protein	O
interactions	O
,	O
phosphorylation	O
,	O
ubiquitination	O
,	O
proteolytic	O
degradation	O
,	O
and	O
nucleocytoplasmic	O
translocation	O
.	O

The	O
sophisticated	O
control	O
of	O
Rel	O
/	O
NF-kappa	O
B	O
activity	O
is	O
not	B-NEGATION
surprising	I-NEGATION
since	O
this	O
transcription	O
factor	O
is	O
involved	O
in	O
a	O
wide	O
array	O
of	O
cellular	O
responses	O
to	O
extracellular	O
cues	O
,	O
associated	O
with	O
growth	O
,	O
development	O
,	O
apoptosis	O
,	O
and	O
pathogen	O
invasion	O
.	O

Thus	O
,	O
it	O
is	O
not	B-NEGATION
unexpected	I-NEGATION
that	I-NEGATION
this	B-SPECULATION
versatile	I-SPECULATION
cellular	I-SPECULATION
homeostatic	I-SPECULATION
switch	I-SPECULATION
would	I-SPECULATION
be	I-SPECULATION
affected	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
variety	I-SPECULATION
of	I-SPECULATION
viral	I-SPECULATION
pathogens	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
have	I-SPECULATION
evolved	I-SPECULATION
mechanisms	I-SPECULATION
to	I-SPECULATION
utilize	I-SPECULATION
various	I-SPECULATION
aspects	I-SPECULATION
of	I-SPECULATION
Rel	I-SPECULATION
/	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
activity	I-SPECULATION
to	I-SPECULATION
facilitate	I-SPECULATION
their	I-SPECULATION
replication	I-SPECULATION
,	I-SPECULATION
cell	I-SPECULATION
survival	I-SPECULATION
and	I-SPECULATION
possibly	B-SPECULATION
evasion	I-SPECULATION
of	I-SPECULATION
immune	I-SPECULATION
responses	I-SPECULATION
.	O

This	O
review	O
will	O
cover	O
the	O
molecular	O
mechanisms	O
that	O
are	O
utilized	O
by	O
mammalian	O
oncogenic	O
viruses	O
to	O
affect	O
the	O
activity	O
of	O
Rel	O
/	O
NF-kappa	O
B	O
transcription	O
factors	O
and	O
the	O
role	O
of	O
Rel	O
/	O
NF-kappa	O
B	O
in	O
the	O
regulation	O
of	O
viral	O
gene	O
expression	O
and	O
replication	O
.	O

Abnormal	O
apoptosis	O
and	O
cell	O
cycle	O
progression	O
in	O
humans	O
exposed	O
to	O
methyl	O
tertiary-butyl	O
ether	O
and	O
benzene	O
contaminating	O
water	O
.	O

1.	O
In	O
this	O
study	O
we	O
hypothesized	B-SPECULATION
that	I-SPECULATION
in	I-SPECULATION
individuals	I-SPECULATION
with	I-SPECULATION
certain	I-SPECULATION
genetic	I-SPECULATION
makeup	I-SPECULATION
,	I-SPECULATION
MTBE	I-SPECULATION
,	I-SPECULATION
benzene	I-SPECULATION
or	I-SPECULATION
their	I-SPECULATION
metabolites	I-SPECULATION
act	I-SPECULATION
as	I-SPECULATION
adducts	I-SPECULATION
and	I-SPECULATION
may	B-SPECULATION
induce	I-SPECULATION
programmed	I-SPECULATION
cell	I-SPECULATION
death	I-SPECULATION
.	O

2.	O
Our	O
study	O
involved	O
a	O
group	O
of	O
60	O
male	O
and	O
female	O
subjects	O
who	O
were	O
exposed	O
to	O
MTBE	O
and	O
benzene-contaminated	O
water	O
concentrations	O
up	O
to	O
76	O
PPB	O
for	O
MTBE	O
and	O
14	O
PPB	O
for	O
benzene	O
,	O
for	O
a	O
period	O
of	O
5	O
to	O
8	O
years	O
.	O

For	O
comparison	O
,	O
we	O
recruited	O
a	O
control	O
group	O
consisting	O
of	O
32	O
healthy	O
males	O
and	O
females	O
with	O
similar	O
age	O
distribution	O
and	O
without	B-NEGATION
a	I-NEGATION
history	I-NEGATION
of	I-NEGATION
exposure	I-NEGATION
to	I-NEGATION
MTBE	I-NEGATION
or	I-NEGATION
benzene	I-NEGATION
.	O

3.	O
Peripheral	O
blood	O
lymphocytes	O
(	O
PBL	O
)	O
of	O
both	O
groups	O
were	O
tested	O
for	O
the	O
percentage	O
of	O
apoptotic	O
cells	O
and	O
cell	O
cycle	O
progression	O
using	O
flow	O
cytometry	O
.	O

4.	O
When	O
apoptotic	O
lymphocytes	O
from	O
exposed	O
individuals	O
were	O
compared	O
to	O
apoptotic	O
lymphocytes	O
from	O
the	O
control	O
group	O
,	O
statistically-significant	O
differences	O
between	O
each	O
mean	O
group	O
were	O
detected	O
(	O
26.4	O
±	O
1.8	O
and	O
12.1	O
±	O
1.3	O
,	O
respectively	O
)	O
,	O
indicating	O
an	O
increased	O
rate	O
of	O
apoptosis	O
in	O
80.5	O
%	O
of	O
exposed	O
individuals	O
(	O
P	O
<	O
0.0001	O
,	O
Mann-Whitney	O
U-Test	O
)	O
.	O

MTBE	O
and	O
benzene-induced	O
apoptosis	O
is	O
attributed	O
to	O
a	O
discrete	O
block	O
within	O
the	O
cell	O
cycle	O
progression	O
.	O

Because	O
cell	O
cycle	O
analysis	O
showed	O
that	O
in	O
PBL	O
from	O
chemically-exposed	O
individuals	O
,	O
between	O
20-50	O
%	O
of	O
cells	O
were	O
accumulated	O
at	O
the	O
S-G2	O
/	O
M	O
boundaries	O
.	O

5.	O
One	O
of	O
the	O
signaling	O
molecules	O
which	O
mediates	O
programmed	O
cell	O
death	O
is	O
nuclear	O
factor	O
Kappa-B	O
(	O
NF-kappa	O
B	O
)	O
.	O

NF-kappa	O
B	O
was	O
examined	O
as	O
one	O
of	O
the	O
many	O
molecular	O
mechanisms	O
for	O
mediating	O
cell	O
death	O
by	O
MTBE	O
and	O
benzene	O
.	O

Indeed	O
,	O
addition	O
of	O
inhibitors	O
of	O
NF-kappa	O
B	O
activation	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
to	O
the	O
lymphocytes	O
of	O
the	O
chemically-exposed	O
group	O
was	O
capable	O
of	O
inhibiting	O
programmed	O
cell	O
death	O
by	O
40	O
%	O
.	O

This	O
reversal	O
of	O
apoptosis	O
almost	O
to	O
the	O
control	O
level	O
by	O
inhibitor	O
of	O
NF-kappa	O
B	O
activation	O
may	B-SPECULATION
indicate	B-SPECULATION
involvement	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
signaling	I-SPECULATION
molecule	I-SPECULATION
in	I-SPECULATION
MTBE	I-SPECULATION
and	I-SPECULATION
benzene	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
programmed	I-SPECULATION
cell	I-SPECULATION
death	I-SPECULATION
.	O

Activation	O
of	O
a	O
novel	O
gene	O
in	O
3q21	O
and	O
identification	O
of	O
intergenic	O
fusion	O
transcripts	O
with	O
ecotropic	O
viral	O
insertion	O
site	O
I	O
in	O
leukemia	O
.	O

We	O
have	O
identified	O
a	O
novel	O
gene	O
,	O
GR6	O
,	O
located	O
within	O
the	O
leukemia	O
breakpoint	O
region	O
of	O
3q21	O
,	O
that	O
is	O
normally	O
expressed	O
in	O
early	O
fetal	O
development	O
but	O
not	B-NEGATION
in	I-NEGATION
adult	I-NEGATION
peripheral	I-NEGATION
blood	I-NEGATION
.	O

GR6	O
is	O
activated	O
in	O
the	O
UCSD-AML1	O
cell	O
line	O
and	O
in	O
a	O
leukemic	O
sample	O
,	O
both	O
of	O
which	O
carry	O
a	O
t	O
(	O
3	O
;	O
3	O
)(	O
q21	O
;	O
q26	O
)	O
.	O

In	O
UCSD-AML1	O
,	O
we	O
have	O
also	O
identified	O
fusion	O
transcripts	O
between	O
the	O
ecotropic	O
viral	O
insertion	O
site	O
I	O
(	O
EVI1	O
)	O
gene	O
in	O
3q26	O
and	O
GR6	O
and	O
between	O
EVI1	O
and	O
Ribophorin	O
I	O
that	O
maps	O
30	O
kb	O
telomeric	O
to	O
GR6	O
in	O
3q21	O
.	O

All	O
fusions	O
splice	O
the	O
5	O
'	O
ends	O
of	O
the	O
3q21	O
genes	O
into	O
exon	O
2	O
of	O
the	O
EVI1	O
gene	O
,	O
an	O
event	O
that	O
is	O
similar	O
to	O
the	O
normal	O
intergenic	O
splicing	O
of	O
MDS1-EVI1	O
and	O
to	O
those	O
previously	O
documented	O
in	O
leukemias	O
with	O
t	O
(	O
3	O
;	O
21	O
)	O
and	O
t	O
(	O
3	O
;	O
12	O
)	O
,	O
in	O
which	O
acute	O
myelogenous	O
leukemia	O
1-EVI1	O
fusions	O
and	O
ETV6-EVI1	O
fusions	O
,	O
respectively	O
,	O
occur	O
.	O

The	O
Ribophorin	O
I-EVI1	O
fusion	O
in	O
particular	O
may	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
common	I-SPECULATION
occurrence	I-SPECULATION
in	I-SPECULATION
t	I-SPECULATION
(	I-SPECULATION
3	I-SPECULATION
;	I-SPECULATION
3	I-SPECULATION
)	I-SPECULATION
.	O

Alcohol-induced	O
regulation	O
of	O
nuclear	O
regulatory	O
factor-kappa	O
beta	O
in	O
human	O
monocytes	O
.	O

Acute	O
ethanol	O
exposure	O
has	O
the	O
capacity	O
to	O
modulate	O
immune	O
functions	O
,	O
particularly	O
,	O
to	O
down	O
regulate	O
monocyte	O
production	O
of	O
inflammatory	O
cytokines	O
.	O

However	O
,	O
the	B-SPECULATION
intracellular	I-SPECULATION
mechanisms	I-SPECULATION
for	I-SPECULATION
these	I-SPECULATION
effects	I-SPECULATION
of	I-SPECULATION
ethanol	I-SPECULATION
are	I-SPECULATION
yet	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
understood	I-SPECULATION
.	O

Considering	O
that	O
nuclear	O
regulatory	O
factor-kappa	O
beta	O
(	O
NF-kappa	O
B	O
)/	O
Rel	O
is	O
a	O
common	O
regulatory	O
element	O
of	O
the	O
promoter	O
region	O
of	O
the	O
inflammatory	O
cytokine	O
genes	O
,	O
herein	O
,	O
we	O
tested	O
the	O
hypothesis	B-SPECULATION
that	I-SPECULATION
acute	I-SPECULATION
ethanol	I-SPECULATION
affects	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
activation	I-SPECULATION
in	I-SPECULATION
human	I-SPECULATION
monocytes	I-SPECULATION
.	O

Adherence-isolated	O
monocytes	O
showed	O
constitutive	O
DNA	O
binding	O
activity	O
of	O
NF-kappa	O
B	O
.	O

A	O
clinically	O
relevant	O
dose	O
(	O
25	O
mM	O
)	O
of	O
acute	O
ethanol	O
treatment	O
in	O
vitro	O
increased	O
NF-kappa	O
B	O
binding	O
activity	O
in	O
monocytes	O
with	O
a	O
preferential	O
induction	O
of	O
the	O
inhibitory	O
,	O
p50	O
/	O
p50	O
,	O
NF-kappa	O
B	O
/	O
Rel	O
homodimer	O
,	O
and	O
resulted	O
in	O
no	B-NEGATION
induction	I-NEGATION
of	I-NEGATION
the	I-NEGATION
p65	I-NEGATION
/	I-NEGATION
p50	I-NEGATION
heterodimer	I-NEGATION
.	O

In	O
contrast	O
,	O
lipopolysaccharide	O
stimulation	O
primarily	O
induced	O
the	O
p65	O
/	O
p50	O
heterodimer	O
that	O
has	O
been	O
shown	O
to	O
result	O
in	O
gene	O
activation	O
.	O

Thus	O
,	O
such	O
unique	O
activation	O
of	O
the	O
inhibitory	O
p50	O
/	O
p50	O
homodimer	O
by	O
acute	O
ethanol	O
treatment	O
may	B-SPECULATION
result	I-SPECULATION
in	I-SPECULATION
inhibition	I-SPECULATION
rather	B-NEGATION
than	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
NF-kappa	I-NEGATION
B-regulated	I-NEGATION
inflammatory	I-NEGATION
cytokine	I-NEGATION
genes	I-NEGATION
.	O

Consequently	O
,	O
these	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
physiologically	I-SPECULATION
relevant	I-SPECULATION
concentrations	I-SPECULATION
of	I-SPECULATION
ethanol	I-SPECULATION
may	B-SPECULATION
affect	I-SPECULATION
production	I-SPECULATION
of	I-SPECULATION
inflammatory	I-SPECULATION
cytokines	I-SPECULATION
,	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
tumor	I-SPECULATION
necrosis	I-SPECULATION
factor-alpha	I-SPECULATION
,	I-SPECULATION
interleukin-1	I-SPECULATION
beta	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
interleukin-6	I-SPECULATION
by	I-SPECULATION
disrupting	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
signaling	I-SPECULATION
in	I-SPECULATION
monocytes	I-SPECULATION
.	O

Four	O
P-like	O
elements	O
are	O
required	O
for	O
optimal	O
transcription	O
of	O
the	O
mouse	O
IL-4	O
gene	O
:	O
involvement	O
of	O
a	O
distinct	O
set	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
and	O
activator	O
protein-1	O
family	O
proteins	O
.	O

We	O
previously	O
identified	O
the	O
P	O
sequence	O
as	O
a	O
critical	O
regulatory	O
element	O
of	O
the	O
human	O
IL-4	O
promoter	O
.	O

In	O
the	O
mouse	O
IL-4	O
promoter	O
,	O
there	O
are	O
five	O
elements	O
homologous	O
to	O
the	O
human	O
P	O
sequence	O
designated	O
conserved	O
lymphokine	O
element	O
0	O
(	O
CLE0	O
)	O
,	O
P	O
,	O
P2	O
,	O
P3	O
and	O
P4	O
.	O

To	O
characterize	O
the	O
role	O
of	O
these	O
P-like	O
elements	O
and	O
their	O
binding	O
factors	O
in	O
the	O
native	O
promoter	O
,	O
we	O
did	O
transient	O
transfection	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
.	O

Transfection	O
of	O
EL-4	O
cells	O
with	O
the	O
IL-4	O
promoter-reporter	O
constructs	O
carrying	O
mutated	O
P-like	O
elements	O
showed	O
that	O
four	O
P-like	O
elements	O
,	O
CLE0	O
,	O
P	O
,	O
P2	O
and	O
P4	O
,	O
but	O
not	B-NEGATION
P3	I-NEGATION
,	O
were	O
required	O
for	O
optimal	O
activation	O
of	O
the	O
IL-4	O
promoter	O
.	O

EMSA	O
showed	O
that	O
both	O
constitutive	O
and	O
inducible	O
complexes	O
bound	O
to	O
CLE0	O
,	O
P	O
,	O
P2	O
and	O
P4	O
,	O
whereas	O
only	O
a	O
constitutive	O
complex	O
bound	O
to	O
P3	O
.	O

In	O
competition	O
and	O
antibody	O
supershift	O
assays	O
in	O
EMSA	O
,	O
complexes	O
formed	O
with	O
P	O
or	O
P2	O
proved	O
to	O
contain	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
family	O
proteins	O
as	O
major	O
components	O
.	O

Activator	O
protein	O
(	O
AP	O
)-	O
1	O
family	O
proteins	O
interacted	O
with	O
CLE0	O
,	O
P	O
,	O
P2	O
and	O
P4	O
.	O

NFAT	O
/	O
AP-1	O
complex	O
formed	O
only	O
with	O
P	O
and	O
P2	O
.	O

Cross-competition	O
assays	O
among	O
the	O
P-like	O
elements	O
revealed	O
element-specific	O
and	O
common	O
complexes	O
.	O

Six	O
tandem	O
repeats	O
of	O
the	O
P	O
element	O
linked	O
to	O
the	O
SV40	O
promoter	O
responded	O
to	O
phorbol	O
12-myristate	O
13-acetate	O
,	O
while	O
that	O
of	O
other	O
elements	O
did	O
not	B-NEGATION
.	O

It	O
would	B-SPECULATION
thus	I-SPECULATION
appear	B-SPECULATION
that	I-SPECULATION
components	I-SPECULATION
of	I-SPECULATION
each	I-SPECULATION
P-like	I-SPECULATION
element-binding	I-SPECULATION
complexes	I-SPECULATION
are	I-SPECULATION
not	B-NEGATION
identical	I-NEGATION
and	O
may	B-SPECULATION
coordinately	I-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
transcriptional	I-SPECULATION
activity	I-SPECULATION
.	O

The	O
ability	O
of	O
BHRF1	O
to	O
inhibit	O
apoptosis	O
is	O
dependent	O
on	O
stimulus	O
and	O
cell	O
type	O
.	O

The	O
development	O
of	O
resistance	O
to	O
host	O
defense	O
mechanisms	O
such	O
as	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
and	O
Fas-mediated	O
apoptosis	O
of	O
transformed	O
or	O
virus-infected	O
cells	O
may	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
critical	I-SPECULATION
component	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
development	I-SPECULATION
of	I-SPECULATION
disease	I-SPECULATION
.	O

To	O
find	O
genes	O
that	O
protect	O
cells	O
from	O
apoptosis	O
,	O
we	O
used	O
an	O
expression	O
cloning	O
strategy	O
and	O
identified	O
BHRF1	O
,	O
an	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
early-lytic-cycle	O
protein	O
with	O
distant	O
homology	O
to	O
Bcl-2	O
,	O
as	O
an	O
anti-apoptosis	O
protein	O
.	O

Expression	O
of	O
BHRF1	O
in	O
MCF-Fas	O
cells	O
conferred	O
nearly	O
complete	O
resistance	O
against	O
both	O
anti-Fas	O
antibody	O
and	O
TNF-mediated	O
apoptosis	O
.	O

In	O
addition	O
,	O
BHRF1	O
protected	O
these	O
cells	O
from	O
monocyte-mediated	O
killing	O
but	O
failed	B-NEGATION
to	I-NEGATION
protect	I-NEGATION
them	I-NEGATION
from	I-NEGATION
killing	I-NEGATION
mediated	I-NEGATION
by	I-NEGATION
lymphokine-activated	I-NEGATION
killer	I-NEGATION
cells	I-NEGATION
.	O

The	O
ability	O
of	O
BHRF1	O
to	O
protect	O
MCF-Fas	O
cells	O
from	O
apoptosis	O
induced	O
by	O
various	O
stimuli	O
was	O
identical	O
to	O
that	O
of	O
Bcl-2	O
and	O
Bcl-xL	O
.	O

Moreover	O
,	O
the	O
mechanism	O
of	O
action	O
of	O
BHRF1	O
resembled	O
that	O
of	O
Bcl-2	O
and	O
Bcl-xL	O
as	O
it	O
inhibited	O
TNF	O
-	O
and	O
anti-Fas-induced	O
activation	O
of	O
two	O
enzymes	O
participating	O
in	O
the	O
apoptosis	O
pathway	O
,	O
cytosolic	O
phospholipase	O
A2	O
and	O
caspase-3	O
/	O
CPP32	O
,	O
but	O
did	O
not	B-NEGATION
interfere	I-NEGATION
with	I-NEGATION
the	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
NF-kappaB-like	I-NEGATION
transcription	I-NEGATION
factors	I-NEGATION
.	O

A	O
putative	B-SPECULATION
function	I-SPECULATION
of	I-SPECULATION
BHRF1	I-SPECULATION
in	I-SPECULATION
EBV-infected	I-SPECULATION
epithelial	I-SPECULATION
cells	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
to	I-SPECULATION
protect	I-SPECULATION
virus-infected	I-SPECULATION
cells	I-SPECULATION
from	I-SPECULATION
TNF	I-SPECULATION
-	I-SPECULATION
and	I-SPECULATION
/	I-SPECULATION
or	I-SPECULATION
anti-Fas	I-SPECULATION
-	I-SPECULATION
induced	I-SPECULATION
cell	I-SPECULATION
death	I-SPECULATION
in	I-SPECULATION
order	I-SPECULATION
to	I-SPECULATION
maximize	I-SPECULATION
virus	I-SPECULATION
production	I-SPECULATION
.	O

Surprisingly	O
,	O
expression	O
of	O
neither	B-NEGATION
BHRF1	I-NEGATION
even	O
though	O
they	O
increased	O
the	O
survival	O
of	O
serum-starved	O
cells	O
.	O

Thus	O
,	O
the	O
protective	O
role	O
of	O
BHRF1	O
against	O
apoptosis	O
resembles	O
that	O
of	O
Bcl-2	O
in	O
being	O
cell	O
type	O
specific	O
and	O
dependent	O
on	O
the	O
apoptotic	O
stimulus	O
.	O

NF-AT	O
activation	O
induced	O
by	O
a	O
CAML-interacting	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
superfamily	O
.	O

Activation	O
of	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
transcription	O
factor	O
(	O
NF-AT	O
)	O
is	O
a	O
key	O
event	O
underlying	O
lymphocyte	O
action	O
.	O

The	O
CAML	O
(	O
calcium-modulator	O
and	O
cyclophilin	O
ligand	O
)	O
protein	O
is	O
a	O
coinducer	O
of	O
NF-AT	O
activation	O
when	O
overexpressed	O
in	O
Jurkat	O
T	O
cells	O
.	O

A	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
superfamily	O
was	O
isolated	O
by	O
virtue	O
of	O
its	O
affinity	O
for	O
CAML	O
.	O

Cross-linking	O
of	O
this	O
lymphocyte-specific	O
protein	O
,	O
designated	O
TACI	O
(	O
transmembrane	O
activator	O
and	O
CAML-interactor	O
)	O
,	O
on	O
the	O
surface	O
of	O
transfected	O
Jurkat	O
cells	O
with	O
TACI-specific	O
antibodies	O
led	O
to	O
activation	O
of	O
the	O
transcription	O
factors	O
NF-AT	O
,	O
AP-1	O
,	O
and	O
NFkappaB	O
.	O

TACI-induced	O
activation	O
of	O
NF-AT	O
was	O
specifically	O
blocked	O
by	O
a	O
dominant-negative	O
CAML	O
mutant	O
,	O
thus	O
implicating	O
CAML	O
as	O
a	O
signaling	O
intermediate	O
.	O

The	O
DNA	O
binding	O
domain	O
of	O
the	O
A-MYB	O
transcription	O
factor	O
is	O
responsible	O
for	O
its	O
B	O
cell-specific	O
activity	O
and	O
binds	O
to	O
a	O
B	O
cell	O
110-kDa	O
nuclear	O
protein	O
.	O

Expression	O
studies	O
as	O
well	O
as	O
the	O
use	O
of	O
transgenic	O
animals	O
have	O
demonstrated	O
that	O
the	O
A-MYB	O
transcription	O
factor	O
plays	O
central	O
and	O
specific	O
role	O
in	O
the	O
regulation	O
of	O
mature	O
B	O
cell	O
proliferation	O
and	O
/	O
or	O
differentiation	O
.	O

Furthermore	O
,	O
it	O
is	O
highly	O
expressed	O
in	O
Burkitt's	O
lymphoma	O
cells	O
and	O
may	B-SPECULATION
participate	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
pathogenesis	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
disease	I-SPECULATION
.	O

We	O
have	O
therefore	O
investigated	O
the	O
transcriptional	O
activity	O
of	O
A-MYB	O
and	O
its	O
regulation	O
in	O
several	O
human	O
lymphoid	O
cell	O
lines	O
using	O
co-transfection	O
assays	O
and	O
show	O
that	O
A-MYB	O
is	O
transcriptionally	O
active	O
in	O
all	O
the	O
B	O
cell	O
lines	O
studied	O
,	O
but	O
not	B-NEGATION
in	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
.	O

In	O
particular	O
the	O
best	O
responder	O
cell	O
line	O
was	O
the	O
Burkitt's	O
cell	O
line	O
Namalwa	O
.	O

The	O
activity	O
of	O
A-MYB	O
in	O
B	O
and	O
not	B-NEGATION
T	I-NEGATION
cells	I-NEGATION
was	O
observed	O
when	O
either	O
an	O
artificial	O
construct	O
or	O
the	O
c-MYC	O
promoter	O
was	O
used	O
as	O
a	O
reporter	O
.	O

Furthermore	O
,	O
the	O
functional	O
domains	O
responsible	O
for	O
DNA	O
binding	O
,	O
transactivation	O
,	O
and	O
negative	O
regulation	O
,	O
previously	O
characterized	O
in	O
a	O
fibroblast	O
context	O
,	O
were	O
found	O
to	O
have	O
similar	O
activity	O
in	O
B	O
cells	O
.	O

The	O
region	O
of	O
A-MYB	O
responsible	O
for	O
the	O
B	O
cell	O
specific	O
activity	O
was	O
defined	O
to	O
be	O
the	O
N-terminal	O
218	O
amino	O
acids	O
containing	O
the	O
DNA	O
binding	O
domain	O
.	O

Finally	O
,	O
a	O
110-kDa	O
protein	O
has	O
been	O
identified	O
in	O
the	O
nuclei	O
of	O
all	O
the	O
B	O
,	O
but	O
not	B-NEGATION
T	I-NEGATION
,	O
cell	O
lines	O
that	O
specifically	O
binds	O
to	O
this	O
A-MYB	O
N-terminal	O
domain	O
.	O

We	O
hypothesize	B-SPECULATION
that	I-SPECULATION
this	I-SPECULATION
110-kDa	I-SPECULATION
protein	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
functionally	I-SPECULATION
important	I-SPECULATION
B	I-SPECULATION
cell-specific	I-SPECULATION
co-activator	I-SPECULATION
of	I-SPECULATION
A-MYB	I-SPECULATION
.	O

Evidence	O
that	O
calcineurin	O
is	O
rate-limiting	O
for	O
primary	O
human	O
lymphocyte	O
activation	O
.	O

Cyclosporine	O
(	O
CsA	O
)	O
is	O
both	O
a	O
clinical	O
immunosuppressive	O
drug	O
and	O
a	O
probe	O
to	O
dissect	O
intracellular	O
signaling	O
pathways	O
.	O

In	O
vitro	O
,	O
CsA	O
inhibits	O
lymphocyte	O
gene	O
activation	O
by	O
inhibiting	O
the	O
phosphatase	O
activity	O
of	O
calcineurin	O
(	O
CN	O
)	O
.	O

In	O
clinical	O
use	O
,	O
CsA	O
treatment	O
inhibits	O
50-75	O
%	O
of	O
CN	O
activity	O
in	O
circulating	O
leukocytes	O
.	O

We	O
modeled	O
this	O
degree	O
of	O
CN	O
inhibition	O
in	O
primary	O
human	O
leukocytes	O
in	O
vitro	O
in	O
order	O
to	O
study	O
the	O
effect	O
of	O
partial	O
CN	O
inhibition	O
on	O
the	O
downstream	O
signaling	O
events	O
that	O
lead	O
to	O
gene	O
activation	O
.	O

In	O
CsA-treated	O
leukocytes	O
stimulated	O
by	O
calcium	O
ionophore	O
,	O
the	O
degree	O
of	O
reduction	O
in	O
CN	O
activity	O
was	O
accompanied	O
by	O
a	O
similar	O
degree	O
of	O
inhibition	O
of	O
each	O
event	O
tested	O
:	O
dephosphorylation	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cell	O
proteins	O
,	O
nuclear	O
DNA	O
binding	O
,	O
activation	O
of	O
a	O
transfected	O
reporter	O
gene	O
construct	O
,	O
IFN-gamma	O
and	O
IL-2	O
mRNA	O
accumulation	O
,	O
and	O
IFN-gamma	O
production	O
.	O

Furthermore	O
,	O
the	O
degree	O
of	O
CN	O
inhibition	O
was	O
reflected	O
by	O
a	O
similar	O
degree	O
of	O
reduction	O
in	O
lymphocyte	O
proliferation	O
and	O
IFN-gamma	O
production	O
in	O
the	O
allogeneic	O
mixed	O
lymphocyte	O
cultures	O
.	O

These	O
data	O
support	O
the	O
conclusion	O
that	O
CN	O
activity	O
is	O
rate-limiting	O
for	O
the	O
activation	O
of	O
primary	O
human	O
T	O
lymphocytes	O
.	O

Thus	O
,	O
the	O
reduction	O
of	O
CN	O
activity	O
observed	O
in	O
CsA-treated	O
patients	O
is	O
accompanied	O
by	O
a	O
similar	O
degree	O
of	O
reduction	O
in	O
lymphocyte	O
gene	O
activation	O
,	O
and	O
accounts	O
for	O
the	O
immunosuppression	O
observed	O
.	O

Cooperation	O
of	O
binding	O
sites	O
for	O
STAT6	O
and	O
NF	O
kappa	O
B	O
/	O
rel	O
in	O
the	O
IL-4-induced	O
up-regulation	O
of	O
the	O
human	O
IgE	O
germline	O
promoter	O
.	O

Ig	O
heavy	O
chain	O
class	O
switching	O
is	O
directed	O
by	O
cytokines	O
inducing	O
transcription	O
from	O
unrearranged	O
CH	O
genes	O
.	O

Subsequently	O
,	O
such	O
primed	O
cells	O
can	O
undergo	O
switch	O
recombination	O
to	O
express	O
the	O
selected	O
new	O
isotype	O
.	O

In	O
the	O
case	O
of	O
IgE	O
class	O
switching	O
,	O
IL-4	O
activates	O
the	O
IgE	O
germline	O
promoter	O
by	O
inducing	O
the	O
interaction	O
of	O
the	O
transcription	O
factor	O
STAT6	O
(	O
IL-4STAT	O
)	O
with	O
a	O
responsive	O
DNA	O
element	O
in	O
the	O
proximal	O
region	O
of	O
the	O
promoter	O
.	O

This	O
study	O
describes	O
the	O
characterization	O
of	O
two	O
additional	O
cis-acting	O
elements	O
that	O
interact	O
with	O
members	O
of	O
the	O
NF	O
kappa	O
B	O
/	O
rel	O
transcription	O
factor	O
family	O
in	O
an	O
IL-4-independent	O
fashion	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
show	O
that	O
the	O
nucleoprotein	O
complex	O
formed	O
on	O
the	O
upstream	O
site	O
(	O
NF	O
kappa	O
B1	O
)	O
contains	O
the	O
classical	O
p50	O
/	O
p65	O
heterodimer	O
.	O

The	B-SPECULATION
complex	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
proximal	I-SPECULATION
site	I-SPECULATION
(	I-SPECULATION
NF	I-SPECULATION
kappa	I-SPECULATION
B2	I-SPECULATION
)	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
composed	I-SPECULATION
of	I-SPECULATION
p50	I-SPECULATION
and	I-SPECULATION
relB	I-SPECULATION
.	O

IgE	O
germline	O
promoter	O
reporter	O
gene	O
constructs	O
carrying	O
point	O
mutations	O
in	O
the	O
NF	O
kappa	O
B2	O
site	O
were	O
largely	O
unresponsive	O
to	O
IL-4	O
stimulation	O
in	O
transient	O
transfection	O
experiments	O
,	O
while	O
plasmids	O
with	O
similar	O
mutations	O
in	O
the	O
NF	O
kappa	O
B1	O
site	O
responded	O
to	O
cytokine	O
stimulation	O
better	O
than	O
the	O
wild-type	O
promoter	O
.	O

The	O
NF	O
kappa	O
B2	O
effect	O
was	O
dependent	O
on	O
the	O
presence	O
of	O
the	O
STAT6	O
binding	O
site	O
,	O
demonstrating	O
that	O
the	O
NF	O
kappa	O
B2	O
motif	O
is	O
necessary	O
but	O
not	B-NEGATION
sufficient	I-NEGATION
for	I-NEGATION
mediating	I-NEGATION
cytokine	I-NEGATION
up-regulation	I-NEGATION
.	O

In	O
addition	O
,	O
the	O
combination	O
of	O
a	O
NF	O
kappa	O
B	O
/	O
rel	O
binding	O
site	O
and	O
the	O
STAT6	O
response	O
element	O
conferred	O
IL-4	O
inducibility	O
to	O
a	O
heterologous	O
minimal	O
promoter	O
,	O
while	O
the	O
individual	O
sites	O
had	O
no	B-NEGATION
effect	I-NEGATION
.	O

The	O
available	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
NF	I-SPECULATION
kappa	I-SPECULATION
B2	I-SPECULATION
nucleoprotein	I-SPECULATION
complex	I-SPECULATION
may	B-SPECULATION
cooperate	I-SPECULATION
with	I-SPECULATION
DNA-bound	I-SPECULATION
STAT6	I-SPECULATION
to	I-SPECULATION
achieve	I-SPECULATION
IL-4-dependent	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
human	I-SPECULATION
IgE	I-SPECULATION
germline	I-SPECULATION
gene	I-SPECULATION
.	O

Dual	O
effects	O
of	O
LPS	O
antibodies	O
on	O
cellular	O
uptake	O
of	O
LPS	O
and	O
LPS-induced	O
proinflammatory	O
functions	O
.	O

Human	O
phagocytes	O
recognize	O
bacterial	O
LPS	O
(	O
endotoxin	O
)	O
through	O
membrane	O
CD14	O
(	O
mCD14	O
)	O
,	O
a	O
proinflammatory	O
LPS	O
receptor	O
.	O

This	O
study	O
tested	O
the	O
hypothesis	B-SPECULATION
that	I-SPECULATION
anti-LPS	I-SPECULATION
Abs	I-SPECULATION
neutralize	I-SPECULATION
endotoxin	I-SPECULATION
by	I-SPECULATION
blocking	I-SPECULATION
cellular	I-SPECULATION
uptake	I-SPECULATION
through	I-SPECULATION
mCD14	I-SPECULATION
.	O

Ab-associated	O
changes	O
in	O
the	O
uptake	O
and	O
cellular	O
distribution	O
of	O
FITC-LPS	O
were	O
assessed	O
by	O
flow	O
cytometry	O
and	O
laser	O
scanning	O
confocal	O
microscopy	O
in	O
human	O
CD14-transfected	O
Chinese	O
hamster	O
ovary	O
fibroblasts	O
(	O
CHO-CD14	O
cells	O
)	O
and	O
human	O
peripheral	O
blood	O
monocytes	O
.	O

LPS	O
core	O
-	O
and	O
O-side	O
chain-specific	O
mAbs	O
inhibited	O
mCD14-mediated	O
LPS	O
uptake	O
by	O
both	O
cell	O
types	O
in	O
the	O
presence	O
of	O
serum	O
.	O

O-side	O
chain-specific	O
mAb	O
concurrently	O
enhanced	O
complement-dependent	O
LPS	O
uptake	O
by	O
monocytes	O
through	O
complement	O
receptor-1	O
(	O
CR1	O
)	O
and	O
uptake	O
by	O
CHO-CD14	O
cells	O
involving	O
another	O
heat-labile	O
serum	O
factor	O
(	O
s	O
)	O
and	O
cell-associated	O
recognition	O
molecule	O
(	O
s	O
)	O
.	O

Core-specific	O
mAb	O
inhibited	O
mCD14-mediated	O
uptake	O
of	O
homologous	O
and	O
heterologous	O
LPS	O
,	O
while	O
producing	O
less	O
concurrent	O
enhancement	O
of	O
non-mCD14-mediated	O
LPS	O
uptake	O
.	O

The	O
modulation	O
by	O
anti-LPS	O
mAbs	O
of	O
mCD14-mediated	O
LPS	O
uptake	O
was	O
associated	O
with	O
inhibition	O
of	O
LPS-induced	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
translocation	O
and	O
TNF-alpha	O
secretion	O
in	O
CHO-CD14	O
cells	O
and	O
monocytes	O
,	O
respectively	O
,	O
while	O
mAb	O
enhancement	O
of	O
non-mCD14-mediated	O
LPS	O
uptake	O
stimulated	O
these	O
activities	O
.	O

LPS-specific	O
Abs	O
thus	O
mediate	O
anti-inflammatory	O
and	O
proinflammatory	O
functions	O
,	O
respectively	O
,	O
by	O
preventing	O
target	O
cell	O
uptake	O
of	O
LPS	O
through	O
mCD14	O
and	O
augmenting	O
uptake	O
through	O
CR1	O
or	O
other	O
cell	O
receptors	O
.	O

Human	O
neutrophils	O
express	O
GH-N	O
gene	O
transcripts	O
and	O
the	O
pituitary	O
transcription	O
factor	O
Pit-1b	O
.	O

Since	O
GH	O
stimulates	O
the	O
development	O
and	O
function	O
of	O
granulocytes	O
,	O
we	O
investigated	O
the	O
expression	O
of	O
GH	O
in	O
granulocyte	O
subsets	O
.	O

By	O
immunocytochemistry	O
,	O
25	O
±	O
7	O
%	O
of	O
the	O
human	O
neutrophils	O
were	O
shown	O
to	O
express	O
immunoreactive	O
GH	O
,	O
whereas	O
eosinophils	O
were	O
negative	O
.	O

Reversed	O
transcription	O
(	O
RT	O
)-	O
PCR	O
analysis	O
demonstrated	O
GH	O
mRNA	O
in	O
neutrophils	O
.	O

Restriction	O
analysis	O
revealed	O
that	O
neutrophils	O
express	O
the	O
GH-N	O
gene	O
but	O
not	B-NEGATION
the	I-NEGATION
GH-V	I-NEGATION
gene	I-NEGATION
.	O

Furthermore	O
,	O
we	O
demonstrated	O
by	O
western	O
blot	O
analysis	O
that	O
neutrophils	O
express	O
an	O
alternatively	O
spliced	O
variant	O
of	O
the	O
pituitary	O
transcription	O
factor	O
Pit-1	O
,	O
designated	O
Pit-1b	O
.	O

Interleukin-7	O
upregulates	O
the	O
interleukin-2-gene	O
expression	O
in	O
activated	O
human	O
T	O
lymphocytes	O
at	O
the	O
transcriptional	O
level	O
by	O
enhancing	O
the	O
DNA	O
binding	O
activities	O
of	O
both	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
and	O
activator	O
protein-1	O
.	O

In	O
the	O
present	O
report	O
,	O
we	O
studied	O
the	O
role	O
of	O
the	O
stromal-derived	O
cytokine	O
interleukin-7	O
(	O
IL-7	O
)	O
in	O
the	O
IL-2-gene	O
regulation	O
in	O
activated	O
T	O
lymphocytes	O
.	O

Production	O
of	O
IL-2	O
requires	O
the	O
formation	O
of	O
transcription	O
factors	O
involved	O
in	O
the	O
IL-2-gene	O
regulation	O
.	O

T-cell	O
receptor	O
(	O
TCR	O
)/	O
CD3	O
engagement	O
results	O
in	O
the	O
activation	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
,	O
activator	O
protein-1	O
(	O
AP-1	O
)	O
,	O
and	O
nuclear	O
factor	O
kappaB	O
(	O
NFkappaB	O
)	O
,	O
whereas	O
the	O
CD28	O
responsive	O
complex	O
(	O
CD28RC	O
)	O
is	O
activated	O
in	O
response	O
to	O
the	O
CD28	O
signal	O
.	O

Costimulation	O
of	O
phytohemagglutinin	O
/	O
anti-CD28	O
activated	O
T	O
lymphocytes	O
with	O
IL-7	O
induces	O
a	O
fivefold	O
enhanced	O
IL-2-mRNA	O
accumulation	O
and	O
a	O
2.5-fold	O
enhanced	O
protein	O
secretion	O
.	O

The	O
IL-2-gene	O
transcription	O
rate	O
is	O
increased	O
3.4-fold	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
effect	I-SPECULATION
of	I-SPECULATION
IL-7	I-SPECULATION
is	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
mediated	I-SPECULATION
at	I-SPECULATION
the	I-SPECULATION
transcriptional	I-SPECULATION
level	I-SPECULATION
.	O

The	O
molecular	O
mechanisms	O
underlying	O
the	O
IL-7	O
effect	O
involve	O
the	O
upregulation	O
of	O
the	O
DNA	O
binding	O
activity	O
of	O
NFAT	O
(	O
60	O
%)	O
and	O
AP-1	O
(	O
120	O
%)	O
,	O
without	B-NEGATION
affecting	I-NEGATION
the	I-NEGATION
activities	I-NEGATION
of	I-NEGATION
NFkappaB	I-NEGATION
and	I-NEGATION
CD28RC	I-NEGATION
,	O
which	O
was	O
confirmed	O
by	O
transfection	O
assays	O
.	O

We	O
also	O
show	O
that	O
the	O
IL-7-induced	O
enhancement	O
of	O
the	O
AP-1-DNA	O
binding	O
activity	O
is	O
not	B-NEGATION
cyclosporin	I-NEGATION
A-sensitive	I-NEGATION
.	O

Since	O
AP-1	O
is	O
part	O
of	O
the	O
NFAT	O
complex	O
,	O
we	O
conclude	O
that	O
the	O
IL-7-signaling	O
pathway	O
is	O
involved	O
in	O
the	O
activation	O
of	O
the	O
fos	O
and	O
jun	O
proteins	O
of	O
which	O
AP-1	O
consists	O
.	O

Analysis	O
of	O
myeloid-associated	O
genes	O
in	O
human	O
hematopoietic	O
progenitor	O
cells	O
.	O

The	O
distribution	O
of	O
myeloid	O
lineage-associated	O
cytokine	O
receptors	O
and	O
lysosomal	O
proteins	O
was	O
analyzed	O
in	O
human	O
CD34	O
+	O
cord	O
blood	O
cell	O
(	O
CB	O
)	O
subsets	O
at	O
different	O
stages	O
of	O
myeloid	O
commitment	O
by	O
reverse-transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
.	O

The	O
highly	O
specific	O
granulomonocyte-associated	O
lysosomal	O
proteins	O
myeloperoxidase	O
(	O
MPO	O
)	O
and	O
lysozyme	O
(	O
LZ	O
)	O
,	O
as	O
well	O
as	O
the	O
transcription	O
factor	O
PU.1	O
,	O
were	O
already	O
detectable	O
in	O
the	O
most	O
immature	O
CD34	O
+	O
Thy-1	O
+	O
subset	O
.	O

Messenger	O
RNA	O
(	O
mRNA	O
)	O
levels	O
for	O
the	O
granulocyte-colony	O
stimulating	O
factor	O
(	O
G-CSF	O
)	O
receptor	O
,	O
granulocyte-macrophage	O
(	O
GM	O
)-	O
CSF	O
receptor	O
alpha	O
subunit	O
and	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
receptors	O
I	O
(	O
p55	O
)	O
and	O
II	O
(	O
p75	O
)	O
were	O
also	O
detected	O
in	O
this	O
subset	O
in	O
addition	O
to	O
c-kit	O
and	O
flt-3	O
,	O
receptors	O
known	O
to	O
be	O
expressed	O
on	O
progenitor	O
cells	O
.	O

By	O
contrast	O
,	O
the	B-NEGATION
monocyte-macrophage	I-NEGATION
colony	I-NEGATION
stimulating	I-NEGATION
factor	I-NEGATION
(	I-NEGATION
M-CSF	I-NEGATION
)	I-NEGATION
receptor	I-NEGATION
was	I-NEGATION
largely	I-NEGATION
absent	I-NEGATION
at	I-NEGATION
this	I-NEGATION
stage	I-NEGATION
and	I-NEGATION
in	I-NEGATION
the	I-NEGATION
CD34	I-NEGATION
+	I-NEGATION
Thy-1-CD45RA	I-NEGATION
-	I-NEGATION
subsets	I-NEGATION
.	O

The	O
M-CSF	O
receptor	O
was	O
first	O
detectable	O
in	O
the	O
myeloid-committed	O
CD34	O
+	O
Thy-l-CD45RA	O
+	O
subset	O
.	O

All	O
other	O
molecules	O
studied	O
were	O
found	O
to	O
be	O
expressed	O
at	O
this	O
stage	O
of	O
differentiation	O
.	O

Different	O
cocktails	O
of	O
the	O
identified	O
ligands	O
were	O
added	O
to	O
sorted	O
CD34	O
+	O
Thy-1	O
+	O
single	O
cells	O
.	O

Low	O
proliferative	O
capacity	O
was	O
observed	O
after	O
1	O
week	O
in	O
culture	O
in	O
the	O
presence	O
of	O
stem	O
cell	O
factor	O
(	O
SCF	O
)	O
+	O
Flt-3	O
ligand	O
(	O
FL	O
)	O
+	O
G-CSF	O
.	O

Addition	O
of	O
GM-CSF	O
to	O
this	O
basic	O
cocktail	O
consistently	O
increased	O
the	O
clonogenic	O
capacity	O
of	O
single	O
CD34	O
+	O
Thy-1	O
+	O
cells	O
,	O
and	O
this	O
effect	O
was	O
further	O
enhanced	O
(	O
up	O
to	O
72.3	O
±	O
4.3	O
%	O
on	O
day	O
7	O
)	O
by	O
the	O
inclusion	O
of	O
TNF-alpha	O
.	O

In	O
conclusion	O
,	O
the	O
presence	O
of	O
myeloid-associated	O
growth	O
factor	O
receptor	O
transcripts	O
in	O
CD34	O
+	O
CB	O
subsets	O
does	O
not	B-NEGATION
discriminate	I-NEGATION
the	I-NEGATION
various	I-NEGATION
stages	I-NEGATION
of	I-NEGATION
differentiation	I-NEGATION
,	I-NEGATION
with	B-NEGATION
the	I-NEGATION
exception	I-NEGATION
of	I-NEGATION
the	I-NEGATION
M-CSF	I-NEGATION
receptor	I-NEGATION
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
TNF-alpha	O
is	O
a	O
potent	O
costimulatory	O
factor	O
of	O
the	O
very	O
immature	O
CD34	O
+	O
Thy-1	O
+	O
CB	O
subset	O
.	O

Monochloramine	O
inhibits	O
phorbol	O
ester-inducible	O
neutrophil	O
respiratory	O
burst	O
activation	O
and	O
T	O
cell	O
interleukin-2	O
receptor	O
expression	O
by	O
inhibiting	O
inducible	O
protein	O
kinase	O
C	O
activity	O
.	O

Monochloramine	O
derivatives	O
are	O
long	O
lived	O
physiological	O
oxidants	O
produced	O
by	O
neutrophils	O
during	O
the	O
respiratory	O
burst	O
.	O

The	O
effects	O
of	O
chemically	O
prepared	O
monochloramine	O
(	O
NH2Cl	O
)	O
on	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
and	O
PKC-mediated	O
cellular	O
responses	O
were	O
studied	O
in	O
elicited	O
rat	O
peritoneal	O
neutrophils	O
and	O
human	O
Jurkat	O
T	O
cells	O
.	O

Neutrophils	O
pretreated	O
with	O
NH2Cl	O
(	O
30-50	O
microM	O
)	O
showed	O
a	O
marked	O
decrease	O
in	O
the	O
respiratory	O
burst	O
activity	O
induced	O
by	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
,	O
which	O
is	O
a	O
potent	O
PKC	O
activator	O
.	O

These	O
cells	O
,	O
however	O
,	O
were	O
viable	O
and	O
showed	O
a	O
complete	O
respiratory	O
burst	O
upon	O
arachidonic	O
acid	O
stimulation	O
,	O
which	O
induces	O
the	O
respiratory	O
burst	O
by	O
a	O
PKC-independent	O
mechanism	O
.	O

The	O
NH2Cl-treated	O
neutrophils	O
showed	O
a	O
decrease	O
in	O
both	O
PKC	O
activity	O
and	O
PMA-induced	O
phosphorylation	O
of	O
a	O
47-kDa	O
protein	O
,	O
which	O
corresponds	O
to	O
the	O
cytosolic	O
factor	O
of	O
NADPH	O
oxidase	O
,	O
p47	O
(	O
phox	O
)	O
.	O

Jurkat	O
T	O
cells	O
pretreated	O
with	O
NH2Cl	O
(	O
20-70	O
microM	O
)	O
showed	O
a	O
decrease	O
in	O
the	O
expression	O
of	O
the	O
interleukin-2	O
receptor	O
alpha	O
chain	O
following	O
PMA	O
stimulation	O
.	O

This	O
was	O
also	O
accompanied	O
by	O
a	O
decrease	O
in	O
both	O
PKC	O
activity	O
and	O
nuclear	O
transcription	O
factor-kappaB	O
activation	O
,	O
also	O
without	B-NEGATION
loss	I-NEGATION
of	I-NEGATION
cell	I-NEGATION
viability	I-NEGATION
.	O

These	O
results	O
show	O
that	O
NH2Cl	O
inhibits	O
PKC-mediated	O
cellular	O
responses	O
through	O
inhibition	O
of	O
the	O
inducible	O
PKC	O
activity	O
.	O

HIV-1	O
Vpr	O
suppresses	O
immune	O
activation	O
and	O
apoptosis	O
through	O
regulation	O
of	O
nuclear	O
factor	O
kappa	O
B	O
[	O
see	O
comments	O
]	O

The	O
HIV-1	O
accessory	O
gene	O
product	O
Vpr	O
can	O
influence	O
viral	O
pathogenesis	O
by	O
affecting	O
viral	O
replication	O
as	O
well	O
as	O
host	O
cell	O
transcription	O
and	O
proliferation	O
.	O

We	O
have	O
investigated	O
the	O
effects	O
of	O
Vpr	O
on	O
host	O
cell	O
activation	O
and	O
confirm	O
that	O
it	O
influences	O
cellular	O
proliferation	O
.	O

However	O
,	O
we	O
have	O
also	O
found	O
that	O
Vpr	O
modulates	O
T-cell	O
receptor	O
(	O
TCR	O
)-	O
triggered	O
apoptosis	O
in	O
a	O
manner	O
similar	O
to	O
that	O
of	O
glucocorticoids	O
.	O

In	O
the	O
absence	B-NEGATION
of	I-NEGATION
TCR-mediated	I-NEGATION
activation	I-NEGATION
,	O
Vpr	O
induces	O
apoptosis	O
whereas	O
in	O
its	O
presence	O
,	O
Vpr	O
interrupts	O
the	O
expected	O
induction	O
of	O
apoptosis	O
.	O

This	O
regulation	O
of	O
apoptosis	O
is	O
linked	O
to	O
Vpr	O
suppression	O
of	O
NF-kappa	O
B	O
activity	O
via	O
the	O
induction	O
of	O
I	O
kappa	O
B	O
,	O
an	O
inhibitor	O
of	O
NF-kappa	O
B	O
.	O

Further	O
,	O
Vpr	O
suppresses	O
expression	O
of	O
IL-2	O
,	O
IL-10	O
,	O
IL-12	O
,	O
TNF	O
alpha	O
and	O
IL-4	O
,	O
all	O
of	O
which	O
are	O
NF-kappa	O
B-dependent	O
.	O

The	O
effects	O
of	O
Vpr	O
could	O
be	O
reversed	O
by	O
RU486	O
.	O

Our	O
finding	O
that	O
Vpr	O
can	O
regulate	O
NF-kappa	O
B	O
supports	O
the	O
hypothesis	B-SPECULATION
that	I-SPECULATION
some	I-SPECULATION
aspects	I-SPECULATION
of	I-SPECULATION
viral	I-SPECULATION
pathogenesis	I-SPECULATION
are	I-SPECULATION
the	I-SPECULATION
consequence	I-SPECULATION
of	I-SPECULATION
cell	I-SPECULATION
dysregulation	I-SPECULATION
by	I-SPECULATION
Vpr	I-SPECULATION
.	O

The	O
tax	O
protein	O
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
mediates	O
the	O
transactivation	O
of	O
the	O
c-sis	O
/	O
platelet-derived	O
growth	O
factor-B	O
promoter	O
through	O
interactions	O
with	O
the	O
zinc	O
finger	O
transcription	O
factors	O
Sp1	O
and	O
NGFI-A	O
/	O
Egr-1	O
.	O

Transcriptional	O
up-regulation	O
of	O
the	O
c-sis	O
/	O
platelet-derived	O
growth	O
factor-B	O
(	O
PDGF-B	O
)	O
proto-oncogene	O
by	O
the	O
Tax	O
protein	O
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
has	O
been	O
implicated	O
as	O
one	O
possible	B-SPECULATION
mechanism	I-SPECULATION
of	I-SPECULATION
cellular	I-SPECULATION
transformation	I-SPECULATION
by	I-SPECULATION
human	I-SPECULATION
T-cell	I-SPECULATION
leukemia	I-SPECULATION
virus	I-SPECULATION
type	I-SPECULATION
1	I-SPECULATION
.	O

In	O
previous	O
work	O
,	O
we	O
identified	O
an	O
essential	O
site	O
in	O
the	O
c-sis	O
/	O
PDGF-B	O
promoter	O
,	O
Tax-responsive	O
element	O
1	O
(	O
TRE1	O
)	O
,	O
necessary	O
for	O
transactivation	O
by	O
Tax	O
.	O

We	O
also	O
identified	O
Sp1	O
,	O
Sp3	O
,	O
and	O
NGFI-A	O
/	O
Egr-1	O
as	O
the	O
primary	O
nuclear	O
transcription	O
factors	O
binding	O
to	O
TRE1	O
which	O
mediate	O
Tax	O
responsiveness	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
have	O
investigated	O
the	O
mechanism	O
(	O
s	O
)	O
whereby	O
Tax	O
transactivates	O
the	O
c-sis	O
/	O
PDGF-B	O
proto-oncogene	O
.	O

In	O
vitro	O
transcription	O
assays	O
showed	O
that	O
Tax	O
was	O
able	O
to	O
significantly	O
increase	O
the	O
transcriptional	O
activity	O
of	O
a	O
template	O
containing	O
the	O
-	O
257	O
to	O
+	O
74	O
region	O
of	O
the	O
c-sis	O
/	O
PDGF-B	O
promoter	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
showed	O
that	O
Tax	O
increased	O
the	O
DNA	O
binding	O
activity	O
of	O
both	O
Sp1	O
and	O
NGFI-A	O
/	O
Egr-1	O
using	O
a	O
TRE1	O
probe	O
.	O

Analysis	O
of	O
Tax	O
mutants	O
showed	O
that	O
two	B-NEGATION
mutants	I-NEGATION
,	I-NEGATION
IEXC29S	I-NEGATION
and	I-NEGATION
IEXL320G	I-NEGATION
,	I-NEGATION
were	I-NEGATION
unable	I-NEGATION
to	I-NEGATION
significantly	I-NEGATION
transactivate	I-NEGATION
the	I-NEGATION
c-sis	I-NEGATION
/	I-NEGATION
PDGF-B	I-NEGATION
promoter	I-NEGATION
.	O

Finally	O
,	O
co-immunoprecipitation	O
analysis	O
revealed	O
that	O
Tax	O
is	O
able	O
to	O
stably	O
bind	O
to	O
both	O
Sp1	O
and	O
NGFI-A	O
/	O
Egr-1	O
.	O

Interestingly	O
,	O
co-immunoprecipitation	O
analysis	O
also	O
revealed	O
that	O
Tax	B-NEGATION
mutant	I-NEGATION
IEXC29S	I-NEGATION
is	I-NEGATION
unable	I-NEGATION
to	I-NEGATION
interact	I-NEGATION
with	I-NEGATION
NGFI-A	I-NEGATION
/	I-NEGATION
Egr-1	I-NEGATION
,	O
whereas	O
Tax	O
mutant	O
IEXL320G	O
is	O
able	O
to	O
interact	O
with	O
NGFI-A	O
/	O
Egr-1	O
.	O

Induction	O
of	O
endothelial	O
cell	O
surface	O
adhesion	O
molecules	O
by	O
tumor	O
necrosis	O
factor	O
is	O
blocked	O
by	O
protein	O
tyrosine	O
phosphatase	O
inhibitors	O
:	O
role	O
of	O
the	O
nuclear	O
transcription	O
factor	O
NF-kappa	O
B	O
.	O

Recent	O
studies	O
from	O
our	O
laboratory	O
have	O
indicated	B-SPECULATION
that	I-SPECULATION
protein	I-SPECULATION
tyrosine	I-SPECULATION
phosphatase	I-SPECULATION
(	I-SPECULATION
PTPase	I-SPECULATION
)	I-SPECULATION
inhibitors	I-SPECULATION
can	I-SPECULATION
down-modulate	I-SPECULATION
the	I-SPECULATION
tumor	I-SPECULATION
necrosis	I-SPECULATION
factor	I-SPECULATION
(	I-SPECULATION
TNF	I-SPECULATION
)-	I-SPECULATION
mediated	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
nuclear	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
in	I-SPECULATION
ML-1a	I-SPECULATION
,	I-SPECULATION
a	I-SPECULATION
monocytic	I-SPECULATION
cell	I-SPECULATION
line	I-SPECULATION
(	O
Singh	O
and	O
Aggarwal	O
,	O
J.	O
Biol.	O
Chem.	O
1995	O
:	O
270	O
:	O
10631	O
)	O
.	O

Since	O
TNF	O
is	O
one	O
of	O
the	O
major	O
inducers	O
of	O
various	O
adhesion	O
molecules	O
in	O
human	O
endothelial	O
cells	O
and	O
their	O
expression	O
is	O
known	O
to	O
require	O
the	O
activation	O
of	O
NF-kappa	O
B	O
,	O
we	O
examined	O
the	O
effect	O
of	O
PTPase	O
inhibitors	O
on	O
the	O
TNF-mediated	O
induction	O
of	O
intracellular	O
adhesion	O
molecule	O
(	O
ICAM	O
)-	O
1	O
,	O
vascular	O
cell	O
adhesion	O
molecule	O
(	O
VCAM	O
)-	O
1	O
and	O
endothelial	O
leukocyte	O
adhesion	O
molecule	O
(	O
ELAM	O
)-	O
1	O
.	O

Like	O
ML-1a	O
,	O
human	O
dermal	O
microvessel	O
endothelial	O
cells	O
(	O
MVEC	O
)	O
treated	O
with	O
TNF	O
rapidly	O
activated	O
(	O
within	O
30	O
min	O
)	O
NF-kappa	O
B	O
;	O
this	O
effect	O
was	O
completely	O
abolished	O
by	O
co-treatment	O
with	O
phenylarsine	O
oxide	O
(	O
PAO	O
)	O
,	O
a	O
specific	O
inhibitor	O
of	O
PTPase	O
.	O

The	O
induction	O
of	O
ICAM-1	O
,	O
VCAM-1	O
,	O
and	O
ELAM-1	O
by	O
TNF	O
in	O
MVEC	O
occurred	O
within	O
6	O
h	O
and	O
was	O
also	O
completely	O
down-regulated	O
by	O
PAO	O
in	O
a	O
dose-dependent	O
manner	O
.	O

PAO	O
was	O
found	O
to	O
be	O
effective	O
even	O
when	O
added	O
3	O
h	O
after	O
TNF	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
rapid	I-SPECULATION
mode	I-SPECULATION
of	I-SPECULATION
action	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
inhibitor	I-SPECULATION
.	O

Besides	O
PAO	O
,	O
other	O
inhibitors	O
of	O
PTPase	O
,	O
including	O
pervanadate	O
and	O
diamide	O
,	O
also	O
blocked	O
TNF-dependent	O
NF-kappa	O
B	O
activation	O
and	O
induction	O
of	O
all	O
the	O
three	O
adhesion	O
proteins	O
.	O

Consistent	O
with	O
these	O
results	O
,	O
the	O
attachment	O
of	O
monocytes	O
to	O
MVEC	O
was	O
also	O
blocked	O
by	O
the	O
PTPase	O
inhibitors	O
.	O

Thus	O
,	O
overall	O
,	O
our	O
results	O
demonstrate	O
that	O
a	O
PTPase	O
is	O
involved	O
either	B-SPECULATION
directly	I-SPECULATION
in	O
the	O
pathway	O
leading	O
to	O
the	O
induction	O
of	O
endothelial	O
cell	O
adhesion	O
molecules	O
by	O
TNF	O
.	O

Because	O
of	O
their	O
role	O
in	O
cell	O
adhesion	O
,	O
PTPase	O
may	B-SPECULATION
provide	I-SPECULATION
a	I-SPECULATION
novel	I-SPECULATION
target	I-SPECULATION
of	I-SPECULATION
drug	I-SPECULATION
development	I-SPECULATION
for	I-SPECULATION
treatment	I-SPECULATION
of	I-SPECULATION
inflammation	I-SPECULATION
,	I-SPECULATION
atherogenesis	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
tumor	I-SPECULATION
metastasis	I-SPECULATION
.	O

The	O
spatial	O
distribution	O
of	O
human	O
immunoglobulin	O
genes	O
within	O
the	O
nucleus	O
:	O
evidence	O
for	O
gene	O
topography	O
independent	O
of	O
cell	O
type	O
and	O
transcriptional	O
activity	O
.	O

The	O
three-dimensional	O
positioning	O
of	O
immunoglobulin	O
(	O
Ig	O
)	O
genes	O
within	O
the	O
nucleus	O
of	O
human	O
cells	O
was	O
investigated	O
using	O
in	O
situ	O
hybridization	O
and	O
confocal	O
microscopy	O
.	O

The	O
visualization	O
of	O
heavy	O
and	O
light	O
chain	O
genes	O
in	O
B-lymphoid	O
cells	O
showed	O
that	O
the	O
three	O
Ig	O
genes	O
are	O
differentially	O
and	O
nonrandomly	O
distributed	O
in	O
different	O
nuclear	O
subvolumes	O
:	O
the	O
kappa	O
genes	O
were	O
found	O
to	O
be	O
preferentially	O
confined	O
to	O
an	O
outer	O
nuclear	O
volume	O
,	O
whereas	O
the	O
gamma	O
and	O
lambda	O
genes	O
consistently	O
occupied	O
more	O
central	O
positions	O
within	O
the	O
nucleus	O
,	O
the	O
lambda	O
genes	O
being	O
more	O
interior	O
when	O
compared	O
with	O
the	O
gamma	O
genes	O
.	O

The	O
data	O
further	O
show	O
that	O
these	O
overall	O
topographical	O
distributions	O
are	O
independent	O
of	O
gene	O
transcriptional	O
activity	O
and	O
are	O
conserved	O
in	O
different	O
cell	O
types	O
.	O

Although	O
subtle	B-SPECULATION
gene	I-SPECULATION
movements	I-SPECULATION
within	I-SPECULATION
those	I-SPECULATION
defined	I-SPECULATION
topographical	I-SPECULATION
regions	I-SPECULATION
cannot	I-SPECULATION
be	I-SPECULATION
excluded	I-SPECULATION
by	I-SPECULATION
this	I-SPECULATION
study	I-SPECULATION
,	O
the	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
,	O
rather	O
tissue	B-NEGATION
specificity	I-NEGATION
of	I-NEGATION
gene	I-NEGATION
expression	I-NEGATION
is	I-NEGATION
not	I-NEGATION
accompanied	I-NEGATION
by	I-NEGATION
drastic	I-NEGATION
changes	I-NEGATION
in	I-NEGATION
gene	I-NEGATION
nuclear	I-NEGATION
topography	I-NEGATION
suggesting	B-SPECULATION
that	I-SPECULATION
gene	I-SPECULATION
organization	I-SPECULATION
within	I-SPECULATION
the	I-SPECULATION
nucleus	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
primarily	I-SPECULATION
dependent	I-SPECULATION
on	I-SPECULATION
structural	I-SPECULATION
constraints	I-SPECULATION
imposed	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
respective	I-SPECULATION
chromosomes	I-SPECULATION
.	O

Transcriptional	O
activation	O
of	O
the	O
vascular	O
cell	O
adhesion	O
molecule-1	O
gene	O
in	O
T	O
lymphocytes	O
expressing	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	O
protein	O
.	O

Recruitment	O
and	O
extravasation	O
of	O
T	O
cells	O
through	O
the	O
blood-brain	O
barrier	O
are	O
favored	O
by	O
adhesion	O
molecule-mediated	O
interactions	O
of	O
circulating	O
T	O
cells	O
with	O
endothelial	O
cells	O
.	O

Since	O
a	O
common	O
pathological	O
finding	O
in	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)-	O
associated	O
diseases	O
is	O
the	O
infiltration	O
of	O
HTLV-1-infected	O
T	O
lymphocytes	O
into	O
various	O
organs	O
,	O
we	O
have	O
looked	O
for	O
the	O
profile	O
of	O
adhesion	O
molecules	O
expressed	O
by	O
HTLV-1-transformed	O
T	O
cells	O
.	O

Flow	O
cytometry	O
analysis	O
indicated	B-SPECULATION
that	I-SPECULATION
these	I-SPECULATION
cells	I-SPECULATION
were	I-SPECULATION
expressing	I-SPECULATION
high	I-SPECULATION
levels	I-SPECULATION
of	I-SPECULATION
vascular	I-SPECULATION
cell	I-SPECULATION
adhesion	I-SPECULATION
molecule	I-SPECULATION
1	I-SPECULATION
(	I-SPECULATION
VCAM-1	I-SPECULATION
[	I-SPECULATION
CD106	I-SPECULATION
])	I-SPECULATION
,	I-SPECULATION
a	I-SPECULATION
110-kDa	I-SPECULATION
member	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
immunoglobulin	I-SPECULATION
gene	I-SPECULATION
superfamily	I-SPECULATION
,	I-SPECULATION
first	I-SPECULATION
identified	I-SPECULATION
on	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
stimulated	I-SPECULATION
with	I-SPECULATION
inflammatory	I-SPECULATION
cytokines	I-SPECULATION
.	O

This	O
adhesion	O
molecule	O
was	O
also	O
expressed	O
by	O
T	O
cells	O
obtained	O
from	O
one	O
patient	O
with	O
HTLV-1-associated	O
myelopathy	O
/	O
tropical	O
spastic	O
paraparesis	O
but	O
not	B-NEGATION
by	I-NEGATION
activated	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
isolated	I-NEGATION
from	I-NEGATION
one	I-NEGATION
normal	I-NEGATION
blood	I-NEGATION
donor	I-NEGATION
.	O

The	O
role	O
of	O
the	O
viral	O
trans-activator	O
Tax	O
protein	O
in	O
the	O
induction	O
of	O
VCAM-1	O
was	O
first	O
indicated	O
by	O
the	O
detection	O
of	O
this	O
adhesion	O
molecule	O
on	O
Jurkat	O
T-cell	O
clones	O
stably	O
expressing	O
the	O
tax	O
gene	O
.	O

The	O
effect	O
of	O
Tax	O
on	O
VCAM-1	O
gene	O
transcription	O
was	O
next	O
confirmed	O
in	O
JPX-9	O
cells	O
,	O
a	O
subclone	O
of	O
Jurkat	O
cells	O
,	O
carrying	O
the	O
tax	O
sequences	O
under	O
the	O
control	O
of	O
an	O
inducible	O
promoter	O
.	O

Furthermore	O
,	O
deletion	O
and	O
mutation	O
analyses	O
of	O
the	O
VCAM-1	O
promoter	O
performed	O
with	O
chloramphenicol	O
acetyltransferase	O
constructs	O
revealed	O
that	O
Tax	O
was	O
trans	O
activating	O
the	O
VCAM-1	O
promoter	O
via	O
two	O
NF-kappaB	O
sites	O
present	O
at	O
bp	O
-	O
72	O
and	O
-	O
57	O
in	O
the	O
VCAM-1	O
gene	O
promoter	O
,	O
with	O
both	O
of	O
them	O
being	O
required	O
for	O
the	O
Tax-induced	O
expression	O
of	O
this	O
adhesion	O
molecule	O
.	O

Finally	O
,	O
gel	O
mobility	O
shift	O
assays	O
demonstrated	O
the	O
nuclear	O
translocation	O
of	O
proteins	O
specifically	O
bound	O
to	O
these	O
two	O
NF-kappaB	O
motifs	O
,	O
confirming	O
that	O
VCAM-1	O
was	O
induced	O
on	O
Tax-expressing	O
cells	O
in	O
a	O
kappaB-dependent	O
manner	O
.	O

Collectively	O
,	O
these	O
results	O
therefore	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
exclusive	I-SPECULATION
Tax-induced	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
VCAM-1	I-SPECULATION
on	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
may	B-SPECULATION
represent	I-SPECULATION
a	I-SPECULATION
pivotal	I-SPECULATION
event	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
progression	I-SPECULATION
of	I-SPECULATION
HTLV-1-associated	I-SPECULATION
diseases	I-SPECULATION
.	O

Blockade	O
of	O
T-cell	O
activation	O
by	O
dithiocarbamates	O
involves	O
novel	O
mechanisms	O
of	O
inhibition	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
.	O

Dithiocarbamates	O
(	O
DTCs	O
)	O
have	O
recently	O
been	O
reported	O
as	O
powerful	O
inhibitors	O
of	O
NF-kappaB	O
activation	O
in	O
a	O
number	O
of	O
cell	O
types	O
.	O

Given	O
the	O
role	O
of	O
this	O
transcription	O
factor	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
in	O
the	O
inflammatory	O
response	O
,	O
NF-kappaB	B-SPECULATION
inhibitors	I-SPECULATION
have	I-SPECULATION
been	I-SPECULATION
suggested	I-SPECULATION
as	I-SPECULATION
potential	B-SPECULATION
therapeutic	I-SPECULATION
drugs	I-SPECULATION
for	I-SPECULATION
inflammatory	I-SPECULATION
diseases	I-SPECULATION
.	O

We	O
show	O
here	O
that	O
DTCs	O
inhibited	O
both	O
interleukin	O
2	O
(	O
IL-2	O
)	O
synthesis	O
and	O
membrane	O
expression	O
of	O
antigens	O
which	O
are	O
induced	O
during	O
T-cell	O
activation	O
.	O

This	O
inhibition	O
,	O
which	O
occurred	O
with	O
a	O
parallel	O
activation	O
of	O
c-Jun	O
transactivating	O
functions	O
and	O
expression	O
,	O
was	O
reflected	O
by	O
transfection	O
experiments	O
at	O
the	O
IL-2	O
promoter	O
level	O
,	O
and	O
involved	O
not	O
only	O
the	O
inhibition	O
of	O
NF-kappaB-driven	O
reporter	O
activation	O
but	O
also	O
that	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
.	O

Accordingly	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
indicated	B-SPECULATION
that	I-SPECULATION
pyrrolidine	I-SPECULATION
DTC	I-SPECULATION
(	I-SPECULATION
PDTC	I-SPECULATION
)	I-SPECULATION
prevented	I-SPECULATION
NF-kappaB	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
NFAT	I-SPECULATION
DNA-binding	I-SPECULATION
activity	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
stimulated	I-SPECULATION
with	I-SPECULATION
either	I-SPECULATION
phorbol	I-SPECULATION
myristate	I-SPECULATION
acetate	I-SPECULATION
plus	I-SPECULATION
ionophore	I-SPECULATION
or	I-SPECULATION
antibodies	I-SPECULATION
against	I-SPECULATION
the	I-SPECULATION
CD3-T-cell	I-SPECULATION
receptor	I-SPECULATION
complex	I-SPECULATION
and	I-SPECULATION
simultaneously	I-SPECULATION
activated	I-SPECULATION
the	I-SPECULATION
binding	I-SPECULATION
of	I-SPECULATION
AP-1	I-SPECULATION
.	O

Furthermore	O
,	O
PDTC	O
differentially	O
targeted	O
both	O
NFATp	O
and	O
NFATc	O
family	O
members	O
,	O
inhibiting	O
the	O
transactivation	O
functions	O
of	O
NFATp	O
and	O
mRNA	O
induction	O
of	O
NFATc	O
.	O

Strikingly	O
,	O
Western	O
blotting	O
and	O
immunocytochemical	O
experiments	O
indicated	B-SPECULATION
that	I-SPECULATION
PDTC	I-SPECULATION
promoted	I-SPECULATION
a	I-SPECULATION
transient	I-SPECULATION
and	I-SPECULATION
rapid	I-SPECULATION
shuttling	I-SPECULATION
of	I-SPECULATION
NFATp	I-SPECULATION
and	I-SPECULATION
NFATc	I-SPECULATION
,	I-SPECULATION
leading	I-SPECULATION
to	I-SPECULATION
their	I-SPECULATION
accelerated	I-SPECULATION
export	I-SPECULATION
from	I-SPECULATION
the	I-SPECULATION
nucleus	I-SPECULATION
of	I-SPECULATION
activated	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

We	O
propose	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
an	I-SPECULATION
NFAT	I-SPECULATION
kinase	I-SPECULATION
by	I-SPECULATION
PDTC	I-SPECULATION
,	O
and	O
show	O
that	O
c-Jun	O
NH2-terminal	O
kinase	O
(	O
JNK	O
)	O
can	O
act	O
by	O
directly	O
phosphorylating	O
NFATp	O
.	O
could	B-SPECULATION
be	I-SPECULATION
responsible	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
rapid	I-SPECULATION
shuttling	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
NFAT	I-SPECULATION
,	O
therefore	O
transiently	O
converting	O
the	O
sustained	O
transactivation	O
of	O
this	O
transcription	O
factor	O
that	O
occurs	O
during	O
lymphocyte	O
activation	O
.	O

In	O
addition	O
,	O
the	O
combined	O
inhibitory	O
effects	O
on	O
NFAT	O
and	O
NF-KB	O
support	O
a	O
potential	B-SPECULATION
use	I-SPECULATION
of	I-SPECULATION
DTCs	I-SPECULATION
as	I-SPECULATION
immunosuppressants	I-SPECULATION
.	O

Suppression	O
of	O
nuclear	O
factor	O
kappa	O
B	O
and	O
CD18-mediated	O
leukocyte	O
adhesion	O
to	O
the	O
corneal	O
endothelium	O
by	O
dexamethasone	O
.	O

PURPOSE	O
:	O
To	O
demonstrate	O
that	O
leukocyte	O
adhesion	O
to	O
cultured	O
corneal	O
endothelial	O
cells	O
is	O
mediated	O
by	O
the	O
CD18	O
antigen	O
,	O
and	O
to	O
determine	O
whether	B-SPECULATION
dexamethasone	I-SPECULATION
directly	I-SPECULATION
suppresses	I-SPECULATION
adhesion	I-SPECULATION
by	I-SPECULATION
inhibiting	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
nuclear	I-SPECULATION
factor	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
(	I-SPECULATION
NFkappaB	I-SPECULATION
)	I-SPECULATION
.	O

METHODS	O
:	O
Cultured	O
bovine	O
corneal	O
endothelium	O
was	O
stimulated	O
for	O
6	O
hours	O
by	O
40	O
micron	O
/	O
ml	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNFalpha	O
)	O
.	O

Dexamethasone	O
was	O
added	O
1	O
hour	O
before	O
TNFalpha	O
stimulation	O
in	O
the	O
dexamethasone	O
group	O
.	O

After	O
stimulation	O
,	O
neutrophils	O
separated	O
from	O
a	O
healthy	O
human	O
volunteer	O
were	O
added	O
with	O
or	O
without	B-NEGATION
anti-CD18	I-NEGATION
antibody	I-NEGATION
.	O

The	O
culture	O
plate	O
was	O
settled	O
for	O
15	O
minutes	O
at	O
37	O
degrees	O
C	O
,	O
and	O
then	O
neutrophils	O
were	O
activated	O
by	O
N-formyl-methionyl-leucyl-phenylalanine	O
for	O
5	O
minutes	O
.	O

Nonadherent	O
neutrophils	O
were	O
removed	O
by	O
sealing	O
and	O
inverting	O
the	O
culture	O
well	O
.	O

The	O
intracellular	O
localization	O
of	O
NFkappaB	O
after	O
TNFalpha	O
simulation	O
was	O
determined	O
by	O
confocal	O
immunocytochemistry	O
using	O
an	O
anti-p65	O
antibody	O
.	O

RESULTS	O
:	O
Neutrophil	O
adhesion	O
to	O
cultured	O
corneal	O
endothelial	O
cells	O
increased	O
significantly	O
on	O
exposure	O
to	O
TNFalpha	O
(	O
451.4	O
+/-	O
45.4	O
cells	O
/	O
mm2	O
,	O
n	O
=	O
16	O
)	O
compared	O
to	O
control	O
(	O
156.7	O
+/-	O
27.3	O
cells	O
/	O
mm2	O
,	O
n	O
=	O
16	O
,	O
P	O
<	O
0.01	O
)	O
.	O

This	O
increased	O
adhesion	O
was	O
suppressed	O
by	O
the	O
addition	O
of	O
anti-CD18	O
antibody	O
(	O
157.6	O
+/-	O
25.1	O
cells	O
/	O
mm2	O
,	O
n	O
=	O
8	O
,	O
P	O
<	O
0.01	O
)	O
and	O
by	O
pretreatment	O
with	O
10	O
(-	O
7	O
)	O
M	O
dexamethasone	O
(	O
207.9	O
+/-	O
31.5	O
cells	O
/	O
mm2	O
,	O
n	O
=	O
10	O
,	O
P	O
<	O
0.01	O
)	O
.	O

Immunocytochemistry	O
60	O
minutes	O
after	O
stimulation	O
revealed	O
that	O
NFkappaB	O
was	O
located	O
in	O
the	O
cytoplasm	O
in	O
unstimulated	O
cells	O
;	O
however	O
,	O
the	O
addition	O
of	O
TNFalpha	O
caused	O
NFkappaB	O
to	O
translocate	O
into	O
the	O
nucleus	O
.	O

Pretreatment	O
with	O
dexamethasone	O
tapered	O
NFkappaB	O
translocation	O
into	O
the	O
nucleus	O
.	O

CONCLUSIONS	O
:	O
Leukocyte	O
adhesion	O
to	O
the	O
corneal	O
endothelium	O
was	O
shown	O
to	O
be	O
mediated	O
by	O
CD18	O
expressed	O
on	O
activated	O
leukocytes	O
.	O

Pretreatment	O
of	O
the	O
endothelium	O
with	O
dexamethasone	O
inhibited	O
leukocyte	O
adhesion	O
;	O
this	O
may	B-SPECULATION
be	I-SPECULATION
due	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
suppression	I-SPECULATION
of	I-SPECULATION
NFkappaB	I-SPECULATION
entry	I-SPECULATION
into	I-SPECULATION
the	I-SPECULATION
nucleus	I-SPECULATION
.	O

Helenalin	O
,	O
an	O
anti-inflammatory	O
sesquiterpene	O
lactone	O
from	O
Arnica	O
,	O
selectively	O
inhibits	O
transcription	O
factor	O
NF-kappaB	O
[	O
see	O
comments	O
]	O

Alcoholic	O
extracts	O
prepared	O
form	O
Arnicae	O
flos	O
,	O
the	O
collective	O
name	O
for	O
flowerheads	O
from	O
Arnica	O
montana	O
and	O
A.	O
chamissonis	O
ssp.	O
foliosa	O
,	O
are	O
used	O
therapeutically	O
as	O
anti-inflammatory	O
remedies	O
.	O

The	O
active	O
ingredients	O
mediating	O
the	O
pharmacological	O
effect	O
are	O
mainly	O
sesquiterpene	O
lactones	O
,	O
such	O
as	O
helenalin	O
,	O
11alpha,13-dihydrohelenalin	O
,	O
chamissonolid	O
and	O
their	O
ester	O
derivatives	O
.	O

While	O
these	O
compounds	O
affect	O
various	O
cellular	O
processes	O
,	O
current	O
data	O
do	O
not	O
fully	O
explain	O
how	O
sesquiterpene	O
lactones	O
exert	O
their	O
anti-inflammatory	O
effect	O
.	O

We	O
show	O
here	O
that	O
helenalin	O
,	O
and	O
,	O
to	O
a	O
much	O
lesser	O
degree	O
,	O
11alpha,13-dihydrohelenalin	O
and	O
chamissonolid	O
,	O
inhibit	O
activation	O
of	O
transcription	O
factor	O
NF-kappaB	O
.	O

This	B-SPECULATION
difference	I-SPECULATION
in	I-SPECULATION
efficacy	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
correlates	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
compounds'	I-SPECULATION
anti-inflammatory	I-SPECULATION
potency	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
,	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
explained	I-SPECULATION
by	I-SPECULATION
differences	I-SPECULATION
in	I-SPECULATION
structure	I-SPECULATION
and	I-SPECULATION
conformation	I-SPECULATION
.	O

NF-kappaB	O
,	O
which	O
resides	O
in	O
an	O
inactive	O
,	O
cytoplasmic	O
complex	O
in	O
unstimulated	O
cells	O
,	O
is	O
activated	O
by	O
phosphorylation	O
and	O
degradation	O
of	O
its	O
inhibitory	O
subunit	O
,	O
IkappaB	O
.	O

Helenalin	O
inhibits	O
NF-kappaB	O
activation	O
in	O
response	O
to	O
four	O
different	O
stimuli	O
in	O
T-cells	O
,	O
B-cells	O
and	O
epithelial	O
cells	O
and	O
abrogates	O
kappaB-driven	O
gene	O
expression	O
.	O

This	O
inhibition	O
is	O
selective	O
,	O
as	O
the	B-NEGATION
activity	I-NEGATION
of	I-NEGATION
four	I-NEGATION
other	I-NEGATION
transcription	I-NEGATION
factors	I-NEGATION
,	I-NEGATION
Oct-1	I-NEGATION
,	I-NEGATION
TBP	I-NEGATION
,	I-NEGATION
Sp1	I-NEGATION
and	I-NEGATION
STAT	I-NEGATION
5	I-NEGATION
was	I-NEGATION
not	I-NEGATION
affected	I-NEGATION
.	O

We	O
show	O
that	O
inhibition	O
is	O
not	B-NEGATION
due	I-NEGATION
to	I-NEGATION
a	I-NEGATION
direct	I-NEGATION
modification	I-NEGATION
of	I-NEGATION
the	I-NEGATION
active	I-NEGATION
NF-kappaB	I-NEGATION
heterodimer	I-NEGATION
.	O

Rather	O
,	O
helenalin	O
modifies	O
the	O
NF-kappaB	O
/	O
IkappaB	O
complex	O
,	O
preventing	O
the	O
release	O
of	O
IkappaB	O
.	O

These	O
data	O
suggest	B-SPECULATION
a	I-SPECULATION
molecular	I-SPECULATION
mechanism	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
anti-inflammatory	I-SPECULATION
effect	I-SPECULATION
of	I-SPECULATION
sesquiterpene	I-SPECULATION
lactones	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
differs	I-SPECULATION
from	I-SPECULATION
that	I-SPECULATION
of	I-SPECULATION
other	I-SPECULATION
nonsteroidal	I-SPECULATION
anti-inflammatory	I-SPECULATION
drugs	I-SPECULATION
(	I-SPECULATION
NSAIDs	I-SPECULATION
)	I-SPECULATION
,	I-SPECULATION
indomethacin	I-SPECULATION
and	I-SPECULATION
acetyl	I-SPECULATION
salicylic	I-SPECULATION
acid	I-SPECULATION
.	O

Involvement	O
of	O
different	O
transduction	O
pathways	O
in	O
NF-kappa	O
B	O
activation	O
by	O
several	O
inducers	O
.	O

Double-stimulation	O
was	O
used	O
to	O
demonstrate	O
that	O
,	O
in	O
a	O
T	O
lymphocytic	O
cell	O
line	O
(	O
CEM	O
)	O
,	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
rapidly	O
induced	O
NF-kappa	O
B	O
through	O
a	O
signaling	O
pathway	O
which	O
did	O
not	B-NEGATION
involve	I-NEGATION
reactive	I-NEGATION
oxygen	I-NEGATION
species	I-NEGATION
(	I-NEGATION
ROS	I-NEGATION
)	I-NEGATION
and	O
was	O
different	O
from	O
the	O
activation	O
triggered	O
by	O
either	O
H2O2	O
or	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
.	O

Since	O
these	O
latter	O
compounds	O
were	O
known	O
to	O
activate	O
NF-kappa	O
B	O
translocation	O
in	O
a	O
redox-sensitive	O
way	O
,	O
we	O
have	O
demonstrated	O
that	O
NF-kappa	O
B	O
activation	O
by	O
PMA	O
was	O
resistant	O
to	O
antioxidant	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
and	O
sensitive	O
to	O
kinase	O
inhibitors	O
staurosporine	O
and	O
H7	O
while	O
activation	O
by	O
H2O2	O
or	O
TNF-alpha	O
were	O
not	B-NEGATION
.	O

Dysregulation	O
of	O
monocytic	O
nuclear	O
factor-kappa	O
B	O
by	O
oxidized	O
low-density	O
lipoprotein	O
.	O

Nuclear	B-SPECULATION
factor-kappa	I-SPECULATION
B	I-SPECULATION
(	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
)/	I-SPECULATION
Rel	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
atherosclerosis	I-SPECULATION
,	O
as	O
is	B-SPECULATION
suggested	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
presence	I-SPECULATION
of	I-SPECULATION
activated	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
in	I-SPECULATION
human	I-SPECULATION
atherosclerotic	I-SPECULATION
lesions	I-SPECULATION
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
oxidized	O
LDL	O
(	O
oxLDL	O
)	O
on	O
the	O
NF-kappa	O
B	O
system	O
in	O
human	O
THP-1	O
monocytic	O
cells	O
as	O
well	O
as	O
adherent	O
monocytes	O
.	O

Our	O
results	O
demonstrate	O
that	O
short-term	O
incubation	O
of	O
these	O
cells	O
with	O
oxLDL	O
activated	O
p50	O
/	O
p65	O
containing	O
NF-kappa	O
B	O
dimers	O
and	O
induced	O
the	O
expression	O
of	O
the	O
target	O
gene	O
IL-8	O
.	O

This	O
activation	O
of	O
NF-kappa	O
B	O
was	O
inhibited	O
by	O
the	O
antioxidant	O
and	O
H2O2	O
scavenger	O
pyrrolidine	O
dithiocarbamate	O
and	O
the	O
proteasome	O
inhibitor	O
PSI	O
.	O

The	O
oxLDL-induced	O
NF-kappa	O
B	O
activation	O
was	O
accompanied	O
by	O
an	O
initial	O
depletion	O
of	O
I	O
kappa	O
B-alpha	O
followed	O
by	O
a	O
slight	O
transient	O
increase	O
in	O
the	O
level	O
of	O
this	O
inhibitor	O
protein	O
.	O

In	O
contrast	O
,	O
long-term	O
treatment	O
with	O
oxLDL	O
prevented	O
the	O
lipopolysaccharide-induced	O
depletion	O
of	O
I	O
kappa	O
B-alpha	O
,	O
accompanied	O
by	O
an	O
inhibition	O
of	O
both	O
NF-kappa	O
B	O
activation	O
and	O
the	O
expression	O
of	O
tumor	O
necrosis	O
factor-alpha	O
and	O
interleukin-1	O
beta	O
genes	O
.	O

These	O
observations	O
provide	O
additional	O
evidence	O
that	O
oxLDL	O
is	O
a	O
potent	O
modulator	O
of	O
gene	O
expression	O
and	O
suggest	B-SPECULATION
that	I-SPECULATION
(	B-SPECULATION
dys	I-SPECULATION
)	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
/	I-SPECULATION
Rel	I-SPECULATION
is	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
atherogenesis	I-SPECULATION
.	O

Suppression	O
of	O
MHC	O
class	O
II	O
expression	O
by	O
human	O
class	O
II	O
trans-activator	O
constructs	O
lacking	B-NEGATION
the	I-NEGATION
N-terminal	I-NEGATION
domain	I-NEGATION
.	O

The	O
class	O
II	O
trans-activator	O
(	O
CIITA	O
)	O
is	O
a	O
bi	O
-	O
or	O
multi-functional	O
domain	O
protein	O
which	O
plays	O
a	O
critical	O
role	O
in	O
the	O
expression	O
of	O
MHC	O
class	O
II	O
genes	O
.	O

We	O
report	O
that	O
removal	O
of	O
the	O
N-terminal	O
151	O
amino	O
acids	O
,	O
encompassing	O
all	O
of	O
the	O
acidic	O
domain	O
but	O
leaving	O
intact	O
the	O
proline	O
/	O
serine	O
/	O
threonine-rich	O
domain	O
,	O
results	O
in	O
a	O
mutant	O
protein	O
with	O
potent	O
suppressive	O
properties	O
for	O
MHC	O
class	O
II	O
expression	O
.	O

HeLa	O
cells	O
stably	O
or	O
transiently	O
transfected	O
with	O
mutant	O
CIITA	O
constructs	O
showed	O
up	O
to	O
99	O
%	O
suppression	O
of	O
MHC	O
class	O
II	O
antigen	O
induction	O
by	O
IFN-gamma	O
and	O
marked	O
suppression	O
of	O
HLA-DRA	O
mRNA	O
expression	O
.	O

Transient	O
transfection	O
of	O
a	O
B	O
lymphoma	O
line	O
resulted	O
in	O
up	O
to	O
89	O
%	O
reduction	O
of	O
constitutive	O
MHC	O
class	O
II	O
expression	O
within	O
5	O
days	O
and	O
suppression	O
of	O
HLA-DRA	O
mRNA	O
synthesis	O
.	O

CD30-dependent	O
degradation	O
of	O
TRAF2	O
:	O
implications	O
for	O
negative	O
regulation	O
of	O
TRAF	O
signaling	O
and	O
the	O
control	O
of	O
cell	O
survival	O
.	O

CD30	O
is	O
a	O
cell-surface	O
receptor	O
that	O
can	O
augment	O
lymphocyte	O
activation	O
and	O
survival	O
through	O
its	O
ability	O
to	O
induce	O
the	O
transcription	O
factor	O
NF-kappaB	O
.	O

CD30	O
,	O
however	O
,	O
has	O
also	O
been	O
implicated	O
in	O
the	O
induction	O
of	O
apoptotic	O
cell	O
death	O
of	O
lymphocytes	O
.	O

Here	O
we	O
show	O
that	O
one	O
of	O
the	O
effects	O
of	O
CD30	O
signal	O
transduction	O
is	O
to	O
render	O
cells	O
sensitive	O
to	O
apoptosis	O
induced	O
by	O
the	O
type	O
1	O
tumor	O
necrosis	O
factor	O
receptor	O
(	O
TNFR1	O
)	O
.	O

This	O
sensitization	O
is	O
dependent	O
on	O
the	O
TRAF-binding	O
sites	O
within	O
the	O
CD30	O
cytoplasmic	O
domain	O
.	O

One	O
of	O
the	O
proteins	O
that	O
binds	O
to	O
these	O
sites	O
is	O
TRAF2	O
,	O
a	O
signal	O
transduction	O
molecule	O
that	O
is	O
also	O
utilized	O
by	O
TNFR1	O
to	O
mediate	O
the	O
activation	O
of	O
several	O
downstream	O
kinases	O
and	O
transcription	O
factors	O
.	O

During	O
CD30	O
signal	O
transduction	O
,	O
we	O
found	O
that	O
binding	O
of	O
TRAF2	O
to	O
the	O
cytoplasmic	O
domain	O
of	O
CD30	O
results	O
in	O
the	O
rapid	O
depletion	O
of	O
TRAF2	O
and	O
the	O
associated	O
protein	O
TRAF1	O
by	O
proteolysis	O
.	O

These	O
data	O
suggest	B-SPECULATION
a	I-SPECULATION
model	I-SPECULATION
in	I-SPECULATION
which	I-SPECULATION
CD30	I-SPECULATION
limits	I-SPECULATION
its	I-SPECULATION
own	I-SPECULATION
ability	I-SPECULATION
to	I-SPECULATION
transduce	I-SPECULATION
cell	I-SPECULATION
survival	I-SPECULATION
signals	I-SPECULATION
through	I-SPECULATION
signal-coupled	I-SPECULATION
depletion	I-SPECULATION
of	I-SPECULATION
TRAF2	I-SPECULATION
.	O

Depletion	O
of	O
intracellular	O
TRAF2	O
and	O
its	O
coassociated	O
proteins	O
also	O
increased	O
the	O
sensitivity	O
of	O
the	O
cell	O
to	O
undergoing	O
apoptosis	O
during	O
activation	O
of	O
death-inducing	O
receptors	O
such	O
as	O
TNFR1	O
.	O

Consistent	O
with	O
this	O
hypothesis	O
,	O
expression	O
of	O
a	O
dominant-negative	O
form	O
of	O
TRAF2	O
was	O
found	O
to	O
potentiate	O
TNFR1-mediated	O
death	O
.	O

These	O
studies	O
provide	O
a	O
potential	B-SPECULATION
mechanism	I-SPECULATION
through	I-SPECULATION
which	I-SPECULATION
CD30	I-SPECULATION
,	I-SPECULATION
as	I-SPECULATION
well	I-SPECULATION
as	I-SPECULATION
other	I-SPECULATION
TRAF-binding	I-SPECULATION
members	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
TNFR	I-SPECULATION
superfamily	I-SPECULATION
,	I-SPECULATION
can	I-SPECULATION
negatively	I-SPECULATION
regulate	I-SPECULATION
cell	I-SPECULATION
survival	I-SPECULATION
.	O

TNFalpha	O
cooperates	O
with	O
the	O
protein	O
kinase	O
A	O
pathway	O
to	O
synergistically	O
increase	O
HIV-1	O
LTR	O
transcription	O
via	O
downstream	O
TRE-like	O
cAMP	O
response	O
elements	O
.	O

Activating	O
protein-1	O
(	O
AP-1	O
)	O
binding	O
TPA	O
responsive	O
elements	O
(	O
TRE	O
)	O
are	O
located	O
downstream	O
of	O
the	O
transcription	O
initiation	O
site	O
in	O
the	O
U5	O
region	O
of	O
the	O
HIV-1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

These	O
downstream	O
sequence	O
elements	O
,	O
termed	O
DSE	O
,	O
can	O
bind	O
both	O
AP-1	O
and	O
CREB	O
/	O
ATF	O
transcription	O
factors	O
.	O

Recently	O
,	O
we	O
demonstrated	O
that	O
the	O
DSE	O
are	O
also	O
cAMP-responsive	O
elements	O
(	O
CRE	O
)	O
,	O
since	O
they	O
mediated	O
activation	O
signals	O
elicited	O
by	O
cholera	O
toxin	O
(	O
Ctx	O
)	O
,	O
a	O
potent	O
activator	O
of	O
the	O
cAMP-dependent	O
protein	O
kinase	O
A	O
(	O
PKA	O
)	O
signal	O
transduction	O
pathway	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
HIV-1	O
DSE	O
can	O
mediate	O
the	O
transcriptional	O
synergy	O
elicited	O
by	O
the	O
combination	O
of	O
Ctx	O
and	O
TNFalpha	O
.	O

Ctx	O
combined	O
with	O
TNFalpha	O
or	O
IL-1beta	O
to	O
produce	O
a	O
synergistic	O
increase	O
in	O
p24	O
antigen	O
production	O
in	O
U1	O
promonocytic	O
cells	O
.	O

Transfection	O
studies	O
of	O
LTR	O
reporter	O
constructs	O
indicated	O
that	O
mutation	O
of	O
the	O
DSE	O
sites	O
abrogated	O
the	O
LTR-mediated	O
synergy	O
induced	O
by	O
Ctx	O
and	O
TNFalpha	O
,	O
whereas	O
the	O
synergy	O
induced	O
by	O
Ctx	O
and	O
IL-1beta	O
was	O
unaffected	O
,	O
suggesting	B-SPECULATION
TNFalpha	I-SPECULATION
and	I-SPECULATION
IL-1beta	I-SPECULATION
cooperate	I-SPECULATION
differently	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
cAMP	I-SPECULATION
/	I-SPECULATION
PKA	I-SPECULATION
activation	I-SPECULATION
pathway	I-SPECULATION
to	I-SPECULATION
induce	I-SPECULATION
HIV-1	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
U1	I-SPECULATION
cells	I-SPECULATION
.	O

Because	O
the	O
DSE	O
are	O
also	O
TRE	O
sites	O
,	O
we	O
assessed	O
the	O
effect	O
of	O
the	O
agonist	O
combinations	O
on	O
AP-1-dependent	O
transcription	O
.	O

TNFalpha	O
as	O
well	O
as	O
IL-1beta	O
cooperated	O
with	O
Ctx	O
to	O
produce	O
a	O
synergistic	O
activation	O
of	O
AP-1-mediated	O
transcription	O
.	O

These	O
data	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
TRE-like	I-SPECULATION
cAMP-responsive	I-SPECULATION
DSE	I-SPECULATION
sites	I-SPECULATION
within	I-SPECULATION
the	I-SPECULATION
5	I-SPECULATION
'-	I-SPECULATION
untranslated	I-SPECULATION
leader	I-SPECULATION
can	I-SPECULATION
mediate	I-SPECULATION
the	I-SPECULATION
transcriptional	I-SPECULATION
cooperativity	I-SPECULATION
between	I-SPECULATION
TNFalpha	I-SPECULATION
and	I-SPECULATION
the	I-SPECULATION
cAMP	I-SPECULATION
/	I-SPECULATION
PKA	I-SPECULATION
pathway	I-SPECULATION
.	O

Since	O
the	O
DSE	O
and	O
TRE	O
sites	O
cannot	B-NEGATION
bind	I-NEGATION
CREB	I-NEGATION
/	I-NEGATION
ATF	I-NEGATION
homodimers	I-NEGATION
,	O
we	O
propose	B-SPECULATION
a	I-SPECULATION
mechanism	I-SPECULATION
in	I-SPECULATION
which	I-SPECULATION
the	I-SPECULATION
HIV-1	I-SPECULATION
DSE	I-SPECULATION
bind	I-SPECULATION
heterodimers	I-SPECULATION
composed	I-SPECULATION
of	I-SPECULATION
both	I-SPECULATION
AP-1	I-SPECULATION
and	I-SPECULATION
CREB	I-SPECULATION
/	I-SPECULATION
ATF	I-SPECULATION
proteins	I-SPECULATION
.	O

Copyright	O
1997	O
Academic	O
Press	O
.	O

The	O
Epstein-Barr	O
virus	O
oncogene	O
product	O
latent	O
membrane	O
protein	O
1	O
engages	O
the	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
death	O
domain	O
protein	O
to	O
mediate	O
B	O
lymphocyte	O
growth	O
transformation	O
and	O
activate	O
NF-kappaB	O
.	O

The	O
Epstein-Barr	O
virus	O
latent	O
membrane	O
protein	O
1	O
(	O
LMP1	O
)	O
is	O
essential	O
for	O
the	O
transformation	O
of	O
B	O
lymphocytes	O
into	O
lymphoblastoid	O
cell	O
lines	O
.	O

Previous	O
data	O
are	O
consistent	O
with	O
a	O
model	O
that	O
LMP1	O
is	O
a	O
constitutively	O
activated	O
receptor	O
that	O
transduces	O
signals	O
for	O
transformation	O
through	O
its	O
carboxyl-terminal	O
cytoplasmic	O
tail	O
.	O

One	O
transformation	O
effector	O
site	O
(	O
TES1	O
)	O
,	O
located	O
within	O
the	O
membrane	O
proximal	O
45	O
residues	O
of	O
the	O
cytoplasmic	O
tail	O
,	O
constitutively	O
engages	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
factors	O
.	O

Signals	O
from	O
TES1	O
are	O
sufficient	O
to	O
drive	O
initial	O
proliferation	O
of	O
infected	O
resting	O
B	O
lymphocytes	O
,	O
but	O
most	O
lymphoblastoid	O
cells	O
infected	O
with	O
a	O
virus	O
that	O
does	O
not	B-NEGATION
express	I-NEGATION
the	I-NEGATION
155	I-NEGATION
residues	I-NEGATION
beyond	I-NEGATION
TES1	I-NEGATION
fail	B-NEGATION
to	I-NEGATION
grow	I-NEGATION
as	I-NEGATION
long-term	I-NEGATION
cell	I-NEGATION
lines	I-NEGATION
.	O

We	O
now	O
find	O
that	O
mutating	O
two	O
tyrosines	O
to	O
an	O
isoleucine	O
at	O
the	O
carboxyl	O
end	O
of	O
the	O
cytoplasmic	O
tail	O
cripples	O
the	O
ability	O
of	O
EBV	O
to	O
cause	O
lymphoblastoid	O
cell	O
outgrowth	O
,	O
thereby	O
marking	O
a	O
second	O
transformation	O
effector	O
site	O
,	O
TES2	O
.	O

A	O
yeast	O
two-hybrid	O
screen	O
identified	O
TES2	O
interacting	O
proteins	O
,	O
including	O
the	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
death	O
domain	O
protein	O
(	O
TRADD	O
)	O
.	O

TRADD	O
was	O
the	O
only	O
protein	O
that	O
interacted	O
with	O
wild-type	O
TES2	O
and	O
not	B-NEGATION
with	I-NEGATION
isoleucine-mutated	I-NEGATION
TES2	I-NEGATION
.	O

TRADD	O
associated	O
with	O
wild-type	O
LMP1	O
but	O
not	B-NEGATION
with	I-NEGATION
isoleucine-mutated	I-NEGATION
LMP1	I-NEGATION
in	I-NEGATION
mammalian	I-NEGATION
cells	I-NEGATION
,	O
and	O
TRADD	O
constitutively	O
associated	O
with	O
LMP1	O
in	O
EBV-transformed	O
cells	O
.	O

In	O
transfection	O
assays	O
,	O
TRADD	O
and	O
TES2	O
synergistically	O
mediated	O
high-level	O
NF-kappaB	O
activation	O
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
LMP1	I-SPECULATION
appropriates	I-SPECULATION
TRADD	I-SPECULATION
to	I-SPECULATION
enable	I-SPECULATION
efficient	I-SPECULATION
long-term	I-SPECULATION
lymphoblastoid	I-SPECULATION
cell	I-SPECULATION
outgrowth	I-SPECULATION
.	O

High-level	B-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
also	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
critical	I-SPECULATION
component	I-SPECULATION
of	I-SPECULATION
long-term	I-SPECULATION
outgrowth	I-SPECULATION
.	O

Switching	O
gears	O
during	O
T-cell	O
maturation	O
:	O
RANTES	O
and	O
late	O
transcription	O
.	O

Although	O
much	O
is	O
understood	O
about	O
the	O
induction	O
of	O
genes	O
expressed	O
early	O
(	O
within	O
24	O
h	O
)	O
after	O
T-cell	O
activation	O
,	O
little	O
is	O
known	O
about	O
the	O
regulation	O
of	O
expression	O
of	O
genes	O
expressed	O
'	O
late	O
'	O
(	O
three	O
or	O
more	O
days	O
)	O
post-stimulation	O
.	O

A	O
better	O
understanding	O
of	O
transcriptional	O
regulation	O
at	O
this	O
important	O
stage	O
of	O
T-cell	O
maturation	O
may	B-SPECULATION
yield	I-SPECULATION
new	I-SPECULATION
insights	I-SPECULATION
into	I-SPECULATION
T-cell	I-SPECULATION
development	I-SPECULATION
and	I-SPECULATION
new	I-SPECULATION
immunotherapeutic	I-SPECULATION
targets	I-SPECULATION
.	O

Transcription	O
factor	O
NF-kappaB	O
regulates	O
inducible	O
Oct-2	O
gene	O
expression	O
in	O
precursor	O
B	O
lymphocytes	O
.	O

The	O
POU	O
transcription	O
factors	O
Oct-1	O
and	O
Oct-2	O
regulate	O
the	O
activity	O
of	O
octamer-dependent	O
promoters	O
,	O
including	O
those	O
that	O
direct	O
transcription	O
from	O
rearranged	O
immunoglobulin	O
genes	O
.	O

Unlike	O
Oct-1	O
,	O
which	O
is	O
constitutively	O
expressed	O
in	O
many	O
cell	O
types	O
,	O
Oct-2	O
expression	O
is	O
restricted	O
primarily	O
to	O
B	O
lymphocytes	O
and	O
can	O
be	O
induced	O
in	O
precursor	O
B	O
cells	O
by	O
stimulation	O
with	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

However	O
,	O
the	B-SPECULATION
precise	I-SPECULATION
factors	I-SPECULATION
that	I-SPECULATION
mediate	I-SPECULATION
this	I-SPECULATION
induction	I-SPECULATION
mechanism	I-SPECULATION
remain	I-SPECULATION
unknown	I-SPECULATION
.	O

In	O
the	O
present	O
study	O
,	O
we	O
monitored	O
Oct-2	O
expression	O
in	O
cells	O
arrested	O
for	O
the	O
activation	O
of	O
NF-kappaB	O
,	O
an	O
LPS-responsive	O
member	O
of	O
the	O
Rel	O
transcription	O
factor	O
family	O
.	O

Despite	O
stimulation	O
with	O
LPS	O
,	O
disruption	O
of	O
the	O
NF-kappaB	O
signaling	O
pathway	O
in	O
precursor	O
B	O
cells	O
led	O
to	O
the	O
loss	O
of	O
inducible	O
Oct-2	O
DNA	O
binding	O
activity	O
in	O
vitro	O
and	O
the	O
suppression	O
of	O
Oct-2-directed	O
transcription	O
in	O
vivo	O
.	O

This	O
biochemical	O
defect	O
correlated	O
with	O
a	O
specific	O
block	O
to	O
Oct-2	O
gene	O
expression	O
at	O
the	O
level	O
of	O
transcription	O
,	O
whereas	O
the	O
expression	O
of	O
Oct-1	O
was	O
unaffected	O
.	O

The	O
finding	O
that	O
Oct-2	O
is	O
under	O
NF-kappaB	O
control	O
highlights	O
an	O
important	O
cross-talk	O
mechanism	O
involving	O
two	O
distinct	O
transcription	O
factor	O
families	O
that	O
regulate	O
B	O
lymphocyte	O
function	O
.	O

Paternal	O
expression	O
of	O
WT1	O
in	O
human	O
fibroblasts	O
and	O
lymphocytes	O
.	O

The	O
Wilms'	O
tumor	O
suppressor	O
gene	O
(	O
WT1	O
)	O
was	O
previously	O
identified	O
as	O
being	O
imprinted	O
,	O
with	O
frequent	O
maternal	O
expression	O
in	O
human	O
placentae	O
and	O
fetal	O
brains	O
.	O

We	O
examined	O
the	O
allele-specific	O
expression	O
of	O
WT1	O
in	O
cultured	O
human	O
fibroblasts	O
from	O
15	O
individuals	O
.	O

Seven	O
of	O
15	O
fibroblast	O
lines	O
were	O
heterozygous	O
for	O
polymorphic	O
alleles	O
,	O
and	O
the	O
expression	O
patterns	O
were	O
variable	O
,	O
i.e.	O
,	O
equal	O
,	O
unequal	O
or	O
monoallelic	O
paternal	O
expression	O
in	O
three	O
,	O
two	O
and	O
two	O
cases	O
,	O
respectively	O
.	O

Exclusive	O
paternal	O
expression	O
of	O
WT1	O
was	O
also	O
shown	O
in	O
non-cultured	O
peripheral	O
lymphocytes	O
from	O
the	O
latter	O
two	O
individuals	O
.	O

The	O
allele-specific	O
expression	O
profiles	O
of	O
other	O
imprinted	O
genes	O
,	O
IGF2	O
and	O
H19	O
,	O
on	O
human	O
chromosome	O
11	O
were	O
constant	O
and	O
consistent	O
with	O
those	O
in	O
other	O
tissues	O
.	O

Our	O
unexpected	O
observations	O
of	O
paternal	O
or	O
biallelic	O
expression	O
of	O
WT1	O
in	O
fibroblasts	O
and	O
lymphocytes	O
,	O
together	O
with	O
the	O
previous	O
findings	O
of	O
maternal	O
or	O
biallelic	O
expression	O
in	O
placentae	O
and	O
brains	O
,	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
allele-specific	I-SPECULATION
regulatory	I-SPECULATION
system	I-SPECULATION
of	I-SPECULATION
WT1	I-SPECULATION
is	I-SPECULATION
unique	I-SPECULATION
and	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
controlled	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
putative	I-SPECULATION
tissue	I-SPECULATION
-	I-SPECULATION
and	I-SPECULATION
individual-specific	I-SPECULATION
modifier	I-SPECULATION
.	O

Characterization	O
of	O
CD40	O
signaling	O
determinants	O
regulating	O
nuclear	O
factor-kappa	O
B	O
activation	O
in	O
B	O
lymphocytes	O
.	O

CD40	O
signaling	O
to	O
B	O
cells	O
is	O
important	O
for	O
generating	O
an	O
effective	O
humoral	O
immune	O
response	O
.	O

CD40	O
ligation	O
leads	O
to	O
B	O
cell	O
activation	O
events	O
such	O
as	O
proliferation	O
,	O
Ig	O
secretion	O
,	O
isotype	O
switching	O
,	O
and	O
up-regulation	O
of	O
cell	O
surface	O
molecules	O
,	O
as	O
well	O
as	O
the	O
generation	O
of	O
memory	O
B	O
cells	O
.	O

Many	O
of	O
these	O
events	O
are	O
dependent	O
upon	O
the	O
ability	O
of	O
CD40	O
to	O
activate	O
the	O
transcription	O
factor	O
NF-kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
.	O

To	O
define	O
the	O
CD40	O
signaling	O
components	O
upstream	O
of	O
NF-kappa	O
B	O
activation	O
and	O
the	O
functional	O
consequences	O
downstream	O
of	O
NF-kappa	O
B	O
activation	O
,	O
we	O
examined	O
mouse	O
B	O
cell	O
transfectants	O
expressing	O
wild-type	O
or	O
mutant	O
human	O
CD40	O
.	O

Analysis	O
of	O
CD40	O
cytoplasmic	O
domain	O
truncation	O
and	O
point	O
mutants	O
defined	O
a	O
10-amino	O
acid	O
CD40	O
cytoplasmic	O
signaling	O
determinant	O
required	O
for	O
NF-kappa	O
B	O
activation	O
.	O

A	B-NEGATION
threonine	I-NEGATION
residue	I-NEGATION
at	I-NEGATION
position	I-NEGATION
234	I-NEGATION
,	I-NEGATION
previously	I-NEGATION
shown	I-NEGATION
to	I-NEGATION
be	I-NEGATION
important	I-NEGATION
for	I-NEGATION
CD40	I-NEGATION
association	I-NEGATION
with	I-NEGATION
TNF	I-NEGATION
receptor-associated	I-NEGATION
factor	I-NEGATION
2	I-NEGATION
(	I-NEGATION
TRAF2	I-NEGATION
)	I-NEGATION
,	I-NEGATION
TRAF3	I-NEGATION
,	I-NEGATION
and	I-NEGATION
TRAF5	I-NEGATION
,	I-NEGATION
was	I-NEGATION
not	I-NEGATION
required	I-NEGATION
for	I-NEGATION
NF-kappa	I-NEGATION
B	I-NEGATION
activation	I-NEGATION
.	O

This	O
suggests	B-SPECULATION
that	I-SPECULATION
in	I-SPECULATION
B	I-SPECULATION
cells	I-SPECULATION
,	I-SPECULATION
CD40-induced	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
activation	I-SPECULATION
can	I-SPECULATION
occur	I-SPECULATION
independently	I-SPECULATION
of	I-SPECULATION
TRAF2	I-SPECULATION
and	I-SPECULATION
TRAF5	I-SPECULATION
association	I-SPECULATION
.	O

NF-kappa	O
B	O
activation	O
was	O
independent	O
of	O
the	O
transmembrane	O
domain	O
of	O
CD40	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
it	I-SPECULATION
is	I-SPECULATION
independent	I-SPECULATION
of	I-SPECULATION
p23	I-SPECULATION
,	I-SPECULATION
a	I-SPECULATION
molecule	I-SPECULATION
that	I-SPECULATION
associates	I-SPECULATION
with	I-SPECULATION
CD40	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
region	I-SPECULATION
other	I-SPECULATION
than	I-SPECULATION
the	I-SPECULATION
cytoplasmic	I-SPECULATION
domain	I-SPECULATION
.	O

Proteasome-dependent	O
inhibitory	O
kappa	O
B	O
alpha	O
(	O
I	O
kappa	O
B	O
alpha	O
)	O
and	O
I	O
kappa	O
B	O
beta	O
degradation	O
occurred	O
downstream	O
of	O
CD40	O
ligation	O
and	O
preceded	O
CD40-mediated	O
NF-kappa	O
B	O
nuclear	O
translocation	O
.	O

CD40	B-NEGATION
-	I-NEGATION
or	I-NEGATION
pervanadate-mediated	I-NEGATION
I	I-NEGATION
kappa	I-NEGATION
B	I-NEGATION
tyrosine	I-NEGATION
phosphorylation	I-NEGATION
was	I-NEGATION
not	I-NEGATION
detected	I-NEGATION
.	O

NF-kappa	O
B	O
activation	O
correlated	O
with	O
the	O
ability	O
of	O
CD40	O
to	O
induce	O
Ab	O
secretion	O
and	O
the	O
up-regulation	O
of	O
ICAM-1	O
and	O
LFA-1	O
.	O

However	O
,	O
NF-kappa	O
B	O
activation	O
was	O
insufficient	O
for	O
CD40-mediated	O
up-regulation	O
of	O
B7-1	O
,	O
Fas	O
,	O
and	O
CD23	O
.	O

Extinction	O
of	O
immunoglobulin	O
gene	O
expression	O
in	O
B	O
cells	O
upon	O
fusion	O
with	O
HeLa	O
cells	O
is	O
preceded	O
by	O
rapid	O
nuclear	O
depletion	O
of	O
essential	O
transcription	O
factors	O
and	O
is	O
accompanied	O
by	O
widespread	O
inactivation	O
of	O
genes	O
expressed	O
in	O
a	O
B	O
cell-specific	O
manner	O
.	O

When	O
immunoglobulin	O
(	O
Ig	O
)	O
expressing	O
B	O
cells	O
are	O
fused	O
with	O
non-B	O
cells	O
,	O
Ig	O
expression	O
is	O
rapidly	O
suppressed	O
at	O
the	O
level	O
of	O
transcription	O
,	O
a	O
phenomenon	O
termed	O
extinction	O
.	O

Here	O
we	O
demonstrate	O
that	O
fusion	O
of	O
HeLa	O
cells	O
with	O
either	O
diploid	O
or	O
tetraploid	O
B	O
cells	O
(	O
Daudi	O
)	O
results	O
in	O
widespread	O
extinction	O
of	O
several	O
other	O
B	O
cell-encoded	O
genes	O
that	O
are	O
expressed	O
in	O
a	O
B	O
cell-specific	O
manner	O
.	O

In	O
contrast	O
,	O
expression	O
of	O
B	O
cell-expressed	O
genes	O
that	O
are	O
not	B-NEGATION
dependent	I-NEGATION
on	I-NEGATION
cell-specific	I-NEGATION
controls	I-NEGATION
is	O
unaffected	O
.	O

We	O
show	O
that	O
the	O
molecular	O
mechanism	O
(	O
s	O
)	O
underlying	O
Ig	O
gene	O
extinction	O
can	O
be	O
explained	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
a	O
lack	B-NEGATION
of	I-NEGATION
transcription	I-NEGATION
factors	I-NEGATION
that	I-NEGATION
are	I-NEGATION
essential	I-NEGATION
for	I-NEGATION
Ig	I-NEGATION
gene	I-NEGATION
transcription	I-NEGATION
.	O

These	O
transcription	O
factors	O
are	O
either	B-SPECULATION
not	B-NEGATION
produced	I-NEGATION
due	I-NEGATION
to	I-NEGATION
block	I-NEGATION
of	I-NEGATION
transcription	I-NEGATION
of	I-NEGATION
their	I-NEGATION
respective	I-NEGATION
genes	I-NEGATION
(	I-NEGATION
Oct-2	I-NEGATION
,	I-NEGATION
OBF-1	I-NEGATION
,	I-NEGATION
PU.1	I-NEGATION
)	I-NEGATION
,	O
.	O

By	O
isolating	O
Daudi	O
x	O
HeLa	O
heterokaryons	O
a	O
few	O
hours	O
after	O
fusion	O
,	O
we	O
have	O
studied	O
the	O
initial	O
fate	O
of	O
two	O
B	O
cell-specific	O
transcription	O
factors	O
involved	O
in	O
Ig	O
gene	O
transcription	O
,	O
Oct-2	O
and	O
NF-kappa	O
B	O
.	O

This	O
report	O
provides	O
the	O
first	O
demonstration	O
that	O
upon	O
fusion	O
with	O
HeLa	O
cells	O
,	O
the	O
nuclear	O
contents	O
of	O
B	O
cell-expressed	O
transcription	O
factors	O
are	O
depleted	O
within	O
a	O
few	O
hours	O
with	O
kinetics	O
that	O
are	O
as	O
fast	O
or	O
faster	O
than	O
that	O
of	O
Ig	O
gene	O
extinction	O
.	O

Thus	O
,	O
the	O
extinguishing	O
mechanism	O
is	O
effective	O
very	O
early	O
after	O
fusion	O
.	O

We	O
suggest	B-SPECULATION
that	I-SPECULATION
extinction	I-SPECULATION
of	I-SPECULATION
Ig	I-SPECULATION
genes	I-SPECULATION
is	I-SPECULATION
part	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
global	I-SPECULATION
mechanism	I-SPECULATION
that	I-SPECULATION
suppresses	I-SPECULATION
the	I-SPECULATION
differentiation	I-SPECULATION
program	I-SPECULATION
foreign	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
HeLa	I-SPECULATION
phenotype	I-SPECULATION
.	O

Regulation	O
of	O
Id3	O
cell	O
cycle	O
function	O
by	O
Cdk-2-dependent	O
phosphorylation	O
.	O

The	O
functions	O
of	O
basic	O
helix-loop-helix	O
(	O
bHLH	O
)	O
transcription	O
factors	O
in	O
activating	O
differentiation-linked	O
gene	O
expression	O
and	O
in	O
inducing	O
G1	O
cell	O
cycle	O
arrest	O
are	O
negatively	O
regulated	O
by	O
members	O
of	O
the	O
Id	O
family	O
of	O
HLH	O
proteins	O
.	O

These	O
bHLH	O
antagonists	O
are	O
induced	O
during	O
a	O
mitogenic	O
signalling	O
response	O
,	O
and	O
they	O
function	O
by	O
sequestering	O
their	O
bHLH	O
targets	O
in	O
inactive	O
heterodimers	O
that	O
are	B-NEGATION
unable	I-NEGATION
to	I-NEGATION
bind	I-NEGATION
to	I-NEGATION
specific	I-NEGATION
gene	I-NEGATION
regulatory	I-NEGATION
(	I-NEGATION
E	I-NEGATION
box	I-NEGATION
)	I-NEGATION
sequences	I-NEGATION
.	O

Recently	O
,	O
cyclin	O
E-Cdk2	O
-	O
and	O
cyclin	O
A-Cdk2-dependent	O
phosphorylation	O
of	O
a	O
single	O
conserved	O
serine	O
residue	O
(	O
Ser5	O
)	O
in	O
Id2	O
has	O
been	O
shown	O
to	O
occur	O
during	O
late	O
G1-to-S	O
phase	O
transition	O
of	O
the	O
cell	O
cycle	O
,	O
and	O
this	O
neutralizes	O
the	O
function	O
of	O
Id2	O
in	O
abrogating	O
E-box-dependent	O
bHLH	O
homo	O
-	O
or	O
heterodimer	O
complex	O
formation	O
in	O
vitro	O
(	O
E.Hara	O
,	O
M.Hall	O
,	O
and	O
G.Peters	O
,	O
EMBO	O
J.16:332-342	O
,	O
1997	O
)	O
.	O

We	O
now	O
show	O
that	O
an	O
analogous	O
cell-cycle-regulated	O
phosphorylation	O
of	O
Id3	O
alters	O
the	O
specificity	O
of	O
Id3	O
for	O
abrogating	O
both	O
E-box-dependent	O
bHLH	O
homo	O
-	O
or	O
heterodimer	O
complex	O
formation	O
in	O
vitro	O
and	O
E-box-dependent	O
reporter	O
gene	O
function	O
in	O
vivo	O
.	O

Furthermore	O
,	O
compared	O
with	O
wild-type	O
Id3	O
,	O
an	B-NEGATION
Id3	I-NEGATION
Asp5	I-NEGATION
mutant	I-NEGATION
(	I-NEGATION
mimicking	I-NEGATION
phosphorylation	I-NEGATION
)	I-NEGATION
is	I-NEGATION
unable	I-NEGATION
to	I-NEGATION
promote	I-NEGATION
cell	I-NEGATION
cycle	I-NEGATION
S	I-NEGATION
phase	I-NEGATION
entry	I-NEGATION
in	I-NEGATION
transfected	I-NEGATION
fibroblasts	I-NEGATION
,	O
whereas	O
an	O
Id3	O
Ala5	O
mutant	O
(	O
ablating	O
phosphorylation	O
)	O
displays	O
an	O
activity	O
significantly	O
greater	O
than	O
that	O
of	O
wild-type	O
Id3	O
protein	O
.	O

Cdk2-dependent	O
phosphorylation	O
therefore	O
provides	O
a	O
switch	O
during	O
late	O
G1-to-S	O
phase	O
that	O
both	O
nullifies	O
an	O
early	O
G1	O
cell	O
cycle	O
regulatory	O
function	O
of	O
Id3	O
and	O
modulates	O
its	O
target	O
bHLH	O
specificity	O
.	O

These	O
data	O
also	O
demonstrate	O
that	O
the	O
ability	O
of	O
Id3	O
to	O
promote	O
cell	O
cycle	O
S	O
phase	O
entry	O
is	O
not	B-NEGATION
simply	I-NEGATION
a	I-NEGATION
function	I-NEGATION
of	I-NEGATION
its	I-NEGATION
ability	I-NEGATION
to	I-NEGATION
modulate	I-NEGATION
bHLH	I-NEGATION
heterodimer-dependent	I-NEGATION
gene	I-NEGATION
expression	I-NEGATION
and	O
establish	O
a	O
biologically	O
important	O
mechanism	O
through	O
which	O
Cdk2	O
and	O
Id-bHLH	O
functions	O
are	O
integrated	O
in	O
the	O
coordination	O
of	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

Nuclear	O
accumulation	O
of	O
NFAT4	O
opposed	O
by	O
the	O
JNK	O
signal	O
transduction	O
pathway	O
.	O

The	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
group	O
of	O
transcription	O
factors	O
is	O
retained	O
in	O
the	O
cytoplasm	O
of	O
quiescent	O
cells	O
.	O

NFAT	O
activation	O
is	O
mediated	O
in	O
part	O
by	O
induced	O
nuclear	O
import	O
.	O

This	O
process	O
requires	O
calcium-dependent	O
dephosphorylation	O
of	O
NFAT	O
caused	O
by	O
the	O
phosphatase	O
calcineurin	O
.	O

The	O
c-Jun	O
amino-terminal	O
kinase	O
(	O
JNK	O
)	O
phosphorylates	O
NFAT4	O
on	O
two	O
sites	O
.	O

Mutational	O
removal	O
of	O
the	O
JNK	O
phosphorylation	O
sites	O
caused	O
constitutive	O
nuclear	O
localization	O
of	O
NFAT4	O
.	O

In	O
contrast	O
,	O
JNK	O
activation	O
in	O
calcineurin-stimulated	O
cells	O
caused	O
nuclear	O
exclusion	O
of	O
NFAT4	O
.	O

These	O
findings	O
show	O
that	O
the	O
nuclear	O
accumulation	O
of	O
NFAT4	O
promoted	O
by	O
calcineurin	O
is	O
opposed	O
by	O
the	O
JNK	O
signal	O
transduction	O
pathway	O
.	O

Hypoxia	O
enhances	O
induction	O
of	O
endothelial	O
ICAM-1	O
:	O
role	O
for	O
metabolic	O
acidosis	O
and	O
proteasomes	O
.	O

Intercellular	O
adhesion	O
molecule	O
1	O
(	O
ICAM-1	O
)	O
is	O
an	O
important	O
molecule	O
in	O
promotion	O
of	O
polymorphonuclear	O
neutrophil	O
transendothelial	O
migration	O
during	O
inflammation	O
.	O

Coincident	O
with	O
many	O
inflammatory	O
diseases	O
is	O
tissue	O
hypoxia	O
.	O

Thus	O
we	O
hypothesized	B-SPECULATION
that	I-SPECULATION
combinations	I-SPECULATION
of	I-SPECULATION
hypoxia	I-SPECULATION
and	I-SPECULATION
inflammatory	I-SPECULATION
stimuli	I-SPECULATION
may	B-SPECULATION
differentially	I-SPECULATION
regulate	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
endothelial	I-SPECULATION
ICAM-1	I-SPECULATION
.	O

Human	O
endothelial	O
cells	O
were	O
exposed	O
to	O
hypoxia	O
in	O
the	O
presence	O
or	O
absence	B-NEGATION
of	I-NEGATION
added	I-NEGATION
lipopolysaccharide	I-NEGATION
(	I-NEGATION
LPS	I-NEGATION
)	I-NEGATION
and	O
examined	O
for	O
expression	O
of	O
functional	O
ICAM-1	O
.	O

Although	O
hypoxia	O
alone	O
did	O
not	B-NEGATION
induce	I-NEGATION
ICAM-1	I-NEGATION
,	O
the	O
combination	O
of	O
LPS	O
and	O
hypoxia	O
enhanced	O
(	O
3	O
±	O
0.4-fold	O
over	O
normoxia	O
)	O
ICAM-1	O
expression	O
.	O

Combinations	O
of	O
hypoxia	O
and	O
LPS	O
significantly	O
increased	O
lymphocyte	O
binding	O
,	O
and	O
such	O
increases	O
were	O
inhibited	O
by	O
addition	O
of	O
anti-ICAM-1	O
antibodies	O
or	O
antisense	O
oligonucleotides	O
.	O

Hypoxic	O
endothelia	O
showed	O
a	O
>	O
10-fold	O
increase	O
in	O
sensitivity	O
to	O
inhibitors	O
of	O
proteasome	O
activation	O
,	O
and	O
combinations	O
of	O
hypoxia	O
and	O
LPS	O
enhanced	O
proteasome-dependent	O
cytoplasmic-to-nuclear	O
localization	O
of	O
the	O
nuclear	O
transcription	O
factor-kappa	O
B	O
p65	O
(	O
Rel	O
A	O
)	O
subunit	O
.	O

Such	O
proteasome	O
activation	O
correlated	O
with	O
hypoxia-evoked	O
decreases	O
in	O
both	O
extracellular	O
and	O
intracellular	O
pH	O
.	O

We	O
conclude	O
from	O
these	O
studies	O
that	O
endothelial	O
hypoxia	O
provides	O
a	O
novel	O
,	O
proteasome-dependent	O
stimulus	O
for	O
ICAM-1	O
induction	O
.	O

Modulation	O
of	O
mRNA	O
expression	O
of	O
a	O
novel	O
human	O
myeloid-selective	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
gene	O
(	O
C	O
/	O
EBP	O
epsilon	O
)	O
.	O

Human	O
C	O
/	O
EBP	O
epsilon	O
is	O
a	O
newly	O
cloned	O
gene	O
coding	O
for	O
a	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
that	O
may	B-SPECULATION
be	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
myeloid	I-SPECULATION
differentiation	I-SPECULATION
.	O

Our	O
studies	O
showed	O
that	O
levels	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
were	O
markedly	O
increased	O
in	O
NB4	O
cells	O
(	O
promyelocytic	O
leukemia	O
line	O
)	O
,	O
because	O
they	O
were	O
induced	O
by	O
9-cis	O
retinoic	O
acid	O
(	O
9-cis	O
RA	O
)	O
to	O
differentiate	O
towards	O
granulocytes	O
.	O

Accumulation	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
occurred	O
as	O
early	O
as	O
1	O
hour	O
after	O
exposure	O
of	O
NB4	O
cells	O
to	O
9-cis	O
RA	O
(	O
5	O
x	O
10	O
(-	O
7	O
)	O
mol	O
/	O
L	O
)	O
;	O
and	O
at	O
48	O
hours	O
,	O
levels	O
were	O
increased	O
by	O
5.1-fold	O
.	O

Dose-response	O
studies	O
showed	O
that	O
10	O
(-	O
7	O
)	O
to	O
10	O
(-	O
6	O
)	O
mol	O
/	O
L	O
9-cis	O
RA	O
(	O
12	O
hours	O
)	O
resulted	O
in	O
peak	O
levels	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
;	O
but	O
even	O
10	O
(-	O
10	O
)	O
mol	O
/	O
L	O
9-cis	O
RA	O
increased	O
levels	O
of	O
these	O
transcripts	O
.	O

NB4	O
cells	O
pulse-exposed	O
(	O
30	O
minutes	O
)	O
to	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
,	O
washed	O
,	O
and	O
cultured	O
(	O
3	O
days	O
)	O
with	O
either	O
dimethylsulfoxide	O
(	O
DMSO	O
)	O
or	O
hexamethylene	O
bisacetamide	O
(	O
HMBA	O
)	O
had	O
a	O
prominent	O
increase	O
in	O
levels	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
and	O
an	O
increase	O
in	O
granulocytic	O
differentiation	O
,	O
but	O
exposure	O
to	O
either	O
DMSO	O
or	O
HMBA	O
alone	O
had	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
base	I-NEGATION
levels	I-NEGATION
of	I-NEGATION
C	I-NEGATION
/	I-NEGATION
EBP	I-NEGATION
epsilon	I-NEGATION
and	O
did	O
not	B-NEGATION
induce	I-NEGATION
differentiation	I-NEGATION
.	O

Macrophage-differentiation	O
of	O
NB4	O
reduced	O
levels	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
.	O

Nuclear	O
run-off	O
assays	O
and	O
half-life	O
studies	O
showed	O
that	O
accumulation	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
by	O
9-cis	O
RA	O
was	O
due	O
to	O
enhanced	O
transcription	O
.	O

Furthermore	O
,	O
this	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
accumulation	O
did	O
not	B-NEGATION
require	I-NEGATION
synthesis	I-NEGATION
of	I-NEGATION
new	I-NEGATION
protein	I-NEGATION
factors	I-NEGATION
because	O
9-cis	O
RA	O
induced	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
accumulation	O
in	O
the	O
absence	B-NEGATION
of	I-NEGATION
new	I-NEGATION
protein	I-NEGATION
synthesis	I-NEGATION
.	O

ATRA	O
also	O
induced	O
expression	O
of	O
C	O
/	O
EBP	O
epsilon	O
protein	O
in	O
NB4	O
cells	O
,	O
as	O
shown	O
by	O
Western	O
blotting	O
.	O

In	O
contrast	O
to	O
the	O
increase	O
of	O
C	O
/	O
EBP	O
epsilon	O
in	O
9-cis	O
RA-mediated	O
granulocytic	O
differentiation	O
,	O
the	O
DMSO-induced	O
differentiation	O
of	O
HL-60	O
cells	O
down	O
the	O
granulocytic	O
pathway	O
was	O
associated	O
with	O
an	O
initial	O
reduction	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
levels	O
.	O

In	O
summary	O
,	O
we	O
have	O
discovered	O
that	O
expression	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
is	O
markedly	O
enhanced	O
as	O
the	O
NB4	O
promyelocytes	O
are	O
induced	O
by	O
retinoids	O
to	O
differentiate	O
towards	O
granulocytes	O
.	O

This	O
induction	O
of	O
C	O
/	O
EBP	O
epsilon	O
mRNA	O
expression	O
is	O
transcriptionally	O
mediated	O
and	O
occurs	O
in	O
the	O
absence	B-NEGATION
of	I-NEGATION
synthesis	I-NEGATION
of	I-NEGATION
additional	I-NEGATION
protein	I-NEGATION
factors	I-NEGATION
.	O

We	O
suspect	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
C	I-SPECULATION
/	I-SPECULATION
EBP	I-SPECULATION
epsilon	I-SPECULATION
promoter	I-SPECULATION
/	I-SPECULATION
enhancer	I-SPECULATION
contains	I-SPECULATION
a	I-SPECULATION
retinoic	I-SPECULATION
acid-response	I-SPECULATION
element	I-SPECULATION
that	I-SPECULATION
is	I-SPECULATION
directly	I-SPECULATION
stimulated	I-SPECULATION
by	I-SPECULATION
retinoids	I-SPECULATION
.	O

Regulation	O
of	O
nuclear	O
factor-kappa	O
B	O
and	O
its	O
inhibitor	O
I	O
kappa	O
B-alpha	O
/	O
MAD-3	O
in	O
monocytes	O
by	O
Mycobacterium	O
tuberculosis	O
and	O
during	O
human	O
tuberculosis	O
.	O

Blood	O
monocytes	O
from	O
patients	O
with	O
active	O
tuberculosis	O
are	O
activated	O
in	O
vivo	O
,	O
as	O
evidenced	O
by	O
an	O
increase	O
in	O
the	O
stimulated	O
release	O
of	O
proinflammatory	O
cytokines	O
,	O
such	O
as	O
TNF-alpha	O
,	O
and	O
the	O
spontaneous	O
expression	O
of	O
IL-2R	O
.	O

Further	O
,	O
monocytes	O
from	O
patients	O
demonstrate	O
an	O
augmented	O
susceptibility	O
to	O
a	O
productive	O
infection	O
with	O
HIV-1	O
in	O
vitro	O
.	O

Mycobacterium	O
tuberculosis	O
and	O
its	O
components	O
are	O
strong	O
signals	O
to	O
activate	O
monocytes	O
to	O
production	O
of	O
cytokines	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
basis	O
of	O
activation	O
of	O
monocytes	O
during	O
active	O
tuberculosis	O
and	O
by	O
M.	O
tuberculosis	O
.	O

We	O
found	O
a	O
constitutive	O
degradation	O
of	O
I	O
kappa	O
B-alpha	O
,	O
the	O
major	O
cytoplasmic	O
inhibitor	O
of	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
,	O
in	O
freshly	O
isolated	O
PBMC	O
and	O
monocytes	O
from	O
patients	O
with	O
tuberculosis	O
.	O

In	O
contrast	O
,	O
I	O
kappa	O
B-alpha	O
levels	O
in	O
PBMC	O
and	O
monocytes	O
from	O
healthy	O
subjects	O
or	O
from	O
patients	O
with	O
nontuberculous	O
pulmonary	O
conditions	O
were	O
intact	O
.	O

Further	O
,	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
NF-kappa	O
B	O
was	O
activated	O
in	O
monocytes	O
from	O
tuberculous	O
patients	O
.	O

The	O
expression	O
of	O
I	O
kappa	O
B-alpha	O
gene	O
,	O
which	O
is	O
responsive	O
to	O
activation	O
by	O
NF-kappa	O
B	O
,	O
was	O
up-regulated	O
in	O
PBMC	O
and	O
monocytes	O
from	O
patients	O
,	O
but	O
not	B-NEGATION
in	I-NEGATION
mononuclear	I-NEGATION
cells	I-NEGATION
from	I-NEGATION
healthy	I-NEGATION
subjects	I-NEGATION
or	I-NEGATION
those	I-NEGATION
with	I-NEGATION
nontuberculous	I-NEGATION
lung	I-NEGATION
diseases	I-NEGATION
.	O

By	O
contrast	O
,	O
the	B-NEGATION
expression	I-NEGATION
of	I-NEGATION
other	I-NEGATION
adherence-associated	I-NEGATION
early	I-NEGATION
genes	I-NEGATION
,	I-NEGATION
such	I-NEGATION
as	I-NEGATION
IL-8	I-NEGATION
and	I-NEGATION
IL-1	I-NEGATION
beta	I-NEGATION
,	I-NEGATION
was	I-NEGATION
not	I-NEGATION
up-regulated	I-NEGATION
in	I-NEGATION
PBMC	I-NEGATION
of	I-NEGATION
tuberculous	I-NEGATION
patients	I-NEGATION
.	O

Further	O
,	O
M.	O
tuberculosis	O
and	O
its	O
tuberculin	O
,	O
purified	O
protein	O
derivative	O
,	O
induced	O
the	O
degradation	O
of	O
I	O
kappa	O
B-alpha	O
and	O
the	O
expression	O
of	O
I	O
kappa	O
B-alpha	O
mRNA	O
,	O
and	O
purified	O
protein	O
derivative	O
induced	O
the	O
activation	O
of	O
NF-kappa	O
B	O
in	O
monocytes	O
.	O

Expression	O
of	O
c-fos	O
correlates	O
with	O
IFN-alpha	O
responsiveness	O
in	O
Philadelphia	O
chromosome	O
positive	O
chronic	O
myelogenous	O
leukemia	O
.	O

This	O
study	O
evaluates	O
(	O
i	O
)	O
constitutive	O
levels	O
of	O
oncogene	O
and	O
p53	O
transcripts	O
in	O
chronic	O
phase	O
CML	O
patients	O
and	O
(	O
ii	O
)	O
their	O
modulations	O
subsequent	O
to	O
in	O
vivo	O
therapy	O
with	O
rIFN-alpha	O
2c	O
.	O

Peripheral	O
blood	O
mononuclear	O
cells	O
(	O
pbmc	O
)	O
and	O
bone	O
marrow	O
cells	O
of	O
26	O
patients	O
were	O
examined	O
for	O
c-fos	O
,	O
c-myc	O
,	O
p53	O
and	O
the	O
hybrid	O
bcr	O
/	O
abl	O
mRNA	O
levels	O
.	O

Results	O
indicated	B-SPECULATION
that	I-SPECULATION
(	I-SPECULATION
i	I-SPECULATION
)	I-SPECULATION
constitutive	I-SPECULATION
c-fos	I-SPECULATION
transcript	I-SPECULATION
levels	I-SPECULATION
are	I-SPECULATION
significantly	I-SPECULATION
higher	I-SPECULATION
in	I-SPECULATION
patients	I-SPECULATION
subsequently	I-SPECULATION
responding	I-SPECULATION
to	I-SPECULATION
IFN-alpha	I-SPECULATION
therapy	I-SPECULATION
(	I-SPECULATION
p	I-SPECULATION
<	I-SPECULATION
0.01	I-SPECULATION
)	I-SPECULATION
and	I-SPECULATION
positively	I-SPECULATION
correlated	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
proportion	I-SPECULATION
of	I-SPECULATION
lymphocytes	I-SPECULATION
(	I-SPECULATION
r	I-SPECULATION
=	I-SPECULATION
0.6895	I-SPECULATION
,	I-SPECULATION
p	I-SPECULATION
<	I-SPECULATION
0.01	I-SPECULATION
)	I-SPECULATION
and	I-SPECULATION
negatively	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
proportion	I-SPECULATION
of	I-SPECULATION
immature	I-SPECULATION
cells	I-SPECULATION
(	I-SPECULATION
r	I-SPECULATION
=	I-SPECULATION
-	I-SPECULATION
0.568	I-SPECULATION
,	I-SPECULATION
p	I-SPECULATION
<	I-SPECULATION
0.01	I-SPECULATION
)	I-SPECULATION
contained	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
pbmc	I-SPECULATION
preparations	I-SPECULATION
tested	I-SPECULATION
,	I-SPECULATION
(	I-SPECULATION
ii	I-SPECULATION
)	I-SPECULATION
constitutive	I-SPECULATION
mRNA	I-SPECULATION
levels	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
hybrid	I-SPECULATION
bcr	I-SPECULATION
/	I-SPECULATION
abl	I-SPECULATION
,	I-SPECULATION
c-myc	I-SPECULATION
and	I-SPECULATION
p53	I-SPECULATION
are	I-SPECULATION
positively	I-SPECULATION
correlated	I-SPECULATION
with	I-SPECULATION
each	I-SPECULATION
other	I-SPECULATION
,	I-SPECULATION
but	I-SPECULATION
failed	B-NEGATION
to	I-NEGATION
relate	I-NEGATION
to	I-NEGATION
disease	I-NEGATION
parameters	I-NEGATION
,	O
and	O
(	O
iii	O
)	O
acute	O
and	O
chronic	O
in	O
vivo	O
exposure	O
to	O
IFN-alpha	O
is	O
accompanied	O
by	O
upregulation	O
of	O
c-fos	O
and	O
downregulation	O
of	O
c-myc	O
mRNA	O
levels	O
in	O
responder	O
patients	O
.	O

Molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
murine	O
cDNA	O
encoding	O
transcription	O
factor	O
NFATc	O
.	O

Transcription	O
factors	O
of	O
the	O
NFAT	O
(	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
)	O
family	O
play	O
important	O
roles	O
in	O
immune	O
and	O
inflammatory	O
responses	O
by	O
regulating	O
the	O
expression	O
of	O
genes	O
encoding	O
cytokines	O
and	O
immunoregulatory	O
proteins	O
.	O

Here	O
we	O
describe	O
cloning	O
and	O
characterization	O
of	O
full-length	O
cDNA	O
encoding	O
murine	O
(	O
m	O
)	O
NFATc	O
which	O
predicts	O
that	O
the	O
protein	O
has	O
all	O
the	O
conserved	O
structural	O
motifs	O
of	O
NFAT	O
family	O
members	O
,	O
including	O
the	O
rel	O
homology	O
domain	O
,	O
the	O
NFAT	O
homology	O
domain	O
and	O
the	O
nuclear	O
translocation	O
signals	O
.	O

mNFATc	O
complexed	O
with	O
AP-1	O
bound	O
specifically	O
to	O
the	O
murine	O
IL-2	O
NFAT	O
recognition	O
sequence	O
and	O
activated	O
transcription	O
from	O
the	O
co-transfected	O
IL-2	O
promoter	O
in	O
COS-7	O
cells	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
the	O
cDNA	O
probe	O
hybridized	O
with	O
a	O
4.5	O
kb	O
transcript	O
which	O
is	O
highly	O
inducible	O
in	O
murine	O
T	O
cells	O
.	O

By	O
Northern	O
and	O
in	O
situ	O
hybridization	O
,	O
mNFATc	O
transcript	O
was	O
detected	O
from	O
the	O
early	O
stage	O
of	O
development	O
.	O

In	O
the	O
mouse	O
embryo	O
,	O
mNFATc	O
transcript	O
was	O
strongly	O
expressed	O
in	O
thymus	O
,	O
lung	O
and	O
submandibular	O
gland	O
and	O
weakly	O
in	O
skeletal	O
muscle	O
and	O
heart	O
suggesting	B-SPECULATION
that	I-SPECULATION
mNFATc	I-SPECULATION
may	B-SPECULATION
have	I-SPECULATION
a	I-SPECULATION
role	I-SPECULATION
both	I-SPECULATION
in	I-SPECULATION
embryogenesis	I-SPECULATION
and	I-SPECULATION
in	I-SPECULATION
mature	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

Phosphatidylinositol	O
3-kinase	O
couples	O
the	O
interleukin-2	O
receptor	O
to	O
the	O
cell	O
cycle	O
regulator	O
E2F	O
.	O

Cell	O
cycle	O
progression	O
initiated	O
by	O
interleukin-2	O
(	O
IL-2	O
)	O
in	O
T	O
cells	O
is	O
critical	O
for	O
lymphoproliferation	O
and	O
an	O
immune	O
response	O
.	O

Phosphatidyl	O
inositol	O
3-kinase	O
(	O
PI3K	O
)	O
is	O
activated	O
by	O
IL-2	O
.	O

However	O
,	O
nuclear	B-SPECULATION
targets	I-SPECULATION
for	I-SPECULATION
PI3K	I-SPECULATION
are	I-SPECULATION
not	I-SPECULATION
known	I-SPECULATION
.	O

Here	O
we	O
identify	O
the	O
cell	O
cycle	O
regulator	O
E2F	O
as	O
an	O
IL-2	O
target	O
in	O
T	O
lymphocytes	O
and	O
PI3K	O
as	O
the	O
critical	O
signaling	O
pathway	O
.	O

We	O
eliminate	O
both	O
Stat5	O
and	O
Raf	O
/	O
MEK	O
pathways	O
from	O
E2F	O
regulation	O
.	O

Protein	O
kinase	O
B	O
(	O
PKB	O
)	O
is	O
activated	O
by	O
IL-2	O
via	O
PI3K	O
.	O

The	O
expression	O
of	O
an	O
active	O
PKB	O
is	O
sufficient	O
to	O
induce	O
E2F	O
activity	O
.	O

Inhibition	O
of	O
PI3K	O
inhibits	O
phosphorylation	O
of	O
Rb	O
,	O
induction	O
of	O
cyclin	O
D3	O
,	O
and	O
degradation	O
of	O
p27kip1	O
.	O

These	O
results	O
establish	O
a	O
crucial	O
PI3K	O
/	O
PKB-mediated	O
link	O
between	O
the	O
IL-2	O
teceptor	O
and	O
the	O
cell	O
cycle	O
machinery	O
.	O

Thiol	O
modulation	O
inhibits	O
the	O
interleukin	O
(	O
IL	O
)-	O
1-mediated	O
activation	O
of	O
an	O
IL-1	O
receptor-associated	O
protein	O
kinase	O
and	O
NF-kappa	O
B	O
.	O

The	O
interleukin-1	O
receptor	O
type	O
I	O
(	O
IL-1RI	O
)	O
is	O
associated	O
with	O
other	O
proteins	O
thus	O
forming	O
a	O
complex	O
system	O
by	O
which	O
IL-1	O
exerts	O
its	O
various	O
signals	O
.	O

The	B-SPECULATION
initiating	I-SPECULATION
event	I-SPECULATION
is	I-SPECULATION
still	I-SPECULATION
uncertain	I-SPECULATION
,	O
but	O
activation	O
of	O
a	O
recently	O
described	O
receptor-associated	O
protein	O
kinase	O
is	O
one	O
of	O
the	O
earliest	O
events	O
detectable	O
(	O
Martin	O
et	O
al.	O
,	O
Eur.J.Immunol.1994.24	O
:	O
1566	O
)	O
.	O

IL-1	O
signaling	O
is	O
commonly	O
accompanied	O
by	O
oxidative	O
processes	O
and	O
is	B-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
subject	I-SPECULATION
to	I-SPECULATION
redox	I-SPECULATION
regulation	I-SPECULATION
.	O

We	O
therefore	O
investigated	O
whether	B-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
IL-1RI-associated	I-SPECULATION
protein	I-SPECULATION
kinase	I-SPECULATION
and	O
could	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
target	I-SPECULATION
for	I-SPECULATION
redox	I-SPECULATION
regulation	I-SPECULATION
whether	B-SPECULATION
an	I-SPECULATION
altered	I-SPECULATION
activity	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
kinase	I-SPECULATION
could	B-SPECULATION
influence	I-SPECULATION
IL-1-mediated	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
activation	I-SPECULATION
.	O

A	O
murine	O
T	O
cell	O
line	O
,	O
EL4	O
,	O
was	O
stimulated	O
with	O
IL-1	O
with	O
and	O
without	B-NEGATION
pretreatment	I-NEGATION
with	I-NEGATION
different	I-NEGATION
compounds	I-NEGATION
known	I-NEGATION
to	I-NEGATION
influence	I-NEGATION
the	I-NEGATION
cellular	I-NEGATION
redox	I-NEGATION
status	I-NEGATION
.	O

Thiol	O
modifying	O
agents	O
like	O
diamide	O
,	O
menadione	O
,	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
diethyl	O
dithiocarbamate	O
or	O
phenylarsine	O
oxide	O
inhibited	O
the	O
IL-1-induced	O
activation	O
of	O
the	O
IL-1RI-associated	O
protein	O
kinase	O
.	O

N-Acetylcysteine	O
,	O
alpha,alpha	O
'-	O
dipyridyl	O
,	O
aminotriazole	O
or	O
nitrofurantoin	O
did	O
not	B-NEGATION
show	I-NEGATION
any	I-NEGATION
effect	I-NEGATION
.	O

The	O
inhibition	O
by	O
PDTC	O
was	O
reversible	O
unless	O
glutathione	O
synthesis	O
was	O
blocked	O
by	O
buthionine	O
sulfoximine	O
.	O

The	O
described	O
conditions	O
which	O
inhibited	O
or	O
prevented	O
the	O
activation	O
of	O
the	O
IL-1RI-associated	O
kinase	O
similarly	O
impaired	O
the	O
activation	O
of	O
NF-kappa	O
B	O
in	O
EL4	O
cells	O
.	O

From	O
these	O
observations	O
we	O
conclude	O
that	O
free	O
thiols	O
in	O
the	O
IL-1RI	O
complex	O
are	O
essential	O
for	O
the	O
activation	O
of	O
the	O
IL-1RI-associated	O
protein	O
kinase	O
and	O
that	O
this	O
process	O
is	O
mandatory	O
for	O
IL-1	O
signaling	O
leading	O
to	O
NF-kappa	O
B	O
activation	O
.	O

ATF1	O
and	O
CREB	O
trans-activate	O
a	O
cell	O
cycle	O
regulated	O
histone	O
H4	O
gene	O
at	O
a	O
distal	O
nuclear	O
matrix	O
associated	O
promoter	O
element	O
.	O

Proteins	O
of	O
the	O
ATF	O
/	O
CREB	O
class	O
of	O
transcription	O
factors	O
stimulate	O
gene	O
expression	O
of	O
several	O
cell	O
growth-related	O
genes	O
through	O
protein	O
kinase	O
A-related	O
cAMP	O
response	O
elements	O
.	O

The	O
promoter	O
activity	O
of	O
cell	O
cycle	O
regulated	O
histone	O
H4	O
genes	O
is	O
regulated	O
by	O
at	O
least	O
four	O
principal	O
cis-acting	O
elements	O
which	O
mediate	O
G1	O
/	O
S	O
phase	O
control	O
and	O
/	O
or	O
enhancement	O
of	O
transcription	O
during	O
the	O
cell	O
cycle	O
.	O

Using	O
protein-DNA	O
interaction	O
assays	O
we	O
show	O
that	O
the	O
H4	O
promoter	O
contains	O
two	O
ATF	O
/	O
CREB	O
recognition	O
motifs	O
which	O
interact	O
with	O
CREB	O
,	O
ATF1	O
,	O
and	O
ATF2	O
but	O
not	B-NEGATION
with	I-NEGATION
ATF4	I-NEGATION
/	I-NEGATION
CREB2	I-NEGATION
.	O

One	O
ATF	O
/	O
CRE	O
motif	O
is	O
located	O
in	O
the	O
distal	O
promoter	O
at	O
the	O
nuclear	O
matrix-associated	O
Site	O
IV	O
,	O
and	O
the	O
second	O
motif	O
is	O
present	O
in	O
the	O
proximal	O
promoter	O
at	O
Site	O
I	O
.	O

Both	O
ATF	O
/	O
CRE	O
motifs	O
overlap	O
binding	O
sequences	O
for	O
the	O
multifunctional	O
YY1	O
transcription	O
factor	O
,	O
which	O
has	O
previously	O
been	O
shown	O
to	O
be	O
nuclear	O
matrix	O
associated	O
.	O

Subnuclear	O
fractionation	O
reveals	O
that	O
there	O
are	O
two	O
ATF1	O
isoforms	O
which	B-SPECULATION
appear	I-SPECULATION
to	I-SPECULATION
differ	I-SPECULATION
with	I-SPECULATION
respect	I-SPECULATION
to	I-SPECULATION
DNA	I-SPECULATION
binding	I-SPECULATION
activity	I-SPECULATION
and	I-SPECULATION
partition	I-SPECULATION
selectively	I-SPECULATION
between	I-SPECULATION
nuclear	I-SPECULATION
matrix	I-SPECULATION
and	I-SPECULATION
nonmatrix	I-SPECULATION
compartments	I-SPECULATION
,	I-SPECULATION
consistent	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
nuclear	I-SPECULATION
matrix	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
.	O

Site-directed	O
mutational	O
studies	O
demonstrate	O
that	O
Site	O
I	O
and	O
Site	O
IV	O
together	O
support	O
ATF1	O
-	O
and	O
CREB-induced	O
trans-activation	O
of	O
the	O
H4	O
promoter	O
.	O

Thus	O
,	O
our	O
data	O
establish	O
that	O
ATF	O
/	O
CREB	O
factors	O
functionally	O
modulate	O
histone	O
H4	O
gene	O
transcription	O
at	O
distal	O
and	O
proximal	O
promoter	O
elements	O
.	O

IL-2	O
and	O
IL-7	O
induce	O
heterodimerization	O
of	O
STAT5	O
isoforms	O
in	O
human	O
peripheral	O
blood	O
T	O
lymphoblasts	O
.	O

Despite	O
differences	O
in	O
T	O
cell	O
responses	O
induced	O
by	O
interleukin	O
(	O
IL	O
)-	O
2	O
and	O
IL-7	O
,	O
both	O
cytokines	O
modulate	O
T	O
cell	O
functions	O
by	O
activation	O
of	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STAT	O
)	O
proteins	O
.	O

We	O
examined	O
the	O
contribution	O
of	O
the	O
two	O
isoforms	O
of	O
STAT5	O
,	O
STAT5A	O
and	O
STAT5B	O
,	O
to	O
IL-2	O
-	O
and	O
IL-7-induced	O
activation	O
of	O
human	O
peripheral	O
blood	O
T	O
lymphoblasts	O
.	O

Both	O
cytokines	O
induced	O
assembly	O
of	O
STAT5A	O
and	O
STAT5B	O
containing	O
complexes	O
capable	O
of	O
binding	O
to	O
the	O
interferon-gamma	O
activation	O
sequence	O
(	O
GAS	O
)	O
,	O
and	O
these	O
complexes	O
rapidly	O
translocated	O
(	O
within	O
1	O
min	O
)	O
into	O
the	O
nucleus	O
of	O
IL-2	O
-	O
or	O
IL-7-treated	O
cells	O
.	O

The	O
kinetics	O
of	O
this	O
translocation	O
were	O
delayed	O
in	O
IL-7-treated	O
as	O
compared	O
to	O
IL-2-treated	O
cells	O
.	O

IL-2	O
and	O
IL-7	O
were	O
equivalent	O
in	O
their	O
ability	O
to	O
induce	O
tyrosine	O
phosphorylation	O
of	O
STAT5A	O
and	O
STAT5B	O
and	O
to	O
facilitate	O
binding	O
of	O
these	O
STATs	O
to	O
an	O
immobilized	O
GAS	O
element	O
.	O

Both	O
IL-2	O
and	O
IL-7	O
induced	O
substantial	O
amounts	O
of	O
STAT5A	O
/	O
STAT5B	O
heterodimerization	O
.	O

Moreover	O
,	O
we	O
observed	O
constitutive	O
association	O
of	O
STAT3	O
with	O
each	O
STAT5	O
isomer	O
.	O

These	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
IL-2	I-SPECULATION
and	I-SPECULATION
IL-7	I-SPECULATION
induce	I-SPECULATION
assembly	I-SPECULATION
of	I-SPECULATION
STAT	I-SPECULATION
heterodimers	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
similar	I-SPECULATION
manner	I-SPECULATION
and	I-SPECULATION
that	I-SPECULATION
subsequent	B-SPECULATION
cellular	I-SPECULATION
responses	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
driven	I-SPECULATION
by	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
similar	I-SPECULATION
sets	I-SPECULATION
of	I-SPECULATION
genes	I-SPECULATION
.	O

Molecular	O
mechanisms	O
of	O
anoxia	O
/	O
reoxygenation-induced	O
neutrophil	O
adherence	O
to	O
cultured	O
endothelial	O
cells	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
(	O
1	O
)	O
determine	O
the	O
time	O
course	O
of	O
neutrophil	O
adhesion	O
to	O
monolayers	O
of	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVECs	O
)	O
that	O
were	O
exposed	O
to	O
60	O
minutes	O
of	O
anoxia	O
followed	O
by	O
30	O
to	O
600	O
minutes	O
of	O
reoxygenation	O
and	O
(	O
2	O
)	O
define	O
the	O
mechanisms	O
responsible	O
for	O
both	O
the	O
early	O
(	O
minutes	O
)	O
and	O
late	O
(	O
hours	O
)	O
hyperadhesivity	O
of	O
postanoxic	O
HUVECs	O
to	O
human	O
neutrophils	O
.	O

The	O
results	O
clearly	O
demonstrate	O
that	O
anoxia	O
/	O
reoxygenation	O
(	O
A	O
/	O
R	O
)	O
leads	O
to	O
a	O
biphasic	O
increase	O
in	O
neutrophil	O
adhesion	O
to	O
HUVECs	O
,	O
with	O
peak	O
responses	O
occurring	O
at	O
30	O
minutes	O
(	O
phase	O
1	O
)	O
and	O
240	O
minutes	O
(	O
phase	O
2	O
)	O
after	O
reoxygenation	O
.	O

Oxypurinol	O
and	O
catalase	O
inhibited	O
phase-1	O
adhesion	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
role	I-SPECULATION
for	I-SPECULATION
xanthine	I-SPECULATION
oxidase	I-SPECULATION
and	I-SPECULATION
H2O2	I-SPECULATION
.	O

In	O
comparison	O
,	O
platelet	O
activating	O
factor	O
(	O
PAF	O
)	O
contributed	O
to	O
both	O
phases	O
of	O
neutrophil	O
adhesion	O
.	O

Anti-intercellular	O
adhesion	O
molecule-1	O
(	O
ICAM-1	O
)	O
and	O
anti-P-selectin	O
antibodies	O
(	O
monoclonal	O
antibodies	O
[	O
mAbs	O
])	O
attenuated	O
phase-1	O
neutrophil	O
adhesion	O
,	O
consistent	O
with	O
roles	O
for	O
constitutively	O
expressed	O
ICAM-1	O
and	O
enhanced	O
surface	O
expression	O
of	O
preformed	O
P-selectin	O
.	O

Phase-2	O
neutrophil	O
adhesion	O
was	O
attenuated	O
by	O
an	O
anti-E-selectin	O
mAb	O
,	O
indicating	B-SPECULATION
a	I-SPECULATION
dominant	I-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
adhesion	I-SPECULATION
molecule	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
late	I-SPECULATION
phase	I-SPECULATION
response	I-SPECULATION
.	O

Pretreatment	O
with	O
actinomycin	O
D	O
and	O
cycloheximide	O
or	O
with	O
competing	O
ds-oligonucleotides	O
containing	O
the	O
nuclear	O
factor-kappa	O
B	O
or	O
activator	O
protein-1	O
cognate	O
DNA	O
sequences	O
significantly	O
attenuated	O
phase-2	O
response	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
role	I-SPECULATION
for	I-SPECULATION
de	I-SPECULATION
novo	I-SPECULATION
macromolecule	I-SPECULATION
synthesis	I-SPECULATION
.	O

Surface	O
expression	O
of	O
ICAM-1	O
,	O
P-selectin	O
,	O
and	O
E-selectin	O
on	O
HUVECs	O
correlated	O
with	O
the	O
phase-1	O
and	O
-	O
2	O
neutrophil	O
adhesion	O
responses	O
.	O

Collectively	O
,	O
these	O
findings	O
indicate	B-SPECULATION
that	I-SPECULATION
A	I-SPECULATION
/	I-SPECULATION
R	I-SPECULATION
elicits	I-SPECULATION
a	I-SPECULATION
two-phase	I-SPECULATION
neutrophil-endothelial	I-SPECULATION
cell	I-SPECULATION
adhesion	I-SPECULATION
response	I-SPECULATION
that	I-SPECULATION
involves	I-SPECULATION
transcription-independent	I-SPECULATION
and	I-SPECULATION
transcription-dependent	I-SPECULATION
surface	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
different	I-SPECULATION
endothelial	I-SPECULATION
cell	I-SPECULATION
adhesion	I-SPECULATION
molecules	I-SPECULATION
.	O

c-Rel	O
and	O
p65	O
subunits	O
bind	O
to	O
an	O
upstream	O
NF-kappaB	O
site	O
in	O
human	O
granulocyte	O
macrophage-colony	O
stimulating	O
factor	O
promoter	O
involved	O
in	O
phorbol	O
ester	O
response	O
in	O
5637	O
cells	O
.	O

To	O
further	O
clarify	O
the	O
complex	O
transcriptional	O
regulation	O
of	O
the	O
human	O
GM-CSF	O
gene	O
,	O
which	O
was	O
extensively	O
investigated	O
in	O
activated	O
T	O
cells	O
,	O
we	O
have	O
studied	O
the	O
role	O
of	O
an	O
upstream	O
NF-kappaB	O
like	O
site	O
in	O
the	O
5637	O
non-lymphoid	O
cell	O
line	O
,	O
which	O
derives	O
from	O
a	O
bladder	O
carcinoma	O
and	O
constitutively	O
produces	O
GM-CSF	O
.	O

This	O
sequence	O
,	O
named	O
the	O
A	O
element	O
,	O
has	O
an	O
active	O
role	O
on	O
GM-CSF	O
transcription	O
and	O
is	O
responsive	O
to	O
the	O
tumor	O
promoter	O
PMA	O
in	O
transient	O
transfection	O
experiments	O
.	O

We	O
describe	O
here	O
a	O
heterodimeric	O
binding	O
complex	O
of	O
NF-kappaB	O
subunits	O
(	O
c-Rel	O
and	O
p65	O
)	O
which	O
is	O
identical	O
to	O
the	O
one	O
obtained	O
using	O
the	O
HIV-LTR-kappaB	O
site	O
as	O
recognition	O
sequence	O
and	O
different	O
from	O
the	O
one	O
(	O
c-Rel	O
and	O
p50	O
)	O
observed	O
with	O
nuclear	O
extracts	O
from	O
Mo	O
T-lymphoid	O
HTLV-II	O
infected	O
cells	O
.	O

Cyclosporin	O
A	O
inhibits	O
monocyte	O
tissue	O
factor	O
activation	O
in	O
cardiac	O
transplant	O
recipients	O
.	O

BACKGROUND	O
:	O
Fibrin	O
deposition	O
and	O
thrombosis	O
have	O
been	O
implicated	O
in	O
both	O
allograft	O
rejection	O
and	O
vasculopathy	O
after	O
cardiac	O
transplantation	O
.	O

Because	O
monocytes	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
pathophysiology	O
of	O
intravascular	O
coagulation	O
activation	O
through	O
their	O
ability	O
to	O
synthesize	O
tissue	O
factor	O
(	O
TF	O
)	O
,	O
we	O
asked	O
(	O
1	O
)	O
whether	B-SPECULATION
monocyte	I-SPECULATION
TF	I-SPECULATION
activation	I-SPECULATION
occurs	I-SPECULATION
in	I-SPECULATION
cardiac	I-SPECULATION
transplant	I-SPECULATION
recipients	I-SPECULATION
and	O
(	O
2	O
)	O
whether	B-SPECULATION
monocyte	I-SPECULATION
TF	I-SPECULATION
expression	I-SPECULATION
is	I-SPECULATION
affected	I-SPECULATION
by	I-SPECULATION
treatment	I-SPECULATION
with	I-SPECULATION
cyclosporin	I-SPECULATION
A	I-SPECULATION
(	I-SPECULATION
CsA	I-SPECULATION
)	I-SPECULATION
.	O

METHODS	O
AND	O
RESULTS	O
:	O
We	O
measured	O
levels	O
of	O
TF	O
activity	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
and	O
highly	O
purified	O
monocytes	O
/	O
macrophages	O
from	O
10	O
consecutive	O
cardiac	O
transplant	O
recipients	O
and	O
10	O
healthy	O
control	O
subjects	O
.	O

TF	O
activity	O
generated	O
by	O
both	O
unstimulated	O
and	O
endotoxin-stimulated	O
cells	O
was	O
significantly	O
higher	O
in	O
transplant	O
recipients	O
than	O
in	O
control	O
subjects	O
(	O
P	O
<.	O
05	O
)	O
.	O

Increased	O
monocyte	O
TF	O
expression	O
in	O
transplant	O
recipients	O
was	O
shown	O
to	O
be	O
adversely	O
affected	O
by	O
treatment	O
with	O
CsA	O
:	O
TF	O
induction	O
was	O
markedly	O
reduced	O
by	O
CsA	O
serum	O
concentrations	O
reaching	O
peak	O
CsA	O
drug	O
levels	O
.	O

Inhibition	O
of	O
TF	O
induction	O
in	O
the	O
presence	O
of	O
high	O
CsA	O
blood	O
concentrations	O
was	O
also	O
observed	O
when	O
stimulation	O
of	O
cells	O
was	O
performed	O
with	O
interferon-gamma	O
or	O
interleukin-1beta	O
.	O

As	O
shown	O
by	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
and	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
respectively	O
,	O
treatment	O
with	O
CsA	O
leads	O
to	O
decreased	O
TF	O
mRNA	O
expression	O
and	O
reduced	O
activation	O
of	O
the	O
NF-kappaB	O
transcription	O
factor	O
,	O
which	O
is	O
known	O
to	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
TF	O
promotor	O
in	O
human	O
monocytes	O
.	O

CONCLUSIONS	O
:	O
This	O
study	O
demonstrates	O
that	O
TF	O
activation	O
,	O
occurring	O
in	O
mononuclear	O
cells	O
of	O
cardiac	O
transplant	O
recipients	O
,	O
is	O
inhibited	O
by	O
treatment	O
with	O
CsA	O
.	O

Inhibition	O
of	O
monocyte	O
TF	O
induction	O
by	O
CsA	O
may	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
its	I-SPECULATION
successful	I-SPECULATION
use	I-SPECULATION
in	I-SPECULATION
cardiac	I-SPECULATION
transplant	I-SPECULATION
medicine	I-SPECULATION
and	O
might	B-SPECULATION
be	I-SPECULATION
useful	I-SPECULATION
in	I-SPECULATION
managing	I-SPECULATION
further	I-SPECULATION
settings	I-SPECULATION
of	I-SPECULATION
vascular	I-SPECULATION
pathology	I-SPECULATION
also	I-SPECULATION
known	I-SPECULATION
to	I-SPECULATION
involve	I-SPECULATION
TF	I-SPECULATION
expression	I-SPECULATION
and	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
.	O

Agonistic	O
activity	O
of	O
a	O
CD40-specific	O
single-chain	O
Fv	O
constructed	O
from	O
the	O
variable	O
regions	O
of	O
mAb	O
G28-5	O
.	O

A	O
single-chain	O
Fv	O
(	O
sFv	O
)	O
was	O
expressed	O
from	O
the	O
variable	O
regions	O
of	O
the	O
CD40-specific	O
mAb	O
G28-5	O
.	O

The	O
molecule	O
bound	O
CD40	O
with	O
a	O
high	O
affinity	O
(	O
2.2	O
nM	O
)	O
and	O
was	O
a	O
monomer	O
in	O
solution	O
.	O

Surprisingly	O
,	O
G28-5	O
sFv	O
was	O
a	O
potent	O
CD40	O
agonist	O
that	O
rapidly	O
crosslinked	O
CD40	O
on	O
the	O
cell	O
surface	O
but	O
did	O
not	B-NEGATION
crosslink	I-NEGATION
CD40-Ig	I-NEGATION
in	I-NEGATION
solution	I-NEGATION
.	O

G28-5	O
sFv	O
was	O
a	O
more	O
potent	O
agonist	O
than	O
G28-5	O
IgG	O
and	O
was	O
able	O
to	O
stimulate	O
CD40	O
responses	O
by	O
B	O
cells	O
and	O
monocytes	O
.	O

G28-5	O
IgG	O
partially	O
blocked	O
,	O
whereas	O
G28-5	O
sFv	O
augmented	O
CD40	O
responses	O
during	O
stimulation	O
with	O
natural	O
ligand	O
(	O
gp39-CD8	O
fusion	O
protein	O
)	O
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
functional	I-SPECULATION
activity	I-SPECULATION
of	I-SPECULATION
ligands	I-SPECULATION
built	I-SPECULATION
from	I-SPECULATION
the	I-SPECULATION
binding	I-SPECULATION
site	I-SPECULATION
of	I-SPECULATION
G28-5	I-SPECULATION
is	I-SPECULATION
highly	I-SPECULATION
dependent	I-SPECULATION
upon	I-SPECULATION
the	I-SPECULATION
size	I-SPECULATION
and	I-SPECULATION
physical	I-SPECULATION
properties	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
molecule	I-SPECULATION
both	I-SPECULATION
in	I-SPECULATION
solution	I-SPECULATION
and	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
cell	I-SPECULATION
surfaces	I-SPECULATION
.	O

Competent	O
transcription	O
initiation	O
by	O
RNA	O
polymerase	O
II	O
in	O
cell-free	O
extracts	O
from	O
xeroderma	O
pigmentosum	O
groups	O
B	O
and	O
D	O
in	O
an	O
optimized	O
RNA	O
transcription	O
assay	O
.	O

The	O
human	O
autosomal	O
recessive	O
disease	O
,	O
xeroderma	O
pigmentosum	O
(	O
XP	O
)	O
,	O
can	O
result	O
from	O
mutations	O
in	O
any	O
one	O
of	O
seven	O
genes	O
,	O
designated	O
XPA	O
through	O
XPG	O
.	O

Of	O
these	O
,	O
the	O
XPB	O
and	O
XPD	O
genes	O
encode	O
proteins	O
that	O
are	O
subunits	O
of	O
a	O
general	O
transcription	O
factor	O
,	O
TFIIH	O
,	O
involved	O
in	O
both	O
nucleotide	O
excision	O
repair	O
(	O
NER	O
)	O
and	O
initiation	O
of	O
mRNA	O
transcription	O
by	O
RNA	O
polymerase	O
II	O
.	O

In	O
humans	O
,	O
mutation	O
of	O
the	O
XPB	O
or	O
XPD	O
gene	O
impairs	O
NER	O
,	O
resulting	O
in	O
hyper-sensitivity	O
to	O
sunlight	O
and	O
greatly	O
increased	O
skin	O
tumor	O
formation	O
.	O

However	O
,	O
no	B-NEGATION
transcription	I-NEGATION
deficiency	I-NEGATION
has	I-NEGATION
been	I-NEGATION
demonstrated	I-NEGATION
in	I-NEGATION
either	I-NEGATION
XP-B	I-NEGATION
or	I-NEGATION
XP-D	I-NEGATION
.	O

We	O
have	O
employed	O
an	O
optimized	O
cell-free	O
RNA	O
transcription	O
assay	O
to	O
analyze	O
transcription	O
activity	O
of	O
XP-B	O
and	O
XP-D	O
.	O

Although	O
the	O
growth	O
rate	O
was	O
normal	O
,	O
the	O
XP-B	O
and	O
XP-D	O
cells	O
contained	O
reduced	O
amounts	O
of	O
TFIIH	O
.	O

Extracts	O
prepared	O
from	O
XP-B	O
and	O
XP-D	O
lymphoblastoid	O
cells	O
exhibited	O
similar	O
transcription	O
activity	O
from	O
the	O
adenovirus	O
major	O
late	O
promoter	O
when	O
compared	O
to	O
that	O
in	O
extracts	O
from	O
normal	O
cells	O
.	O

Thus	O
,	O
we	O
conclude	O
that	O
the	O
XP-B	O
and	O
XP-D	O
lymphoblastoid	O
cells	O
do	O
not	B-NEGATION
have	I-NEGATION
impaired	I-NEGATION
RNA	I-NEGATION
transcription	I-NEGATION
activity	I-NEGATION
.	O

We	O
consider	O
the	O
possible	B-SPECULATION
consequences	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
reduced	I-SPECULATION
cellular	I-SPECULATION
content	I-SPECULATION
of	I-SPECULATION
TFIIH	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
clinical	I-SPECULATION
symptoms	I-SPECULATION
in	I-SPECULATION
XP-B	I-SPECULATION
or	I-SPECULATION
XP-D	I-SPECULATION
patients	I-SPECULATION
,	O
and	O
discuss	O
a	O
'	O
conditional	O
phenotype	O
'	O
that	O
may	B-SPECULATION
involve	I-SPECULATION
an	I-SPECULATION
impairment	I-SPECULATION
of	I-SPECULATION
cellular	I-SPECULATION
function	I-SPECULATION
only	I-SPECULATION
under	I-SPECULATION
certain	I-SPECULATION
growth	I-SPECULATION
conditions	I-SPECULATION
.	O

Cyclosporin	O
A	O
inhibits	O
early	O
mRNA	O
expression	O
of	O
G0	O
/	O
G1	O
switch	O
gene	O
2	O
(	O
G0S2	O
)	O
in	O
cultured	O
human	O
blood	O
mononuclear	O
cells	O
.	O

Cyclosporin	O
A	O
(	O
CsA	O
)	O
may	B-SPECULATION
achieve	I-SPECULATION
its	I-SPECULATION
immunosuppressive	I-SPECULATION
effects	I-SPECULATION
by	I-SPECULATION
inhibiting	I-SPECULATION
the	I-SPECULATION
calcium	I-SPECULATION
-	I-SPECULATION
and	I-SPECULATION
calmodulin-dependent	I-SPECULATION
phosphatase	I-SPECULATION
calcineurin	I-SPECULATION
which	I-SPECULATION
is	I-SPECULATION
required	I-SPECULATION
for	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
target	I-SPECULATION
genes	I-SPECULATION
by	I-SPECULATION
members	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
NFAT	I-SPECULATION
(	I-SPECULATION
nuclear	I-SPECULATION
factor	I-SPECULATION
of	I-SPECULATION
activated	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
)	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
family	I-SPECULATION
.	O

Among	O
these	O
target	O
genes	O
is	O
the	O
gene	O
encoding	O
interleukin-2	O
(	O
IL2	O
)	O
,	O
a	O
cytokine	O
facilitating	O
progression	O
through	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

However	O
,	O
IL2	O
does	O
not	B-NEGATION
reverse	I-NEGATION
CsA	I-NEGATION
inhibition	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
at	B-SPECULATION
least	I-SPECULATION
one	I-SPECULATION
other	I-SPECULATION
NFAT-sensitive	I-SPECULATION
gene	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
involved	I-SPECULATION
.	O

The	O
human	O
G0	O
/	O
G1	O
switch	O
gene	O
,	O
G0S2	O
,	O
has	O
potential	B-SPECULATION
NFAT-binding	I-SPECULATION
sites	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
5	I-SPECULATION
'	I-SPECULATION
flank	I-SPECULATION
and	O
encodes	O
a	O
small	O
basic	O
potential	B-SPECULATION
phosphoprotein	I-SPECULATION
of	I-SPECULATION
unknown	B-SPECULATION
function	I-SPECULATION
.	O

Using	O
a	O
sensitive	O
,	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
assay	O
,	O
G0S2	O
mRNA	O
levels	O
were	O
assayed	O
in	O
cultured	O
blood	O
mononuclear	O
cells	O
.	O

Freshly	O
isolated	O
cells	O
contain	O
high	O
levels	O
of	O
G0S2	O
mRNA	O
which	O
rapidly	O
decline	O
.	O

This	O
"	O
spontaneous	O
stimulation	O
"	O
is	O
also	O
noted	O
with	O
some	O
other	O
G0S	O
genes	O
and	O
has	O
been	O
attributed	O
to	O
some	O
aspect	O
of	O
the	O
isolation	O
procedure	O
.	O

In	O
cells	O
that	O
have	O
been	O
preincubated	O
to	O
lower	O
mRNA	O
levels	O
,	O
there	O
is	O
a	O
transient	O
increase	O
in	O
G0S2	O
mRNA	O
,	O
peaking	O
between	O
1-2	O
h	O
,	O
in	O
response	O
to	O
Concanavalin-A	O
(	O
ConA	O
)	O
,	O
or	O
to	O
the	O
combination	O
of	O
phorbol	O
ester	O
(	O
TPA	O
)	O
,	O
and	O
the	O
calcium	O
ionophore	O
,	O
ionomycin	O
.	O

Both	O
these	O
responses	O
are	O
inhibited	O
by	O
CsA	O
.	O

Our	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
G0S2	I-SPECULATION
expression	I-SPECULATION
is	I-SPECULATION
required	I-SPECULATION
to	I-SPECULATION
commit	I-SPECULATION
cells	I-SPECULATION
to	I-SPECULATION
enter	I-SPECULATION
the	I-SPECULATION
G1	I-SPECULATION
phase	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
cell	I-SPECULATION
cycle	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
that	I-SPECULATION
,	I-SPECULATION
while	I-SPECULATION
not	B-NEGATION
excluding	I-NEGATION
other	I-NEGATION
,	O
early	O
inhibition	O
of	O
G0S2	O
expression	O
by	O
CsA	O
possible	B-SPECULATION
targets	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
important	I-SPECULATION
in	I-SPECULATION
achieving	I-SPECULATION
immunosuppression	I-SPECULATION
.	O

G0S2	O
may	B-SPECULATION
be	I-SPECULATION
of	I-SPECULATION
value	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
reporter	I-SPECULATION
gene	I-SPECULATION
for	I-SPECULATION
analyzing	I-SPECULATION
the	I-SPECULATION
mechanism	I-SPECULATION
of	I-SPECULATION
action	I-SPECULATION
of	I-SPECULATION
CsA	I-SPECULATION
and	I-SPECULATION
its	I-SPECULATION
influence	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
positive	I-SPECULATION
and	I-SPECULATION
negative	I-SPECULATION
selection	I-SPECULATION
of	I-SPECULATION
lymphocytes	I-SPECULATION
in	I-SPECULATION
response	I-SPECULATION
to	I-SPECULATION
self	I-SPECULATION
and	I-SPECULATION
not-self	I-SPECULATION
antigens	I-SPECULATION
.	O

Estrogen	O
receptor	O
diminishes	O
DNA-binding	O
activities	O
of	O
chicken	O
GATA-1	O
and	O
CACCC-binding	O
proteins	O
.	O

The	O
estrogen	O
receptor	O
(	O
ER	O
)	O
repressed	O
erythroid	O
differentiation	O
and	O
erythroid-specific	O
gene	O
expression	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
ER	O
alpha	O
(	O
referred	O
to	O
throughout	O
as	O
ER	O
)	O
on	O
DNA-binding	O
activities	O
of	O
transcription	O
factors	O
involved	O
in	O
regulating	O
the	O
expression	O
of	O
erythroid-specific	O
genes	O
,	O
and	O
,	O
in	O
particular	O
,	O
the	O
histone	O
H5	O
gene	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
found	O
that	O
in	O
the	O
presence	O
of	O
rabbit	O
reticulocyte	O
lysate	O
,	O
human	O
ER	O
reduced	O
the	O
binding	O
activities	O
of	O
chicken	O
immature	O
erythrocyte	O
nuclear	O
extracted	O
proteins	O
to	O
GATA	O
and	O
CACCC	O
sites	O
in	O
the	O
H5	O
promoter	O
and	O
enhancer	O
.	O

In	O
contrast	O
,	O
the	B-NEGATION
binding	I-NEGATION
activities	I-NEGATION
of	I-NEGATION
NF1	I-NEGATION
and	I-NEGATION
Sp1	I-NEGATION
were	I-NEGATION
not	I-NEGATION
affected	I-NEGATION
by	I-NEGATION
ER	I-NEGATION
.	O

Binding	O
of	O
ER	O
to	O
an	O
estrogen	O
response	O
element	O
was	O
enhanced	O
by	O
addition	O
of	O
rabbit	O
reticulocyte	O
lysate	O
.	O

This	O
lysate	O
was	O
also	O
necessary	O
for	O
ER	O
to	O
diminish	O
the	O
DNA-binding	O
activity	O
of	O
GATA-1	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
additional	I-SPECULATION
factor	I-SPECULATION
(	I-SPECULATION
s	I-SPECULATION
)	I-SPECULATION
are	I-SPECULATION
necessary	I-SPECULATION
for	I-SPECULATION
full	I-SPECULATION
ER	I-SPECULATION
function	I-SPECULATION
.	O

Both	O
GATA-1	O
and	O
CACCC-binding	O
proteins	O
are	O
critical	O
for	O
the	O
developmentally	O
regulated	O
expression	O
of	O
erythroid-specific	O
genes	O
.	O

We	O
hypothesize	B-SPECULATION
that	I-SPECULATION
interference	I-SPECULATION
in	I-SPECULATION
DNA-binding	I-SPECULATION
activities	I-SPECULATION
of	I-SPECULATION
GATA-1	I-SPECULATION
and	I-SPECULATION
CACCC-binding	I-SPECULATION
proteins	I-SPECULATION
is	I-SPECULATION
the	I-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
the	I-SPECULATION
ER	I-SPECULATION
inhibits	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
these	I-SPECULATION
genes	I-SPECULATION
.	O

Constitutive	O
expression	O
c-fos	O
,	O
c-jun	O
,	O
and	O
NF	O
kappa	O
B	O
mRNA	O
is	O
in	O
nucleated	O
fetal	O
blood	O
cells	O
and	O
up-regulation	O
of	O
c-fos	O
and	O
c-jun	O
with	O
anti-CD3	O
stimulation	O
.	O

Fetal	O
and	O
neonatal	O
lymphocytes	O
are	O
relatively	O
resistant	O
to	O
activation	O
and	O
cytokine	O
production	O
when	O
stimulated	O
either	O
via	O
their	O
T-cell	O
antigen	O
receptors	O
or	O
lectins	O
.	O

The	B-SPECULATION
molecular	I-SPECULATION
mechanism	I-SPECULATION
(	I-SPECULATION
s	I-SPECULATION
)	I-SPECULATION
responsible	I-SPECULATION
for	I-SPECULATION
this	I-SPECULATION
phenomenon	I-SPECULATION
have	I-SPECULATION
not	I-SPECULATION
been	I-SPECULATION
clearly	I-SPECULATION
elucidated	I-SPECULATION
.	O

We	O
have	O
hypothesized	B-SPECULATION
that	I-SPECULATION
such	I-SPECULATION
defects	I-SPECULATION
in	I-SPECULATION
fetal	I-SPECULATION
/	I-SPECULATION
neonatal	I-SPECULATION
T-cell	I-SPECULATION
activation	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
due	I-SPECULATION
to	I-SPECULATION
lack	B-NEGATION
of	I-NEGATION
expression	I-NEGATION
of	I-NEGATION
the	I-NEGATION
transcriptional	I-NEGATION
regulatory	I-NEGATION
elements	I-NEGATION
required	I-NEGATION
for	I-NEGATION
T-cell	I-NEGATION
activation	I-NEGATION
.	O

We	O
used	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
to	O
examine	O
both	O
fetal	O
and	O
term	O
neonatal	O
cord	O
bloods	O
for	O
mRNA	O
expression	O
of	O
three	O
transcription	O
factors	O
implicated	O
in	O
T-cell	O
activation	O
:	O
c-jun	O
,	O
c-fos	O
,	O
and	O
NF	O
kappa	O
B	O
(	O
p50	O
subunit	O
)	O
.	O

We	O
demonstrate	O
that	O
mRNAs	O
for	O
all	O
three	O
of	O
these	O
regulatory	O
factors	O
are	O
expressed	O
in	O
fetal	O
blood	O
cells	O
by	O
the	O
27th	O
week	O
of	O
gestation	O
and	O
in	O
term	O
cord	O
bloods	O
.	O

Activation	O
of	O
term	O
infant	O
cord	O
blood	O
mononuclear	O
cells	O
with	O
anti-CD3	O
monoclonal	O
antibodies	O
resulted	O
in	O
up-regulation	O
of	O
both	O
c-jun	O
and	O
c-fos	O
mRNAs	O
within	O
15	O
min	O
of	O
stimulation	O
.	O

However	O
,	O
secretion	O
of	O
IL-2	O
by	O
anti-CD3-stimulated	O
cord	O
blood	O
mononuclear	O
cells	O
was	O
still	O
blunted	O
compared	O
with	O
control	O
cells	O
from	O
adults	O
.	O

We	O
conclude	O
that	O
fetal	O
nucleated	O
blood	O
cells	O
constitutively	O
express	O
important	O
genes	O
for	O
cytokine	O
regulation	O
and	O
are	O
able	O
to	O
increase	O
intracellular	O
accumulation	O
of	O
the	O
mRNAs	O
for	O
these	O
factors	O
in	O
response	O
to	O
anti-CD3	O
stimulation	O
.	O

Thus	O
,	O
qualitative	B-NEGATION
differences	I-NEGATION
in	I-NEGATION
the	I-NEGATION
capacity	I-NEGATION
to	I-NEGATION
regulate	I-NEGATION
these	I-NEGATION
factors	I-NEGATION
could	I-NEGATION
not	I-NEGATION
be	I-NEGATION
shown	I-NEGATION
in	I-NEGATION
fetal	I-NEGATION
blood	I-NEGATION
cells	I-NEGATION
.	O

Quantitative	O
experiments	O
comparing	O
binding	O
of	O
these	O
transcription	O
factors	O
to	O
the	O
IL-2	O
promoter	O
are	O
currently	O
under	O
investigation	O
.	O

Replication	O
of	O
human	O
immunodeficiency	O
virus-1	O
in	O
primary	O
human	O
T	O
cells	O
is	O
dependent	O
on	O
the	O
autocrine	O
secretion	O
of	O
tumor	O
necrosis	O
factor	O
through	O
the	O
control	O
of	O
nuclear	O
factor-kappa	O
B	O
activation	O
.	O

Tumor	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
alpha	O
controls	O
T-cell	O
activation	O
and	O
is	O
a	O
major	O
inducer	O
of	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-	O
1	O
replication	O
in	O
chronically	O
infected	O
cells	O
.	O

Therefore	O
,	O
we	O
have	O
investigated	O
its	O
role	O
in	O
primary	O
cultures	O
of	O
HIV-infected	O
human	O
T	O
lymphocytes	O
by	O
using	O
neutralizing	O
anti-TNF-alpha	O
antibodies	O
or	O
TNF-alpha	O
.	O

Primary	O
resting	O
T	O
lymphocytes	O
produced	O
TNF-alpha	O
and	O
supported	O
HIV	O
replication	O
after	O
T-cell	O
receptor	O
activation	O
.	O

Addition	O
of	O
neutralizing	O
anti-TNF-alpha	O
antibodies	O
drastically	O
reduced	O
p24	O
antigen	O
release	O
and	O
prevented	O
CD4	O
+	O
cell	O
depletion	O
associated	O
with	O
infection	O
.	O

Anti-TNF-alpha	O
also	O
prevented	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
activation	O
,	O
and	O
a	O
good	O
correlation	O
between	O
this	O
inhibition	O
and	O
inhibition	O
of	O
HIV	O
replication	O
was	O
observed	O
.	O

Moreover	O
,	O
supplementing	O
the	O
cultures	O
with	O
high	O
doses	O
of	O
IL-2	O
reverted	O
anti-TNF-alpha	O
inhibition	O
of	O
cell	O
proliferation	O
but	O
did	O
not	B-NEGATION
affect	I-NEGATION
the	I-NEGATION
inhibition	I-NEGATION
of	I-NEGATION
HIV	I-NEGATION
p24	I-NEGATION
antigen	I-NEGATION
release	I-NEGATION
or	I-NEGATION
NF-kappa	I-NEGATION
B	I-NEGATION
activation	I-NEGATION
in	I-NEGATION
the	I-NEGATION
same	I-NEGATION
cultures	I-NEGATION
.	O

Moreover	O
,	O
anti-TNF-alpha	O
inhibited	O
HIV-1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)-	O
driven	O
transcription	O
of	O
a	O
reporter	O
gene	O
in	O
primary	O
T	O
cells	O
in	O
response	O
to	O
activation	O
,	O
either	O
in	O
the	O
presence	O
or	O
the	O
absence	B-NEGATION
of	I-NEGATION
HIV-1	I-NEGATION
Tat	I-NEGATION
.	O

Our	O
results	O
support	O
an	O
important	O
role	O
for	O
autocrine	O
TNF-alpha	O
secretion	O
in	O
controlling	O
HIV	O
replication	O
in	O
primary	O
T	O
cells	O
because	O
of	O
its	O
ability	O
to	O
maintain	O
NF-kappa	O
B	O
elevated	O
in	O
the	O
nucleus	O
of	O
T	O
cells	O
.	O

A	O
thiol	O
antioxidant	O
regulates	O
IgE	O
isotype	O
switching	O
by	O
inhibiting	O
activation	O
of	O
nuclear	O
factor-kappaB	O
.	O

The	O
binding	O
site	O
for	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
is	O
present	O
at	O
the	O
promoter	O
region	O
of	O
the	O
germline	O
Cepsilon	O
gene	O
,	O
but	O
there	O
is	O
little	O
information	O
on	O
whether	B-SPECULATION
this	I-SPECULATION
factor	I-SPECULATION
is	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
IgE	I-SPECULATION
synthesis	I-SPECULATION
by	I-SPECULATION
human	I-SPECULATION
B	I-SPECULATION
cells	I-SPECULATION
.	O

Accordingly	O
,	O
we	O
studied	O
the	O
role	O
of	O
NF-kappaB	O
in	O
germline	O
Cepsilon	O
transcription	O
by	O
using	O
two	O
human	O
Burkitt's	O
lymphoma	O
B	O
cell	O
lines	O
,	O
DND39	O
and	O
DG75	O
.	O

In	O
both	O
cell	O
lines	O
,	O
n-acetyl-L-cysteine	O
(	O
NAC	O
)	O
,	O
a	O
potent	O
thiol	O
antioxidant	O
,	O
inhibited	O
the	O
triggering	O
of	O
the	O
nuclear	O
expression	O
of	O
NF-kappaB	O
by	O
IL-4	O
and	O
by	O
anti-CD40	O
monoclonal	O
antibody	O
.	O

Although	O
IL-4	O
activated	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STAT	O
)	O
6	O
in	O
addition	O
to	O
NF-kappaB	O
,	O
NAC	O
treatment	O
or	O
the	O
transfection	O
of	O
decoy	O
oligodeoxynucleotides	O
for	O
NF-kappaB	O
or	O
STAT6	O
only	O
partly	O
blocked	O
IL-4-induced	O
germline	O
Cepsilon	O
transcription	O
.	O

However	O
,	O
these	O
two	O
decoy	O
oligodeoxynucleotides	O
together	O
almost	O
completely	O
abrogated	O
IL-4-induced	O
germline	O
Cepsilon	O
transcription	O
.	O

Of	O
note	O
,	O
CD40-mediated	O
enhancement	O
of	O
IL-4-driven	O
germline	O
Cepsilon	O
transcription	O
was	O
markedly	O
decreased	O
by	B-SPECULATION
NAC	I-SPECULATION
or	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
decoy	I-SPECULATION
oligodeoxynucleotide	I-SPECULATION
for	I-SPECULATION
NF-kappaB	I-SPECULATION
.	O

The	O
effect	O
of	O
NAC	O
was	O
also	O
examined	O
on	O
deletional	O
switch	O
recombination	O
underlying	O
the	O
isotype	O
switch	O
to	O
IgE	O
.	O

NAC	O
inhibited	O
the	O
generation	O
of	O
Smu	O
/	O
Sepsilon	O
switch	O
fragments	O
in	O
normal	O
human	O
B	O
cells	O
costimulated	O
with	O
IL-4	O
and	O
anti-CD40	O
monoclonal	O
antibody	O
.	O

It	O
also	O
abolished	O
IL-4-induced	O
upregulation	O
of	O
CD40	O
but	O
promoted	O
upregulation	O
of	O
CD23	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
coordination	B-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
and	I-SPECULATION
STAT6	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
required	I-SPECULATION
for	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
germline	I-SPECULATION
Cepsilon	I-SPECULATION
transcription	I-SPECULATION
by	I-SPECULATION
IL-4	I-SPECULATION
,	O
and	O
that	O
CD40-mediated	O
NF-kappaB	O
activation	O
may	B-SPECULATION
be	I-SPECULATION
important	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
both	I-SPECULATION
enhancement	I-SPECULATION
of	I-SPECULATION
germline	I-SPECULATION
Cepsilon	I-SPECULATION
transcription	I-SPECULATION
and	I-SPECULATION
class	I-SPECULATION
switching	I-SPECULATION
to	I-SPECULATION
IgE	I-SPECULATION
.	O

Cellular	O
and	O
molecular	O
mechanisms	O
of	O
IL-5	O
synthesis	O
in	O
atopic	O
diseases	O
:	O
a	O
study	O
with	O
allergen-specific	O
human	O
helper	O
T	O
cells	O
.	O

BACKGROUND	O
:	O
Cytokines	O
produced	O
by	O
helper	O
T	O
cells	O
are	O
intimately	O
involved	O
in	O
chronic	O
allergic	O
diseases	O
associated	O
with	O
eosinophilic	O
inflammation	O
.	O

OBJECTIVE	O
:	O
We	O
investigated	O
the	O
production	O
of	O
IL-5	O
,	O
a	O
potent	O
growth	O
factor	O
and	O
chemotactic	O
factor	O
for	O
eosinophils	O
,	O
by	O
CD4	O
+	O
T	O
lymphocytes	O
in	O
patients	O
with	O
asthma	O
.	O

METHODS	O
:	O
Allergen-specific	O
T	O
cell	O
clones	O
and	O
T	O
cell	O
hybridomas	O
were	O
established	O
from	O
the	O
peripheral	O
blood	O
lymphocytes	O
of	O
patients	O
with	O
asthma	O
,	O
and	O
the	O
responses	O
to	O
various	O
stimuli	O
were	O
determined	O
.	O

RESULTS	O
:	O
After	O
nonspecific	O
stimulation	O
,	O
IL-5	O
production	O
by	O
CD4	O
+	O
T	O
cells	O
from	O
both	O
atopic	O
and	O
nonatopic	O
subjects	O
with	O
asthma	O
was	O
significantly	O
enhanced	O
compared	O
with	O
that	O
by	O
cells	O
from	O
healthy	O
controls	O
.	O

Peripheral	O
blood	O
mononuclear	O
cells	O
from	O
atopic	O
asthma	O
patients	O
both	O
proliferated	O
and	O
produced	O
IL-5	O
after	O
incubation	O
with	O
mite	O
allergen	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
mite-specific	I-SPECULATION
helper	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
were	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
eosinophilic	I-SPECULATION
inflammation	I-SPECULATION
of	I-SPECULATION
atopic	I-SPECULATION
asthma	I-SPECULATION
.	O

A	O
human	O
IL-5	O
promoter	O
/	O
enhancer	O
luciferase	O
gene	O
construct	O
transfected	O
into	O
IL-5-producing	O
T	O
cell	O
clones	O
was	O
clearly	O
transcribed	O
after	O
stimulation	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
515	I-SPECULATION
base	I-SPECULATION
pair	I-SPECULATION
IL-5	I-SPECULATION
gene	I-SPECULATION
segment	I-SPECULATION
upstream	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
coding	I-SPECULATION
region	I-SPECULATION
was	I-SPECULATION
sufficient	I-SPECULATION
to	I-SPECULATION
respond	I-SPECULATION
to	I-SPECULATION
activating	I-SPECULATION
signals	I-SPECULATION
in	I-SPECULATION
human	I-SPECULATION
helper	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

The	B-NEGATION
same	I-NEGATION
gene	I-NEGATION
segment	I-NEGATION
was	I-NEGATION
not	I-NEGATION
transcribed	I-NEGATION
in	I-NEGATION
IL-5-nonproducing	I-NEGATION
T	I-NEGATION
cell	I-NEGATION
clones	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
human	I-SPECULATION
T	I-SPECULATION
cell	I-SPECULATION
IL-5	I-SPECULATION
synthesis	I-SPECULATION
is	I-SPECULATION
regulated	I-SPECULATION
at	I-SPECULATION
the	I-SPECULATION
transcriptional	I-SPECULATION
level	I-SPECULATION
.	O

Experiments	O
with	O
T	O
cell	O
hybridomas	O
confirmed	O
these	O
findings	O
and	O
suggested	B-SPECULATION
that	I-SPECULATION
a	I-SPECULATION
unique	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
essential	I-SPECULATION
for	I-SPECULATION
human	I-SPECULATION
IL-5	I-SPECULATION
gene	I-SPECULATION
transcription	I-SPECULATION
.	O

CONCLUSION	O
:	O
Enhanced	B-SPECULATION
IL-5	I-SPECULATION
production	I-SPECULATION
by	I-SPECULATION
helper	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
seems	I-SPECULATION
to	I-SPECULATION
cause	I-SPECULATION
the	I-SPECULATION
eosinophilic	I-SPECULATION
inflammation	I-SPECULATION
of	I-SPECULATION
both	I-SPECULATION
atopic	I-SPECULATION
and	I-SPECULATION
nonatopic	I-SPECULATION
asthma	I-SPECULATION
.	O

Elucidation	O
of	O
IL-5-specific	O
regulatory	O
mechanisms	O
may	B-SPECULATION
facilitate	I-SPECULATION
the	I-SPECULATION
development	I-SPECULATION
of	I-SPECULATION
novel	I-SPECULATION
treatments	I-SPECULATION
for	I-SPECULATION
allergic	I-SPECULATION
diseases	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
eosinophilic	I-SPECULATION
inflammation	I-SPECULATION
.	O

Regulation	O
of	O
NF-kappa	O
B	O
activity	O
by	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
stability	O
.	O

Transcription	O
factor	O
NF-kappa	O
B	O
must	O
be	O
released	O
from	O
cytoplasmic	O
inhibitory	O
molecules	O
(	O
I	O
kappa	O
Bs	O
)	O
in	O
order	O
to	O
move	O
to	O
the	O
nucleus	O
and	O
to	O
activate	O
its	O
target	O
genes	O
.	O

Little	O
is	O
known	O
about	O
the	O
mechanisms	O
regulating	O
the	O
maintenance	O
of	O
constitutive	O
nuclear	O
NF-kappa	O
B	O
in	O
some	O
cell-types	O
and	O
of	O
sustained	O
nuclear	O
NF-kappa	O
B	O
activity	O
after	O
stimulation	O
.	O

Increased	O
turnover	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
constitutive	O
NF-kappa	O
B	O
activity	O
in	O
mature	O
B	O
cells	O
.	O

We	O
therefore	O
compared	O
the	O
turnover	O
of	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
in	O
mature	O
B	O
cells	O
and	O
HeLa	O
cells	O
.	O

Both	O
proteins	O
display	O
a	O
high	O
turnover	O
in	O
B	O
cells	O
although	O
I	O
kappa	O
B	O
beta	O
is	O
considerably	O
more	O
stable	O
than	O
I	O
kappa	O
B	O
alpha	O
.	O

The	O
half-life	O
of	O
both	O
inhibitors	O
is	O
increased	O
in	O
HeLa	O
cells	O
.	O

In	O
contrast	O
,	O
all	O
other	O
NF-kappa	O
B	O
/	O
I	O
kappa	O
B	O
molecules	O
tested	O
are	O
relatively	O
stable	O
in	O
both	O
cell-types	O
.	O

The	O
elevated	O
turnover	O
of	O
endogenous	O
I	O
kappa	O
B	O
alpha	O
in	O
Namalwa	O
cells	O
is	O
inhibited	O
by	O
a	O
proteasome	O
inhibitor	O
and	O
thus	O
seems	B-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
driven	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
same	I-SPECULATION
degradation	I-SPECULATION
machinery	I-SPECULATION
as	I-SPECULATION
the	I-SPECULATION
slower	I-SPECULATION
turnover	I-SPECULATION
in	I-SPECULATION
non-B	I-SPECULATION
cells	I-SPECULATION
.	O

Furthermore	O
,	O
we	O
investigated	O
the	O
processes	O
involved	O
in	O
persistent	O
activation	O
of	O
NF-kappa	O
B	O
.	O

TNF-alpha	O
signaling	O
leads	O
to	O
a	O
rapid	O
depletion	O
of	O
cellular	O
I	O
kappa	O
B	O
beta	O
pools	O
.	O

I	O
kappa	O
B	O
alpha	O
is	O
efficiently	O
resynthesized	O
whereas	O
I	O
kappa	O
B	O
beta	O
levels	O
stay	O
low	O
for	O
a	O
prolonged	O
time	O
.	O

NF-kappa	O
B	O
binding	O
activity	O
can	O
be	O
detected	O
for	O
several	O
hours	O
after	O
stimulation	O
.	O

We	O
found	O
that	O
removal	O
of	O
the	O
TNF-alpha	O
containing	O
medium	O
causes	O
a	O
rapid	O
decrease	O
in	O
nuclear	O
NF-kappa	O
B	O
.	O

A	O
phosphoform	O
of	O
newly	O
synthesized	O
I	O
kappa	O
B	O
alpha	O
is	O
visible	O
when	O
degradation	O
by	O
the	O
proteasome	O
is	O
inhibited	O
and	O
new	O
I	O
kappa	O
B	O
alpha	O
displays	O
the	O
same	O
properties	O
regarding	O
phosphorylation	O
and	O
degradation	O
in	O
response	O
to	O
a	O
second	O
inducer	O
.	O

There	O
is	O
no	B-NEGATION
significant	I-NEGATION
difference	I-NEGATION
in	I-NEGATION
the	I-NEGATION
turnover	I-NEGATION
of	I-NEGATION
pre	I-NEGATION
-	I-NEGATION
and	I-NEGATION
post-inductive	I-NEGATION
I	I-NEGATION
kappa	I-NEGATION
B	I-NEGATION
alpha	I-NEGATION
.	O

These	O
observations	O
suggest	B-SPECULATION
that	I-SPECULATION
resynthesis	I-SPECULATION
of	I-SPECULATION
I	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
alpha	I-SPECULATION
and	I-SPECULATION
removal	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
stimulus	I-SPECULATION
are	I-SPECULATION
obligatory	I-SPECULATION
steps	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
inactivation	I-SPECULATION
of	I-SPECULATION
nuclear	I-SPECULATION
NF	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
.	O

Control	O
of	O
NF-kappa	O
B	O
activity	O
by	O
the	O
I	O
kappa	O
B	O
beta	O
inhibitor	O
.	O

The	O
transcription	O
factor	O
NF-kappa	O
B	O
is	O
maintained	O
in	O
an	O
inactive	O
cytoplasmic	O
state	O
by	O
I	O
kappa	O
B	O
inhibitors	O
.	O

In	O
mammalian	O
cells	O
,	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
proteins	O
have	O
been	O
purified	O
and	O
shown	O
to	O
be	O
the	O
inhibitors	O
of	O
NF-kappa	O
B	O
through	O
their	O
association	O
with	O
the	O
p65	O
or	O
c-Rel	O
subunits	O
.	O

In	O
addition	O
,	O
we	O
have	O
isolated	O
a	O
third	O
NF-kappa	O
B	O
inhibitor	O
,	O
I	O
kappa	O
B	O
epsilon	O
(	O
1	O
)	O
.	O

Upon	O
treatment	O
with	O
a	O
large	O
variety	O
of	O
inducers	O
,	O
I	O
kappa	O
B	O
alpha	O
,	O
I	O
kappa	O
B	O
beta	O
are	O
proteolytically	O
degraded	O
,	O
resulting	O
in	O
NF-kappa	O
B	O
translocation	O
into	O
the	O
nucleus	O
.	O

Here	O
we	O
show	O
that	O
in	O
E29.1	O
T	O
cell	O
hybridoma	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
are	O
equally	O
associated	O
with	O
p65	O
and	O
that	O
I	O
kappa	O
B	O
beta	O
is	O
degraded	O
in	O
response	O
to	O
TNF	O
alpha	O
in	O
contrast	O
to	O
what	O
has	O
been	O
originally	O
published	O
.	O

Our	O
data	O
also	O
suggest	B-SPECULATION
that	I-SPECULATION
,	I-SPECULATION
unlike	I-SPECULATION
I	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
alpha	I-SPECULATION
,	I-SPECULATION
I	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
beta	I-SPECULATION
is	I-SPECULATION
constitutively	I-SPECULATION
phosphorylated	I-SPECULATION
and	I-SPECULATION
resynthesized	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
hypophosphorylated	I-SPECULATION
form	I-SPECULATION
.	O

The	O
absence	B-NEGATION
of	I-NEGATION
slow	I-NEGATION
migrating	I-NEGATION
forms	I-NEGATION
of	I-NEGATION
I	I-NEGATION
kappa	I-NEGATION
B	I-NEGATION
beta	I-NEGATION
following	I-NEGATION
stimulation	I-NEGATION
suggests	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
phosphorylation	I-SPECULATION
does	I-SPECULATION
not	I-SPECULATION
necessarily	I-SPECULATION
constitute	I-SPECULATION
the	I-SPECULATION
signal-induced	I-SPECULATION
event	I-SPECULATION
which	I-SPECULATION
targets	I-SPECULATION
the	I-SPECULATION
molecule	I-SPECULATION
for	I-SPECULATION
proteolysis	I-SPECULATION
.	O

NF-kappa	O
B	O
/	O
Rel	O
family	O
members	O
regulating	O
the	O
ICAM-1	O
promoter	O
in	O
monocytic	O
THP-1	O
cells	O
.	O

A	O
kappa	O
B-site	O
was	O
identified	O
in	O
the	O
promoter	O
of	O
the	O
intercellular	O
adhesion	O
molecule-1	O
(	O
ICAM-1	O
)	O
gene	O
,	O
which	O
is	O
involved	O
in	O
regulation	O
of	O
ICAM-1	O
expression	O
by	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)	O
and	O
glucocorticoids	O
.	O

We	O
now	O
report	O
on	O
the	O
transcription	O
factors	O
which	O
bind	O
and	O
transactivate	O
this	O
enhancer	O
sequence	O
.	O

In	O
vitro	O
,	O
the	B-SPECULATION
ICAM-1	I-SPECULATION
kappa	I-SPECULATION
B	I-SPECULATION
site	I-SPECULATION
appeared	I-SPECULATION
to	I-SPECULATION
bind	I-SPECULATION
RelA	I-SPECULATION
and	I-SPECULATION
c-Rel	I-SPECULATION
homodimers	I-SPECULATION
as	I-SPECULATION
well	I-SPECULATION
as	I-SPECULATION
heterodimers	I-SPECULATION
with	I-SPECULATION
NF-kappa	I-SPECULATION
B1	I-SPECULATION
,	I-SPECULATION
but	I-SPECULATION
weakly	I-SPECULATION
NF-kappa	I-SPECULATION
B1	I-SPECULATION
homodimers	I-SPECULATION
.	O

In	O
addition	O
,	O
both	O
RelA	O
and	O
c-Rel	O
,	O
but	O
not	B-NEGATION
NF-kappa	I-NEGATION
B1	I-NEGATION
,	O
were	O
shown	O
to	O
transactivate	O
an	O
ICAM-1	O
kappa	O
B-reporter	O
construct	O
.	O

In	O
monocytic	O
THP-1	O
cells	O
TNF-alpha	O
induced	O
two	O
nuclear	O
complexes	O
which	O
in	O
vitro	O
bound	O
to	O
the	O
ICAM-1	O
kappa	O
B	O
site	O
.	O

Using	O
antibodies	O
in	O
an	O
electrophoretic	O
mobility	O
supershift	O
assay	O
,	O
one	O
of	O
these	O
complexes	O
was	O
shown	O
to	O
contain	O
NF-kappa	O
B1	O
and	O
RelA	O
,	O
and	O
to	O
bind	O
with	O
higher	O
affinity	O
to	O
the	O
consensus	O
kappa	O
B	O
site	O
in	O
the	O
HIV	O
long	O
terminal	O
repeat	O
.	O

The	O
second	O
complex	O
contained	O
RelA	O
,	O
and	O
exhibited	O
higher	O
affinity	O
towards	O
the	O
ICAM-1	O
kappa	O
B	O
than	O
to	O
the	O
HIV	O
kappa	O
B	O
site	O
.	O

The	O
glucocorticoid	O
receptor	O
was	O
shown	O
to	O
repress	O
activity	O
of	O
both	O
the	O
RelA	O
homodimer	O
and	O
the	O
NF-kappa	O
B1	O
/	O
RelA	O
heterodimer	O
.	O

We	O
argue	O
that	O
in	O
vivo	O
RelA	B-SPECULATION
homodimers	I-SPECULATION
are	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
a	I-SPECULATION
dominant	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
TNF-alpha-induced	I-SPECULATION
ICAM-1	I-SPECULATION
transcription	I-SPECULATION
in	I-SPECULATION
monocytic	I-SPECULATION
cells	I-SPECULATION
.	O

LPS	O
tolerance	O
in	O
monocytes	O
/	O
macrophages	O
:	O
three	O
3	O
'	O
cytosins	O
are	O
required	O
in	O
the	O
DNA	O
binding	O
motif	O
for	O
detection	O
of	O
upregulated	O
NF-kappa	O
B	O
p50	O
homodimers	O
.	O

When	O
monocytes	O
are	O
stimulated	O
with	O
LPS	O
(	O
lipopolysaccharide	O
)	O
repeatedly	O
then	O
the	O
initially	O
high	O
expression	O
of	O
the	O
TNF	O
(	O
tumor	O
necrosis	O
factor	O
)	O
gene	O
is	O
only	O
very	O
low	O
,	O
i.e.	O
the	O
cells	O
are	O
tolerant	O
to	O
LPS	O
.	O

Tolerant	O
cells	O
still	O
express	O
the	O
CD14	O
receptor	O
and	O
they	O
can	O
still	O
be	O
activated	O
to	O
mobilize	O
NF-kappa	O
B	O
into	O
nucleus	O
.	O

Analysis	O
of	O
the	O
binding	O
proteins	O
employing	O
the	O
-	O
605	O
motif	O
of	O
the	O
human	O
TNF	O
promoter	O
(	O
GGGGCTGTCCC	O
)	O
revealed	O
that	O
in	O
tolerant	O
cells	O
of	O
the	O
human	O
monocytic	O
cell	O
line	O
Mono	O
Mac	O
6	O
there	O
is	O
a	O
predominance	O
of	O
p50p50	O
of	O
NF-kappa	O
B	O
.	O

We	O
now	O
show	O
that	O
a	O
mutant	O
motif	O
that	O
exchanges	O
the	O
terminal	O
3	O
'	O
C	O
for	O
a	O
G	O
fails	B-NEGATION
to	I-NEGATION
bind	I-NEGATION
the	I-NEGATION
p50	I-NEGATION
homodimer	I-NEGATION
that	I-NEGATION
is	I-NEGATION
upregulated	I-NEGATION
in	I-NEGATION
LPS	I-NEGATION
toler	I-NEGATION
ant	I-NEGATION
human	I-NEGATION
Mono	I-NEGATION
Mac	I-NEGATION
6	I-NEGATION
cells	I-NEGATION
.	O

The	O
same	O
is	O
true	O
for	O
nuclear	O
extracts	O
taken	O
from	O
the	O
murine	O
P388D1	O
macrophage	O
cell	O
line	O
when	O
tested	O
with	O
the	O
-	O
516	O
motif	O
of	O
the	O
murine	O
TNF	O
promoter	O
(	O
GGGGGCTTTCCC	O
)	O
.	O

Here	O
the	O
wild	O
type	O
motif	O
gives	O
efficient	O
binding	O
of	O
p50p50	O
that	O
again	O
is	O
upregulated	O
in	O
tolerant	O
cells	O
whereas	O
a	O
mutant	O
with	O
a	O
3	O
'	O
G	O
shows	O
hardly	O
any	O
binding	O
of	O
p50p50	O
.	O

Conversely	O
,	O
the	O
murine	O
kappa	O
light	O
chain	O
enhancer	O
motif	O
(	O
GGGGACTTTCCG	O
)	O
does	O
not	B-NEGATION
efficiently	I-NEGATION
bind	I-NEGATION
the	I-NEGATION
nuclear	I-NEGATION
p50p50	I-NEGATION
from	I-NEGATION
tolerant	I-NEGATION
murine	I-NEGATION
P388	I-NEGATION
macrophages	I-NEGATION
.	O

Binding	O
is	O
,	O
however	O
,	O
readily	O
detected	O
when	O
the	O
3	O
'	O
G	O
is	O
replaced	O
by	O
a	O
C	O
.	O

These	O
data	O
show	O
that	O
the	O
detection	O
of	O
upregulated	O
p50	O
homodimers	O
in	O
LPS	O
tolerant	O
cells	O
is	O
dependent	O
on	O
subtle	O
differences	O
in	O
the	O
sequence	O
of	O
the	O
DNA	O
binding	O
motif	O
.	O

Temporal	O
control	O
of	O
IgH	O
gene	O
expression	O
in	O
developing	O
B	O
cells	O
by	O
the	O
3	O
'	O
locus	O
control	O
region	O
.	O

The	O
suggested	B-SPECULATION
roles	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
downstream	I-SPECULATION
3	I-SPECULATION
'	I-SPECULATION
regions	I-SPECULATION
acting	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
Locus	I-SPECULATION
Control	I-SPECULATION
Region	I-SPECULATION
(	I-SPECULATION
LCR	I-SPECULATION
)	I-SPECULATION
,	O
have	O
allowed	O
comparisons	O
to	O
be	O
made	O
between	O
the	O
regulation	O
of	O
the	O
IgH	O
locus	O
with	O
other	O
model	O
systems	O
whose	O
gene	O
expression	O
is	O
governed	O
by	O
LCR	O
activity	O
.	O

Here	O
we	O
summarize	O
the	O
importance	O
of	O
the	O
IgH	O
3'LCR	O
and	O
its	O
putative	B-SPECULATION
functional	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
IgH	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
and	O
compare	O
it	O
with	O
the	O
5'LCR	O
regulatory	O
region	O
of	O
the	O
human	O
beta-globin	O
locus	O
.	O

Expression	O
of	O
transcription	O
factor	O
genes	O
after	O
influenza	O
A	O
virus	O
infection	O
.	O

Infection	O
of	O
human	O
monocytes	O
with	O
influenza	O
A	O
virus	O
induces	O
a	O
broad	O
range	O
of	O
proinflammatory	O
cytokines	O
and	O
mononuclear	O
cell	O
attracting	O
chemokines	O
before	O
the	O
infected	O
cells	O
undergo	O
apoptosis	O
.	O

The	O
underlying	O
mechanisms	O
by	O
which	O
the	O
corresponding	O
genes	O
are	O
transcriptionally	O
initiated	O
after	O
virus	O
infection	O
are	O
still	O
poorly	O
understood	O
.	O

Activation	B-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
seems	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
many	I-SPECULATION
proinflammatory	I-SPECULATION
cytokine	I-SPECULATION
genes	I-SPECULATION
,	O
but	O
cannot	B-SPECULATION
be	I-SPECULATION
the	I-SPECULATION
only	I-SPECULATION
mechanism	I-SPECULATION
,	O
since	O
several	O
cytokine	O
genes	O
lack	B-NEGATION
respective	I-NEGATION
binding	I-NEGATION
sites	I-NEGATION
in	I-NEGATION
their	I-NEGATION
promoter	I-NEGATION
regions	I-NEGATION
.	O

Therefore	O
,	O
we	O
additionally	O
investigated	O
other	O
transcription	O
factors	O
of	O
possible	B-SPECULATION
importance	I-SPECULATION
such	O
as	O
CREB	O
,	O
CTF	O
,	O
OTF-1	O
,	O
and	O
OTF-2	O
.	O

To	O
explore	O
long-term	O
regulatory	O
mechanisms	O
,	O
we	O
investigated	O
the	O
induction	O
of	O
transcription	O
factors	O
on	O
the	O
gene	O
expression	O
level	O
which	O
may	B-SPECULATION
be	I-SPECULATION
important	I-SPECULATION
to	I-SPECULATION
substitute	I-SPECULATION
for	I-SPECULATION
metabolized	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
proteins	I-SPECULATION
after	I-SPECULATION
their	I-SPECULATION
activation	I-SPECULATION
.	O

We	O
identified	O
a	O
cell-type-specific	O
differential	O
response	O
:	O
CREB	O
,	O
CTF	O
,	O
OTF-1	O
,	O
OFT-2	O
,	O
and	O
NF-kappa	O
B	O
genes	O
were	O
strongly	O
induced	O
1	O
to	O
4	O
hours	O
after	O
influenza	O
A	O
virus	O
infection	O
in	O
the	O
monocytic	O
cell	O
line	O
Mono	O
Mac	O
6	O
,	O
while	O
in	O
freshly	O
prepared	O
human	O
monocytes	O
no	B-NEGATION
significant	I-NEGATION
changes	I-NEGATION
were	I-NEGATION
detected	I-NEGATION
.	O

In	O
infected	O
monocytes	O
,	O
which	O
die	O
by	O
apoptosis	O
,	O
the	O
expression	O
of	O
CREB	O
,	O
CTF	O
,	O
and	O
OTF-2	O
was	O
rather	O
suppressed	O
8	O
hours	O
after	O
infection	O
.	O

In	O
conclusion	O
,	O
the	B-SPECULATION
long-term	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
non-proliferating	I-SPECULATION
cells	I-SPECULATION
seems	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
of	I-SPECULATION
minor	I-SPECULATION
importance	I-SPECULATION
after	I-SPECULATION
influenza	I-SPECULATION
infection	I-SPECULATION
since	O
in	O
apoptosisprone	O
cells	O
an	O
immediate	O
availability	O
of	O
transcription	O
factor	O
proteins	O
is	O
required	O
.	O

[	O
Molecular-biologic	O
aspects	O
of	O
interaction	O
between	O
nervous	O
and	O
immune	O
systems	O
]	O

The	O
problem	O
of	O
the	O
neuro-immuno	O
interactions	O
on	O
the	O
level	O
of	O
the	O
protein	O
trans-factors	O
,	O
stimulating	O
interleukin-2	O
(	O
IL-2	O
)	O
gene	O
expression	O
was	O
discussed	O
.	O

The	O
physico-chemical	O
and	O
functional	O
parameters	O
of	O
the	O
low	O
molecular	O
nuclear	O
proteins	O
(	O
SP	O
and	O
BP	O
-	O
14	O
,	O
18	O
,	O
19	O
kDs	O
)	O
isolated	O
from	O
splenic	O
and	O
brain	O
cells	O
of	O
immunized	O
rats	O
were	O
studied	O
.	O

The	O
binding	O
of	O
these	O
proteins	O
to	O
the	O
regulatory	O
region	O
of	O
IL-2	O
gene	O
in	O
vitro	O
and	O
stimulation	O
of	O
the	O
IL-2mRNA	O
synthesis	O
in	O
splenic	O
T-lymphocytes	O
culture	O
in	O
normal	O
conditions	O
were	O
shown	O
.	O

The	O
protective	O
effect	O
of	O
SP	O
and	O
BP	O
on	O
the	O
IL-2mRNA	O
synthesis	O
in	O
stressful	O
conditions	O
and	O
by	O
the	O
T-cells	O
treatment	O
with	O
the	O
CsA	O
was	O
demonstrated	O
.	O

Induction	O
of	O
interleukin-12	O
p40	O
transcript	O
by	O
CD40	O
ligation	O
via	O
activation	O
of	O
nuclear	O
factor-kappaB	O
.	O

Interleukin-12	O
is	O
produced	O
in	O
response	O
to	O
infection	O
with	O
bacteria	O
or	O
parasites	O
or	O
to	O
bacterial	O
constituents	O
such	O
as	O
LPS	O
in	O
monocytes	O
/	O
macrophages	O
and	O
dendritic	O
cells	O
,	O
and	O
also	O
generated	O
by	O
the	O
interaction	O
between	O
activated	O
T	O
cells	O
and	O
antigen-presenting	O
cells	O
via	O
CD40-CD40	O
ligand	O
(	O
CD40L	O
)	O
.	O

So	O
far	O
,	O
transcriptional	O
analyses	O
of	O
p40	O
have	O
been	O
carried	O
out	O
only	O
using	O
bacterial	O
constituents	O
such	O
as	O
LPS	O
as	O
stimuli	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
characterized	O
the	O
transcriptional	O
induction	O
of	O
p40	O
by	O
CD40	O
ligation	O
in	O
a	O
human	O
B	O
lymphoblastoid	O
cell	O
line	O
,	O
Daudi	O
,	O
and	O
a	O
human	O
acute	O
monocytic	O
leukemia	O
cell	O
line	O
,	O
THP-1	O
.	O

These	O
cells	O
,	O
stimulated	O
by	O
an	O
agonistic	O
monoclonal	O
antibody	O
against	O
CD40	O
or	O
by	O
transfection	O
with	O
a	O
CD40L	O
expression	O
vector	O
,	O
secreted	O
p40	O
and	O
showed	O
enhanced	O
p40	O
mRNA	O
expression	O
.	O

Sequence	O
analysis	O
of	O
the	O
p40	O
promoter	O
region	O
identified	O
two	O
potential	B-SPECULATION
nuclear	I-SPECULATION
factor	I-SPECULATION
(	I-SPECULATION
NF	I-SPECULATION
)-	I-SPECULATION
kappaB	I-SPECULATION
binding	I-SPECULATION
sites	I-SPECULATION
conserved	I-SPECULATION
between	I-SPECULATION
mouse	I-SPECULATION
and	I-SPECULATION
human	I-SPECULATION
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
revealed	O
that	O
the	O
potential	B-SPECULATION
NF-kappaB	I-SPECULATION
binding	I-SPECULATION
sequence	I-SPECULATION
which	I-SPECULATION
is	I-SPECULATION
located	I-SPECULATION
around	I-SPECULATION
120	I-SPECULATION
bp	I-SPECULATION
upstream	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
initiation	I-SPECULATION
site	I-SPECULATION
in	I-SPECULATION
murine	I-SPECULATION
and	I-SPECULATION
human	I-SPECULATION
p40	I-SPECULATION
genes	I-SPECULATION
formed	O
an	O
NF-kappaB	O
complex	O
with	O
nuclear	O
extract	O
from	O
Daudi	O
cells	O
stimulated	O
by	O
CD40	O
ligation	O
.	O

Moreover	O
,	O
transfection	O
of	O
Daudi	O
cells	O
with	O
the	O
polymerized	O
NF-kappaB	O
binding	O
sequence	O
ligated	O
to	O
a	O
thymidine	O
kinase	O
/	O
chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
reporter	O
plasmid	O
greatly	O
induced	O
CAT	O
activity	O
,	O
but	O
transfection	O
with	O
the	O
polymerized	O
mutated	O
NF-kappaB	O
binding	O
sequence	O
did	O
not	B-NEGATION
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
NF-kappaB	I-SPECULATION
binding	I-SPECULATION
site	I-SPECULATION
located	I-SPECULATION
around	I-SPECULATION
120	I-SPECULATION
bp	I-SPECULATION
upstream	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
initiation	I-SPECULATION
site	I-SPECULATION
in	I-SPECULATION
murine	I-SPECULATION
and	I-SPECULATION
human	I-SPECULATION
p40	I-SPECULATION
promoter	I-SPECULATION
regions	I-SPECULATION
could	B-SPECULATION
be	I-SPECULATION
important	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
p40	I-SPECULATION
induction	I-SPECULATION
by	I-SPECULATION
CD40	I-SPECULATION
ligation	I-SPECULATION
via	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
.	O

Oxidants	O
,	O
transcription	O
factors	O
,	O
and	O
intestinal	O
inflammation	O
.	O

It	O
is	O
now	O
well	O
appreciated	O
that	O
chronic	O
gut	O
inflammation	O
is	O
characterized	O
by	O
enhanced	O
production	O
of	O
reactive	O
metabolites	O
of	O
oxygen	O
and	O
nitrogen	O
.	O

Some	O
of	O
these	O
oxidants	O
are	O
known	O
to	O
modulate	O
the	O
expression	O
of	O
a	O
variety	O
of	O
genes	O
that	O
are	O
involved	O
in	O
the	O
immune	O
and	O
inflammatory	O
responses	O
.	O

For	O
example	O
,	O
certain	O
oxidants	O
are	O
known	O
to	O
activate	O
the	O
nuclear	O
transcription	O
factor	O
kappa	O
B	O
,	O
which	O
regulates	O
the	O
expression	O
of	O
a	O
variety	O
of	O
different	O
adhesion	O
molecules	O
,	O
cytokines	O
,	O
and	O
enzymes	O
.	O

Oxidants	O
are	O
also	O
known	O
to	O
activate	O
another	O
transcription	O
factor	O
,	O
activator	O
protein-1	O
.	O

This	O
transcription	O
factor	O
is	O
composed	O
of	O
products	O
from	O
the	O
fos	O
and	O
jun	O
proto-oncogene	O
family	O
and	O
is	B-SPECULATION
believed	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
important	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
cell	I-SPECULATION
growth	I-SPECULATION
and	I-SPECULATION
proliferation	I-SPECULATION
.	O

Finally	O
,	O
oxidants	B-SPECULATION
are	I-SPECULATION
believed	I-SPECULATION
to	I-SPECULATION
promote	I-SPECULATION
intestinal	I-SPECULATION
epithelial	I-SPECULATION
cell	I-SPECULATION
apoptosis	I-SPECULATION
,	O
and	O
the	B-SPECULATION
B-cell	I-SPECULATION
lymphoma	I-SPECULATION
/	I-SPECULATION
leukemia-2	I-SPECULATION
gene	I-SPECULATION
product	I-SPECULATION
is	I-SPECULATION
believed	I-SPECULATION
to	I-SPECULATION
inhibit	I-SPECULATION
this	I-SPECULATION
phenomenon	I-SPECULATION
in	I-SPECULATION
an	I-SPECULATION
antioxidant-dependent	I-SPECULATION
manner	I-SPECULATION
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	B-SPECULATION
that	I-SPECULATION
nontoxic	I-SPECULATION
concentrations	I-SPECULATION
of	I-SPECULATION
reactive	I-SPECULATION
metabolites	I-SPECULATION
of	I-SPECULATION
oxygen	I-SPECULATION
and	I-SPECULATION
nitrogen	I-SPECULATION
play	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
the	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
genes	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
inflammatory	I-SPECULATION
response	I-SPECULATION
and	I-SPECULATION
in	I-SPECULATION
modulating	I-SPECULATION
apoptosis	I-SPECULATION
.	O

Cytokine	O
rescue	O
from	O
glucocorticoid	O
induced	O
apoptosis	O
in	O
T	O
cells	O
is	O
mediated	O
through	O
inhibition	O
of	O
IkappaBalpha	O
.	O

We	O
previously	O
reported	O
that	O
dexamethasone	O
(	O
DEX	O
)	O
,	O
a	O
synthetic	O
glucocorticoid	O
,	O
causes	O
apoptosis	O
in	O
mature	O
Th	O
cell	O
lines	O
,	O
and	O
that	O
this	O
induction	O
of	O
cell	O
death	O
is	O
prevented	O
by	O
specific	O
cytokines	O
,	O
namely	O
,	O
by	O
IL-2	O
in	O
Th1	O
cells	O
and	O
by	O
IL-4	O
in	O
Th2	O
cells	O
.	O

We	O
now	O
show	O
that	O
this	O
differential	O
rescue	O
by	O
specific	O
cytokines	O
in	O
Th	O
cells	O
correlates	O
with	O
the	O
level	O
of	O
IkappaBalpha	O
that	O
is	O
regulated	O
by	O
DEX	O
and	O
cytokines	O
.	O

In	O
both	O
cell	O
types	O
the	O
cellular	O
levels	O
of	O
IkappaBalpha	O
mRNA	O
and	O
protein	O
were	O
evaluated	O
by	O
DEX	O
treatment	O
.	O

Interestingly	O
,	O
the	O
DEX-mediated	O
IkappaBalpha	O
induction	O
was	O
completely	O
inhibited	O
by	O
IL-2	O
,	O
but	O
not	B-NEGATION
IL-4	I-NEGATION
,	O
in	O
Th1	O
cells	O
,	O
while	O
the	O
reverse	O
profile	O
was	O
seen	O
in	O
Th2	O
cells	O
.	O

In	O
both	O
cell	O
types	O
,	O
the	O
cytokine	O
that	O
inhibits	O
the	O
induction	O
of	O
IkappaBalpha	O
by	O
DEX	O
,	O
also	O
rescues	O
these	O
cells	O
from	O
DEX-induced	O
apoptosis	O
,	O
although	O
the	O
rescue	O
cytokine	O
is	O
different	O
in	O
Th1	O
and	O
Th2	O
cells	O
.	O

Our	O
results	O
imply	B-SPECULATION
that	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
need	I-SPECULATION
to	I-SPECULATION
maintain	I-SPECULATION
a	I-SPECULATION
certain	I-SPECULATION
level	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
transcriptional	I-SPECULATION
activity	I-SPECULATION
in	I-SPECULATION
order	I-SPECULATION
to	I-SPECULATION
survive	I-SPECULATION
;	O
up	O
-	O
or	O
down-regulation	O
of	O
nuclear	O
NF	O
kappaB	O
through	O
modulation	O
of	O
IkappaBalpha	O
expression	O
by	O
cytokines	O
or	O
DEX	O
may	B-SPECULATION
lead	I-SPECULATION
to	I-SPECULATION
cell	I-SPECULATION
survival	I-SPECULATION
or	I-SPECULATION
cell	I-SPECULATION
death	I-SPECULATION
,	I-SPECULATION
respectively	I-SPECULATION
.	O

Xenogeneic	O
human	O
serum	O
promotes	O
leukocyte	O
adhesion	O
to	O
porcine	O
endothelium	O
under	O
flow	O
conditions	O
,	O
possibly	B-SPECULATION
through	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
.	O

Endothelial	O
cell	O
activation	O
and	O
leukocyte	O
infiltration	O
are	O
a	O
consistent	O
feature	O
of	O
discordant	O
xenograft	O
rejection	O
.	O

Here	O
we	O
evaluated	O
whether	B-SPECULATION
xenogeneic	I-SPECULATION
serum	I-SPECULATION
,	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
source	I-SPECULATION
of	I-SPECULATION
xenoreactive	I-SPECULATION
natural	I-SPECULATION
antibodies	I-SPECULATION
and	I-SPECULATION
complement	I-SPECULATION
,	I-SPECULATION
induced	I-SPECULATION
endothelial	I-SPECULATION
cell	I-SPECULATION
activation	I-SPECULATION
with	I-SPECULATION
consequent	I-SPECULATION
leukocyte	I-SPECULATION
adhesion	I-SPECULATION
under	I-SPECULATION
flow	I-SPECULATION
conditions	I-SPECULATION
.	O

Porcine	O
aortic	O
endothelial	O
cells	O
(	O
PAEC	O
)	O
were	O
incubated	O
for	O
1	O
hr	O
30	O
min	O
or	O
5	O
hr	O
with	O
10	O
%	O
homologous	O
porcine	O
serum	O
(	O
control	O
)	O
or	O
10	O
%	O
xenogeneic	O
human	O
serum	O
and	O
then	O
perfused	O
with	O
total	O
human	O
leukocytes	O
in	O
a	O
parallel	O
plate	O
flow	O
chamber	O
under	O
laminar	O
flow	O
(	O
1.5	O
dynes	O
/	O
cm2	O
)	O
.	O

Adherent	O
cells	O
were	O
counted	O
by	O
digital	O
image	O
analysis	O
.	O

Xenogeneic	O
human	O
serum	O
significantly	O
(	O
P	O
<	O
0.01	O
)	O
increased	O
the	O
number	O
of	O
adherent	O
leukocytes	O
as	O
compared	O
with	O
porcine	O
serum	O
.	O

A	O
similar	O
adhesive	O
response	O
was	O
elicited	O
by	O
TNF	O
alpha	O
(	O
100	O
U	O
/	O
ml	O
)	O
,	O
one	O
of	O
the	O
most	O
potent	O
inducers	O
of	O
endothelial	O
cell	O
adhesive	O
properties	O
,	O
here	O
used	O
as	O
positive	O
control	O
.	O

In	O
order	O
to	O
elucidate	O
possible	B-SPECULATION
mechanisms	I-SPECULATION
underlying	I-SPECULATION
endothelial	I-SPECULATION
cell	I-SPECULATION
activation	I-SPECULATION
by	I-SPECULATION
xenogeneic	I-SPECULATION
serum	I-SPECULATION
,	O
we	O
focussed	O
on	O
transcription	O
factor	O
NF-kappa	O
B	O
,	O
a	O
central	O
regulator	O
for	O
the	O
induction	O
of	O
different	O
genes	O
,	O
including	O
adhesive	O
molecules	O
and	O
chemoattractants	O
.	O

By	O
confocal	O
fluorescence	O
microscopy	O
,	O
we	O
observed	O
a	O
positive	O
staining	O
for	O
NF-kappa	O
B	O
(	O
p65	O
subunit	O
)	O
in	O
the	O
nuclei	O
of	O
PAEC	O
exposed	O
for	O
1	O
hr	O
30	O
min	O
to	O
human	O
serum	O
,	O
which	O
indicated	O
NF-kappa	O
B	O
activation	O
in	O
this	O
setting	O
.	O

At	O
variance	O
,	O
in	O
PAEC	O
incubated	O
with	O
the	O
homologous	O
serum	O
,	O
NF-kappa	O
B	O
was	O
strictly	O
localized	O
in	O
the	O
cell	O
cytoplasm	O
.	O

Treatment	O
of	O
PAEC	O
exposed	O
to	O
xenogeneic	O
serum	O
with	O
the	O
NF-kappa	O
B	O
inhibitors	O
pyrrolidinedithiocarbamate	O
(	O
PDTC	O
,	O
25	O
microM	O
)	O
and	O
tosyl-phechloromethylketone	O
(	O
TPCK	O
,	O
25	O
microM	O
)	O
significantly	O
(	O
P	O
<	O
0.01	O
)	O
reduced	O
leukocyte	O
adhesion	O
in	O
respect	O
to	O
PAEC	O
treated	O
with	O
human	O
serum	O
alone	O
.	O

Findings	O
that	O
xenogeneic	O
serum	O
promotes	O
leukocyte-endothelium	O
interaction	O
possibly	B-SPECULATION
through	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
activation	I-SPECULATION
might	B-SPECULATION
be	I-SPECULATION
relevant	I-SPECULATION
for	I-SPECULATION
designing	I-SPECULATION
future	I-SPECULATION
therapeutic	I-SPECULATION
strategies	I-SPECULATION
aimed	I-SPECULATION
at	I-SPECULATION
prolonging	I-SPECULATION
xenograft	I-SPECULATION
survival	I-SPECULATION
.	O

Role	O
of	O
cyclic	O
AMP	O
response	O
element-binding	O
protein	O
in	O
cyclic	O
AMP	O
inhibition	O
of	O
NF-kappaB-mediated	O
transcription	O
.	O

The	O
NF-kappaB	O
family	O
of	O
transcription	O
factors	O
regulates	O
the	O
inducible	O
expression	O
of	O
a	O
variety	O
of	O
genes	O
.	O

Recently	O
,	O
we	O
showed	O
that	O
elevation	O
of	O
intracellular	O
cyclic	O
AMP	O
inhibits	O
NF-kappaB-mediated	O
transcription	O
in	O
human	O
monocytes	O
and	O
endothelial	O
cells	O
without	B-NEGATION
preventing	I-NEGATION
nuclear	I-NEGATION
translocation	I-NEGATION
of	I-NEGATION
NF-kappaB	I-NEGATION
complexes	I-NEGATION
.	O

The	O
present	O
study	O
examined	O
the	O
molecular	O
mechanism	O
of	O
this	O
inhibition	O
.	O

We	O
hypothesized	B-SPECULATION
that	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
protein	I-SPECULATION
kinase	I-SPECULATION
A	I-SPECULATION
signaling	I-SPECULATION
pathway	I-SPECULATION
may	B-SPECULATION
inhibit	I-SPECULATION
NF-kappaB-mediated	I-SPECULATION
transcription	I-SPECULATION
by	I-SPECULATION
phosphorylating	I-SPECULATION
proteins	I-SPECULATION
,	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
cAMP	I-SPECULATION
response	I-SPECULATION
element-binding	I-SPECULATION
protein	I-SPECULATION
(	I-SPECULATION
CREB	I-SPECULATION
)	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
compete	I-SPECULATION
for	I-SPECULATION
limiting	I-SPECULATION
amounts	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
coactivator	I-SPECULATION
CBP	I-SPECULATION
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
amino-terminal	O
region	O
(	O
amino	O
acids	O
1-450	O
)	O
of	O
CBP	O
specifically	O
interacts	O
with	O
the	O
carboxyl-terminal	O
region	O
(	O
amino	O
acids	O
286-551	O
)	O
of	O
NF-kappaB	O
p65	O
(	O
RelA	O
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Functional	O
studies	O
using	O
human	O
endothelial	O
cells	O
demonstrated	O
that	O
overexpression	O
of	O
CBP	O
rescued	O
cAMP	O
inhibition	O
of	O
NF-kappaB-mediated	O
transcription	O
and	O
transcription	O
mediated	O
by	O
a	O
chimeric	O
protein	O
,	O
GAL4-p65	O
(	O
286-551	O
)	O
,	O
which	O
contained	O
the	O
GAL4	O
DNA	O
binding	O
domain	O
fused	O
to	O
the	O
carboxyl-terminal	O
region	O
of	O
p65	O
(	O
amino	O
acids	O
286-551	O
)	O
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
CREB	O
inhibited	O
GAL4-p65	O
(	O
286-551	O
)-	O
mediated	O
transcription	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
protein	I-SPECULATION
kinase	I-SPECULATION
A	I-SPECULATION
pathway	I-SPECULATION
inhibits	I-SPECULATION
NF-kappaB	I-SPECULATION
transcription	I-SPECULATION
by	I-SPECULATION
phosphorylating	I-SPECULATION
CREB	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
competes	I-SPECULATION
with	I-SPECULATION
p65	I-SPECULATION
for	I-SPECULATION
limiting	I-SPECULATION
amounts	I-SPECULATION
of	I-SPECULATION
CBP	I-SPECULATION
.	O

Differential	O
induction	O
of	O
DNA-binding	O
activities	O
following	O
CD19	O
cross-linking	O
in	O
human	O
B	O
lineage	O
cells	O
.	O

The	O
B	O
cell-specific	O
cell	O
surface	O
molecule	O
CD19	O
is	O
expressed	O
at	O
all	O
stages	O
of	O
B	O
cell	O
development	O
,	O
including	O
normal	O
plasma	O
cells	O
,	O
and	O
mediates	O
signal	O
transduction	O
via	O
interaction	O
with	O
cytoplasmic	O
effector	O
proteins	O
.	O

Cross-linking	O
CD19	O
on	O
early	O
human	O
B	O
lineage	O
cells	O
induces	O
the	O
formation	O
of	O
a	O
CD19	O
/	O
Vav	O
/	O
phosphatidylinositol-3	O
kinase	O
complex	O
,	O
tyrosine	O
phosphorylation	O
of	O
CD19	O
and	O
Vav	O
,	O
and	O
activation	O
of	O
the	O
Ras	O
pathway	O
.	O

To	O
further	O
explore	O
the	O
ramifications	O
of	O
CD19	O
signaling	O
,	O
the	O
current	O
study	O
examined	O
whether	B-SPECULATION
phosphorylation	I-SPECULATION
of	I-SPECULATION
Elk-1	I-SPECULATION
,	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
activator	I-SPECULATION
protein-1	I-SPECULATION
(	I-SPECULATION
AP-1	I-SPECULATION
)	I-SPECULATION
,	I-SPECULATION
or	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
nuclear	I-SPECULATION
factor-kappaB	I-SPECULATION
(	I-SPECULATION
NF-kappaB	I-SPECULATION
)	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
occurred	I-SPECULATION
following	I-SPECULATION
CD19	I-SPECULATION
cross-linking	I-SPECULATION
.	O

The	O
cells	O
used	O
were	O
the	O
BLIN-1	O
pre-B	O
cell	O
line	O
expressing	O
low	O
levels	O
of	O
cell	O
surface	O
mu	O
heavy	O
chain	O
associated	O
with	O
surrogate	O
light	O
chain	O
and	O
the	O
1E8	O
immature	O
B	O
cell	O
line	O
expressing	O
cell	O
surface	O
mu	O
/	O
kappa	O
.	O

Lysates	O
from	O
CD19	O
cross-linked	O
1E8	O
cells	O
induced	O
robust	O
phosphorylation	O
of	O
an	O
Elk-1	O
fusion	O
protein	O
in	O
vitro	O
,	O
whereas	O
no	B-NEGATION
phosphorylation	I-NEGATION
of	I-NEGATION
Elk-1	I-NEGATION
fusion	I-NEGATION
protein	I-NEGATION
occurred	I-NEGATION
using	I-NEGATION
lysates	I-NEGATION
from	I-NEGATION
CD19	I-NEGATION
cross-linked	I-NEGATION
BLIN-1	I-NEGATION
cells	I-NEGATION
.	O

An	O
electrophoretic	O
mobility	O
shift	O
assay	O
employing	O
AP-1	O
and	O
NF-kappaB	O
consensus	O
oligonucleotides	O
was	O
used	O
to	O
demonstrate	O
that	O
AP-1	O
-	O
binding	O
activity	O
increased	O
,	O
while	O
constitutive	B-NEGATION
NF-kappaB-binding	I-NEGATION
activity	I-NEGATION
was	I-NEGATION
not	I-NEGATION
enhanced	I-NEGATION
,	O
following	O
2	O
h	O
of	O
CD19	O
cross-linking	O
in	O
1E8	O
cells	O
.	O

Supershift	O
experiments	O
revealed	O
that	O
JunD	O
and	O
c-Fos	O
proteins	O
mediated	O
anti-CD19	O
induced	O
AP-1-binding	O
activity	O
in	O
1E8	O
cells	O
.	O

In	O
contrast	O
,	O
CD19	O
cross-linking	O
in	O
BLIN-1	O
cells	O
resulted	O
in	O
the	O
induction	O
of	O
NF-kappaB	O
,	O
but	O
had	O
no	B-NEGATION
apparent	I-NEGATION
effect	I-NEGATION
on	I-NEGATION
AP-1-binding	I-NEGATION
activity	I-NEGATION
.	O

These	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
CD19-mediated	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
activates	I-SPECULATION
different	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
at	I-SPECULATION
juxtaposed	I-SPECULATION
stages	I-SPECULATION
of	I-SPECULATION
B	I-SPECULATION
cell	I-SPECULATION
development	I-SPECULATION
that	I-SPECULATION
may	B-SPECULATION
culminate	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
or	I-SPECULATION
suppression	I-SPECULATION
of	I-SPECULATION
distinct	I-SPECULATION
sets	I-SPECULATION
of	I-SPECULATION
genes	I-SPECULATION
.	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
long	O
terminal	O
repeat	O
quasispecies	O
differ	O
in	O
basal	O
transcription	O
and	O
nuclear	O
factor	O
recruitment	O
in	O
human	O
glial	O
cells	O
and	O
lymphocytes	O
.	O

The	O
generation	O
of	O
genomic	O
diversity	O
during	O
the	O
course	O
of	O
infection	O
has	O
the	O
potential	O
to	O
affect	O
all	O
aspects	O
of	O
HIV-1	O
replication	O
,	O
including	O
expression	O
of	O
the	O
proviral	O
genome	O
.	O

To	O
gain	O
a	O
better	O
understanding	O
of	O
the	O
impact	O
of	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
sequence	O
diversity	O
on	O
LTR-directed	O
gene	O
expression	O
in	O
cells	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
and	O
immune	O
system	O
,	O
we	O
amplified	O
and	O
cloned	O
LTRs	O
from	O
proviral	O
DNA	O
in	O
HIV-1-infected	O
peripheral	O
blood	O
.	O

Sequence	O
analysis	O
of	O
nineteen	O
LTRs	O
cloned	O
from	O
2	O
adult	O
and	O
3	O
pediatric	O
patients	O
revealed	O
an	O
average	O
of	O
33	O
nucleotide	O
changes	O
(	O
with	O
respect	O
to	O
the	O
sequence	O
of	O
the	O
LAI	O
LTR	O
)	O
within	O
the	O
455-bp	O
U3	O
region	O
.	O

Transient	O
expression	O
analyses	O
in	O
cells	O
of	O
neuroglial	O
and	O
lymphocytic	O
origin	O
demonstrated	O
that	O
some	O
of	O
these	O
LTRs	O
had	O
activities	O
which	O
varied	O
significantly	O
from	O
the	O
LAI	O
LTR	O
in	O
U-373	O
MG	O
cells	O
(	O
an	O
astrocytoma	O
cell	O
line	O
)	O
as	O
well	O
as	O
in	O
Jurkat	O
cells	O
(	O
a	O
CD4-positive	O
lymphocyte	O
cell	O
line	O
)	O
.	O

While	O
LTRs	O
which	O
demonstrated	O
the	O
highest	O
activities	O
in	O
U-373	O
MG	O
cells	O
also	O
yielded	O
high	O
activities	O
in	O
Jurkat	O
cells	O
,	O
the	O
LTRs	O
were	O
generally	O
more	O
active	O
in	O
Jurkat	O
cells	O
when	O
compared	O
to	O
the	O
LAI	O
LTR	O
.	O

Differences	O
in	O
LTR	O
sequence	O
also	O
resulted	O
in	O
differences	O
in	O
transcription	O
factor	O
recruitment	O
to	O
cis-acting	O
sites	O
within	O
the	O
U3	O
region	O
of	O
the	O
LTR	O
,	O
as	O
demonstrated	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

In	O
particular	O
,	O
naturally	O
occurring	O
sequence	O
variation	O
impacted	O
transcription	O
factor	O
binding	O
to	O
an	O
activating	O
transcription	O
factor	O
/	O
cAMP	O
response	O
element	O
binding	O
(	O
ATF	O
/	O
CREB	O
)	O
binding	O
site	O
(	O
located	O
between	O
the	O
LEF-1	O
and	O
distal	O
NF-kappaB	O
transcription	O
factor	O
binding	O
sites	O
)	O
that	O
we	O
identified	O
in	O
previous	O
studies	O
of	O
the	O
HIV-1	O
LTR	O
.	O

These	O
findings	O
suggest	B-SPECULATION
that	I-SPECULATION
LTR	I-SPECULATION
sequence	I-SPECULATION
changes	I-SPECULATION
can	I-SPECULATION
significantly	I-SPECULATION
affect	I-SPECULATION
basal	I-SPECULATION
LTR	I-SPECULATION
function	I-SPECULATION
and	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
recruitment	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
may	B-SPECULATION
,	I-SPECULATION
in	I-SPECULATION
turn	I-SPECULATION
,	I-SPECULATION
alter	I-SPECULATION
the	I-SPECULATION
course	I-SPECULATION
of	I-SPECULATION
viral	I-SPECULATION
replication	I-SPECULATION
in	I-SPECULATION
cells	I-SPECULATION
of	I-SPECULATION
CNS	I-SPECULATION
and	I-SPECULATION
immune	I-SPECULATION
system	I-SPECULATION
origin	I-SPECULATION
.	O

Inhibition	O
of	O
nuclear	O
factor	O
kappaB	O
activation	O
attenuates	O
apoptosis	O
resistance	O
in	O
lymphoid	O
cells	O
.	O

Death-inducing	O
ligands	O
(	O
DILs	O
)	O
such	O
as	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNFalpha	O
)	O
or	O
the	O
cytotoxic	O
drug	O
doxorubicin	O
have	O
been	O
shown	O
to	O
activate	O
a	O
nuclear	O
factor	O
kappaB	O
(	O
NFkappaB	O
)-	O
dependent	O
program	O
that	O
may	B-SPECULATION
rescue	I-SPECULATION
cells	I-SPECULATION
from	I-SPECULATION
apoptosis	I-SPECULATION
induction	I-SPECULATION
.	O

We	O
demonstrate	O
here	O
that	O
TRAIL	O
(	O
TNF-related	O
apoptosis-inducing	O
ligand	O
)	O
,	O
a	O
recently	O
identified	O
DIL	O
,	O
also	O
activates	O
NFkappaB	O
in	O
lymphoid	O
cell	O
lines	O
in	O
a	O
kinetic	O
similar	O
to	O
TNFalpha	O
.	O

NFkappaB	O
activity	O
is	O
independent	O
from	O
FADD	O
,	O
caspases	O
,	O
and	O
apoptosis	O
induction	O
.	O

To	O
study	O
the	O
influence	O
of	O
NFkappaB	O
activity	O
on	O
apoptosis	O
mediated	O
by	O
TRAIL	O
,	O
CD95	O
,	O
TNFalpha	O
,	O
or	O
doxorubicin	O
,	O
NFkappaB	O
activation	O
was	O
inhibited	O
using	O
the	O
proteasome	O
inhibitor	O
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal	O
or	O
transient	O
overexpression	O
of	O
mutant	O
IkappaBalpha	O
.	O

Sensitivity	O
for	O
induction	O
of	O
apoptosis	O
was	O
markedly	O
increased	O
by	O
these	O
treatments	O
in	O
apoptosis	O
sensitive	O
cell	O
lines	O
.	O

Moreover	O
,	O
both	O
in	O
cell	O
lines	O
and	O
in	O
primary	O
leukemia	O
cells	O
that	O
are	O
resistant	O
towards	O
induction	O
of	O
apoptosis	O
by	O
DILs	O
and	O
doxorubicin	O
,	O
antagonization	O
of	O
NFkappaB	O
activity	O
partially	O
restored	O
apoptosis	O
sensitivity	O
.	O

These	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
NFkappaB	I-SPECULATION
activation	I-SPECULATION
may	B-SPECULATION
provide	I-SPECULATION
a	I-SPECULATION
molecular	I-SPECULATION
approach	I-SPECULATION
to	I-SPECULATION
increase	I-SPECULATION
apoptosis	I-SPECULATION
sensitivity	I-SPECULATION
in	I-SPECULATION
anticancer	I-SPECULATION
treatment	I-SPECULATION
.	O

IL-2-induced	O
growth	O
of	O
CD8	O
+	O
T	O
cell	O
prolymphocytic	O
leukemia	O
cells	O
mediated	O
by	O
NF-kappaB	O
induction	O
and	O
IL-2	O
receptor	O
alpha	O
expression	O
.	O

The	O
binding	O
of	O
interleukin-2	O
(	O
IL-2	O
)	O
to	O
its	O
receptor	O
on	O
normal	O
T	O
cells	O
induces	O
nuclear	O
expression	O
of	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)	O
,	O
activation	O
of	O
the	O
IL-2	O
receptor	O
(	O
IL-2R	O
)	O
alpha	O
chain	O
gene	O
,	O
and	O
cell	O
proliferation	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
role	O
of	O
IL-2R	O
signaling	O
in	O
the	O
growth	O
of	O
CD8	O
+	O
T	O
cell	O
prolymphocytic	O
leukemia	O
(	O
T-PLL	O
)	O
cells	O
has	O
been	O
investigated	O
.	O

Flow	O
cytometry	O
revealed	O
that	O
primary	O
leukemia	O
cells	O
from	O
a	O
patient	O
with	O
CD8	O
+	O
T-PLL	O
expressed	O
IL-2Ralpha	O
and	O
beta	O
chains	O
,	O
and	O
the	O
cells	O
showed	O
a	O
proliferative	O
response	O
and	O
an	O
increase	O
in	O
IL-2Ralpha	O
expression	O
on	O
culture	O
with	O
exogeneous	O
IL-2	O
.	O

Northern	O
blot	O
analysis	O
failed	B-NEGATION
to	I-NEGATION
detect	I-NEGATION
IL-2	I-NEGATION
mRNA	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
IL-2	I-SPECULATION
may	B-SPECULATION
act	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
paracrine	I-SPECULATION
manner	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
.	O

Electrophoretic	O
mobility-shift	O
assays	O
revealed	O
that	O
recombinant	O
IL-2	O
increased	O
NF-kappaB	O
binding	O
activity	O
in	O
nuclear	O
extracts	O
of	O
the	O
leukemia	O
cells	O
,	O
and	O
Northern	O
blot	O
analysis	O
showed	O
that	O
IL-2	O
increased	O
the	O
abundance	O
of	O
mRNAs	O
encoding	O
the	O
NF-kappaB	O
components	O
c-Rel	O
and	O
KBF1	O
in	O
these	O
cells	O
.	O

IL-2	O
binding	O
analysis	O
demonstrated	O
that	O
IL-2	O
markedly	O
increased	O
the	O
number	O
of	O
low	O
affinity	O
IL-2Rs	O
on	O
the	O
leukemia	O
cells	O
,	O
without	B-NEGATION
an	I-NEGATION
effect	I-NEGATION
on	I-NEGATION
the	I-NEGATION
number	I-NEGATION
of	I-NEGATION
high-affinity	I-NEGATION
IL-2Rs	I-NEGATION
.	O

These	O
results	O
show	O
that	O
IL-2	O
is	O
capable	O
of	O
inducing	O
the	O
nuclear	O
expression	O
of	O
NF-kappaB	O
in	O
primary	O
CD8	O
+	O
T-PLL	O
cells	O
,	O
and	O
that	O
this	O
effect	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
at	O
a	O
pretranslational	O
level	O
.	O

The	O
human	O
toll	O
signaling	O
pathway	O
:	O
divergence	O
of	O
nuclear	O
factor	O
kappaB	O
and	O
JNK	O
/	O
SAPK	O
activation	O
upstream	O
of	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
factor	O
6	O
(	O
TRAF6	O
)	O
.	O

The	O
human	O
homologue	O
of	O
Drosophila	O
Toll	O
(	O
hToll	O
)	O
is	O
a	O
recently	O
cloned	O
receptor	O
of	O
the	O
interleukin	O
1	O
receptor	O
(	O
IL-1R	O
)	O
superfamily	O
,	O
and	O
has	O
been	O
implicated	O
in	O
the	O
activation	O
of	O
adaptive	O
immunity	O
.	O

Signaling	O
by	O
hToll	O
is	O
shown	O
to	O
occur	O
through	O
sequential	O
recruitment	O
of	O
the	O
adapter	O
molecule	O
MyD88	O
and	O
the	O
IL-1R-associated	O
kinase	O
.	O

Tumor	O
necrosis	O
factor	O
receptor-activated	O
factor	O
6	O
(	O
TRAF6	O
)	O
and	O
the	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)-	O
inducing	O
kinase	O
(	O
NIK	O
)	O
are	O
both	O
involved	O
in	O
subsequent	O
steps	O
of	O
NF-kappaB	O
activation	O
.	O

Conversely	O
,	O
a	O
dominant	O
negative	O
version	O
of	O
TRAF6	O
failed	B-NEGATION
to	I-NEGATION
block	I-NEGATION
hToll-induced	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
stress-activated	I-NEGATION
protein	I-NEGATION
kinase	I-NEGATION
/	I-NEGATION
c-Jun	I-NEGATION
NH2-terminal	I-NEGATION
kinases	I-NEGATION
,	O
thus	O
suggesting	B-SPECULATION
an	I-SPECULATION
early	I-SPECULATION
divergence	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
two	I-SPECULATION
pathways	I-SPECULATION
.	O

Coactivation	O
by	O
OCA-B	O
:	O
definition	O
of	O
critical	O
regions	O
and	O
synergism	O
with	O
general	O
cofactors	O
.	O

Molecular	O
dissection	O
of	O
the	O
B-cell-specific	O
transcription	O
coactivator	O
OCA-B	O
has	O
revealed	O
distinct	O
regions	O
important	O
,	O
respectively	O
,	O
for	O
recruitment	O
to	O
immunoglobulin	O
promoters	O
through	O
interaction	O
with	O
octamer-bound	O
Oct-1	O
and	O
for	O
subsequent	O
coactivator	O
function	O
.	O

Further	O
analysis	O
of	O
general	O
coactivator	O
requirements	O
showed	O
that	O
selective	O
removal	O
of	O
PC4	O
from	O
the	O
essential	O
USA	O
fraction	O
severely	O
impairs	O
Oct-1	O
and	O
OCA-B	O
function	O
in	O
a	O
cell-free	O
system	O
reconstituted	O
with	O
partially	O
purified	O
factors	O
.	O

Full	O
activity	O
can	O
be	O
restored	O
by	O
the	O
combined	O
action	O
of	O
recombinant	O
PC4	O
and	O
the	O
PC4-depleted	O
USA	O
fraction	O
,	O
thus	O
suggesting	B-SPECULATION
a	I-SPECULATION
joint	I-SPECULATION
requirement	I-SPECULATION
for	I-SPECULATION
PC4	I-SPECULATION
and	I-SPECULATION
another	I-SPECULATION
,	I-SPECULATION
USA-derived	I-SPECULATION
component	I-SPECULATION
(	I-SPECULATION
s	I-SPECULATION
)	I-SPECULATION
for	I-SPECULATION
optimal	I-SPECULATION
function	I-SPECULATION
of	I-SPECULATION
Oct-1	I-SPECULATION
/	I-SPECULATION
OCA-B	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
reconstituted	I-SPECULATION
system	I-SPECULATION
.	O

Indeed	O
,	O
USA-derived	O
PC2	O
was	O
found	O
to	O
act	O
synergistically	O
with	O
PC4	O
in	O
reproducing	O
the	O
function	O
of	O
intact	O
USA	O
in	O
the	O
assay	O
system	O
.	O

Consistent	O
with	O
the	O
requirement	O
for	O
PC4	O
in	O
the	O
reconstituted	O
system	O
,	O
OCA-B	O
was	O
found	O
to	O
interact	O
directly	O
with	O
PC4	O
.	O

Surprisingly	O
,	O
however	O
,	O
removal	O
of	O
PC4	O
from	O
the	O
unfractionated	O
nuclear	O
extract	O
has	O
no	B-NEGATION
detrimental	I-NEGATION
effect	I-NEGATION
on	I-NEGATION
OCA-B	I-NEGATION
/	I-NEGATION
Oct-1-dependent	I-NEGATION
transcription	I-NEGATION
.	O

These	O
results	O
lead	O
to	O
a	O
general	O
model	O
for	O
the	O
synergistic	O
function	O
of	O
activation	O
domains	O
in	O
Oct-1	O
and	O
OCA-B	O
(	O
mediated	O
by	O
the	O
combined	O
action	O
of	O
the	O
multiple	O
USA	O
components	O
)	O
and	O
,	O
further	O
,	O
suggest	B-SPECULATION
a	I-SPECULATION
functional	I-SPECULATION
redundancy	I-SPECULATION
in	I-SPECULATION
general	I-SPECULATION
coactivators	I-SPECULATION
.	O

Limited	O
proteolysis	O
for	O
assaying	O
ligand	O
binding	O
affinities	O
of	O
nuclear	O
receptors	O
.	O

The	O
binding	O
of	O
natural	O
or	O
synthetic	O
ligands	O
to	O
nuclear	O
receptors	O
is	O
the	O
triggering	O
event	O
leading	O
to	O
gene	O
transcription	O
activation	O
or	O
repression	O
.	O

Ligand	O
binding	O
to	O
the	O
ligand	O
binding	O
domain	O
of	O
these	O
receptors	O
induces	O
conformational	O
changes	O
that	O
are	O
evidenced	O
by	O
an	O
increased	O
resistance	O
of	O
this	O
domain	O
to	O
proteases	O
.	O

In	O
vitro	O
labeled	O
receptors	O
were	O
incubated	O
with	O
various	O
synthetic	O
or	O
natural	O
agonists	O
or	O
antagonists	O
and	O
submitted	O
to	O
trypsin	O
digestion	O
.	O

Proteolysis	O
products	O
were	O
separated	O
by	O
SDS-PAGE	O
and	O
quantified	O
.	O

The	O
amount	O
of	O
trypsin-resistant	O
fragments	O
was	O
proportional	O
to	O
receptor	O
occupancy	O
by	O
the	O
ligand	O
,	O
and	O
allowed	O
the	O
determination	O
of	O
dissociation	O
constants	O
(	O
kDa	O
)	O
.	O

Using	O
the	O
wild-type	O
or	O
mutated	O
human	O
retinoic	O
acid	O
receptor	O
alpha	O
as	O
a	O
model	O
,	O
kDa	O
values	O
determined	O
by	O
classical	O
competition	O
binding	O
assays	O
using	O
tritiated	O
ligands	O
are	O
in	O
agreement	O
with	O
those	O
measured	O
by	O
the	O
proteolytic	O
assay	O
.	O

This	O
method	O
was	O
successfully	O
extended	O
to	O
human	O
retinoic	O
X	O
receptor	O
alpha	O
,	O
glucocorticoid	O
receptor	O
,	O
and	O
progesterone	O
receptor	O
,	O
thus	O
providing	O
a	O
basis	O
for	O
a	O
new	O
,	O
faster	O
assay	O
to	O
determine	O
simultaneously	O
the	O
affinity	O
and	O
conformation	O
of	O
receptors	O
when	O
bound	O
to	O
a	O
given	O
ligand	O
.	O

Mycobacterium	O
tuberculosis	O
mannose-capped	O
lipoarabinomannan	O
can	O
induce	O
NF-kappaB-dependent	O
activation	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
long	O
terminal	O
repeat	O
in	O
T	O
cells	O
.	O

Tuberculosis	O
has	O
emerged	O
as	O
an	O
epidemic	O
,	O
extended	O
by	O
the	O
large	O
number	O
of	O
individuals	O
infected	O
with	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
.	O

The	O
major	O
goal	O
of	O
this	O
study	O
was	O
to	O
determine	O
whether	B-SPECULATION
the	I-SPECULATION
mycobacterial	I-SPECULATION
cell	I-SPECULATION
wall	I-SPECULATION
component	I-SPECULATION
mannose-capped	I-SPECULATION
lipoarabinomannan	I-SPECULATION
(	I-SPECULATION
ManLAM	I-SPECULATION
)	I-SPECULATION
of	I-SPECULATION
Mycobacterium	I-SPECULATION
tuberculosis	I-SPECULATION
(	I-SPECULATION
M.	I-SPECULATION
tuberculosis	I-SPECULATION
)	I-SPECULATION
could	I-SPECULATION
activate	I-SPECULATION
transcription	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
use	I-SPECULATION
of	I-SPECULATION
an	I-SPECULATION
in	I-SPECULATION
vitro	I-SPECULATION
cell	I-SPECULATION
culture	I-SPECULATION
system	I-SPECULATION
.	O

These	O
experiments	O
are	O
of	O
prime	O
importance	O
considering	O
that	O
CD4-expressing	O
T	O
lymphocytes	O
represent	O
the	O
major	O
virus	O
reservoir	O
in	O
the	O
peripheral	O
blood	O
of	O
infected	O
individuals	O
.	O

Using	O
the	O
1G5	O
cell	O
line	O
harbouring	O
the	O
luciferase	O
reporter	O
gene	O
under	O
the	O
control	O
of	O
the	O
HIV-1	O
LTR	O
,	O
it	O
was	O
first	O
found	O
that	O
culture	O
protein	O
filtrates	O
(	O
CFP	O
)	O
from	O
M.	O
tuberculosis	O
or	O
purified	O
ManLAM	O
could	O
activate	O
HIV-1	O
LTR-dependent	O
gene	O
expression	O
unlike	O
similarly	O
prepared	O
CFP	O
extracts	O
devoid	O
of	O
ManLAM	O
.	O

The	O
implication	O
of	O
protein	O
tyrosine	O
kinase	O
(	O
s	O
)	O
,	O
protein	O
kinase	O
A	O
and	O
/	O
or	O
protein	O
kinase	O
C	O
was	O
highlighted	O
by	O
the	O
abrogation	O
of	O
the	O
ManLAM-mediated	O
activation	O
of	O
HIV-1	O
LTR-driven	O
gene	O
expression	O
using	O
herbimycin	O
A	O
and	O
H7	O
.	O

It	O
was	O
also	O
determined	O
,	O
using	O
electrophoresis	O
mobility	O
shift	O
assays	O
,	O
that	O
M.	O
tuberculosis	O
ManLAM	O
led	O
to	O
the	O
nuclear	O
translocation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	O
.	O

M.	O
tuberculosis	O
ManLAM	O
resulted	O
in	O
clear	O
induction	O
of	O
the	O
luciferase	O
gene	O
placed	O
under	O
the	O
control	O
of	O
the	O
wild-type	O
,	O
but	O
not	B-NEGATION
the	I-NEGATION
kappaB-mutated	I-NEGATION
,	O
HIV-1	O
LTR	O
region	O
.	O

Finally	O
,	O
the	O
ManLAM-mediated	O
activation	O
of	O
HIV-1	O
LTR	O
transcription	O
was	O
found	O
to	O
be	O
independent	O
of	O
the	O
autocrine	O
or	O
paracrine	O
action	O
of	O
endogenous	O
TNF-alpha	O
.	O

The	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
M.	I-SPECULATION
tuberculosis	I-SPECULATION
can	I-SPECULATION
upregulate	I-SPECULATION
HIV-1	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
and	I-SPECULATION
could	B-SPECULATION
thus	I-SPECULATION
have	I-SPECULATION
the	I-SPECULATION
potential	I-SPECULATION
to	I-SPECULATION
influence	I-SPECULATION
the	I-SPECULATION
pathogenesis	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
infection	I-SPECULATION
.	O

Oxidative	O
stress	O
suppresses	O
transcription	O
factor	O
activities	O
in	O
stimulated	O
lymphocytes	O
.	O

Effects	O
of	O
oxidative	O
stress	O
on	O
stimulation-dependent	O
signal	O
transduction	O
,	O
leading	O
to	O
IL-2	O
expression	O
,	O
were	O
studied	O
.	O

Purified	O
quiescent	O
human	O
blood	O
T	O
lymphocytes	O
were	O
subjected	O
to	O
:	O
(	O
i	O
)	O
acute	O
exposure	O
to	O
hydrogen	O
peroxide	O
;	O
(	O
ii	O
)	O
chronic	O
exposure	O
to	O
hydrogen	O
peroxide	O
;	O
and	O
(	O
iii	O
)	O
acute	O
exposure	O
to	O
ionizing	O
radiation	O
.	O

The	O
cells	O
were	O
then	O
stimulated	O
for	O
6	O
h	O
.	O

DNA-binding	O
activities	O
(	O
determined	O
by	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
)	O
of	O
three	O
transcription	O
factors	O
:	O
NFkappaB	O
,	O
AP-1	O
and	O
NFAT	O
,	O
were	O
abolished	O
in	O
the	O
lymphocytes	O
by	O
all	O
three	O
modes	O
of	O
oxidative	O
stress	O
.	O

The	O
lymphocytes	O
exhibited	O
lipid	O
peroxidation	O
only	O
upon	O
exposure	O
to	O
the	O
lowest	O
level	O
of	O
hydrogen	O
peroxide	O
used	O
(	O
20	O
microM	O
)	O
.	O

All	O
three	O
modes	O
of	O
oxidative	O
stress	O
induced	O
catalase	O
activity	O
in	O
the	O
lymphocytes	O
.	O

The	O
only	O
exception	O
was	O
hydrogen	O
peroxide	O
at	O
20	O
microM	O
,	O
which	O
did	O
not	B-NEGATION
induce	I-NEGATION
catalase	I-NEGATION
activity	I-NEGATION
.	O

We	O
conclude	O
that	O
:	O
(	O
i	O
)	O
suppression	O
of	O
specific	O
transcription	O
factor	O
functions	O
can	O
potentially	B-SPECULATION
serve	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
marker	I-SPECULATION
of	I-SPECULATION
exposure	I-SPECULATION
to	I-SPECULATION
oxidative	I-SPECULATION
stress	I-SPECULATION
and	I-SPECULATION
its	I-SPECULATION
effects	I-SPECULATION
on	I-SPECULATION
human	I-SPECULATION
lymphocytes	I-SPECULATION
;	O
(	O
ii	O
)	O
lipid	O
peroxidation	O
is	O
only	O
detectable	O
in	O
human	O
lymphocytes	O
upon	O
exposure	O
to	O
weak	O
oxidative	O
stress	O
which	O
does	O
not	B-NEGATION
induce	I-NEGATION
catalase	I-NEGATION
activity	I-NEGATION
;	O
(	O
iii	O
)	O
therefore	O
,	O
transcription	O
factor	O
DNA-binding	O
activities	O
are	O
more	O
sensitive	O
to	O
oxidative	O
stress	O
than	O
lipid	O
peroxidation	O
.	O

DNA	O
damaging	O
agents	O
induce	O
expression	O
of	O
Fas	O
ligand	O
and	O
subsequent	O
apoptosis	O
in	O
T	O
lymphocytes	O
via	O
the	O
activation	O
of	O
NF-kappa	O
B	O
and	O
AP-1	O
.	O

Apoptosis	O
induced	O
by	O
DNA	O
damage	O
and	O
other	O
stresses	O
can	O
proceed	O
via	O
expression	O
of	O
Fas	O
ligand	O
(	O
FasL	O
)	O
and	O
ligation	O
of	O
its	O
receptor	O
,	O
Fas	O
(	O
CD95	O
)	O
.	O

We	O
report	O
that	O
activation	O
of	O
the	O
two	O
transcription	O
factors	O
NF-kappa	O
B	O
and	O
AP-1	O
is	O
crucially	O
involved	O
in	O
FasL	O
expression	O
induced	O
by	O
etoposide	O
,	O
teniposide	O
,	O
and	O
UV	O
irradiation	O
.	O

A	O
nondegradable	O
mutant	O
of	O
I	O
kappa	O
B	O
blocked	O
both	O
FasL	O
expression	O
and	O
apoptosis	O
induced	O
by	O
DNA	O
damage	O
but	O
not	B-NEGATION
Fas	I-NEGATION
ligation	I-NEGATION
.	O

These	O
stimuli	O
also	O
induced	O
the	O
stress-activated	O
kinase	O
pathway	O
(	O
SAPK	O
/	O
JNK	O
)	O
,	O
which	O
was	O
required	O
for	O
the	O
maximal	O
induction	O
of	O
apoptosis	O
.	O

A	O
1.2	O
kb	O
FasL	O
promoter	O
responded	O
to	O
DNA	O
damage	O
,	O
as	O
well	O
as	O
coexpression	O
with	O
p65	O
Rel	O
or	O
Fos	O
/	O
Jun	O
.	O

Mutations	O
in	O
the	O
relevant	O
NF-kappa	O
B	O
and	O
AP-1	O
binding	O
sites	O
eliminated	O
these	O
responses	O
.	O

Thus	O
,	O
activation	O
of	O
NF-kappa	O
B	O
and	O
AP-1	O
contributes	O
to	O
stress-induced	O
apoptosis	O
via	O
the	O
expression	O
of	O
FasL	O
.	O

Thrombopoietin	O
supports	O
in	O
vitro	O
erythroid	O
differentiation	O
via	O
its	O
specific	O
receptor	O
c-Mpl	O
in	O
a	O
human	O
leukemia	O
cell	O
line	O
.	O

Thrombopoietin	O
(	O
TPO	O
)	O
acts	O
on	O
megakaryopoiesis	O
and	O
erythropoiesis	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

We	O
isolated	O
a	O
novel	O
subline	O
,	O
UT-7	O
/	O
GMT	O
,	O
from	O
the	O
human	O
leukemia	O
cell	O
line	O
UT-7	O
/	O
GM	O
(	O
N.	O
Komatsu	O
,	O
et	O
al.	O
,	O
Blood	O
,	O
89	O
:	O
4021-4033	O
,	O
1997	O
)	O
.	O

A	O
small	O
population	O
of	O
UT-7	O
/	O
GM	O
cells	O
positively	O
stained	O
for	O
hemoglobin	O
(	O
Hb	O
)	O
after	O
a	O
7-day	O
exposure	O
to	O
TPO	O
.	O

More	O
than	O
50	O
%	O
of	O
TPO-treated	O
UT-7	O
/	O
GMT	O
cells	O
positively	O
stained	O
for	O
Hb	O
.	O

Using	O
UT-7	O
/	O
GMT	O
cells	O
,	O
we	O
examined	O
how	O
TPO	O
promotes	O
hemoglobinization	O
.	O

TPO	O
induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
TPO	O
receptor	O
but	O
not	B-NEGATION
the	I-NEGATION
erythropoietin	I-NEGATION
(	I-NEGATION
EPO	I-NEGATION
)	I-NEGATION
receptor	I-NEGATION
.	O

There	O
was	O
no	B-NEGATION
competition	I-NEGATION
between	I-NEGATION
TPO	I-NEGATION
and	I-NEGATION
EPO	I-NEGATION
for	I-NEGATION
binding	I-NEGATION
to	I-NEGATION
EPO	I-NEGATION
receptor	I-NEGATION
.	O

These	O
findings	O
suggest	B-SPECULATION
that	I-SPECULATION
TPO	I-SPECULATION
has	I-SPECULATION
a	I-SPECULATION
direct	I-SPECULATION
effect	I-SPECULATION
on	I-SPECULATION
hemoglobinization	I-SPECULATION
via	I-SPECULATION
a	I-SPECULATION
specific	I-SPECULATION
receptor	I-SPECULATION
on	I-SPECULATION
UT-7	I-SPECULATION
/	I-SPECULATION
GMT	I-SPECULATION
cells	I-SPECULATION
.	O

Isoelectric	O
focusing	O
demonstrated	O
that	O
TPO	O
induced	O
fetal	O
and	O
adult	O
Hb	O
synthesis	O
,	O
whereas	O
EPO	O
induced	O
embryonic	O
,	O
fetal	O
,	O
and	O
adult	O
Hb	O
synthesis	O
.	O

Thus	O
,	O
our	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
TPO	I-SPECULATION
has	I-SPECULATION
a	I-SPECULATION
distinct	I-SPECULATION
action	I-SPECULATION
on	I-SPECULATION
erythropoiesis	I-SPECULATION
.	O

Redox	O
signals	O
and	O
NF-kappaB	O
activation	O
in	O
T	O
cells	O
.	O

Accumulating	O
data	O
from	O
a	O
number	O
of	O
laboratories	O
have	O
recently	O
indicated	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
response	I-SPECULATION
of	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
NF-kappaB	I-SPECULATION
to	I-SPECULATION
alterations	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
redox	I-SPECULATION
homeostasis	I-SPECULATION
of	I-SPECULATION
cells	I-SPECULATION
may	B-SPECULATION
play	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
modulating	I-SPECULATION
immune	I-SPECULATION
function	I-SPECULATION
.	O

The	O
activation	O
of	O
NF-kappaB	O
has	O
been	O
recognized	O
to	O
regulate	O
a	O
number	O
of	O
genes	O
necessary	O
for	O
normal	O
T	O
cell	O
responses	O
including	O
IL-2	O
,	O
IL-6	O
,	O
IL-8	O
,	O
and	O
several	O
T	O
cell	O
surface	O
receptors	O
.	O

Diminished	O
NF-kappaB	O
activity	O
has	O
been	O
shown	O
to	O
occur	O
in	O
T	O
cells	O
with	O
aging	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
impaired	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
might	B-SPECULATION
occur	I-SPECULATION
during	I-SPECULATION
cellular	I-SPECULATION
senescence	I-SPECULATION
.	O

In	O
addition	O
,	O
aberrancies	O
in	O
NF-kappaB	O
activity	O
have	O
been	O
implicated	O
in	O
the	O
immunopathogenesis	O
of	O
diseases	O
involving	O
immune	O
or	O
inflammatory	O
processes	O
such	O
as	O
atherosclerosis	O
and	O
HIV-1	O
infection	O
.	O

The	O
role	O
of	O
H2O2	O
and	O
other	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
as	O
an	O
integratory	O
secondary	O
messenger	O
for	O
divergent	O
T	O
cell	O
signals	O
has	O
been	O
complicated	O
by	O
the	O
fact	O
that	O
various	O
T	O
cell	O
lines	O
and	O
peripheral	O
blood	O
T	O
cells	O
differ	O
markedly	O
in	O
the	O
levels	O
of	O
NF-kappaB	O
activation	O
induced	O
by	O
oxidant	O
stress	O
.	O

Additionally	O
,	O
proposed	O
pathways	O
of	O
NF-kappaB	O
activation	O
have	O
been	O
based	O
on	O
indirect	O
evidence	O
provided	O
by	O
experiments	O
which	O
used	O
antioxidants	O
to	O
inhibit	O
active	O
NF-kappaB	O
formation	O
.	O

Further	O
,	O
complete	O
activation	O
of	O
T	O
cells	O
requires	O
at	O
least	O
two	O
signals	O
,	O
one	O
that	O
stimulates	O
an	O
increase	O
in	O
intracellular	O
calcium	O
and	O
one	O
that	O
stimulates	O
enzymatic	O
processes	O
including	O
kinases	O
.	O

Similarly	O
,	O
substantial	O
evidence	O
indicates	B-SPECULATION
that	I-SPECULATION
full	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
requires	I-SPECULATION
dual	I-SPECULATION
signals	I-SPECULATION
.	O

The	O
ability	O
of	O
H2O2	O
or	O
other	O
ROS	O
to	O
induce	O
T	O
cell	O
signals	O
and	O
functional	O
responses	O
by	O
these	O
two	O
mechanisms	O
is	O
reviewed	O
and	O
the	O
specific	O
response	O
of	O
NF-kappaB	O
to	O
redox	O
changes	O
in	O
T	O
cells	O
is	O
examined	O
.	O

Data	O
are	O
also	O
presented	O
to	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
redox	I-SPECULATION
regulation	I-SPECULATION
in	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
relevant	I-SPECULATION
to	I-SPECULATION
immune-related	I-SPECULATION
diseases	I-SPECULATION
and	I-SPECULATION
to	I-SPECULATION
aging	I-SPECULATION
.	O

Fibrinogen	O
activates	O
NF-kappa	O
B	O
transcription	O
factors	O
in	O
mononuclear	O
phagocytes	O
.	O

Adhesion	O
to	O
extracellular	O
matrices	O
is	O
known	O
to	O
modulate	O
leukocyte	O
activation	O
,	O
although	O
the	B-SPECULATION
mechanisms	I-SPECULATION
are	I-SPECULATION
not	I-SPECULATION
fully	I-SPECULATION
understood	I-SPECULATION
.	O

Mononuclear	O
phagocytes	O
are	O
exposed	O
to	O
fibrinous	O
provisional	O
matrix	O
throughout	O
migration	O
into	O
inflammatory	O
foci	O
,	O
so	O
this	O
study	O
was	O
undertaken	O
to	O
determine	O
whether	B-SPECULATION
fibrinogen	I-SPECULATION
triggers	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
.	O

U937	O
cells	O
differentiated	O
with	O
PMA	O
in	O
nonadherent	O
culture	O
were	O
shown	O
to	O
express	O
two	O
fibrinogen-binding	O
integrins	O
,	O
predominately	O
CD11b	O
/	O
CD18	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
CD11c	O
/	O
CD18	O
.	O

Cells	O
stimulated	O
with	O
fibrinogen	O
(	O
10-100	O
microg	O
/	O
ml	O
)/	O
Mn2	O
+	O
(	O
50	O
microM	O
)	O
for	O
2	O
h	O
were	O
examined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

NF-kappa	O
B	O
activation	O
,	O
minimal	O
in	O
unstimulated	O
cells	O
,	O
was	O
substantially	O
up-regulated	O
by	O
fibrinogen	O
.	O

Fibrinogen	O
also	O
caused	O
activation	O
of	O
AP-1	O
,	O
but	O
not	B-NEGATION
SP1	I-NEGATION
or	I-NEGATION
cAMP	I-NEGATION
response	I-NEGATION
element-binding	I-NEGATION
protein	I-NEGATION
(	I-NEGATION
CREB	I-NEGATION
)	I-NEGATION
factors	I-NEGATION
.	O

Blocking	O
mAbs	O
against	O
CD18	O
and	O
CD11b	O
abrogated	O
fibrinogen-induced	O
NF-kappa	O
B	O
activation	O
.	O

To	O
determine	O
the	O
effects	O
on	O
transcriptional	O
regulation	O
,	O
U937	O
cells	O
were	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
HIV-1	O
enhancer	O
(	O
bearing	O
two	O
NF-kappa	O
B	O
sites	O
)	O
coupled	O
to	O
a	O
chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
reporter	O
.	O

Cells	O
were	O
subsequently	O
stimulated	O
with	O
1	O
)	O
PMA	O
for	O
24	O
h	O
,	O
inducing	O
CAT	O
activity	O
by	O
2.6-fold	O
,	O
2	O
)	O
fibrinogen	O
/	O
Mn2	O
+	O
for	O
2	O
h	O
,	O
inducing	O
CAT	O
activity	O
by	O
3.2-fold	O
,	O
or	O
3	O
)	O
costimulation	O
with	O
fibrinogen	O
and	O
PMA	O
,	O
inducing	O
5.7-fold	O
the	O
CAT	O
activity	O
induced	O
by	O
PMA	O
alone	O
.	O

We	O
conclude	O
that	O
contact	O
with	O
fibrinogen-derived	O
proteins	O
may	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
mononuclear	I-SPECULATION
phagocyte	I-SPECULATION
activation	I-SPECULATION
by	I-SPECULATION
signaling	I-SPECULATION
through	I-SPECULATION
CD11b	I-SPECULATION
/	I-SPECULATION
CD18	I-SPECULATION
,	I-SPECULATION
resulting	I-SPECULATION
in	I-SPECULATION
selective	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
transcriptional	I-SPECULATION
regulatory	I-SPECULATION
factors	I-SPECULATION
,	I-SPECULATION
including	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
.	O

Ex	O
vivo	O
activation	O
of	O
tumor-draining	O
lymph	O
node	O
T	O
cells	O
reverses	O
defects	O
in	O
signal	O
transduction	O
molecules	O
.	O

The	O
adoptive	O
transfer	O
of	O
tumor-draining	O
lymph	O
node	O
(	O
LN	O
)	O
T	O
cells	O
activated	O
ex	O
vivo	O
with	O
anti-CD3	O
and	O
interleukin	O
2	O
(	O
IL-2	O
)	O
mediates	O
the	O
regression	O
of	O
the	O
poorly	O
immunogenic	O
murine	O
melanoma	O
D5	O
.	O

The	O
efficacy	O
of	O
the	O
activated	O
LN	O
cells	O
is	O
augmented	O
when	O
the	O
sensitizing	O
tumor	O
is	O
a	O
genetically	O
modified	O
variant	O
(	O
designated	O
D5G6	O
)	O
that	O
secretes	O
granulocyte	O
/	O
macrophage-colony-stimulating	O
factor	O
.	O

In	O
contrast	O
to	O
anti-CD3	O
/	O
IL-2-activated	O
LN	O
cells	O
,	O
adoptive	O
transfer	O
of	O
freshly	O
isolated	O
tumor-draining	O
LN	O
T	O
cells	O
has	O
no	B-NEGATION
therapeutic	I-NEGATION
activity	I-NEGATION
.	O

To	O
determine	O
whether	B-SPECULATION
the	I-SPECULATION
acquisition	I-SPECULATION
of	I-SPECULATION
antitumor	I-SPECULATION
function	I-SPECULATION
during	I-SPECULATION
ex	I-SPECULATION
vivo	I-SPECULATION
activation	I-SPECULATION
is	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
modifications	I-SPECULATION
in	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
capacity	I-SPECULATION
,	O
the	O
protein	O
tyrosine	O
kinases	O
p56lck	O
and	O
p59fyn	O
and	O
proteins	O
of	O
the	O
NF-kappaB	O
family	O
were	O
analyzed	O
in	O
tumor-draining	O
LN	O
T	O
cells	O
.	O

The	O
levels	O
of	O
p56lck	O
and	O
p59fyn	O
were	O
lower	O
in	O
tumor-draining	O
than	O
in	O
normal	O
LN	O
T	O
cells	O
and	O
production	O
of	O
tyrosine-phosphorylated	O
substrates	O
was	O
markedly	O
depressed	O
following	O
anti-CD3	O
stimulation	O
.	O

After	O
5-day	O
anti-CD3	O
/	O
IL-2	O
activation	O
,	O
levels	O
of	O
p56lck	O
and	O
p59fyn	O
and	O
protein	O
tyrosine	O
kinase	O
activity	O
increased	O
.	O

Interestingly	O
,	O
the	O
levels	O
of	O
p56lck	O
,	O
p59fyn	O
,	O
and	O
tyrosine	O
kinase	O
activity	O
were	O
higher	O
in	O
activated	O
T	O
cells	O
derived	O
from	O
LN	O
that	O
drained	O
D5G6	O
than	O
they	O
were	O
in	O
those	O
from	O
D5	O
tumors	O
.	O

In	O
contrast	O
,	O
the	O
cytoplasmic	O
levels	O
of	O
c-Rel	O
and	O
Rel	O
A	O
were	O
normal	O
in	O
freshly	O
isolated	O
tumor-draining	O
LN	O
,	O
as	O
was	O
nuclear	O
kappaB	O
DNA-binding	O
activity	O
induced	O
by	O
anti-CD3	O
mAb	O
or	O
phorbol	O
myristate	O
acetate	O
.	O

Stimulation	O
of	O
activated	O
LN	O
cells	O
with	O
D5	O
tumor	O
cells	O
induced	O
the	O
nuclear	O
translocation	O
of	O
NF-kappaB	O
.	O

These	O
findings	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
recovery	I-SPECULATION
of	I-SPECULATION
proteins	I-SPECULATION
mediating	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
through	I-SPECULATION
the	I-SPECULATION
T	I-SPECULATION
cell	I-SPECULATION
receptor	I-SPECULATION
/	I-SPECULATION
CD3	I-SPECULATION
complex	I-SPECULATION
in	I-SPECULATION
LN	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
activated	I-SPECULATION
ex	I-SPECULATION
vivo	I-SPECULATION
was	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
acquisition	I-SPECULATION
of	I-SPECULATION
antitumor	I-SPECULATION
function	I-SPECULATION
.	O

Targeted	O
disruption	O
of	O
the	O
MyD88	O
gene	O
results	O
in	O
loss	O
of	O
IL-1	O
-	O
and	O
IL-18-mediated	O
function	O
.	O

MyD88	O
,	O
originally	O
isolated	O
as	O
a	O
myeloid	O
differentiation	O
primary	O
response	O
gene	O
,	O
is	O
shown	O
to	O
act	O
as	O
an	O
adaptor	O
in	O
interleukin-1	O
(	O
IL-1	O
)	O
signaling	O
by	O
interacting	O
with	O
both	O
the	O
IL-1	O
receptor	O
complex	O
and	O
IL-1	O
receptor-associated	O
kinase	O
(	O
IRAK	O
)	O
.	O

Mice	O
generated	O
by	O
gene	O
targeting	O
to	O
lack	B-NEGATION
MyD88	I-NEGATION
have	O
defects	O
in	O
T	O
cell	O
proliferation	O
as	O
well	O
as	O
induction	O
of	O
acute	O
phase	O
proteins	O
and	O
cytokines	O
in	O
response	O
to	O
IL-1	O
.	O

Increases	O
in	O
interferon-gamma	O
production	O
and	O
natural	O
killer	O
cell	O
activity	O
in	O
response	O
to	O
IL-18	O
are	O
abrogated	O
.	O

In	O
vivo	O
Th1	O
response	O
is	O
also	O
impaired	O
.	O

Furthermore	O
,	O
IL-18-induced	O
activation	O
of	O
NF-kappaB	O
and	O
c-Jun	O
N-terminal	O
kinase	O
(	O
JNK	O
)	O
is	O
blocked	O
in	O
MyD88	O
-/-	O
Th1-developing	O
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
MyD88	O
is	O
a	O
critical	O
component	O
in	O
the	O
signaling	O
cascade	O
that	O
is	O
mediated	O
by	O
IL-1	O
receptor	O
as	O
well	O
as	O
IL-18	O
receptor	O
.	O

Epstein-Barr	O
virus-transforming	O
protein	O
latent	O
infection	O
membrane	O
protein	O
1	O
activates	O
transcription	O
factor	O
NF-kappaB	O
through	O
a	O
pathway	O
that	O
includes	O
the	O
NF-kappaB-inducing	O
kinase	O
and	O
the	O
IkappaB	O
kinases	O
IKKalpha	O
and	O
IKKbeta	O
.	O

The	O
Epstein-Barr	O
virus	O
oncoprotein	O
latent	O
infection	O
membrane	O
protein	O
1	O
(	O
LMP1	O
)	O
is	O
a	O
constitutively	O
aggregated	O
pseudo-tumor	O
necrosis	O
factor	O
receptor	O
(	O
TNFR	O
)	O
that	O
activates	O
transcription	O
factor	O
NF-kappaB	O
through	O
two	O
sites	O
in	O
its	O
C-terminal	O
cytoplasmic	O
domain	O
.	O

One	O
site	O
is	O
similar	O
to	O
activated	O
TNFRII	O
in	O
associating	O
with	O
TNFR-associated	O
factors	O
TRAF1	O
and	O
TRAF2	O
,	O
and	O
the	O
second	O
site	O
is	O
similar	O
to	O
TNFRI	O
in	O
associating	O
with	O
the	O
TNFRI	O
death	O
domain	O
interacting	O
protein	O
TRADD	O
.	O

TNFRI	O
has	O
been	O
recently	O
shown	O
to	O
activate	O
NF-kappaB	O
through	O
association	O
with	O
TRADD	O
,	O
RIP	O
,	O
and	O
TRAF2	O
;	O
activation	O
of	O
the	O
NF-kappaB-inducing	O
kinase	O
(	O
NIK	O
)	O
;	O
activation	O
of	O
the	O
IkappaB	O
alpha	O
kinases	O
(	O
IKKalpha	O
and	O
IKKbeta	O
)	O
;	O
and	O
phosphorylation	O
of	O
IkappaB	O
alpha	O
.	O

IkappaB	O
alpha	O
phosphorylation	O
on	O
Ser-32	O
and	O
Ser-36	O
is	O
followed	O
by	O
its	O
degradation	O
and	O
NF-kappaB	O
activation	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
NF-kappaB	O
activation	O
by	O
LMP1	O
or	O
by	O
each	O
of	O
its	O
effector	O
sites	O
is	O
mediated	O
by	O
a	O
pathway	O
that	O
includes	O
NIK	O
,	O
IKKalpha	O
,	O
and	O
IKKbeta	O
.	O

Dominant	O
negative	O
mutants	O
of	O
NIK	O
,	O
IKKalpha	O
,	O
or	O
IKKbeta	O
substantially	O
inhibited	O
NF-kappaB	O
activation	O
by	O
LMP1	O
or	O
by	O
each	O
of	O
its	O
effector	O
sites	O
.	O

Dimethyldithiocarbamate	O
inhibits	O
in	O
vitro	O
activation	O
of	O
primary	O
human	O
CD4	O
+	O
T	O
lymphocytes	O
.	O

Dithiocarbamates	O
(	O
DTC	O
)	O
,	O
a	O
diverse	O
group	O
of	O
industrial	O
and	O
therapeutic	O
chemicals	O
,	O
have	O
been	O
reported	O
to	O
inhibit	O
,	O
enhance	O
or	O
have	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
the	I-NEGATION
immune	I-NEGATION
system	I-NEGATION
.	O

These	O
apparent	O
inconsistencies	O
reflect	O
the	O
complexity	O
of	O
the	O
DTCs	O
biological	O
activities	O
and	O
are	O
probably	B-SPECULATION
due	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
to	I-SPECULATION
differences	I-SPECULATION
in	I-SPECULATION
dose	I-SPECULATION
,	I-SPECULATION
route	I-SPECULATION
of	I-SPECULATION
exposure	I-SPECULATION
,	I-SPECULATION
animal	I-SPECULATION
species	I-SPECULATION
used	I-SPECULATION
and	I-SPECULATION
/	I-SPECULATION
or	I-SPECULATION
specific	I-SPECULATION
compound	I-SPECULATION
tested	I-SPECULATION
.	O

The	O
studies	O
described	O
herein	O
were	O
undertaken	O
to	O
investigate	O
the	O
immunotoxicity	O
of	O
one	O
member	O
of	O
this	O
family	O
,	O
dimethyldithiocarbamate	O
(	O
DMDTC	O
)	O
.	O

We	O
demonstrate	O
that	O
0.1-0.5	O
microM	O
DMDTC	O
inhibits	O
TNF-alpha-induced	O
activation	O
of	O
NF-kappaB	O
in	O
primary	O
human	O
CD4	O
+	O
T	O
cells	O
.	O

This	B-NEGATION
inhibition	I-NEGATION
is	I-NEGATION
not	I-NEGATION
accompanied	I-NEGATION
by	I-NEGATION
a	I-NEGATION
loss	I-NEGATION
in	I-NEGATION
viability	I-NEGATION
,	O
and	O
DMDTC-treated	O
T	O
cells	O
retain	O
other	O
active	O
signaling	O
pathways	O
throughout	O
the	O
exposure	O
duration	O
.	O

The	O
inhibition	O
of	O
NF-kappaB	O
is	O
apparently	O
permanent	O
as	O
DMDTC-treated	O
T	O
cells	O
did	O
not	B-NEGATION
regain	I-NEGATION
normal	I-NEGATION
TNF-alpha	I-NEGATION
activation	I-NEGATION
,	I-NEGATION
even	I-NEGATION
after	I-NEGATION
72	I-NEGATION
h	I-NEGATION
in	I-NEGATION
culture	I-NEGATION
.	O

DMDTC	B-NEGATION
does	I-NEGATION
not	I-NEGATION
appear	I-SPECULATION
to	I-SPECULATION
alter	I-SPECULATION
NF-kappaB	I-SPECULATION
directly	I-SPECULATION
as	O
pre-incubation	O
of	O
nuclear	O
extracts	O
with	O
DMDTC	O
does	O
not	B-NEGATION
diminish	I-NEGATION
binding	I-NEGATION
activity	I-NEGATION
of	I-NEGATION
this	I-NEGATION
protein	I-NEGATION
.	O

We	O
further	O
demonstrate	O
that	O
0.1-0.5	O
microM	O
DMDTC	O
inhibits	O
intracellular	O
IL-2	O
production	O
and	O
decreases	O
surface	O
expression	O
of	O
CD25	O
(	O
the	O
alpha	O
subunit	O
of	O
the	O
IL-2	O
receptor	O
)	O
in	O
T	O
cells	O
stimulated	O
with	O
phorbol	O
ester	O
.	O

These	O
data	O
demonstrate	O
that	O
DMDTC	O
is	O
a	O
potent	O
immunosuppressive	O
compound	O
in	O
vitro	O
.	O

The	O
small	O
GTP-binding	O
protein	O
Rho	O
potentiates	O
AP-1	O
transcription	O
in	O
T	O
cells	O
.	O

The	O
Rho	O
family	O
of	O
small	O
GTP-binding	O
proteins	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
cytoskeletal	O
structure	O
,	O
gene	O
transcription	O
,	O
specific	O
cell	O
fate	O
development	O
,	O
and	O
transformation	O
.	O

We	O
demonstrate	O
in	O
this	O
report	O
that	O
overexpression	O
of	O
an	O
activated	O
form	O
of	O
Rho	O
enhances	O
AP-1	O
activity	O
in	O
Jurkat	O
T	O
cells	O
in	O
the	O
presence	O
of	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
,	O
but	O
activated	O
Rho	O
(	O
V14Rho	O
)	O
has	O
little	O
or	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
NFAT	I-NEGATION
,	I-NEGATION
Oct-1	I-NEGATION
,	I-NEGATION
and	I-NEGATION
NF-kappaB	I-NEGATION
enhancer	I-NEGATION
element	I-NEGATION
activities	I-NEGATION
under	I-NEGATION
similar	I-NEGATION
conditions	I-NEGATION
.	O

Overexpression	O
of	O
a	O
V14Rho	O
construct	O
incapable	O
of	O
membrane	O
localization	O
(	O
CAAX	O
deleted	O
)	O
abolishes	O
PMA-induced	O
AP-1	O
transcriptional	O
activation	O
.	O

The	O
effect	O
of	O
Rho	O
on	O
AP-1	O
is	O
independent	O
of	O
the	O
mitogen-activated	O
protein	O
kinase	O
pathway	O
,	O
as	O
a	O
dominant-negative	O
MEK	O
and	O
a	O
MEK	O
inhibitor	O
(	O
PD98059	O
)	O
did	O
not	B-NEGATION
affect	I-NEGATION
Rho-induced	I-NEGATION
AP-1	I-NEGATION
activity	I-NEGATION
.	O

V14Rho	O
binds	O
strongly	O
to	O
protein	O
kinase	O
Calpha	O
(	O
PKCalpha	O
)	O
in	O
vivo	O
;	O
however	O
,	O
deletion	O
of	O
the	O
CAAX	O
site	O
on	O
V14Rho	O
severely	O
diminished	O
this	O
association	O
.	O

Evidence	O
for	O
a	O
role	O
for	O
PKCalpha	O
as	O
an	O
effector	O
of	O
Rho	O
was	O
obtained	O
by	O
the	O
observation	O
that	O
coexpression	O
of	O
the	O
N-terminal	O
domain	O
of	O
PKCalpha	O
blocked	O
the	O
effects	O
of	O
activated	O
Rho	O
plus	O
PMA	O
on	O
AP-1	O
transcriptional	O
activity	O
.	O

These	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
Rho	I-SPECULATION
potentiates	I-SPECULATION
AP-1	I-SPECULATION
transcription	I-SPECULATION
during	I-SPECULATION
T-cell	I-SPECULATION
activation	I-SPECULATION
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
Tax	O
induction	O
of	O
NF-kappaB	O
involves	O
activation	O
of	O
the	O
IkappaB	O
kinase	O
alpha	O
(	O
IKKalpha	O
)	O
and	O
IKKbeta	O
cellular	O
kinases	O
.	O

Tax	O
corresponds	O
to	O
a	O
40-kDa	O
transforming	O
protein	O
from	O
the	O
pathogenic	O
retrovirus	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
that	O
activates	O
nuclear	O
expression	O
of	O
the	O
NF-kappaB	O
/	O
Rel	O
family	O
of	O
transcription	O
factors	O
by	O
an	O
unknown	B-SPECULATION
mechanism	I-SPECULATION
.	O

Tax	O
expression	O
promotes	O
N-terminal	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaB	O
alpha	O
,	O
a	O
principal	O
cytoplasmic	O
inhibitor	O
of	O
NF-kappaB	O
.	O

Our	O
studies	O
now	O
demonstrate	O
that	O
HTLV-1	O
Tax	O
activates	O
the	O
recently	O
identified	O
cellular	O
kinases	O
IkappaB	O
kinase	O
alpha	O
(	O
IKKalpha	O
)	O
and	O
IKKbeta	O
,	O
which	O
normally	O
phosphorylate	O
IkappaB	O
alpha	O
on	O
both	O
of	O
its	O
N-terminal	O
regulatory	O
serines	O
in	O
response	O
to	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)	O
and	O
interleukin-1	O
(	O
IL-1	O
)	O
stimulation	O
.	O

In	O
contrast	O
,	O
a	O
mutant	O
of	O
Tax	O
termed	O
M22	O
,	O
which	O
does	O
not	B-NEGATION
induce	I-NEGATION
NF-kappaB	I-NEGATION
,	O
fails	B-NEGATION
to	I-NEGATION
activate	I-NEGATION
either	I-NEGATION
IKKalpha	I-NEGATION
or	I-NEGATION
IKKbeta	I-NEGATION
.	O

Furthermore	O
,	O
endogenous	O
IKK	O
enzymatic	O
activity	O
was	O
significantly	O
elevated	O
in	O
HTLV-1-infected	O
and	O
Tax-expressing	O
T-cell	O
lines	O
.	O

Transfection	O
of	O
kinase-deficient	O
mutants	O
of	O
IKKalpha	O
and	O
IKKbeta	O
into	O
either	O
human	O
Jurkat	O
T	O
or	O
293	O
cells	O
also	O
inhibits	O
NF-kappaB-dependent	O
reporter	O
gene	O
expression	O
induced	O
by	O
Tax	O
.	O

Similarly	O
,	O
a	O
kinase-deficient	O
mutant	O
of	O
NIK	O
(	O
NF-kappaB-inducing	O
kinase	O
)	O
,	O
which	O
represents	O
an	O
upstream	O
kinase	O
in	O
the	O
TNF-alpha	O
and	O
IL-1	O
signaling	O
pathways	O
leading	O
to	O
IKKalpha	O
and	O
IKKbeta	O
activation	O
,	O
blocks	O
Tax	O
induction	O
of	O
NF-kappaB	O
.	O

However	O
,	O
plasma	O
membrane-proximal	O
elements	O
in	O
these	O
proinflammatory	O
cytokine	O
pathways	O
are	O
apparently	O
not	B-NEGATION
involved	I-NEGATION
since	O
dominant	O
negative	O
mutants	O
of	O
the	O
TRAF2	O
and	O
TRAF6	O
adaptors	O
,	O
which	O
effectively	O
block	O
signaling	O
through	O
the	O
cytoplasmic	O
tails	O
of	O
the	O
TNF-alpha	O
and	O
IL-1	O
receptors	O
,	O
respectively	O
,	O
do	O
not	B-NEGATION
inhibit	I-NEGATION
Tax	I-NEGATION
induction	I-NEGATION
of	I-NEGATION
NF-kappaB	I-NEGATION
.	O

Together	O
,	O
these	O
studies	O
demonstrate	O
that	O
HTLV-1	O
Tax	O
exploits	O
a	O
distal	O
part	O
of	O
the	O
proinflammatory	O
cytokine	O
signaling	O
cascade	O
leading	O
to	O
induction	O
of	O
NF-kappaB	O
.	O

The	O
pathological	O
alteration	O
of	O
this	O
cytokine	O
pathway	O
leading	O
to	O
NF-kappaB	O
activation	O
by	O
Tax	O
may	B-SPECULATION
play	I-SPECULATION
a	I-SPECULATION
central	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
HTLV-1-mediated	I-SPECULATION
transformation	I-SPECULATION
of	I-SPECULATION
human	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
,	I-SPECULATION
clinically	I-SPECULATION
manifested	I-SPECULATION
as	I-SPECULATION
the	I-SPECULATION
adult	I-SPECULATION
T-cell	I-SPECULATION
leukemia	I-SPECULATION
.	O

A	O
CD28-associated	O
signaling	O
pathway	O
leading	O
to	O
cytokine	O
gene	O
transcription	O
and	O
T	O
cell	O
proliferation	O
without	B-NEGATION
TCR	I-NEGATION
engagement	I-NEGATION
.	O

Stimulation	O
of	O
resting	O
human	O
T	O
cells	O
with	O
the	O
CD28-specific	O
mAb	O
BW	O
828	O
induces	O
proliferation	O
and	O
cytokine	O
synthesis	O
without	B-NEGATION
further	I-NEGATION
requirement	I-NEGATION
for	I-NEGATION
TCR	I-NEGATION
coengagement	I-NEGATION
.	O

This	O
observation	O
prompted	O
us	O
to	O
postulate	O
that	O
signal	O
2	O
(	O
costimulatory	O
signal	O
)	O
alone	O
without	B-NEGATION
signal	I-NEGATION
1	I-NEGATION
(	I-NEGATION
TCR	I-NEGATION
signal	I-NEGATION
)	I-NEGATION
can	O
activate	O
T	O
cells	O
.	O

To	O
test	O
whether	B-SPECULATION
this	I-SPECULATION
,	O
we	O
compared	O
early	O
signaling	O
events	O
initiated	O
in	O
resting	O
T	O
cells	O
by	O
the	O
stimulatory	O
mAb	O
BW	O
828	O
with	O
signals	O
triggered	O
by	O
the	O
nonstimulating	O
CD28	O
mAb	O
9.3	O
.	O
putative	B-SPECULATION
function	I-SPECULATION
of	I-SPECULATION
CD28	I-SPECULATION
is	O
mediated	O
via	O
a	O
particular	O
signaling	O
pathway	O
.	O

Stimulation	O
of	O
T	O
cells	O
with	O
BW	O
828	O
induced	O
an	O
increase	O
in	O
intracellular	O
Ca2	O
+	O
,	O
but	O
did	O
not	B-NEGATION
lead	I-NEGATION
to	I-NEGATION
detectable	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
the	I-NEGATION
protein	I-NEGATION
kinases	I-NEGATION
p56	I-NEGATION
(	I-NEGATION
lck	I-NEGATION
)	I-NEGATION
and	I-NEGATION
c-Raf-1	I-NEGATION
.	O

This	O
pathway	O
resulted	O
in	O
the	O
induction	O
of	O
the	O
transcription	O
factors	O
NF-kappa	O
B	O
,	O
NF-AT	O
,	O
and	O
proteins	O
binding	O
to	O
the	O
CD28	O
response	O
element	O
of	O
the	O
IL-2	O
promoter	O
.	O

On	O
the	O
other	O
hand	O
,	O
stimulation	O
of	O
T	O
cells	O
with	O
mAb	O
9.3	O
increased	O
the	O
level	O
of	O
intracellular	O
Ca2	O
+	O
and	O
triggered	O
the	O
activation	O
of	O
p56	O
(	O
lck	O
)	O
and	O
c-Raf-1	O
,	O
but	O
was	B-NEGATION
unable	I-NEGATION
to	I-NEGATION
induce	I-NEGATION
the	I-NEGATION
binding	I-NEGATION
of	I-NEGATION
transcription	I-NEGATION
factors	I-NEGATION
to	I-NEGATION
the	I-NEGATION
IL-2	I-NEGATION
promoter	I-NEGATION
.	O

In	O
contrast	O
to	O
the	O
differential	O
signaling	O
of	O
BW	O
828	O
and	O
9.3	O
in	O
resting	O
T	O
cells	O
,	O
the	O
two	O
mAbs	O
exhibited	O
a	O
similar	O
pattern	O
of	O
early	O
signaling	O
events	O
in	O
activated	O
T	O
cells	O
and	O
Jurkat	O
cells	O
(	O
p56	O
(	O
lck	O
)	O
activation	O
,	O
association	O
of	O
phosphatidylinositol	O
3-kinase	O
with	O
CD28	O
)	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
signaling	I-SPECULATION
capacity	I-SPECULATION
of	I-SPECULATION
CD28	I-SPECULATION
changes	I-SPECULATION
with	I-SPECULATION
activation	I-SPECULATION
.	O

These	O
data	O
support	O
the	O
view	O
that	O
stimulation	O
through	O
CD28	O
can	O
induce	O
some	O
effector	O
functions	O
in	O
T	O
cells	O
and	O
suggest	B-SPECULATION
that	I-SPECULATION
this	I-SPECULATION
capacity	I-SPECULATION
is	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
a	I-SPECULATION
particular	I-SPECULATION
pattern	I-SPECULATION
of	I-SPECULATION
early	I-SPECULATION
signaling	I-SPECULATION
events	I-SPECULATION
.	O

Cyclosporin	O
A-resistant	O
transactivation	O
of	O
the	O
IL-2	O
promoter	O
requires	O
activity	O
of	O
okadaic	O
acid-sensitive	O
serine	O
/	O
threonine	O
phosphatases	O
.	O

Expression	O
of	O
the	O
IL-2	O
gene	O
requires	O
activation	O
of	O
T	O
cells	O
through	O
stimulation	O
of	O
the	O
TCR	O
and	O
costimulation	O
through	O
accessory	O
receptors	O
.	O

We	O
have	O
found	O
recently	O
that	O
okadaic	O
acid-sensitive	O
Ser	O
/	O
Thr	O
phosphatases	O
are	O
involved	O
in	O
a	O
cyclosporin	O
A-insensitive	O
pathway	O
that	O
selectively	O
transmits	O
costimulatory	O
signals	O
.	O

In	O
this	O
study	O
,	O
we	O
analyzed	O
whether	B-SPECULATION
activities	I-SPECULATION
of	I-SPECULATION
these	I-SPECULATION
phosphatases	I-SPECULATION
are	I-SPECULATION
necessary	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
IL-2	I-SPECULATION
gene	I-SPECULATION
.	O

In	O
both	O
activated	O
peripheral	O
blood	O
T	O
lymphocytes	O
and	O
activated	O
tumorigenic	O
T	O
cell	O
lines	O
,	O
IL-2	O
gene	O
expression	O
was	O
blocked	O
at	O
the	O
transcriptional	O
level	O
by	O
okadaic	O
acid	O
.	O

The	O
transcription	O
factors	O
active	O
at	O
the	O
IL-2	O
promoter	O
were	O
differentially	O
influenced	O
:	O
upon	O
down-modulation	O
of	O
okadaic	O
acid-sensitive	O
phosphatases	O
,	O
transactivation	O
by	O
octamer	O
,	O
NF-kappa	O
B	O
,	O
and	O
NF	O
of	O
activated	O
T	O
cells	O
proteins	O
was	O
abrogated	O
,	O
while	O
transactivation	O
by	O
AP-1	O
proteins	O
was	O
even	O
enhanced	O
.	O

Inducible	O
nitric	O
oxide	O
:	O
an	O
autoregulatory	O
feedback	O
inhibitor	O
of	O
vascular	O
inflammation	O
.	O

Inducible	O
nitric	O
oxide	O
(	O
iNO	O
)	O
is	O
produced	O
at	O
sites	O
of	O
vascular	O
inflammation	O
by	O
resident	O
and	O
nonresident	O
vascular	O
wall	O
cells	O
,	O
but	O
its	B-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
inflammatory	I-SPECULATION
process	I-SPECULATION
is	I-SPECULATION
not	I-SPECULATION
known	I-SPECULATION
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
a	O
novel	O
function	O
of	O
iNO	O
is	O
to	O
terminate	O
inflammatory	O
processes	O
.	O

We	O
find	O
that	O
iNO	O
produced	O
by	O
murine	O
macrophage-like	O
cells	O
,	O
RAW264.7	O
,	O
can	O
inhibit	O
cytokine-induced	O
endothelial	O
cell	O
activation	O
in	O
a	O
separated	O
and	O
mixed	O
endothelial-RAW264.7	O
coculture	O
system	O
.	O

Both	O
iNO	O
production	O
and	O
endothelial	O
VCAM-1	O
expression	O
were	O
induced	O
simultaneously	O
with	O
bacterial	O
LPS	O
and	O
murine-specific	O
IFN-gamma	O
.	O

Inhibition	O
of	O
iNO	O
synthase	O
(	O
iNOS	O
)	O
activity	O
with	O
N	O
omega-monomethyl-L-arginine	O
in	O
endothelial-RAW264.7	O
cocultures	O
,	O
stimulated	O
with	O
murine-specific	O
IFN-gamma	O
and	O
LPS	O
,	O
decreased	O
iNO	O
production	O
by	O
86	O
%	O
,	O
augmented	O
VCAM-1	O
and	O
iNOS	O
expression	O
in	O
endothelial	O
and	O
RAW264.7	O
cells	O
,	O
respectively	O
,	O
and	O
increased	O
monocyte	O
adhesion	O
to	O
the	O
endothelial	O
cell	O
surface	O
.	O

Transient	O
transfection	O
studies	O
using	O
various	O
VCAM-1	O
promoter	O
constructs	O
demonstrated	O
that	O
inhibitory	O
effects	O
of	O
iNO	O
on	O
VCAM-1	O
gene	O
transcription	O
were	O
mediated	O
,	O
in	O
part	O
,	O
by	O
inhibitory	O
effects	O
of	O
iNO	O
on	O
kappa	O
B	O
cis-acting	O
elements	O
.	O

Immunofluorescence	O
studies	O
using	O
an	O
Ab	O
to	O
the	O
RelA	O
(	O
p65	O
)	O
subunit	O
of	O
nuclear	O
factor-kappa	O
B	O
revealed	O
that	O
iNO	O
inhibited	O
the	O
activation	O
of	O
nuclear	O
factor-kappa	O
B	O
.	O

These	O
studies	O
indicate	B-SPECULATION
that	I-SPECULATION
iNO	I-SPECULATION
attenuates	I-SPECULATION
iNOS	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
macrophages	I-SPECULATION
and	I-SPECULATION
inhibits	I-SPECULATION
monocyte	I-SPECULATION
adhesion	I-SPECULATION
to	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
,	O
and	O
suggest	B-SPECULATION
that	I-SPECULATION
endogenously	I-SPECULATION
derived	I-SPECULATION
iNO	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
autoregulatory	I-SPECULATION
inhibitor	I-SPECULATION
of	I-SPECULATION
vascular	I-SPECULATION
inflammation	I-SPECULATION
.	O

Characterization	O
of	O
cytokine	O
differential	O
induction	O
of	O
STAT	O
complexes	O
in	O
primary	O
human	O
T	O
and	O
NK	O
cells	O
.	O

Cytokines	O
,	O
IL-2	O
,	O
IL-4	O
,	O
IL-6	O
,	O
IL-7	O
,	O
IL-12	O
,	O
and	O
IL-15	O
are	O
key	O
regulators	O
of	O
human	O
peripheral	O
blood	O
T	O
and	O
NK	O
cell	O
activation	O
and	O
differentiation	O
but	O
the	B-SPECULATION
precise	I-SPECULATION
mechanisms	I-SPECULATION
that	I-SPECULATION
give	I-SPECULATION
rise	I-SPECULATION
to	I-SPECULATION
their	I-SPECULATION
differential	I-SPECULATION
activities	I-SPECULATION
within	I-SPECULATION
these	I-SPECULATION
cells	I-SPECULATION
are	I-SPECULATION
not	I-SPECULATION
clear	I-SPECULATION
.	O

Recent	O
studies	O
reveal	O
that	O
a	O
family	O
of	O
transcription	O
factors	O
,	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STATs	O
)	O
directly	O
mediate	O
many	O
cytokine	O
signals	O
.	O

We	O
analyzed	O
the	O
activation	O
of	O
STATs	O
in	O
primary	O
human	O
T	O
and	O
NK	O
cells	O
by	O
a	O
variety	O
of	O
specific	O
cytokines	O
.	O

We	O
demonstrate	O
that	O
IL-12	O
induces	O
STAT4	O
only	O
in	O
freshly	O
isolated	O
primary	O
NK	O
cells	O
,	O
but	O
not	B-NEGATION
in	I-NEGATION
primary	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
,	O
consistent	O
with	O
the	O
lack	B-NEGATION
of	I-NEGATION
the	I-NEGATION
IL-12	I-NEGATION
receptor	I-NEGATION
in	I-NEGATION
resting	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
.	O

In	O
contrast	O
,	O
IL-4	O
induces	O
different	O
C	O
epsilon	O
GAS	O
DNA-protein	O
binding	O
complexes	O
in	O
both	O
T	O
and	O
NK	O
cells	O
.	O

Moreover	O
,	O
IL-4	O
costimulation	O
with	O
IL-2	O
or	O
IL-12	O
does	O
not	B-NEGATION
alter	I-NEGATION
their	I-NEGATION
own	I-NEGATION
preferential	I-NEGATION
GAS-like	I-NEGATION
DNA	I-NEGATION
binding	I-NEGATION
patterns	I-NEGATION
when	I-NEGATION
C	I-NEGATION
epsilon	I-NEGATION
-	I-NEGATION
,	I-NEGATION
Fc	I-NEGATION
gamma	I-NEGATION
RI	I-NEGATION
-	I-NEGATION
,	I-NEGATION
and	I-NEGATION
SIE	I-NEGATION
GAS	I-NEGATION
motif	I-NEGATION
containing	I-NEGATION
oligonucleotide	I-NEGATION
probes	I-NEGATION
are	I-NEGATION
compared	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
GAS-like	I-SPECULATION
DNA-protein	I-SPECULATION
binding	I-SPECULATION
complexes	I-SPECULATION
by	I-SPECULATION
IL-2	I-SPECULATION
,	I-SPECULATION
IL-4	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
IL-12	I-SPECULATION
is	I-SPECULATION
highly	I-SPECULATION
selective	I-SPECULATION
and	I-SPECULATION
represents	I-SPECULATION
one	I-SPECULATION
important	I-SPECULATION
factor	I-SPECULATION
in	I-SPECULATION
determining	I-SPECULATION
specific	I-SPECULATION
gene	I-SPECULATION
activation	I-SPECULATION
.	O

In	O
addition	O
,	O
IL-6	O
and	O
IL-2	O
synergistically	O
induce	O
homo	O
-	O
and	O
heterodimerized	O
STAT1	O
alpha	O
and	O
STAT3	O
in	O
both	O
NK	O
and	O
T	O
cells	O
,	O
consistent	O
with	O
their	O
reported	O
synergism	O
in	O
modulating	O
perforin	O
gene	O
expression	O
.	O

We	O
further	O
demonstrated	O
that	O
IL-2	O
,	O
-	O
7	O
,	O
and	O
-	O
15	O
induce	O
multiple	O
STAT	O
proteins	O
,	O
including	O
STAT5a	O
,	O
STAT5b	O
,	O
STAT1	O
alpha	O
,	O
STAT3	O
,	O
and	O
another	O
unidentified	O
Fc	O
gamma	O
RI	O
GAS	O
DNA-binding	O
protein	O
.	O

Finally	O
,	O
we	O
observed	O
that	O
activated	O
STAT5a	O
and	O
STAT5b	O
proteins	O
form	O
distinct	O
Fc	O
gamma	O
RI	O
GAS	O
binding	O
patterns	O
in	O
T	O
and	O
NK	O
cells	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
they	I-SPECULATION
might	B-SPECULATION
have	I-SPECULATION
different	I-SPECULATION
roles	I-SPECULATION
in	I-SPECULATION
gene	I-SPECULATION
regulation	I-SPECULATION
.	O

Our	O
data	O
provide	O
evidence	O
that	O
the	O
differential	O
responses	O
in	O
gene	O
expression	O
and	O
cell	O
activation	O
seen	O
in	O
primary	O
NK	O
and	O
T	O
cells	O
on	O
direct	O
stimulation	O
with	O
different	O
cytokines	O
may	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
direct	I-SPECULATION
result	I-SPECULATION
of	I-SPECULATION
distinct	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
STAT	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
.	O

Inhibition	O
of	O
HIV-1	O
replication	O
by	O
combination	O
of	O
a	O
novel	O
inhibitor	O
of	O
TNF-alpha	O
with	O
AZT	O
.	O

The	O
small	O
molecule	O
S9a	O
was	O
derived	O
from	O
an	O
established	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
inhibitor	O
(	O
Canventol	O
)	O
by	O
replacement	O
of	O
the	O
isopropylidine	O
group	O
with	O
a	O
phenyl	O
ring	O
.	O

S9a	O
at	O
10	O
to	O
100	O
nM	O
inhibited	O
HIV	O
production	O
as	O
potently	O
as	O
3	O
'-	O
azido-3	O
'-	O
deoxythymidine	O
(	O
AZT	O
)	O
,	O
an	O
inhibitor	O
of	O
viral	O
reverse	O
transcriptase	O
.	O

Furthermore	O
,	O
S9a	O
and	O
AZT	O
in	O
combination	O
,	O
at	O
noncytoxic	O
concentrations	O
strongly	O
inhibited	O
HIV-1	O
replication	O
that	O
was	O
more	O
than	O
additive	O
and	O
substantially	O
prolonged	O
the	O
appearance	O
of	O
virus	O
both	O
in	O
acutely	O
infected	O
CD4	O
+	O
lymphocytes	O
(	O
SupT	O
)	O
in	O
culture	O
and	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
infected	O
with	O
a	O
primary	O
HIV-1	O
isolate	O
.	O

S9a	O
inhibited	O
TNF-alpha	O
promoter-driven	O
reporter	O
gene	O
activity	O
.	O

It	O
was	O
proposed	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
mechanism	I-SPECULATION
of	I-SPECULATION
antiviral	I-SPECULATION
action	I-SPECULATION
of	I-SPECULATION
S9a	I-SPECULATION
was	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
host	I-SPECULATION
cell	I-SPECULATION
,	I-SPECULATION
by	I-SPECULATION
blocking	I-SPECULATION
TNF-alpha	I-SPECULATION
transcription	I-SPECULATION
via	I-SPECULATION
a	I-SPECULATION
Tat-induced	I-SPECULATION
tar-independent	I-SPECULATION
loop	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
decreases	I-SPECULATION
downstream	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
long	I-SPECULATION
terminal	I-SPECULATION
repeat	I-SPECULATION
(	I-SPECULATION
LTR	I-SPECULATION
)	I-SPECULATION
.	O

S9a	O
was	O
superior	O
to	O
the	O
first	O
generation	O
compound	O
Canventol	O
,	O
which	O
was	O
superior	O
to	O
the	O
natural	O
compound	O
sarcophytol	O
A	O
,	O
demonstrating	O
that	O
further	O
structure-based	O
enhancement	O
of	O
potency	O
of	O
these	O
compounds	O
is	O
feasible	O
.	O

This	O
study	O
suggests	B-SPECULATION
a	I-SPECULATION
therapeutic	I-SPECULATION
approach	I-SPECULATION
against	I-SPECULATION
AIDS	I-SPECULATION
by	I-SPECULATION
application	I-SPECULATION
of	I-SPECULATION
two	I-SPECULATION
drugs	I-SPECULATION
,	I-SPECULATION
one	I-SPECULATION
against	I-SPECULATION
a	I-SPECULATION
cellular	I-SPECULATION
and	I-SPECULATION
the	I-SPECULATION
other	I-SPECULATION
a	I-SPECULATION
viral	I-SPECULATION
target	I-SPECULATION
,	O
which	O
may	B-SPECULATION
provide	I-SPECULATION
an	I-SPECULATION
approach	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
problem	I-SPECULATION
of	I-SPECULATION
frequent	I-SPECULATION
emergence	I-SPECULATION
of	I-SPECULATION
resistant	I-SPECULATION
variants	I-SPECULATION
to	I-SPECULATION
combinations	I-SPECULATION
of	I-SPECULATION
drugs	I-SPECULATION
that	I-SPECULATION
target	I-SPECULATION
only	I-SPECULATION
HIV	I-SPECULATION
genes	I-SPECULATION
.	O

Retinoic	O
acid	O
inhibits	O
CD40	O
+	O
interleukin-4-mediated	O
IgE	O
production	O
in	O
vitro	O
.	O

To	O
elucidate	O
the	O
role	O
of	O
retinoic	O
acid	O
(	O
RA	O
)	O
in	O
anti-CD40	O
+	O
interleukin-4	O
(	O
IL-4	O
)-	O
mediated	O
B-cell	O
activation	O
,	O
the	O
effect	O
of	O
10	O
(-	O
12	O
)	O
to	O
10	O
(-	O
6	O
)	O
mol	O
/	O
L	O
RA	O
was	O
studied	O
in	O
anti-CD40	O
(	O
1	O
microgram	O
/	O
mL	O
)	O
+	O
IL-4	O
(	O
5	O
ng	O
/	O
mL	O
)-	O
mediated	O
proliferation	O
and	O
Ig	O
synthesis	O
by	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
and	O
B	O
cells	O
in	O
healthy	O
donors	O
.	O

Anti-CD40	O
+	O
IL-4-mediated	O
proliferation	O
of	O
PBMC	O
and	O
B	O
cells	O
was	O
inhibited	O
by	O
RA	O
in	O
a	O
dose-dependent	O
manner	O
,	O
with	O
maximal	O
inhibition	O
of	O
62	O
%	O
±	O
5	O
%	O
in	O
PBMC	O
and	O
55	O
%	O
±	O
4.4	O
%	O
in	O
B	O
cells	O
by	O
all-trans	O
RA	O
,	O
and	O
58	O
%	O
±	O
6.7	O
%	O
and	O
51	O
%	O
±	O
4.7	O
%	O
,	O
respectively	O
by	O
13-cis	O
RA	O
.	O

IgE	O
synthesis	O
was	O
even	O
more	O
markedly	O
inhibited	O
by	O
RA	O
starting	O
at	O
concentrations	O
of	O
>	O
10	O
(-	O
14	O
)	O
mol	O
/	O
L	O
for	O
B	O
cells	O
and	O
>	O
10	O
(-	O
10	O
)	O
mol	O
/	O
L	O
for	O
PBMC	O
.	O

Maximal	O
inhibition	O
of	O
IgE	O
production	O
for	O
B	O
cells	O
was	O
at	O
10	O
(-	O
8	O
)	O
mol	O
/	O
L	O
for	O
all-trans	O
RA	O
(	O
94	O
%	O
±	O
1.8	O
%)	O
and	O
96	O
%	O
±	O
3.2	O
%	O
for	O
13-cis	O
RA	O
.	O

Low	O
concentrations	O
of	O
RA	O
inhibiting	O
IgE	O
synthesis	O
(	O
10	O
(-	O
10	O
)	O
mol	O
/	O
L	O
)	O
affected	O
neither	B-NEGATION
B-cell	I-NEGATION
proliferation	I-NEGATION
.	O

Elucidation	O
of	O
the	O
mechanism	O
involved	O
in	O
this	O
inhibition	O
of	O
IgE	O
production	O
shows	O
that	O
epsilon	O
germline	O
transcription	O
is	O
decreased	O
by	O
RA	O
,	O
whereas	O
production	B-NEGATION
of	I-NEGATION
interferon-gamma	I-NEGATION
(	I-NEGATION
IFN-gamma	I-NEGATION
)	I-NEGATION
was	I-NEGATION
not	I-NEGATION
enhanced	I-NEGATION
in	I-NEGATION
the	I-NEGATION
presence	I-NEGATION
of	I-NEGATION
RA	I-NEGATION
.	O

To	O
differentiate	O
whether	B-SPECULATION
the	I-SPECULATION
RA	I-SPECULATION
effect	I-SPECULATION
was	I-SPECULATION
mediated	I-SPECULATION
by	I-SPECULATION
RA	I-SPECULATION
receptors	I-SPECULATION
alpha	I-SPECULATION
,	I-SPECULATION
beta	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
gamma	I-SPECULATION
,	O
the	O
expression	O
of	O
the	O
retinoic	O
acid	O
receptors	O
(	O
RAR	O
)	O
was	O
examined	O
by	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
.	O

The	O
data	O
show	O
that	O
unstimulated	O
human	O
peripheral	O
B	O
cells	O
express	O
mRNA	O
of	O
the	O
RA	O
receptor	O
alpha	O
,	O
beta	O
,	O
and	O
gamma	O
.	O

Using	O
retinoids	O
with	O
different	O
receptor	O
binding	O
specificity	O
(	O
CD336	O
,	O
CD437	O
,	O
CD2019	O
,	O
CD367	O
)	O
,	O
dose-dependent	O
inhibition	O
of	O
IgE	O
synthesis	O
was	O
shown	O
by	O
all	O
four	O
derivates	O
,	O
but	O
was	O
most	O
marked	O
by	O
an	O
RA	O
binding	O
the	O
alpha	O
receptor	O
with	O
high	O
specificity	O
.	O

Taken	O
together	O
,	O
this	O
study	O
shows	O
that	O
RA	O
inhibits	O
IgE	O
production	O
of	O
anti-CD40	O
+	O
IL-4-stimulated	O
B	O
cells	O
in	O
vitro	O
.	O

Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

Nuclear	O
factor-kappaB	O
induction	O
in	O
CD45RO	O
+	O
and	O
CD45RA	O
+	O
T	O
cell	O
subsets	O
during	O
aging	O
.	O

An	O
increase	O
in	O
the	O
ratio	O
of	O
memory	O
to	O
naive	O
T	O
cells	O
has	O
been	O
postulated	O
to	O
underlie	O
immune	O
hyporesponsiveness	O
accompanying	O
aging	O
.	O

Our	O
analyses	O
of	O
the	O
induction	O
of	O
nuclear	O
factor-kappaB	O
(	O
NFkappaB	O
)	O
in	O
activated	O
memory	O
(	O
CD45RO	O
+)	O
and	O
naive	O
(	O
CD45RA	O
+)	O
T	O
cell	O
subsets	O
from	O
young	O
and	O
elderly	O
donors	O
has	O
demonstrated	O
that	O
,	O
regardless	O
of	O
donor	O
age	O
,	O
memory	O
T	O
cells	O
are	O
not	O
significantly	O
altered	O
in	O
their	O
responsiveness	O
to	O
TNF-alpha-mediated	O
induction	O
of	O
NFkappaB	O
.	O

Although	O
treatment	O
with	O
TNF-alpha	O
induced	O
nuclear	O
localization	O
of	O
NFkappaB	O
in	O
both	O
memory	O
and	O
naive	O
T	O
cell	O
subsets	O
,	O
irrespective	O
of	O
the	O
age	O
of	O
the	O
donor	O
,	O
the	O
levels	O
of	O
induced	O
NFkappaB	O
were	O
significantly	O
lower	O
in	O
both	O
subsets	O
of	O
T	O
cells	O
obtained	O
from	O
the	O
elderly	O
,	O
when	O
compared	O
to	O
those	O
in	O
young	O
.	O

Examination	O
of	O
IkappaB	O
alpha	O
regulation	O
revealed	O
that	O
TNF-alpha-mediated	O
degradation	O
of	O
IkappaB	O
alpha	O
in	O
both	O
memory	O
and	O
naive	O
T	O
cells	O
from	O
the	O
elderly	O
was	O
severely	O
impaired	O
,	O
thus	O
contributing	O
to	O
the	O
lowered	O
induction	O
of	O
the	O
observed	O
NFkappaB	O
.	O

In	O
addition	O
,	O
this	O
age-related	O
decrease	O
in	O
induction	O
of	O
nuclear	O
NFkappaB	O
correlated	O
with	O
decrease	O
in	O
intracellular	O
IL-2	O
receptor	O
expression	O
and	O
anti-CD3-induced	O
proliferation	O
of	O
both	O
memory	O
and	O
naive	O
T	O
cells	O
subsets	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
the	B-NEGATION
age-related	I-NEGATION
hyporesponsiveness	I-NEGATION
cannot	I-NEGATION
be	I-NEGATION
attributed	I-NEGATION
to	I-NEGATION
a	I-NEGATION
skewing	I-NEGATION
of	I-NEGATION
the	I-NEGATION
T	I-NEGATION
cell	I-NEGATION
population	I-NEGATION
towards	I-NEGATION
a	I-NEGATION
memory	I-NEGATION
phenotype	I-NEGATION
in	I-NEGATION
the	I-NEGATION
elderly	I-NEGATION
.	O

Activation	O
of	O
E2F-mediated	O
transcription	O
by	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
Tax	O
protein	O
in	O
a	O
p16	O
(	O
INK4A	O
)-	O
negative	O
T-cell	O
line	O
.	O

The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
causative	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O

Although	O
the	B-SPECULATION
exact	I-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
HTLV-I	I-SPECULATION
contributes	I-SPECULATION
to	I-SPECULATION
leukemogenesis	I-SPECULATION
is	I-SPECULATION
still	I-SPECULATION
unclear	I-SPECULATION
,	O
the	B-SPECULATION
Tax	I-SPECULATION
protein	I-SPECULATION
is	I-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
a	I-SPECULATION
major	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
this	I-SPECULATION
process	I-SPECULATION
.	O

This	O
40-kDa	O
polypeptide	O
is	O
able	O
to	O
interact	O
with	O
the	O
tumor	O
suppressor	O
p16	O
(	O
INK4A	O
)	O
.	O

Consequently	O
,	O
Tax	O
can	O
activate	O
the	O
signaling	O
pathway	O
that	O
lead	O
to	O
the	O
release	O
of	O
E2F	O
that	O
in	O
turn	O
induces	O
expression	O
of	O
factors	O
required	O
for	O
cell	O
cycle	O
progression	O
.	O

In	O
this	O
paper	O
,	O
we	O
demonstrate	O
that	O
Tax	O
can	O
also	O
activate	O
E2F-mediated	O
transcription	O
independently	O
of	O
p16	O
(	O
INK4A	O
)	O
.	O

Indeed	O
,	O
when	O
Tax	O
is	O
coexpressed	O
with	O
the	O
E2F-1	O
transcription	O
factor	O
in	O
CEM	O
T-cells	O
,	O
which	O
lack	B-NEGATION
expression	I-NEGATION
of	I-NEGATION
p16	I-NEGATION
(	I-NEGATION
INK4A	I-NEGATION
)	I-NEGATION
,	O
it	O
strongly	O
potentiates	O
the	O
E2F-dependent	O
activation	O
of	O
a	O
reporter	O
construct	O
driven	O
by	O
a	O
promoter	O
containing	O
E2F	O
binding	O
sites	O
.	O

This	O
stimulation	O
is	O
abrogated	O
by	O
mutations	O
affecting	O
the	O
E2F-binding	O
sites	O
.	O

In	O
addition	O
,	O
Tax	O
also	O
stimulates	O
the	O
transcription	O
of	O
the	O
E2F-1	O
gene	O
itself	O
.	O

Using	O
Tax	O
mutants	O
that	O
fail	B-NEGATION
to	I-NEGATION
activate	I-NEGATION
either	I-NEGATION
ATF	I-NEGATION
-	I-NEGATION
or	I-NEGATION
NF-kappaB-dependent	I-NEGATION
promoters	I-NEGATION
and	I-NEGATION
different	I-NEGATION
5	I-NEGATION
'	I-NEGATION
truncation	I-NEGATION
mutants	I-NEGATION
of	I-NEGATION
the	I-NEGATION
E2F-1	I-NEGATION
promoter	I-NEGATION
,	O
we	O
show	O
that	O
the	O
Tax-dependent	O
transcriptional	O
control	O
of	O
the	O
E2F1	O
gene	O
involves	O
,	O
at	O
least	O
in	O
part	O
,	O
the	O
ATF	O
binding	O
site	O
located	O
in	O
the	O
E2F-1	O
promoter	O
.	O

Glucocorticoid-induced	O
apoptosis	O
and	O
regulation	O
of	O
NF-kappaB	O
activity	O
in	O
human	O
leukemic	O
T	O
cells	O
.	O

Glucocorticoid-induced	O
apoptosis	O
was	O
investigated	O
in	O
glucocorticoid-sensitive	O
6TG1.1	O
and	O
resistant	O
ICR27TK.3	O
human	O
leukemic	O
T	O
cells	O
.	O

Following	O
glucocorticoid	O
treatment	O
of	O
6TG1.1	O
cells	O
,	O
chromatin	O
fragmentation	O
was	O
observed	O
after	O
a	O
delay	O
of	O
24	O
h	O
.	O

Fragmentation	B-NEGATION
was	I-NEGATION
not	I-NEGATION
observed	I-NEGATION
in	I-NEGATION
ICR27TK.3	I-NEGATION
cells	I-NEGATION
containing	I-NEGATION
mutant	I-NEGATION
glucocorticoid	I-NEGATION
receptors	I-NEGATION
(	I-NEGATION
L753F	I-NEGATION
)	I-NEGATION
that	I-NEGATION
are	I-NEGATION
activation-deficient	I-NEGATION
but	I-NEGATION
retain	I-NEGATION
the	I-NEGATION
ability	I-NEGATION
to	I-NEGATION
repress	I-NEGATION
AP-1	I-NEGATION
activity	I-NEGATION
.	O

Nor	B-NEGATION
was	I-NEGATION
fragmentation	I-NEGATION
observed	I-NEGATION
after	I-NEGATION
treatment	I-NEGATION
with	I-NEGATION
RU38486	I-NEGATION
,	O
indicating	B-SPECULATION
that	I-SPECULATION
repression	B-NEGATION
of	I-NEGATION
AP-1	I-NEGATION
activity	I-NEGATION
is	I-NEGATION
not	I-NEGATION
involved	I-NEGATION
.	O

As	O
described	O
in	O
other	O
systems	O
,	O
fragmentation	O
required	O
ongoing	O
protein	O
synthesis	O
.	O

However	O
,	O
inhibition	O
of	O
protein	O
synthesis	O
with	O
cycloheximide	O
anytime	O
during	O
the	O
first	O
18	O
h	O
of	O
steroid	O
treatment	O
was	O
as	O
effective	O
in	O
blocking	O
chromatin	O
fragmentation	O
as	O
inhibition	O
for	O
the	O
entire	O
period	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
synthesis	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
component	I-SPECULATION
with	I-SPECULATION
a	I-SPECULATION
rapid	I-SPECULATION
turnover	I-SPECULATION
rate	I-SPECULATION
is	I-SPECULATION
required	I-SPECULATION
.	O

Dexamethasone	O
treatment	O
completely	O
blocked	O
12-O-tetradecanoylphorbol	O
13-acetate	O
induction	O
of	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
activity	O
and	O
elicited	O
an	O
increase	O
in	O
the	O
amount	O
of	O
immunoreactive	O
IkappaB	O
alpha	O
in	O
sensitive	O
6TG1.1	O
cells	O
but	O
not	B-NEGATION
in	I-NEGATION
resistant	I-NEGATION
ICR27TK.3	I-NEGATION
cells	I-NEGATION
.	O

In	O
addition	O
,	O
mild	O
detergent	O
treatment	O
of	O
cell	O
extracts	O
indicated	B-SPECULATION
that	I-SPECULATION
a	I-SPECULATION
substantial	I-SPECULATION
amount	I-SPECULATION
of	I-SPECULATION
cytoplasmic	I-SPECULATION
NF-kappaB	I-SPECULATION
is	I-SPECULATION
complexed	I-SPECULATION
with	I-SPECULATION
IkappaB	B-SPECULATION
alpha	I-SPECULATION
or	I-SPECULATION
some	I-SPECULATION
other	I-SPECULATION
inhibitory	I-SPECULATION
factor	I-SPECULATION
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
labile	I-SPECULATION
inhibitory	I-SPECULATION
factor	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
IkappaB	I-SPECULATION
alpha	I-SPECULATION
may	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
glucocorticoid-induced	I-SPECULATION
apoptosis	I-SPECULATION
.	O

Peripheral	O
T	O
lymphocytes	O
from	O
women	O
with	O
breast	O
cancer	O
exhibit	O
abnormal	O
protein	O
expression	O
of	O
several	O
signaling	O
molecules	O
.	O

We	O
examined	O
signaling	O
molecules	O
of	O
peripheral	O
blood	O
T	O
lymphocytes	O
obtained	O
from	O
women	O
with	O
breast	O
cancer	O
.	O

In	O
6	O
of	O
14	O
patients	O
,	O
T	O
lymphocytes	O
displayed	O
an	O
impaired	O
ability	O
to	O
translocate	O
NFeB	O
p65	O
(	O
Rel-A	O
)	O
following	O
activation	O
by	O
anti-CD3	O
and	O
IL-2	O
.	O

This	O
observation	O
was	O
made	O
despite	O
normal	O
cytoplasmic	O
levels	O
of	O
the	O
Rel-A	O
protein	O
.	O

We	O
also	O
detected	O
abnormally	O
low	O
levels	O
of	O
the	O
signaling	O
molecules	O
T-cell	O
receptor	O
(	O
TCR	O
)-	O
zeta	O
,	O
ZAP-70	O
and	O
p56lck	O
in	O
4	O
of	O
14	O
breast	O
cancer	O
patients	O
,	O
i.e.	O
,	O
defects	O
in	O
T-cell	O
signaling	O
molecules	O
.	O

T	O
lymphocytes	O
from	O
6	O
of	O
the	O
14	O
patients	O
also	O
exhibited	O
an	O
increased	O
expression	O
of	O
the	O
dual	O
specificity	O
phosphatase	O
,	O
map	O
kinase	O
phosphatase-1	O
(	O
MKP-1	O
)	O
.	O

MKP-1	O
inactivates	O
MAP	O
kinase	O
and	O
therefore	O
may	B-SPECULATION
interfere	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
c-jun	I-SPECULATION
and	I-SPECULATION
c-fos	I-SPECULATION
.	O

Abnormalities	O
of	O
I	O
or	O
more	O
signaling	O
molecules	O
were	O
found	O
in	O
9	O
of	O
14	O
patients	O
;	O
however	O
,	O
only	O
3	O
patients	O
had	O
T	O
cells	O
that	O
exhibited	O
all	O
5	O
defects	O
.	O

Our	O
data	O
have	O
implications	O
for	O
the	O
detection	O
of	O
potentially	B-SPECULATION
dysfunctional	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
in	I-SPECULATION
patients	I-SPECULATION
with	I-SPECULATION
cancer	I-SPECULATION
.	O

For	O
example	O
,	O
the	O
analysis	O
of	O
only	O
1	O
signaling	O
molecule	O
may	B-SPECULATION
allow	I-SPECULATION
patients	I-SPECULATION
with	I-SPECULATION
significant	I-SPECULATION
defects	I-SPECULATION
in	I-SPECULATION
T-cell	I-SPECULATION
signaling	I-SPECULATION
to	I-SPECULATION
go	I-SPECULATION
unnoticed	I-SPECULATION
.	O

Finally	O
,	O
despite	O
impaired	O
Rel-A	O
translocation	O
,	O
T	O
cells	O
were	O
capable	O
of	O
transcribing	O
IL-2	O
.	O

Impairments	O
in	O
the	O
translocation	O
of	O
Rel-B	O
and	O
c-Rel	O
further	O
suggest	B-SPECULATION
that	I-SPECULATION
the	B-NEGATION
NFKB	I-NEGATION
family	I-NEGATION
members	I-NEGATION
Rel-A	I-NEGATION
,	I-NEGATION
Rel-B	I-NEGATION
and	I-NEGATION
c-Rel	I-NEGATION
are	I-NEGATION
not	I-NEGATION
required	I-NEGATION
for	I-NEGATION
the	I-NEGATION
transcription	I-NEGATION
of	I-NEGATION
IL-2	I-NEGATION
in	I-NEGATION
the	I-NEGATION
peripheral	I-NEGATION
T	I-NEGATION
lymphocytes	I-NEGATION
of	I-NEGATION
patients	I-NEGATION
with	I-NEGATION
breast	I-NEGATION
cancer	I-NEGATION
.	O

Transcription	O
of	O
a	O
minimal	O
promoter	O
from	O
the	O
NF-IL6	O
gene	O
is	O
regulated	O
by	O
CREB	O
/	O
ATF	O
and	O
SP1	O
proteins	O
in	O
U937	O
promonocytic	O
cells	O
.	O

NF-IL6	O
is	O
an	O
important	O
transcriptional	O
regulator	O
of	O
genes	O
induced	O
in	O
activated	O
monocytes	O
/	O
macrophages	O
,	O
and	O
NF-IL6	O
is	O
the	O
only	O
CCAAT	O
/	O
enhancer-binding	O
protein	O
(	O
C	O
/	O
EBP	O
)	O
family	O
member	O
whose	O
steady-state	O
mRNA	O
levels	O
increase	O
upon	O
activation	O
of	O
monocytes	O
(	O
1	O
)	O
.	O

We	O
show	O
that	O
increased	O
transcription	O
of	O
the	O
NF-IL6	O
gene	O
is	O
responsible	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
induction	O
of	O
NF-IL6	O
mRNA	O
following	O
activation	O
of	O
U937	O
promonocytic	O
cells	O
.	O

We	O
have	O
identified	O
a	O
104-bp	O
minimal	O
promoter	O
region	O
of	O
the	O
NF-IL6	O
gene	O
that	O
is	O
sufficient	O
for	O
basal	O
and	O
activation-dependent	O
induction	O
of	O
transcription	O
in	O
U937	O
cells	O
.	O

This	O
region	O
contains	O
binding	O
sites	O
for	O
the	O
cAMP	O
response	O
element-binding	O
protein	O
/	O
activation	O
transcription	O
factor	O
(	O
CREB	O
/	O
ATF	O
)	O
and	O
Sp1	O
families	O
of	O
transcription	O
factors	O
.	O

Each	O
site	O
is	O
functionally	O
important	O
and	O
contributes	O
independently	O
to	O
transcription	O
of	O
the	O
NF-IL6	O
gene	O
in	O
U937	O
cells	O
.	O

CD30	O
is	O
a	O
CD40-inducible	O
molecule	O
that	O
negatively	O
regulates	O
CD40-mediated	O
immunoglobulin	O
class	O
switching	O
in	O
non-antigen-selected	O
human	O
B	O
cells	O
.	O

We	O
used	O
our	O
monoclonal	O
model	O
of	O
germinal	O
center	O
maturation	O
,	O
CL-01	O
B	O
cells	O
,	O
to	O
investigate	O
the	O
role	O
of	O
CD30	O
in	O
human	O
B	O
cell	O
differentiation	O
.	O

CL-01	O
cells	O
are	O
IgM	O
+	O
IgD	O
+	O
CD30	O
+	O
and	O
switch	O
to	O
IgG	O
,	O
IgA	O
,	O
and	O
IgE	O
when	O
exposed	O
to	O
CD40L	O
and	O
IL-4	O
.	O

Switching	O
is	O
hampered	O
by	O
CD30	O
coengagement	O
,	O
possibly	B-SPECULATION
through	I-SPECULATION
interference	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
CD40-mediated	I-SPECULATION
NF-kappaB-dependent	I-SPECULATION
transcriptional	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
downstream	I-SPECULATION
C	I-SPECULATION
(	I-SPECULATION
H	I-SPECULATION
)	I-SPECULATION
genes	I-SPECULATION
.	O

The	O
physiological	O
relevance	O
of	O
this	O
phenomenon	O
is	O
emphasized	O
by	O
similar	O
CD30-mediated	O
effects	O
in	O
naive	O
B	O
cells	O
.	O

Expression	O
of	O
CD30	O
by	O
these	O
cells	O
is	O
induced	O
by	O
CD40L	O
but	O
is	O
inhibited	O
by	O
B	O
cell	O
receptor	O
coengagement	O
and	O
/	O
or	O
exposure	O
to	O
IL-6	O
and	O
IL-12	O
.	O

Our	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
CD30	I-SPECULATION
critically	I-SPECULATION
regulates	I-SPECULATION
the	I-SPECULATION
CD40-mediated	I-SPECULATION
differentiation	I-SPECULATION
of	I-SPECULATION
non-antigen-selected	I-SPECULATION
human	I-SPECULATION
B	I-SPECULATION
cells	I-SPECULATION
.	O

Induction	O
of	O
Mn	O
SOD	O
in	O
human	O
monocytes	O
without	B-NEGATION
inflammatory	I-NEGATION
cytokine	I-NEGATION
production	I-NEGATION
by	I-NEGATION
a	I-NEGATION
mutant	I-NEGATION
endotoxin	I-NEGATION
.	O

Endotoxin	O
selectively	O
induces	O
monocyte	O
Mn	O
superoxide	O
dismutase	O
(	O
SOD	O
)	O
without	B-NEGATION
affecting	I-NEGATION
levels	I-NEGATION
of	I-NEGATION
Cu,Zn	I-NEGATION
SOD	I-NEGATION
,	I-NEGATION
catalase	I-NEGATION
,	I-NEGATION
or	I-NEGATION
glutathione	I-NEGATION
peroxidase	I-NEGATION
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
structure-activity	O
relationship	O
and	O
the	O
mechanism	O
by	O
which	O
endotoxin	O
induces	O
Mn	O
SOD	O
.	O

In	O
this	O
study	O
we	O
demonstrated	O
that	O
a	O
mutant	O
Escherichia	O
coli	O
endotoxin	O
lacking	B-NEGATION
myristoyl	I-NEGATION
fatty	I-NEGATION
acid	I-NEGATION
at	I-NEGATION
the	I-NEGATION
3	I-NEGATION
'	I-NEGATION
R-3-hydroxymyristate	I-NEGATION
position	I-NEGATION
of	I-NEGATION
the	I-NEGATION
lipid	I-NEGATION
A	I-NEGATION
moiety	I-NEGATION
retained	O
its	O
full	O
capacity	O
to	O
coagulate	O
Limulus	O
amoebocyte	O
lysate	O
compared	O
with	O
the	O
wild-type	O
E.	O
coli	O
endotoxin	O
and	O
markedly	O
stimulated	O
the	O
activation	O
of	O
human	O
monocyte	O
nuclear	O
factor-kappaB	O
and	O
the	O
induction	O
of	O
Mn	O
SOD	O
mRNA	O
and	O
enzyme	O
activity	O
.	O

However	O
,	O
in	O
contrast	O
to	O
the	O
wild-type	O
endotoxin	O
,	O
it	O
failed	B-NEGATION
to	I-NEGATION
induce	I-NEGATION
significant	I-NEGATION
production	I-NEGATION
of	I-NEGATION
tumor	I-NEGATION
necrosis	I-NEGATION
factor-alpha	I-NEGATION
and	I-NEGATION
macrophage	I-NEGATION
inflammatory	I-NEGATION
protein-1alpha	I-NEGATION
by	I-NEGATION
monocytes	I-NEGATION
and	O
did	O
not	B-NEGATION
induce	I-NEGATION
the	I-NEGATION
phosphorylation	I-NEGATION
and	I-NEGATION
nuclear	I-NEGATION
translocation	I-NEGATION
of	I-NEGATION
mitogen-activated	I-NEGATION
protein	I-NEGATION
kinase	I-NEGATION
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
1	I-SPECULATION
)	I-SPECULATION
lipid	I-SPECULATION
A	I-SPECULATION
myristoyl	I-SPECULATION
fatty	I-SPECULATION
acid	I-SPECULATION
,	I-SPECULATION
although	I-SPECULATION
it	I-SPECULATION
is	I-SPECULATION
important	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
inflammatory	I-SPECULATION
cytokine	I-SPECULATION
production	I-SPECULATION
by	I-SPECULATION
human	I-SPECULATION
monocytes	I-SPECULATION
,	I-SPECULATION
is	I-SPECULATION
not	B-NEGATION
necessary	I-NEGATION
for	I-NEGATION
the	I-NEGATION
induction	I-NEGATION
of	I-NEGATION
Mn	I-NEGATION
SOD	I-NEGATION
,	O
2	O
)	O
endotoxin-mediated	O
induction	O
of	O
Mn	O
SOD	O
and	O
inflammatory	O
cytokines	O
are	O
regulated	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
different	O
signal	O
transduction	O
pathways	O
,	O
and	O
3	O
)	O
failure	B-NEGATION
of	I-NEGATION
the	I-NEGATION
mutant	I-NEGATION
endotoxin	I-NEGATION
to	I-NEGATION
induce	I-NEGATION
tumor	I-NEGATION
necrosis	I-NEGATION
factor-alpha	I-NEGATION
production	I-NEGATION
is	O
,	O
at	O
least	O
in	O
part	O
,	O
due	O
to	O
its	O
inability	O
to	O
activate	O
mitogen-activated	O
protein	O
kinase	O
.	O

An	O
allosteric	O
drug	O
,	O
o,o	O
'-	O
bismyristoyl	O
thiamine	O
disulfide	O
,	O
suppresses	O
HIV-1	O
replication	O
through	O
prevention	O
of	O
nuclear	O
translocation	O
of	O
both	O
HIV-1	O
Tat	O
and	O
NF-kappa	O
B	O
.	O

The	O
efficacy	O
of	O
o,o	O
'-	O
bismyristoyl	O
thiamine	O
disulfide	O
(	O
BMT	O
)	O
was	O
examined	O
in	O
detail	O
against	O
HIV-1	O
laboratory	O
isolates	O
(	O
HTLV-IIIB	O
,	O
JRFL	O
,	O
and	O
MN	O
)	O
,	O
primary	O
isolates	O
(	O
KMT	O
and	O
KMO	O
)	O
,	O
and	O
simian	O
immunodeficiency	O
virus	O
(	O
SIVmac251	O
)	O
in	O
vitro	O
.	O

BMT	O
inhibited	O
the	O
replication	O
of	O
HIV-1	O
in	O
both	O
laboratory	O
and	O
primary	O
isolates	O
in	O
vitro	O
.	O

In	O
addition	O
,	O
BMT	O
exhibited	O
antiviral	O
activity	O
against	O
SIVmac251	O
.	O

Minimizing	O
energy	O
studies	O
of	O
BMT	O
structure	O
reveal	O
that	O
a	O
trans-disulfide	O
of	O
thiamine	O
(	O
holo	O
drug	O
)	O
disulfide	O
(	O
TDS	O
,	O
protodrug	O
)	O
is	O
allosterically	O
transited	O
to	O
the	O
reactive	O
twisted	O
disulfide	O
of	O
BMT	O
(	O
allo	O
drug	O
)	O
by	O
o,o	O
'-	O
bismyristoyl	O
esterification	O
of	O
TDS	O
.	O

BMT	O
inhibits	O
nuclear	O
translocation	O
of	O
both	O
HIV-1	O
transactivator	O
(	O
TAT	O
)	O
and	O
the	O
cellular	O
transcriptional	O
nuclear	O
factor-KB	O
(	O
NF-kappa	O
B	O
)	O
,	O
resulting	O
in	O
the	O
suppression	O
of	O
HIV-1	O
replication	O
.	O

Retinoid	O
X	O
receptor	O
and	O
c-cerbA	O
/	O
thyroid	O
hormone	O
receptor	O
regulate	O
erythroid	O
cell	O
growth	O
and	O
differentiation	O
.	O

Nuclear	O
receptors	O
are	O
important	O
regulators	O
of	O
erythroid	O
cell	O
development	O
.	O

Here	O
we	O
investigated	O
the	O
impact	O
of	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
)	O
,	O
retinoic	O
acid	O
receptor	O
(	O
RAR	O
)	O
,	O
and	O
of	O
the	O
c-erbA	O
/	O
thyroid	O
hormone	O
(	O
T3	O
)	O
receptor	O
(	O
c-erbA	O
/	O
TR	O
)	O
on	O
growth	O
and	O
differentiation	O
of	O
erythroid	O
cells	O
using	O
an	O
in	O
vitro	O
culture	O
system	O
of	O
stem	O
cell	O
factor-dependent	O
erythroid	O
progenitors	O
.	O

RXR	O
,	O
RAR	O
,	O
and	O
c-erbA	O
/	O
TR-specific	O
ligands	O
were	O
found	O
to	O
induce	O
erythroid-specific	O
gene	O
expression	O
and	O
to	O
accelerate	O
erythroid	O
differentiation	O
in	O
culture	O
,	O
with	O
T3	O
being	O
most	O
effective	O
.	O

Furthermore	O
,	O
while	O
ligand-activated	O
c-erbA	O
/	O
TR	O
accelerated	O
differentiation	O
,	O
unliganded	O
c-erbA	O
/	O
TR	O
effectively	O
blocked	O
differentiation	O
and	O
supported	O
sustained	O
progenitor	O
growth	O
in	O
culture	O
.	O

Thus	O
,	O
c-erbA	B-SPECULATION
/	I-SPECULATION
TR	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
act	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
binary	I-SPECULATION
switch	I-SPECULATION
affecting	I-SPECULATION
erythroid	I-SPECULATION
cell	I-SPECULATION
fate	I-SPECULATION
:	O
unliganded	O
c-erbA	O
/	O
TR	O
supports	O
growth	O
while	O
ligand-activated	O
c-erbA	O
/	O
TR	O
induces	O
differentiation	O
.	O

Additionally	O
,	O
to	O
determine	O
the	O
impact	O
of	O
RXR	O
for	O
erythroid	O
cell	O
development	O
,	O
dominant	O
interfering	O
mutant	O
RXRs	O
,	O
lacking	B-NEGATION
the	I-NEGATION
transcriptional	I-NEGATION
activator	I-NEGATION
functions	I-NEGATION
AF-1	I-NEGATION
and	I-NEGATION
AF-2	I-NEGATION
,	I-NEGATION
or	I-NEGATION
AF-2	I-NEGATION
only	I-NEGATION
,	I-NEGATION
or	I-NEGATION
the	I-NEGATION
entire	I-NEGATION
DNA-binding	I-NEGATION
domain	I-NEGATION
,	O
were	O
introduced	O
into	O
erythroid	O
progenitor	O
cells	O
via	O
recombinant	O
retrovirus	O
vectors	O
and	O
analyzed	O
for	O
RXR-specific	O
effects	O
.	O

It	O
was	O
found	O
that	O
expression	O
of	O
wild-type	O
RXR	O
and	O
of	O
the	O
RXR	O
mutants	O
devoid	O
of	O
AF-1	O
and	O
/	O
or	O
AF-2	O
supported	O
a	O
transient	O
outgrowth	O
of	O
erythroid	O
cells	O
.	O

In	O
marked	O
contrast	O
,	O
expression	O
of	O
the	O
dominant	O
interfering	O
deltaDNA-binding	O
domain	O
RXR	O
,	O
containing	O
a	O
deletion	O
of	O
the	O
entire	O
DNA-binding	O
domain	O
,	O
was	O
incompatible	O
with	O
erythroid	O
cell	O
growth	O
in	O
vitro	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
pivotal	I-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
RXR	I-SPECULATION
for	I-SPECULATION
erythroid	I-SPECULATION
cell	I-SPECULATION
development	I-SPECULATION
.	O

Phosphatidylinositides	O
bind	O
to	O
plasma	O
membrane	O
CD14	O
and	O
can	O
prevent	O
monocyte	O
activation	O
by	O
bacterial	O
lipopolysaccharide	O
.	O

Although	O
bacterial	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
several	O
other	O
microbial	O
agonists	O
can	O
bind	O
to	O
mCD14	O
(	O
membrane	O
CD14	O
)	O
,	O
a	O
cell-surface	O
receptor	O
found	O
principally	O
on	O
monocytes	O
and	O
neutrophils	O
,	O
host-derived	O
mCD14	O
ligands	O
are	O
poorly	O
defined	O
.	O

We	O
report	O
here	O
that	O
phosphatidylinositol	O
(	O
PtdIns	O
)	O
,	O
phosphatidylinositol-4-phosphate	O
,	O
and	O
other	O
phosphatidylinositides	O
can	O
bind	O
to	O
mCD14	O
.	O

Phosphatidylserine	O
(	O
PS	O
)	O
,	O
another	O
anionic	O
glycerophospholipid	O
,	O
binds	O
to	O
mCD14	O
with	O
lower	O
apparent	O
affinity	O
than	O
does	O
PtdIns	O
.	O

LPS-binding	O
protein	O
,	O
a	O
lipid	O
transfer	O
protein	O
found	O
in	O
serum	O
,	O
facilitates	O
both	O
PS	O
-	O
and	O
PtdIns-mCD14	O
binding	O
.	O

PtdIns	O
binding	O
to	O
mCD14	O
can	O
be	O
blocked	O
by	O
anti-CD14	O
monoclonal	O
antibodies	O
that	O
inhibit	O
LPS-mCD14	O
binding	O
,	O
and	O
PtdIns	O
can	O
inhibit	O
both	O
LPS-mCD14	O
binding	O
and	O
LPS-induced	O
responses	O
in	O
monocytes	O
.	O

Serum-equilibrated	O
PtdIns	O
also	O
binds	O
to	O
mCD14-expressing	O
cells	O
,	O
raising	B-SPECULATION
the	I-SPECULATION
possibility	I-SPECULATION
that	I-SPECULATION
endogenous	I-SPECULATION
PtdIns	I-SPECULATION
may	B-SPECULATION
modulate	I-SPECULATION
cellular	I-SPECULATION
responses	I-SPECULATION
to	I-SPECULATION
LPS	I-SPECULATION
and	I-SPECULATION
other	I-SPECULATION
mCD14	I-SPECULATION
ligands	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
.	O

Molecular	O
and	O
cellular	O
analysis	O
of	O
human	O
immunodeficiency	O
virus-induced	O
apoptosis	O
in	O
lymphoblastoid	O
T-cell-line-expressing	O
wild-type	O
and	O
mutated	O
CD4	O
receptors	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
presence	O
of	O
the	O
CD4	O
cytoplasmic	O
tail	O
is	O
critical	O
for	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-	O
induced	O
apoptosis	O
(	O
J.Corbeil	O
,	O
M.Tremblay	O
,	O
and	O
D.D.Richman	O
,	O
J.Exp.Med.183:39-48	O
,	O
1996	O
)	O
.	O

We	O
have	O
pursued	O
our	O
investigation	O
of	O
the	O
role	O
of	O
the	O
CD4	O
transduction	O
pathway	O
in	O
HIV-induced	O
apoptosis	O
.	O

To	O
do	O
this	O
,	O
wild-type	O
and	O
mutant	O
forms	O
of	O
the	O
CD4	O
cytoplasmic	O
tail	O
were	O
stably	O
expressed	O
in	O
the	O
lymphoblastoid	O
T-cell	O
line	O
A2.01	O
.	O

Apoptosis	O
was	O
prevented	O
when	O
CD4	O
truncated	O
at	O
residue	O
402	O
was	O
expressed	O
;	O
however	O
,	O
cells	O
expressing	O
mutated	O
receptors	O
that	O
do	O
not	B-NEGATION
associate	I-NEGATION
with	I-NEGATION
p56	I-NEGATION
(	I-NEGATION
lck	I-NEGATION
)	I-NEGATION
(	I-NEGATION
mutated	I-NEGATION
at	I-NEGATION
the	I-NEGATION
dicysteine	I-NEGATION
motif	I-NEGATION
and	I-NEGATION
truncated	I-NEGATION
at	I-NEGATION
residue	I-NEGATION
418	I-NEGATION
)	I-NEGATION
but	O
which	O
conserved	O
proximal	O
domains	O
of	O
the	O
cytoplasmic	O
tail	O
underwent	O
apoptosis	O
like	O
wild	O
-	O
type	O
CD4	O
.	O

The	O
differences	O
between	O
wild-type	O
and	O
mutated	O
receptors	O
in	O
the	O
induction	O
of	O
apoptosis	O
were	O
not	B-NEGATION
related	I-NEGATION
to	I-NEGATION
levels	I-NEGATION
of	I-NEGATION
p56	I-NEGATION
(	I-NEGATION
lck	I-NEGATION
)	I-NEGATION
or	I-NEGATION
NF	I-NEGATION
-	I-NEGATION
kappaB	I-NEGATION
activation	I-NEGATION
.	O

Initial	O
signaling	O
through	O
the	O
CD4	O
receptor	O
played	O
a	O
major	O
role	O
in	O
the	O
sensitization	O
of	O
HIV-infected	O
T	O
cells	O
to	O
undergo	O
apoptosis	O
.	O

Incubation	O
of	O
HIV-infected	O
cells	O
with	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
13B8-2	O
,	O
which	O
binds	O
to	O
CD4	O
in	O
a	O
region	O
critical	O
for	O
dimerization	O
of	O
the	O
receptor	O
,	O
prevented	O
apoptosis	O
without	B-NEGATION
inhibiting	I-NEGATION
HIV	I-NEGATION
replication	I-NEGATION
.	O

Moreover	O
,	O
the	O
apoptotic	O
process	O
was	O
not	B-NEGATION
related	I-NEGATION
to	I-NEGATION
Fas-Fas	I-NEGATION
ligand	I-NEGATION
interaction	I-NEGATION
;	O
however	O
,	O
an	O
antagonistic	O
anti-Fas	O
MAb	O
(	O
ZB-4	O
)	O
enhanced	O
apoptosis	O
in	O
HIV-infected	O
cells	O
without	B-NEGATION
inducing	I-NEGATION
apoptosis	I-NEGATION
in	I-NEGATION
uninfected	I-NEGATION
cells	I-NEGATION
.	O

These	O
observations	O
demonstrate	O
that	O
CD4	O
signaling	O
mediates	O
HIV-induced	O
apoptosis	O
by	O
a	O
mechanism	O
independent	O
of	O
Fas-Fas	O
ligand	O
interaction	O
,	O
does	O
not	B-NEGATION
require	I-NEGATION
p56	I-NEGATION
(	I-NEGATION
lck	I-NEGATION
)	I-NEGATION
signaling	I-NEGATION
,	O
and	O
may	B-SPECULATION
involve	I-SPECULATION
a	I-SPECULATION
critical	I-SPECULATION
region	I-SPECULATION
for	I-SPECULATION
CD4	I-SPECULATION
dimerization	I-SPECULATION
.	O

Low	O
CD3	O
+	O
CD28-induced	O
interleukin-2	O
production	O
correlates	O
with	O
decreased	O
reactive	O
oxygen	O
intermediate	O
formation	O
in	O
neonatal	O
T	O
cells	O
.	O

The	O
capacity	O
of	O
neonatal	O
T	O
cells	O
to	O
secrete	O
interleukin-2	O
(	O
IL-2	O
)	O
has	O
been	O
reported	O
to	O
be	O
variable	O
.	O

We	O
analysed	O
IL-2	O
production	O
in	O
purified	O
neonatal	O
and	O
adult	O
T	O
cells	O
using	O
polyclonal	O
activator	O
phorbol	O
ester	O
+	O
calcium	O
ionophore	O
(	O
PDBu	O
+	O
iono	O
)	O
or	O
receptor-mediated	O
anti-CD3	O
/	O
anti-CD3	O
+	O
anti-CD28	O
stimulation	O
.	O

PDBu	O
+	O
iono	O
induced	O
equally	O
high	O
IL-2	O
levels	O
in	O
both	O
groups	O
and	O
,	O
when	O
stimulated	O
with	O
plate-bound	O
anti-CD3	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
,	O
the	O
IL-2	O
secretion	O
by	O
neonatal	O
cells	O
was	O
undetectable	O
and	O
adult	O
cells	O
produced	O
low	O
amounts	O
of	O
IL-2	O
(	O
mean	O
331	O
±	O
86	O
pg	O
/	O
ml	O
)	O
.	O

The	O
addition	O
of	O
anti-CD28	O
mAb	O
to	O
anti-CD3-stimulated	O
cells	O
markedly	O
increased	O
IL-2	O
production	O
in	O
both	O
cell	O
types	O
,	O
but	O
levels	O
of	O
IL-2	O
in	O
neonatal	O
T	O
cells	O
remained	O
clearly	O
lower	O
than	O
those	O
of	O
adult	O
T	O
cells	O
(	O
respective	O
mean	O
values	O
:	O
385	O
±	O
109	O
pg	O
/	O
ml	O
and	O
4494	O
±	O
1199	O
pg	O
/	O
ml	O
)	O
.	O

As	O
NF-kappa	O
B	O
is	O
a	O
critical	O
transcription	O
factor	O
in	O
the	O
control	O
of	O
IL-2	O
expression	O
,	O
we	O
next	O
analysed	O
its	O
nuclear	O
translocation	O
in	O
neonatal	O
and	O
adult	O
T	O
cells	O
using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
and	O
,	O
because	O
induction	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROI	O
)	O
is	O
required	O
for	O
the	O
activation	O
of	O
NF-kappa	O
B	O
,	O
we	O
also	O
analysed	O
levels	O
of	O
intracellular	O
ROI	O
in	O
these	O
cells	O
using	O
the	O
ROI-reactive	O
fluorochrome	O
DCFH-DA	O
and	O
flow	O
cytometry	O
.	O

In	O
neonatal	O
T	O
cells	O
NF-kappa	O
B	O
activation	O
and	O
ROI	O
formation	O
after	O
anti-CD3	O
stimulation	O
were	O
low	O
compared	O
with	O
adult	O
T	O
cells	O
and	O
,	O
although	O
addition	O
of	O
anti-CD28	O
mAb	O
increased	O
induction	O
of	O
NF-kappa	O
B	O
and	O
ROI	O
formation	O
,	O
levels	B-NEGATION
similar	I-NEGATION
to	I-NEGATION
those	I-NEGATION
of	I-NEGATION
adults	I-NEGATION
were	I-NEGATION
not	I-NEGATION
achieved	I-NEGATION
.	O

After	O
PDBu	O
+	O
iono	O
stimulation	O
,	O
the	O
cells	O
showed	O
similar	O
ROI	O
formation	O
and	O
IL-2	O
secretion	O
.	O

Our	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
reduced	I-SPECULATION
IL-2	I-SPECULATION
production	I-SPECULATION
by	I-SPECULATION
neonatal	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
is	I-SPECULATION
specific	I-SPECULATION
for	I-SPECULATION
anti-CD3	I-SPECULATION
and	I-SPECULATION
anti-CD3	I-SPECULATION
+	I-SPECULATION
anti-CD28-mediated	I-SPECULATION
stimulation	I-SPECULATION
and	I-SPECULATION
that	I-SPECULATION
these	I-SPECULATION
activators	I-SPECULATION
cannot	B-NEGATION
effectively	I-NEGATION
activate	I-NEGATION
the	I-NEGATION
ROI-NF-kappa	I-NEGATION
B	I-NEGATION
signalling	I-NEGATION
pathway	I-NEGATION
in	I-NEGATION
neonatal	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
.	O

Activated	O
platelets	O
induce	O
monocyte	O
chemotactic	O
protein-1	O
secretion	O
and	O
surface	O
expression	O
of	O
intercellular	O
adhesion	O
molecule-1	O
on	O
endothelial	O
cells	O
[	O
see	O
comments	O
]	O

BACKGROUND	O
:	O
Platelet	O
/	O
endothelium	O
interaction	O
plays	O
an	O
important	O
role	O
in	O
the	O
pathophysiology	O
of	O
inflammation	O
and	O
atherosclerosis	O
.	O

The	O
role	O
of	O
platelets	O
for	O
monocyte	O
chemotactic	O
protein-1	O
(	O
MCP-1	O
)	O
secretion	O
and	O
surface	O
expression	O
of	O
intercellular	O
adhesion	O
molecule-1	O
(	O
ICAM-1	O
)	O
on	O
endothelial	O
cells	O
has	O
been	O
assessed	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
Monolayers	O
of	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
were	O
incubated	O
with	O
nonstimulated	O
or	O
ADP-activated	O
platelets	O
for	O
6	O
hours	O
,	O
and	O
secretion	O
of	O
MCP-1	O
and	O
surface	O
expression	O
of	O
ICAM-1	O
were	O
determined	O
by	O
ELISA	O
and	O
flow	O
cytometry	O
,	O
respectively	O
.	O

In	O
the	O
presence	O
of	O
ADP-activated	O
platelets	O
,	O
both	O
MCP-1	O
secretion	O
and	O
ICAM-1	O
surface	O
expression	O
were	O
significantly	O
increased	O
compared	O
with	O
nonstimulated	O
platelets	O
(	O
P	O
<	O
0.02	O
)	O
.	O

Activation	O
of	O
the	O
transcription	O
factor	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
determined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
and	O
kappaB-dependent	O
transcriptional	O
activity	O
was	O
enhanced	O
in	O
the	O
presence	O
of	O
activated	O
platelets	O
.	O

In	O
addition	O
,	O
ADP-activated	O
platelets	O
induced	O
MCP-1	O
and	O
ICAM-1	O
promoter-dependent	O
transcription	O
.	O

Liposomal	O
transfection	O
of	O
a	O
double-stranded	O
kappaB	O
phosphorothioate	O
oligonucleotide	O
,	O
but	O
not	B-NEGATION
of	I-NEGATION
the	I-NEGATION
mutated	I-NEGATION
form	I-NEGATION
,	O
inhibited	O
MCP-1	O
secretion	O
and	O
surface	O
expression	O
of	O
ICAM-1	O
on	O
activated	O
endothelium	O
(	O
P	O
<	O
0.05	O
)	O
.	O

CONCLUSIONS	O
:	O
The	O
present	O
study	O
indicates	B-SPECULATION
that	I-SPECULATION
activated	I-SPECULATION
platelets	I-SPECULATION
modulate	I-SPECULATION
chemotactic	I-SPECULATION
(	I-SPECULATION
MCP-1	I-SPECULATION
)	I-SPECULATION
and	I-SPECULATION
adhesive	I-SPECULATION
(	I-SPECULATION
ICAM-1	I-SPECULATION
)	I-SPECULATION
properties	I-SPECULATION
of	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
via	I-SPECULATION
an	I-SPECULATION
NF-kappaB-dependent	I-SPECULATION
mechanism	I-SPECULATION
.	O

Platelet-induced	O
activation	O
of	O
the	O
NF-kappaB	O
system	O
might	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
early	I-SPECULATION
inflammatory	I-SPECULATION
events	I-SPECULATION
in	I-SPECULATION
atherogenesis	I-SPECULATION
.	O

Altered	O
DNA-binding	O
specificity	O
mutants	O
of	O
EKLF	O
and	O
Sp1	O
show	O
that	O
EKLF	O
is	O
an	O
activator	O
of	O
the	O
beta-globin	O
locus	O
control	O
region	O
in	O
vivo	O
.	O

The	O
locus	O
control	O
region	O
of	O
the	O
beta-globin	O
cluster	O
contains	O
five	O
DNase	O
I	O
hypersensitive	O
sites	O
(	O
5'HS1-5	O
)	O
required	O
for	O
locus	O
activation	O
.	O

5'HS3	O
contains	O
six	O
G-rich	O
motifs	O
that	O
are	O
essential	O
for	O
its	O
activity	O
.	O

Members	O
of	O
a	O
protein	O
family	O
,	O
characterized	O
by	O
three	O
zinc	O
fingers	O
highly	O
homologous	O
to	O
those	O
found	O
in	O
transcription	O
factor	O
Sp1	O
,	O
interact	O
with	O
these	O
motifs	O
.	O

Because	O
point	O
mutagenesis	O
cannot	B-NEGATION
distinguish	I-NEGATION
between	I-NEGATION
family	I-NEGATION
members	I-NEGATION
,	O
it	O
is	O
not	B-SPECULATION
known	I-SPECULATION
which	I-SPECULATION
protein	I-SPECULATION
activates	I-SPECULATION
5'HS3	I-SPECULATION
.	O

We	O
show	O
that	O
the	O
function	O
of	O
such	O
closely	O
related	O
proteins	O
can	O
be	O
distinguished	O
in	O
vivo	O
by	O
matching	O
point	O
mutations	O
in	O
5'HS3	O
with	O
amino	O
acid	O
changes	O
in	O
the	O
zinc	O
fingers	O
of	O
Sp1	O
and	O
EKLF	O
.	O

Testing	O
their	O
activity	O
in	O
transgenic	O
mice	O
shows	O
that	O
EKLF	O
is	O
a	O
direct	O
activator	O
of	O
5'HS3	O
.	O

NF-kappaB	O
only	O
partially	O
mediates	O
Epstein-Barr	O
virus	O
latent	O
membrane	O
protein	O
1	O
activation	O
of	O
B	O
cells	O
.	O

The	O
latent	O
membrane	O
protein	O
1	O
(	O
LMP1	O
)	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
is	O
required	O
for	O
EBV-induced	O
immortalization	O
of	O
human	O
B	O
cells	O
and	O
causes	O
tumorigenic	O
transformation	O
of	O
cell	O
lines	O
.	O

LMP1	O
expression	O
induces	O
phenotypic	O
changes	O
resembling	O
B	O
cell	O
activation	O
,	O
such	O
as	O
cell	O
size	O
increase	O
and	O
up-regulation	O
of	O
cell	O
surface	O
activation	O
markers	O
.	O

LMP1	O
contains	O
two	O
domains	O
that	O
activate	O
the	O
transcription	O
factor	O
NF-kappaB	O
,	O
one	O
through	O
interactions	O
with	O
TRAF	O
proteins	O
and	O
the	O
other	O
with	O
the	O
TRADD	O
protein	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
importance	O
of	O
NF-kappaB	O
induction	O
in	O
the	O
up-regulation	O
of	O
the	O
B	O
cell	O
activation	O
markers	O
ICAM-1	O
and	O
CD71	O
by	O
LMP1	O
.	O

This	O
study	O
shows	O
that	O
expression	O
of	O
LMP1	O
activates	O
transcription	O
from	O
p50	O
/	O
p65	O
-	O
and	O
c-Rel	O
-	O
responsive	O
promoters	O
,	O
and	O
that	O
this	O
activity	O
can	O
be	O
completely	O
inhibited	O
by	O
expression	O
of	O
a	O
dominant	O
inhibitory	O
IkappaB	O
mutant	O
.	O

ICAM-1	O
and	O
CD71	O
are	O
nevertheless	O
up-regulated	O
by	O
LMP1	O
in	O
primary	O
B	O
cells	O
and	O
cell	O
lines	O
expressing	O
the	O
dominant	O
IkappaB	O
.	O

Furthermore	O
,	O
LMP1-induced	O
cell	O
size	O
increase	O
of	O
primary	O
B	O
cells	O
was	O
unaffected	O
by	O
IkappaB	O
expression	O
.	O

It	O
was	O
concluded	O
that	O
even	O
when	O
LMP1	B-NEGATION
is	I-NEGATION
unable	I-NEGATION
to	I-NEGATION
activate	I-NEGATION
NF-kappaB	I-NEGATION
,	O
it	O
is	O
still	O
capable	O
of	O
inducing	O
certain	O
characteristics	O
of	O
activated	O
B	O
cells	O
,	O
strongly	O
suggesting	B-SPECULATION
that	I-SPECULATION
LMP1	I-SPECULATION
can	I-SPECULATION
also	I-SPECULATION
activate	I-SPECULATION
cells	I-SPECULATION
independently	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
.	O

Activation	O
of	O
distinct	O
transcription	O
factors	O
in	O
neutrophils	O
by	O
bacterial	O
LPS	O
,	O
interferon-gamma	O
,	O
and	O
GM-CSF	O
and	O
the	O
necessity	O
to	O
overcome	O
the	O
action	O
of	O
endogenous	O
proteases	O
.	O

Human	O
neutrophils	O
can	O
be	O
induced	O
to	O
actively	O
transcribe	O
a	O
number	O
of	O
early-response	O
genes	O
,	O
in	O
particular	O
those	O
encoding	O
cytokines	O
,	O
chemokines	O
,	O
and	O
the	O
high-affinity	O
surface	O
receptor	O
for	O
IgG	O
,	O
FcgammaRI	O
.	O

Although	O
little	O
is	O
known	O
to	O
date	O
about	O
the	O
regulation	O
of	O
gene	O
transcription	O
in	O
neutrophils	O
,	O
several	O
indications	O
point	O
to	O
a	O
role	O
for	O
distinct	O
transcription	O
factors	O
,	O
such	O
as	O
members	O
of	O
the	O
NF-kappaB	O
and	O
STAT	O
families	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
whether	B-SPECULATION
these	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
become	I-SPECULATION
activated	I-SPECULATION
under	I-SPECULATION
stimulatory	I-SPECULATION
conditions	I-SPECULATION
which	I-SPECULATION
are	I-SPECULATION
known	I-SPECULATION
to	I-SPECULATION
induce	I-SPECULATION
gene	I-SPECULATION
transcription	I-SPECULATION
in	I-SPECULATION
neutrophils	I-SPECULATION
.	O

Unexpectedly	O
,	O
we	O
found	O
that	O
conventional	O
procedures	O
employed	O
to	O
prepare	O
cellular	O
extracts	O
cause	O
the	O
release	O
of	O
proteolytic	O
activities	O
that	O
are	O
normally	O
stored	O
in	O
intracellular	O
granules	O
,	O
resulting	O
in	O
the	O
degradation	O
of	O
various	O
NF-kappaB	O
/	O
Rel	O
and	O
STAT	O
proteins	O
.	O

To	O
circumvent	O
this	O
problem	O
,	O
we	O
developed	O
an	O
alternative	O
procedure	O
which	O
allowed	O
us	O
to	O
show	O
that	O
in	O
neutrophils	O
,	O
LPS	O
and	O
TNFalpha	O
induce	O
a	O
NF-kappaB	O
DNA-binding	O
activity	O
which	O
essentially	O
consists	O
of	O
p50	O
/	O
RelA	O
dimers	O
,	O
and	O
that	O
IFNgamma	O
promotes	O
the	O
binding	O
of	O
STAT1	O
homodimers	O
to	O
the	O
IFNgamma	O
response	O
region	O
of	O
the	O
FcgammaRI	O
promoter	O
.	O

Moreover	O
,	O
we	O
report	O
that	O
neutrophil	O
stimulation	O
with	O
GM-CSF	O
results	O
in	O
the	O
formation	O
of	O
a	O
STAT5-containing	O
DNA-binding	O
activity	O
.	O

Collectively	O
,	O
the	O
current	O
findings	O
open	O
new	O
perspectives	O
about	O
mechanisms	O
that	B-SPECULATION
are	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
regulate	I-SPECULATION
gene	I-SPECULATION
transcription	I-SPECULATION
in	I-SPECULATION
neutrophils	I-SPECULATION
.	O

In	O
addition	O
,	O
the	O
procedure	O
described	O
herein	O
could	B-SPECULATION
prove	I-SPECULATION
useful	I-SPECULATION
in	I-SPECULATION
other	I-SPECULATION
cell	I-SPECULATION
types	I-SPECULATION
that	I-SPECULATION
express	I-SPECULATION
high	I-SPECULATION
levels	I-SPECULATION
of	I-SPECULATION
endogenous	I-SPECULATION
proteases	I-SPECULATION
.	O

The	O
PEBP2betaMYH11	O
fusion	O
created	O
by	O
Inv	O
(	O
16	O
)(	O
p13	O
;	O
q22	O
)	O
in	O
myeloid	O
leukemia	O
impairs	O
neutrophil	O
maturation	O
and	O
contributes	O
to	O
granulocytic	O
dysplasia	O
.	O

Chromosomal	O
translocations	O
involving	O
the	O
genes	O
encoding	O
the	O
alpha	O
and	O
beta	O
subunits	O
of	O
the	O
Pebp2	O
/	O
Cbf	O
transcription	O
factor	O
have	O
been	O
associated	O
with	O
human	O
acute	O
myeloid	O
leukemia	O
and	O
the	O
preleukemic	O
condition	O
,	O
myelodysplasia	O
.	O

Inv	O
(	O
16	O
)(	O
p13	O
;	O
q22	O
)	O
fuses	O
the	O
gene	O
encoding	O
the	O
beta	O
subunit	O
of	O
Pebp2	O
to	O
the	O
MYH11	O
gene	O
encoding	O
a	O
smooth	O
muscle	O
myosin	O
heavy	O
chain	O
(	O
Smmhc	O
)	O
.	O

To	O
examine	O
the	O
effect	O
of	O
the	O
inv	O
(	O
16	O
)(	O
p13	O
;	O
q22	O
)	O
on	O
myelopoiesis	O
,	O
we	O
used	O
the	O
hMRP8	O
promoter	O
element	O
to	O
generate	O
transgenic	O
mice	O
expressing	O
the	O
Pebp2beta	O
Smmhc	O
chimeric	O
fusion	O
protein	O
in	O
myeloid	O
cells	O
.	O

Neutrophil	O
maturation	O
was	O
impaired	O
in	O
PEBP2betaMYH11	O
transgenic	O
mice	O
.	O

Although	O
the	O
transgenic	O
mice	O
had	O
normal	O
numbers	O
of	O
circulating	O
neutrophils	O
,	O
their	O
bone	O
marrow	O
contained	O
increased	O
numbers	O
of	O
immature	O
neutrophilic	O
cells	O
,	O
which	O
exhibited	O
abnormal	O
characteristics	O
.	O

In	O
addition	O
,	O
PEBP2betaMYH11	O
inhibited	O
neutrophilic	O
differentiation	O
in	O
colonies	O
derived	O
from	O
hematopoietic	O
progenitors	O
.	O

Coexpression	O
of	O
both	O
PEBP2betaMYH11	O
and	O
activated	O
NRAS	O
induced	O
a	O
more	O
severe	O
phenotype	O
characterized	O
by	O
abnormal	O
nuclear	O
morphology	O
indicative	O
of	O
granulocytic	O
dysplasia	O
.	O

These	O
results	O
show	O
that	O
PEBP2betaMYH11	O
can	O
impair	O
neutrophil	O
development	O
and	O
provide	O
evidence	O
that	O
alterations	O
of	O
Pebp2	O
can	O
contribute	O
to	O
the	O
genesis	O
of	O
myelodysplasia	O
.	O

Transcription	O
factor	O
activation	O
in	O
lymphokine	O
activated	O
killer	O
cells	O
and	O
lymphocytes	O
from	O
patients	O
receiving	O
IL-2	O
immunotherapy	O
.	O

Administration	O
of	O
the	O
cytokine	O
interleukin-2	O
(	O
IL-2	O
)	O
can	O
result	O
in	O
therapeutic	O
benefits	O
for	O
individuals	O
with	O
renal	O
cell	O
carcinoma	O
and	O
melanoma	O
.	O

Here	O
we	O
report	O
an	O
analysis	O
of	O
the	O
transcription	O
factor	O
families	O
AP-1	O
,	O
Sp1	O
,	O
NF-kappaB	O
,	O
and	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STAT	O
)	O
in	O
cancer	O
patients'	O
lymphocytes	O
before	O
and	O
after	O
IL-2	O
immunotherapy	O
,	O
as	O
assessed	O
by	O
a	O
gel-shift	O
assay	O
.	O

An	O
in	O
vitro	O
surrogate	O
of	O
IL-2	O
immunotherapy	O
is	O
the	O
incubation	O
of	O
fresh	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
from	O
healthy	O
individuals	O
in	O
IL-2	O
for	O
several	O
days	O
,	O
resulting	O
in	O
the	O
production	O
of	O
lymphokine-activated	O
killer	O
(	O
LAK	O
)	O
activity	O
in	O
these	O
cultures	O
.	O

One	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
profile	O
of	O
transcription	O
factor	O
activation	O
in	O
these	O
different	O
populations	O
,	O
and	O
assess	O
whether	B-SPECULATION
the	I-SPECULATION
patterns	I-SPECULATION
observed	I-SPECULATION
correlated	I-SPECULATION
with	I-SPECULATION
functional	I-SPECULATION
differences	I-SPECULATION
in	I-SPECULATION
these	I-SPECULATION
cells	I-SPECULATION
.	O

Prior	O
to	O
in	O
vivo	O
IL-2	O
administration	O
,	O
the	O
typical	O
binding	O
pattern	O
of	O
transcription	O
factors	O
in	O
PBMC	O
from	O
patients	O
resembled	O
that	O
seen	O
in	O
fresh	O
PBMC	O
from	O
healthy	O
individuals	O
.	O

Over	O
a	O
3-week	O
course	O
of	O
IL-2	O
therapy	O
,	O
in	O
most	O
patients	O
the	O
binding	O
patterns	O
of	O
AP-1	O
,	O
Sp1	O
,	O
and	O
NF-kappaB	O
proteins	O
changed	O
to	O
resemble	O
those	O
seen	O
in	O
PBMC	O
activated	O
by	O
IL-2	O
in	O
vitro	O
.	O

However	O
,	O
the	O
cells	O
obtained	O
from	O
IL-2-treated	O
patients	O
did	O
not	B-NEGATION
have	I-NEGATION
low-level	I-NEGATION
constitutive	I-NEGATION
expression	I-NEGATION
of	I-NEGATION
STAT	I-NEGATION
binding	I-NEGATION
factors	I-NEGATION
as	O
did	O
LAK	O
cells	O
.	O

When	O
these	O
patient	O
cells	O
were	O
further	O
stimulated	O
by	O
IL-2	O
in	O
vitro	O
,	O
additional	O
differences	O
in	O
STAT	O
induction	O
patterns	O
were	O
noted	O
.	O

These	O
data	O
provide	O
further	O
information	O
on	O
the	O
molecular	O
events	O
occurring	O
in	O
immune	O
cells	O
generated	O
through	O
in	O
vivo	O
and	O
in	O
vitro	O
administration	O
of	O
IL-2	O
,	O
and	O
further	O
document	O
that	O
there	O
is	O
not	B-NEGATION
a	I-NEGATION
precise	I-NEGATION
congruence	I-NEGATION
between	I-NEGATION
PBMC	I-NEGATION
activated	I-NEGATION
in	I-NEGATION
vivo	I-NEGATION
and	I-NEGATION
in	I-NEGATION
vitro	I-NEGATION
by	I-NEGATION
IL-2	I-NEGATION
.	O

A	O
critical	O
role	O
of	O
the	O
p75	O
tumor	O
necrosis	O
factor	O
receptor	O
(	O
p75TNF-R	O
)	O
in	O
organ	O
inflammation	O
independent	O
of	O
TNF	O
,	O
lymphotoxin	O
alpha	O
,	O
or	O
the	O
p55TNF-R	O
.	O

Despite	O
overwhelming	O
evidence	O
that	O
enhanced	O
production	O
of	O
the	O
p75	O
tumor	O
necrosis	O
factor	O
receptor	O
(	O
p75TNF-R	O
)	O
accompanies	O
development	O
of	O
specific	O
human	O
inflammatory	O
pathologies	O
such	O
as	O
multi-organ	O
failure	O
during	O
sepsis	O
,	O
inflammatory	O
liver	O
disease	O
,	O
pancreatitis	O
,	O
respiratory	O
distress	O
syndrome	O
,	O
or	O
AIDS	O
,	O
the	O
function	O
of	O
this	O
receptor	O
remains	O
poorly	O
defined	O
in	O
vivo	O
.	O

We	O
show	O
here	O
that	O
at	O
levels	O
relevant	O
to	O
human	O
disease	O
,	O
production	O
of	O
the	O
human	O
p75TNF-R	O
in	O
transgenic	O
mice	O
results	O
in	O
a	O
severe	O
inflammatory	O
syndrome	O
involving	O
mainly	O
the	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
and	O
lung	O
,	O
and	O
characterized	O
by	O
constitutively	O
increased	O
NF-kappaB	O
activity	O
in	O
the	O
peripheral	O
blood	O
mononuclear	O
cell	O
compartment	O
.	O

This	O
process	O
is	O
shown	O
to	O
evolve	O
independently	O
of	O
the	O
presence	O
of	O
TNF	O
,	O
lymphotoxin	O
alpha	O
,	O
or	O
the	O
p55TNF-R	O
,	O
although	O
coexpression	O
of	O
a	O
human	O
TNF	O
transgene	O
accelerated	O
pathology	O
.	O

These	O
results	O
establish	O
an	O
independent	O
role	O
for	O
enhanced	O
p75TNF-R	O
production	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
disease	O
and	O
implicate	O
the	O
direct	O
involvement	O
of	O
this	O
receptor	O
in	O
a	O
wide	O
range	O
of	O
human	O
inflammatory	O
pathologies	O
.	O

Potent	O
inhibition	O
of	O
HIV	O
type	O
1	O
replication	O
by	O
an	O
antiinflammatory	O
alkaloid	O
,	O
cepharanthine	O
,	O
in	O
chronically	O
infected	O
monocytic	O
cells	O
.	O

Cepharanthine	O
is	O
a	O
biscoclaurine	O
alkaloid	O
isolated	O
from	O
Stephania	O
cepharantha	O
Hayata	O
and	O
has	O
been	O
shown	O
to	O
have	O
antiinflammatory	O
,	O
antiallergic	O
,	O
and	O
immunomodulatory	O
activities	O
in	O
vivo	O
.	O

As	O
several	O
inflammatory	O
cytokines	O
and	O
oxidative	O
stresses	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
HIV-1	O
infection	O
,	O
we	O
investigated	O
the	O
inhibitory	O
effects	O
of	O
cepharanthine	O
on	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)-	O
and	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)-	O
induced	O
HIV-1	O
replication	O
in	O
chronically	O
infected	O
cell	O
lines	O
.	O

Two	O
chronically	O
HIV-1-infected	O
cell	O
lines	O
,	O
U1	O
(	O
monocytic	O
)	O
and	O
ACH-2	O
(	O
T	O
lymphocytic	O
)	O
,	O
were	O
stimulated	O
with	O
TNF-alpha	O
or	O
PMA	O
and	O
cultured	O
in	O
the	O
presence	O
of	O
various	O
concentrations	O
of	O
the	O
compound	O
.	O

HIV-1	O
replication	O
was	O
determined	O
by	O
p24	O
antigen	O
level	O
.	O

The	O
inhibitory	O
effects	O
of	O
cepharanthine	O
on	O
HIV-1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)-	O
driven	O
gene	O
expression	O
and	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)	O
activation	O
were	O
also	O
examined	O
.	O

Cepharanthine	O
dose	O
dependently	O
inhibited	O
HIV-1	O
replication	O
in	O
TNF-alpha	O
-	O
and	O
PMA-stimulated	O
U1	O
cells	O
but	O
not	B-NEGATION
in	I-NEGATION
ACH-2	I-NEGATION
cells	I-NEGATION
.	O

Its	O
50	O
%	O
effective	O
and	O
cytotoxic	O
concentrations	O
were	O
0.016	O
and	O
2.2	O
microg	O
/	O
ml	O
in	O
PMA-stimulated	O
U1	O
cells	O
,	O
respectively	O
.	O

Cepharanthine	O
was	O
found	O
to	O
suppress	O
HIV-1	O
LTR-driven	O
gene	O
expression	O
through	O
the	O
inhibition	O
of	O
NF-kappaB	O
activation	O
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
cepharanthine	I-SPECULATION
is	I-SPECULATION
a	I-SPECULATION
highly	I-SPECULATION
potent	I-SPECULATION
inhibitor	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
replication	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
chronically	I-SPECULATION
infected	I-SPECULATION
monocytic	I-SPECULATION
cell	I-SPECULATION
line	I-SPECULATION
.	O

Since	O
biscoclaurine	O
alkaloids	O
,	O
containing	O
cepharanthine	O
as	O
a	O
major	O
component	O
,	O
are	O
widely	O
used	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
various	O
inflammatory	O
diseases	O
in	O
Japan	O
,	O
cepharanthine	B-SPECULATION
should	I-SPECULATION
be	I-SPECULATION
further	I-SPECULATION
pursued	I-SPECULATION
for	I-SPECULATION
its	I-SPECULATION
chemotherapeutic	I-SPECULATION
potential	I-SPECULATION
in	I-SPECULATION
HIV-1-infected	I-SPECULATION
patients	I-SPECULATION
.	O

Prostaglandin	O
E2	O
Up-regulates	O
HIV-1	O
long	O
terminal	O
repeat-driven	O
gene	O
activity	O
in	O
T	O
cells	O
via	O
NF-kappaB-dependent	O
and	O
-	O
independent	O
signaling	O
pathways	O
.	O

Replication	O
of	O
human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV-1	O
)	O
is	O
highly	O
dependent	O
on	O
the	O
state	O
of	O
activation	O
of	O
the	O
infected	O
cells	O
and	O
is	O
modulated	O
by	O
interactions	O
between	O
viral	O
and	O
host	O
cellular	O
factors	O
.	O

Prostaglandin	O
E2	O
(	O
PGE2	O
)	O
,	O
a	O
pleiotropic	O
immunomodulatory	O
molecule	O
,	O
is	O
observed	O
at	O
elevated	O
levels	O
during	O
HIV-1	O
infection	O
as	O
well	O
as	O
during	O
the	O
course	O
of	O
other	O
pathogenic	O
infections	O
.	O

In	O
1G5	O
,	O
a	O
Jurkat-derived	O
T	O
cell	O
line	O
stably	O
transfected	O
with	O
a	O
luciferase	O
gene	O
driven	O
by	O
HIV-1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
,	O
we	O
found	O
that	O
PGE2	O
markedly	O
enhanced	O
HIV-1	O
LTR-mediated	O
reporter	O
gene	O
activity	O
.	O

Experiments	O
have	O
been	O
conducted	O
to	O
identify	O
second	O
messengers	O
involved	O
in	O
this	O
PGE2-dependent	O
up-regulating	O
effect	O
on	O
the	O
regulatory	O
element	O
of	O
HIV-1	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
evidence	O
indicating	B-SPECULATION
that	I-SPECULATION
signal	I-SPECULATION
transduction	I-SPECULATION
pathways	I-SPECULATION
induced	I-SPECULATION
by	I-SPECULATION
PGE2	I-SPECULATION
necessitate	I-SPECULATION
the	I-SPECULATION
participation	I-SPECULATION
of	I-SPECULATION
cyclic	I-SPECULATION
AMP	I-SPECULATION
,	I-SPECULATION
protein	I-SPECULATION
kinase	I-SPECULATION
A	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
Ca2	I-SPECULATION
+	I-SPECULATION
.	O

Experiments	O
conducted	O
with	O
different	O
HIV-1	O
LTR-based	O
vectors	O
suggested	B-SPECULATION
that	I-SPECULATION
PGE2-mediated	I-SPECULATION
activation	I-SPECULATION
effect	I-SPECULATION
on	I-SPECULATION
HIV-1	I-SPECULATION
transcription	I-SPECULATION
was	I-SPECULATION
transduced	I-SPECULATION
via	I-SPECULATION
both	I-SPECULATION
NF-kappaB-dependent	I-SPECULATION
and	I-SPECULATION
-	I-SPECULATION
independent	I-SPECULATION
signaling	I-SPECULATION
pathways	I-SPECULATION
.	O

The	O
involvement	O
of	O
NF-kappaB	O
in	O
the	O
PGE2-dependent	O
activating	O
effect	O
on	O
HIV-1	O
transcription	O
was	O
further	O
confirmed	O
using	O
a	O
kappaB-regulated	O
luciferase	O
encoding	O
vector	O
and	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

Results	O
from	O
Northern	O
blot	O
and	O
flow	O
cytometric	O
analyses	O
,	O
as	O
well	O
as	O
the	O
use	O
of	O
a	O
selective	O
antagonist	O
indicated	B-SPECULATION
that	I-SPECULATION
PGE2	I-SPECULATION
modulation	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
LTR-driven	I-SPECULATION
reporter	I-SPECULATION
gene	I-SPECULATION
activity	I-SPECULATION
in	I-SPECULATION
studied	I-SPECULATION
T	I-SPECULATION
lymphoid	I-SPECULATION
cells	I-SPECULATION
is	I-SPECULATION
transduced	I-SPECULATION
via	I-SPECULATION
the	I-SPECULATION
EP4	I-SPECULATION
receptor	I-SPECULATION
subtype	I-SPECULATION
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
secretion	I-SPECULATION
of	I-SPECULATION
PGE2	I-SPECULATION
by	I-SPECULATION
macrophages	I-SPECULATION
in	I-SPECULATION
response	I-SPECULATION
to	I-SPECULATION
infection	I-SPECULATION
or	I-SPECULATION
inflammatory	I-SPECULATION
activators	I-SPECULATION
could	B-SPECULATION
induce	I-SPECULATION
signaling	I-SPECULATION
events	I-SPECULATION
resulting	I-SPECULATION
in	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
proviral	I-SPECULATION
DNA	I-SPECULATION
present	I-SPECULATION
into	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
latently	I-SPECULATION
infected	I-SPECULATION
with	I-SPECULATION
HIV-1	I-SPECULATION
.	O

Fcgamma	O
receptor-mediated	O
mitogen-activated	O
protein	O
kinase	O
activation	O
in	O
monocytes	O
is	O
independent	O
of	O
Ras	O
.	O

Receptors	O
for	O
the	O
Fc	O
portion	O
of	O
immunoglobulin	O
molecules	O
(	O
FcR	O
)	O
present	O
on	O
leukocyte	O
cell	O
membranes	O
mediate	O
a	O
large	O
number	O
of	O
cellular	O
responses	O
that	O
are	O
very	O
important	O
in	O
host	O
defense	O
,	O
including	O
phagocytosis	O
,	O
cell	O
cytotoxicity	O
,	O
production	O
and	O
secretion	O
of	O
inflammatory	O
mediators	O
,	O
and	O
modulation	O
of	O
the	O
immune	O
response	O
.	O

Cross-linking	O
of	O
FcR	O
with	O
immune	O
complexes	O
leads	O
,	O
first	O
to	O
activation	O
of	O
protein-tyrosine	O
kinases	O
.	O

The	O
molecular	O
events	O
that	O
follow	O
and	O
that	O
transduce	O
signals	O
from	O
these	O
receptors	O
to	O
the	O
nucleus	O
are	O
still	O
poorly	O
defined	O
.	O

We	O
have	O
investigated	O
the	O
signal	O
transduction	O
pathway	O
from	O
Fc	O
receptors	O
that	O
leads	O
to	O
gene	O
activation	O
and	O
production	O
of	O
cytokines	O
in	O
monocytes	O
.	O

Cross-linking	O
of	O
FcR	O
,	O
on	O
the	O
THP-1	O
monocytic	O
cell	O
line	O
,	O
by	O
immune	O
complexes	O
resulted	O
in	O
both	O
activation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	O
and	O
interleukin	O
1	O
production	O
.	O

These	O
responses	O
were	O
completely	O
blocked	O
by	O
tyrosine	O
kinase	O
inhibitors	O
.	O

In	O
contrast	O
,	O
expression	O
of	O
dominant	O
negative	O
mutants	O
of	O
Ras	O
and	O
Raf-1	O
,	O
in	O
these	O
cells	O
,	O
did	O
not	B-NEGATION
have	I-NEGATION
any	I-NEGATION
effect	I-NEGATION
on	I-NEGATION
FcR-mediated	I-NEGATION
nuclear	I-NEGATION
factor	I-NEGATION
activation	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
the	B-NEGATION
mitogen-activated	I-NEGATION
protein	I-NEGATION
kinase	I-NEGATION
(	I-NEGATION
MAPK	I-NEGATION
)	I-NEGATION
signaling	I-NEGATION
pathway	I-NEGATION
was	I-NEGATION
not	I-NEGATION
used	I-NEGATION
by	I-NEGATION
these	I-NEGATION
receptors	I-NEGATION
.	O

However	O
,	O
MAPK	O
activation	O
was	O
easily	O
detected	O
by	O
in	O
vitro	O
kinase	O
assays	O
,	O
after	O
FcR	O
cross-linking	O
with	O
immune	O
complexes	O
.	O

Using	O
the	O
specific	O
MAPK	O
/	O
extracellular	O
signal-regulated	O
kinase	O
kinase	O
(	O
MAPK	O
kinase	O
)	O
inhibitor	O
PD98059	O
,	O
we	O
found	O
that	O
MAPK	O
activation	O
is	O
necessary	O
for	O
FcR-dependent	O
activation	O
of	O
the	O
nuclear	O
factor	O
NF-kappaB	O
.	O

These	O
results	O
strongly	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
signaling	I-SPECULATION
pathway	I-SPECULATION
from	I-SPECULATION
Fc	I-SPECULATION
receptors	I-SPECULATION
leading	I-SPECULATION
to	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
different	I-SPECULATION
genes	I-SPECULATION
important	I-SPECULATION
to	I-SPECULATION
leukocyte	I-SPECULATION
biology	I-SPECULATION
,	I-SPECULATION
initiates	I-SPECULATION
with	I-SPECULATION
tyrosine	I-SPECULATION
kinases	I-SPECULATION
and	I-SPECULATION
requires	I-SPECULATION
MAPK	I-SPECULATION
activation	I-SPECULATION
;	I-SPECULATION
but	I-SPECULATION
in	I-SPECULATION
contrast	I-SPECULATION
to	I-SPECULATION
other	I-SPECULATION
tyrosine	I-SPECULATION
kinase	I-SPECULATION
receptors	I-SPECULATION
,	I-SPECULATION
FcR-mediated	I-SPECULATION
MAPK	I-SPECULATION
activation	I-SPECULATION
does	I-SPECULATION
not	B-NEGATION
involve	I-NEGATION
Ras	I-NEGATION
and	I-NEGATION
Raf	I-NEGATION
.	O

Differential	O
RNA	O
display	O
identifies	O
novel	O
genes	O
associated	O
with	O
decreased	O
vitamin	O
D	O
receptor	O
expression	O
.	O

To	O
characterize	O
further	O
the	O
function	O
of	O
the	O
intracellular	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
,	O
we	O
have	O
developed	O
stable	O
transfectant	O
variants	O
of	O
a	O
vitamin	O
D-responsive	O
cell	O
line	O
(	O
U937	O
)	O
which	O
express	O
either	O
decreased	O
or	O
increased	O
numbers	O
of	O
VDR	O
.	O

In	O
this	O
study	O
we	O
have	O
analyzed	O
changes	O
in	O
gene	O
expression	O
associated	O
with	O
this	O
variable	O
VDR	O
expression	O
.	O

Initial	O
experiments	O
indicated	B-SPECULATION
that	I-SPECULATION
a	I-SPECULATION
50	I-SPECULATION
%	I-SPECULATION
decrease	I-SPECULATION
in	I-SPECULATION
VDR	I-SPECULATION
levels	I-SPECULATION
was	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
a	I-SPECULATION
2-fold	I-SPECULATION
increase	I-SPECULATION
in	I-SPECULATION
cell	I-SPECULATION
proliferation	I-SPECULATION
and	I-SPECULATION
a	I-SPECULATION
similar	I-SPECULATION
rise	I-SPECULATION
in	I-SPECULATION
c-myc	I-SPECULATION
mRNA	I-SPECULATION
expression	I-SPECULATION
.	O

Further	O
studies	O
were	O
carried	O
out	O
using	O
differential	O
RNA	O
display	O
(	O
DD	O
)	O
.	O

Sequence	O
analysis	O
of	O
DD	O
products	O
revealed	O
two	O
cDNAs	O
with	O
identity	O
to	O
known	O
gene	O
products	O
:	O
the	O
catalytic	O
sub-unit	O
of	O
DNA-protein	O
kinase	O
(	O
DNA-PK	O
(	O
CS	O
))	O
,	O
and	O
the	O
peroxisomal	O
enzyme	O
17beta-hydroxysteroid	O
dehydrogenase	O
type	O
IV	O
(	O
17beta-HSD	O
IV	O
)	O
.	O

Northern	O
analysis	O
confirmed	O
that	O
expression	O
of	O
both	O
mRNAs	O
was	O
reduced	O
in	O
cells	O
with	O
decreased	O
numbers	O
of	O
VDR	O
.	O

Down-regulation	O
of	O
17beta-HSD	O
IV	O
mRNA	O
expression	O
was	O
associated	O
with	O
enhanced	O
estradiol	O
inactivation	O
by	O
U937	O
cells	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
link	I-SPECULATION
between	I-SPECULATION
estrogenic	I-SPECULATION
pathways	I-SPECULATION
and	I-SPECULATION
cell	I-SPECULATION
proliferation	I-SPECULATION
.	O

Further	O
Northern	O
analyses	O
indicated	B-SPECULATION
that	I-SPECULATION
there	I-SPECULATION
was	I-SPECULATION
no	B-NEGATION
significant	I-NEGATION
change	I-NEGATION
in	I-NEGATION
17beta-HSD	I-NEGATION
IV	I-NEGATION
or	I-NEGATION
DNA-PK	I-NEGATION
(	I-NEGATION
CS	I-NEGATION
)	I-NEGATION
mRNA	I-NEGATION
levels	I-NEGATION
following	I-NEGATION
treatment	I-NEGATION
with	I-NEGATION
1,25	I-NEGATION
(	I-NEGATION
OH	I-NEGATION
)	I-NEGATION
2D3	I-NEGATION
,	O
although	O
expression	O
of	O
both	O
genes	O
varied	O
with	O
changes	O
in	O
cell	O
proliferation	O
.	O

These	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
,	I-SPECULATION
in	I-SPECULATION
addition	I-SPECULATION
to	I-SPECULATION
its	I-SPECULATION
established	I-SPECULATION
role	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
hormone-dependent	I-SPECULATION
trans-activator	I-SPECULATION
,	I-SPECULATION
VDR	I-SPECULATION
may	B-SPECULATION
influence	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
by	I-SPECULATION
ligand-independent	I-SPECULATION
mechanisms	I-SPECULATION
.	O

Downstream	O
activation	O
of	O
a	O
TATA-less	O
promoter	O
by	O
Oct-2	O
,	O
Bob1	O
,	O
and	O
NF-kappaB	O
directs	O
expression	O
of	O
the	O
homing	O
receptor	O
BLR1	O
to	O
mature	O
B	O
cells	O
.	O

The	O
chemokine	O
receptor	O
,	O
BLR1	O
,	O
is	O
a	O
major	O
regulator	O
of	O
the	O
microenvironmental	O
homing	O
of	O
B	O
cells	O
in	O
lymphoid	O
organs	O
.	O

In	O
vitro	O
studies	O
identify	O
three	O
essential	O
elements	O
of	O
the	O
TATA-less	O
blr1	O
core	O
promoter	O
that	O
confer	O
cell	O
type	O
-	O
and	O
differentiation-specific	O
expression	O
in	O
the	O
B	O
cells	O
of	O
both	O
humans	O
and	O
mice	O
,	O
a	O
functional	O
promoter	O
region	O
(-	O
36	O
with	O
respect	O
to	O
the	O
transcription	O
start	O
site	O
)	O
,	O
a	O
NF-kappaB	O
motif	O
(+	O
44	O
)	O
,	O
and	O
a	O
noncanonical	O
octamer	O
motif	O
(+	O
157	O
)	O
.	O

The	O
importance	O
of	O
these	O
sites	O
was	O
confirmed	O
by	O
in	O
vivo	O
studies	O
in	O
gene-targeted	O
mice	O
deficient	O
of	O
either	O
Oct-2	O
,	O
Bob1	O
,	O
or	O
both	O
NF-kappaB	O
subunits	O
p50	O
and	O
p52	O
.	O

In	O
all	O
of	O
these	O
animals	O
,	O
the	O
expression	O
of	O
BLR1	O
was	O
reduced	O
or	O
absent	B-NEGATION
.	O

In	O
mice	O
deficient	O
only	O
of	O
p52	O
/	O
NF-kappaB	O
,	O
BLR1	O
expression	O
was	O
unaffected	O
.	O

Thus	O
our	O
data	O
demonstrate	O
that	O
BLR1	O
is	O
a	O
target	O
gene	O
for	O
Oct-2	O
,	O
Bob1	O
,	O
and	O
members	O
of	O
the	O
NF-kappaB	O
/	O
Rel	O
family	O
and	O
provides	O
a	O
link	O
to	O
the	O
impaired	O
B	O
cell	O
functions	O
in	O
mice	O
deficient	O
for	O
these	O
factors	O
.	O

Inhibition	O
of	O
RNA	O
polymerase	O
II	O
transcription	O
in	O
human	O
cells	O
by	O
synthetic	O
DNA-binding	O
ligands	O
[	O
see	O
comments	O
]	O

Sequence-specific	O
DNA-binding	O
small	O
molecules	O
that	O
can	O
permeate	O
human	O
cells	O
potentially	B-SPECULATION
could	B-SPECULATION
regulate	I-SPECULATION
transcription	I-SPECULATION
of	I-SPECULATION
specific	I-SPECULATION
genes	I-SPECULATION
.	O

Multiple	O
cellular	O
DNA-binding	O
transcription	O
factors	O
are	O
required	O
by	O
HIV	O
type	O
1	O
for	O
RNA	O
synthesis	O
.	O

Two	O
pyrrole-imidazole	O
polyamides	O
were	O
designed	O
to	O
bind	O
DNA	O
sequences	O
immediately	O
adjacent	O
to	O
binding	O
sites	O
for	O
the	O
transcription	O
factors	O
Ets-1	O
,	O
lymphoid-enhancer	O
binding	O
factor	O
1	O
,	O
and	O
TATA-box	O
binding	O
protein	O
.	O

These	O
synthetic	O
ligands	O
specifically	O
inhibit	O
DNA-binding	O
of	O
each	O
transcription	O
factor	O
and	O
HIV	O
type	O
1	O
transcription	O
in	O
cell-free	O
assays	O
.	O

When	O
used	O
in	O
combination	O
,	O
the	O
polyamides	O
inhibit	O
virus	O
replication	O
by	O
>	O
99	O
%	O
in	O
isolated	O
human	O
peripheral	O
blood	O
lymphocytes	O
,	O
with	O
no	B-NEGATION
detectable	I-NEGATION
cell	I-NEGATION
toxicity	I-NEGATION
.	O

The	O
ability	O
of	O
small	O
molecules	O
to	O
target	O
predetermined	O
DNA	O
sequences	O
located	O
within	O
RNA	O
polymerase	O
II	O
promoters	O
suggests	B-SPECULATION
a	I-SPECULATION
general	I-SPECULATION
approach	I-SPECULATION
for	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
,	I-SPECULATION
as	I-SPECULATION
well	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
mechanism	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
viral	I-SPECULATION
replication	I-SPECULATION
.	O

Relationship	O
between	O
IkappaBalpha	O
constitutive	O
expression	O
,	O
TNFalpha	O
synthesis	O
,	O
and	O
apoptosis	O
in	O
EBV-infected	O
lymphoblastoid	O
cells	O
.	O

In	O
order	O
to	O
understand	O
the	O
role	O
of	O
NF-kappaB	O
in	O
EBV	O
transformation	O
we	O
have	O
established	O
stably	O
transfected	O
IkappaBalpha	O
into	O
lymphoblastoid	O
cells	O
.	O

Two	O
clones	O
were	O
obtained	O
in	O
which	O
the	O
loss	O
of	O
NF-kappaB	O
binding	O
activity	O
correlated	O
with	O
the	O
constitutive	O
expression	O
of	O
the	O
transgenic	O
IkappaBalpha	O
.	O

Protein	O
latency	O
expression	O
was	O
determined	O
by	O
immunocytochemistry	O
.	O

Expression	O
of	O
surface	O
markers	O
,	O
intracytoplasmic	O
content	O
of	O
cytokines	O
cell	O
cycle	O
analysis	O
after	O
BrdU	O
incorporation	O
and	O
DNA	O
staining	O
with	O
propidium	O
iodide	O
were	O
studied	O
by	O
flow	O
cytometry	O
.	O

Percentage	O
of	O
apoptotic	O
cells	O
was	O
determined	O
by	O
in-situ	O
labelling	O
of	O
DNA	O
strand	O
breaks	O
.	O

No	B-NEGATION
significative	I-NEGATION
changes	I-NEGATION
in	I-NEGATION
EBV	I-NEGATION
latency	I-NEGATION
nor	B-NEGATION
in	I-NEGATION
cell	I-NEGATION
surface	I-NEGATION
marker	I-NEGATION
expression	I-NEGATION
was	I-NEGATION
found	I-NEGATION
.	O

In	O
contrast	O
,	O
intracytoplasmic	O
TNFalpha	O
levels	O
were	O
strongly	O
reduced	O
in	O
transfected	O
clones	O
.	O

Furthermore	O
,	O
30	O
%	O
of	O
IkappaBalpha	O
transfected	O
cells	O
were	O
apoptotic	O
after	O
8	O
h	O
of	O
TNFalpha	O
treatment	O
.	O

This	O
correlated	O
with	O
a	O
strong	O
reduction	O
of	O
BrdU	O
incorporation	O
after	O
24	O
h	O
of	O
TNFalpha	O
treatment	O
.	O

No	B-NEGATION
effect	I-NEGATION
was	I-NEGATION
seen	I-NEGATION
with	I-NEGATION
non	I-NEGATION
transfected	I-NEGATION
cells	I-NEGATION
or	I-NEGATION
with	I-NEGATION
cells	I-NEGATION
transfected	I-NEGATION
with	I-NEGATION
a	I-NEGATION
control	I-NEGATION
plasmid	I-NEGATION
.	O

Our	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
TNFalpha	I-SPECULATION
gene	I-SPECULATION
could	B-SPECULATION
be	I-SPECULATION
one	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
targets	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
in	I-SPECULATION
EBV	I-SPECULATION
infected	I-SPECULATION
cells	I-SPECULATION
and	O
that	O
NF-kappaB	O
protects	O
EBV-infected	O
cells	O
from	O
apoptosis	O
induced	O
by	O
TNFalpha	O
,	O
which	O
may	B-SPECULATION
favour	I-SPECULATION
the	I-SPECULATION
proliferative	I-SPECULATION
effect	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
cytokine	I-SPECULATION
.	O

Uncoupling	O
activation-dependent	O
HS1	O
phosphorylation	O
from	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
transcriptional	O
activation	O
in	O
Jurkat	O
T	O
cells	O
:	O
differential	O
signaling	O
through	O
CD3	O
and	O
the	O
costimulatory	O
receptors	O
CD2	O
and	O
CD28	O
.	O

CD3	O
,	O
CD2	O
,	O
and	O
CD28	O
are	O
functionally	O
distinct	O
receptors	O
on	O
T	O
lymphocytes	O
.	O

Engagement	O
of	O
any	O
of	O
these	O
receptors	O
induces	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
a	O
shared	O
group	O
of	O
intracellular	O
signaling	O
proteins	O
,	O
including	O
Vav	O
,	O
Cbl	O
,	O
p85	O
phosphoinositide	O
3-kinase	O
,	O
and	O
the	O
Src	O
family	O
kinases	O
Lck	O
and	O
Fyn	O
.	O

Ligation	O
of	O
CD3	O
also	O
induces	O
the	O
tyrosine	O
phosphorylation	O
of	O
HS1	O
,	O
a	O
75-kDa	O
hematopoietic	O
cell-specific	O
intracellular	O
signaling	O
protein	O
of	O
unknown	B-SPECULATION
function	I-SPECULATION
.	O

We	O
have	O
examined	O
changes	O
in	O
HS1	O
phosphorylation	O
after	O
differential	O
stimulation	O
of	O
CD3	O
,	O
CD2	O
,	O
and	O
CD28	O
to	O
elucidate	O
its	O
role	O
in	O
T	O
cells	O
and	O
to	O
further	O
delineate	O
the	O
signaling	O
pathways	O
recruited	O
by	O
these	O
receptors	O
.	O

Unlike	O
ligation	O
of	O
CD3	O
,	O
stimulation	O
with	O
anti-CD28	O
mAb	O
or	O
CHO	O
cells	O
expressing	O
the	O
CD28	O
ligands	O
CD80	O
or	O
CD86	O
did	O
not	B-NEGATION
lead	I-NEGATION
to	I-NEGATION
tyrosine	I-NEGATION
phosphorylation	I-NEGATION
of	I-NEGATION
HS1	I-NEGATION
in	I-NEGATION
Jurkat	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
.	O

Additionally	O
,	O
no	B-NEGATION
tyrosine	I-NEGATION
phosphorylation	I-NEGATION
of	I-NEGATION
HS1	I-NEGATION
was	I-NEGATION
induced	I-NEGATION
by	I-NEGATION
mitogenic	I-NEGATION
pairs	I-NEGATION
of	I-NEGATION
anti-CD2	I-NEGATION
mAbs	I-NEGATION
capable	I-NEGATION
of	I-NEGATION
activating	I-NEGATION
the	I-NEGATION
transcription	I-NEGATION
factor	I-NEGATION
NFAT	I-NEGATION
(	I-NEGATION
nuclear	I-NEGATION
factor	I-NEGATION
of	I-NEGATION
activated	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
)	I-NEGATION
.	O

Costimulation	O
through	O
CD28	O
and	O
/	O
or	O
CD2	O
did	O
not	B-NEGATION
modulate	I-NEGATION
the	I-NEGATION
CD3-dependent	I-NEGATION
phosphorylation	I-NEGATION
of	I-NEGATION
HS1	I-NEGATION
.	O

In	O
vivo	O
studies	O
indicated	B-SPECULATION
that	I-SPECULATION
CD3-induced	I-SPECULATION
HSI	I-SPECULATION
phosphorylation	I-SPECULATION
was	I-SPECULATION
dependent	I-SPECULATION
upon	I-SPECULATION
both	I-SPECULATION
the	I-SPECULATION
Src	I-SPECULATION
family	I-SPECULATION
tyrosine	I-SPECULATION
kinase	I-SPECULATION
Lck	I-SPECULATION
and	I-SPECULATION
the	I-SPECULATION
tyrosine	I-SPECULATION
phosphatase	I-SPECULATION
CD45	I-SPECULATION
,	I-SPECULATION
did	I-SPECULATION
not	B-NEGATION
require	I-NEGATION
MEK1	I-NEGATION
kinase	I-NEGATION
activity	I-NEGATION
,	O
and	O
was	O
regulated	O
by	O
protein	O
kinase	O
C	O
activation	O
.	O

Thus	O
,	O
although	O
CD3	O
,	O
CD28	O
,	O
and	O
CD2	O
activate	O
many	O
of	O
the	O
same	O
signaling	O
molecules	O
,	O
they	O
differed	O
in	O
their	O
capacity	O
to	O
induce	O
the	O
tyrosine	O
phosphorylation	O
of	O
HSI	O
.	O

Furthermore	O
,	O
activation-dependent	O
tyrosine	O
phosphorylation	O
of	O
HS1	O
was	O
not	B-NEGATION
required	I-NEGATION
for	I-NEGATION
NFAT	I-NEGATION
transcriptional	I-NEGATION
activation	I-NEGATION
.	O

IL-7	O
reconstitutes	O
multiple	O
aspects	O
of	O
v-Abl-mediated	O
signaling	O
.	O

The	B-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
early	I-SPECULATION
lymphoid	I-SPECULATION
cells	I-SPECULATION
are	I-SPECULATION
selectively	I-SPECULATION
transformed	I-SPECULATION
by	I-SPECULATION
v-Abl	I-SPECULATION
is	I-SPECULATION
currently	I-SPECULATION
unknown	I-SPECULATION
.	O

Previous	O
studies	O
have	O
shown	O
constitutive	O
activation	O
of	O
IL-4	O
and	O
IL-7	O
signaling	O
pathways	O
,	O
as	O
measured	O
by	O
activation	O
of	O
Janus	O
protein	O
kinase	O
(	O
JAK	O
)	O
1	O
,	O
JAK3	O
,	O
STAT5	O
,	O
and	O
STAT6	O
,	O
in	O
pre-B	O
cells	O
transformed	O
by	O
v-Abl	O
.	O

To	O
determine	O
whether	B-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
these	I-SPECULATION
cytokine	I-SPECULATION
signaling	I-SPECULATION
pathways	I-SPECULATION
by	I-SPECULATION
v-Abl	I-SPECULATION
is	I-SPECULATION
important	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
cellular	I-SPECULATION
events	I-SPECULATION
induced	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
Abelson	I-SPECULATION
murine	I-SPECULATION
leukemia	I-SPECULATION
virus	I-SPECULATION
,	O
the	O
effects	O
of	O
IL-4	O
and	O
IL-7	O
on	O
pre-B	O
cells	O
transformed	O
with	O
a	O
temperature-sensitive	O
v-Abl	O
mutant	O
were	O
examined	O
.	O

Whereas	O
IL-4	O
had	O
little	O
or	O
no	B-NEGATION
effect	I-NEGATION
,	O
IL-7	O
delayed	O
both	O
the	O
apoptosis	O
and	O
cell	O
cycle	O
arrest	O
that	O
occur	O
upon	O
v-Abl	O
kinase	O
inactivation	O
.	O

IL-7	O
also	O
delayed	O
the	O
decreases	O
in	O
the	O
levels	O
of	O
c-Myc	O
,	O
Bcl-2	O
,	O
and	O
Bcl-xL	O
that	O
occur	O
upon	O
loss	O
of	O
v-Abl	O
kinase	O
activity	O
.	O

IL-7	O
did	O
not	B-NEGATION
maintain	I-NEGATION
v-Abl-mediated	I-NEGATION
differentiation	I-NEGATION
arrest	I-NEGATION
of	I-NEGATION
the	I-NEGATION
pre-B	I-NEGATION
cells	I-NEGATION
,	O
as	O
activation	O
of	O
NF-kappaB	O
and	O
RAG	O
gene	O
transcription	O
was	O
unaffected	O
by	O
IL-7	O
.	O

These	O
results	O
identify	O
a	O
potential	B-SPECULATION
role	I-SPECULATION
for	I-SPECULATION
IL-7	I-SPECULATION
signaling	I-SPECULATION
pathways	I-SPECULATION
in	I-SPECULATION
transformation	I-SPECULATION
by	I-SPECULATION
v-Abl	I-SPECULATION
while	O
demonstrating	O
that	O
a	O
combination	O
of	O
IL-4	O
and	O
IL-7	O
signaling	O
cannot	B-NEGATION
substitute	I-NEGATION
for	I-NEGATION
an	I-NEGATION
active	I-NEGATION
v-Abl	I-NEGATION
kinase	I-NEGATION
in	I-NEGATION
transformed	I-NEGATION
pre-B	I-NEGATION
cells	I-NEGATION
.	O

p21ras	O
initiates	O
Rac-1	O
but	O
not	B-NEGATION
phosphatidyl	I-NEGATION
inositol	I-NEGATION
3	I-NEGATION
kinase	I-NEGATION
/	I-NEGATION
PKB	I-NEGATION
,	O
mediated	O
signaling	O
pathways	O
in	O
T	O
lymphocytes	O
.	O

p21ras	O
is	O
activated	O
by	O
the	O
T	O
cell	O
antigen	O
receptor	O
(	O
TCR	O
)	O
and	O
then	O
co-ordinates	O
important	O
signaling	O
pathways	O
for	O
T	O
lymphocyte	O
activation	O
.	O

Effector	O
pathways	O
for	O
this	O
guanine	O
nucleotide	O
binding	O
protein	O
in	O
T	O
cells	O
are	O
mediated	O
by	O
the	O
serine	O
/	O
threonine	O
kinase	O
Raf-1	O
and	O
the	O
Ras-related	O
GTPase	O
Rac-1	O
.	O

In	O
fibroblasts	O
,	O
an	O
important	O
effector	O
for	O
the	O
Ras	O
oncogene	O
is	O
Phosphatidylinositol	O
3-kinase	O
(	O
PtdIns	O
3-kinase	O
)	O
.	O

Activation	O
of	O
this	O
lipid	O
kinase	O
is	O
able	O
to	O
induce	O
critical	O
Rac-1	O
signaling	O
pathways	O
and	O
can	O
couple	O
p21ras	O
to	O
cell	O
survival	O
mechanisms	O
via	O
the	O
serine	O
/	O
threonine	O
kinase	O
Akt	O
/	O
PKB	O
.	O

The	B-NEGATION
role	I-NEGATION
of	I-NEGATION
PtdIns	I-NEGATION
3-kinase	I-NEGATION
in	I-NEGATION
Ras	I-NEGATION
signaling	I-NEGATION
in	I-NEGATION
T	I-NEGATION
cells	I-NEGATION
has	I-NEGATION
not	I-NEGATION
been	I-NEGATION
explored	I-NEGATION
.	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
ability	O
of	O
PtdIns	O
3-kinase	O
to	O
initiate	O
the	O
Rac-1	O
signaling	O
pathways	O
important	O
for	O
T	O
cell	O
activation	O
.	O

We	O
also	O
examined	O
the	O
possibility	B-SPECULATION
that	I-SPECULATION
Akt	I-SPECULATION
/	I-SPECULATION
PKB	I-SPECULATION
is	I-SPECULATION
regulated	I-SPECULATION
by	I-SPECULATION
Ras	I-SPECULATION
signaling	I-SPECULATION
pathways	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
lymphocytes	I-SPECULATION
.	O

The	O
results	O
show	O
that	O
Ras	O
can	O
initiate	O
a	O
Rac-1	O
mediated	O
pathway	O
that	O
regulates	O
the	O
transcriptional	O
function	O
of	O
AP-1	O
complexes	O
.	O

PtdIns	O
3-kinase	O
signals	O
cannot	B-NEGATION
mimic	I-NEGATION
p21ras	I-NEGATION
and	I-NEGATION
induce	I-NEGATION
the	I-NEGATION
Rac	I-NEGATION
mediated	I-NEGATION
responses	I-NEGATION
of	I-NEGATION
AP-1	I-NEGATION
transcriptional	I-NEGATION
activation	I-NEGATION
.	O

Moreover	O
,	O
neither	B-NEGATION
TCR	I-NEGATION
or	I-NEGATION
Ras	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
AP-1	I-NEGATION
is	I-NEGATION
dependent	I-NEGATION
on	I-NEGATION
PtdIns	I-NEGATION
3-kinase	I-NEGATION
.	O

PKB	O
is	O
activated	O
in	O
response	O
to	O
triggering	O
of	O
the	O
T	O
cell	O
antigen	O
receptor	O
;	O
PtdIns	O
3-kinase	O
activity	O
is	O
both	O
required	O
and	O
sufficient	O
for	O
this	O
TCR	O
response	O
.	O

In	O
contrast	O
,	O
p21ras	B-NEGATION
signals	I-NEGATION
are	I-NEGATION
unable	I-NEGATION
to	I-NEGATION
induce	I-NEGATION
Akt	I-NEGATION
/	I-NEGATION
PKB	I-NEGATION
activity	I-NEGATION
in	I-NEGATION
T	I-NEGATION
cell	I-NEGATION
nor	B-NEGATION
is	I-NEGATION
Ras	I-NEGATION
function	I-NEGATION
required	I-NEGATION
for	I-NEGATION
Akt	I-NEGATION
/	I-NEGATION
PKB	I-NEGATION
activation	I-NEGATION
in	I-NEGATION
response	I-NEGATION
to	I-NEGATION
the	I-NEGATION
TCR	I-NEGATION
.	O

The	O
present	O
data	O
thus	O
highlight	O
that	O
PtdIns	O
3-kinase	O
and	O
Akt	O
/	O
PKB	O
are	O
not	B-NEGATION
universal	I-NEGATION
Ras	I-NEGATION
effector	I-NEGATION
molecules	I-NEGATION
.	O

Ras	O
can	O
initiate	O
Rac-1	O
regulated	O
signaling	O
pathways	O
in	O
the	O
context	O
of	O
T	O
cell	O
antigen	O
receptor	O
function	O
independently	O
of	O
PtdIns	O
3-kinase	O
activity	O
.	O

Signal	O
transduction	O
abnormalities	O
in	O
T	O
lymphocytes	O
from	O
patients	O
with	O
advanced	O
renal	O
carcinoma	O
:	O
clinical	O
relevance	O
and	O
effects	O
of	O
cytokine	O
therapy	O
.	O

Studies	O
have	O
demonstrated	O
abnormalities	O
of	O
the	O
CD3	O
/	O
T-cell	O
antigen	O
receptor	O
(	O
TCR	O
)	O
and	O
pathways	O
of	O
signal	O
transduction	O
in	O
T	O
lymphocytes	O
from	O
animals	O
and	O
patients	O
with	O
advanced	O
malignancy	O
.	O

Diminished	O
expression	O
of	O
TCRzeta	O
and	O
p56	O
(	O
lck	O
)	O
that	O
are	O
associated	O
with	O
the	O
TCR	O
and	O
reduced	O
nuclear	O
localization	O
of	O
RelA	O
containing	O
nuclear	O
factor	O
kappaB	O
(	O
NFkappaB	O
)	O
complexes	O
have	O
been	O
noted	O
.	O

These	O
defects	O
have	O
been	O
described	O
in	O
T	O
cells	O
from	O
patients	O
with	O
malignant	O
melanoma	O
,	O
renal	O
cell	O
carcinoma	O
(	O
RCC	O
)	O
,	O
ovarian	O
cancer	O
,	O
and	O
colorectal	O
cancer	O
.	O

Preliminary	O
observations	O
also	O
indicate	O
possible	B-SPECULATION
correlation	I-SPECULATION
with	I-SPECULATION
clinical	I-SPECULATION
variables	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
stage	I-SPECULATION
in	I-SPECULATION
selected	I-SPECULATION
instances	I-SPECULATION
.	O

To	O
further	O
characterize	O
altered	O
expression	O
of	O
TCRzeta	O
,	O
p56	O
(	O
lck	O
)	O
,	O
and	O
impaired	O
activation	O
of	O
NFkappaB	O
,	O
T	O
lymphocytes	O
were	O
obtained	O
from	O
65	O
patients	O
with	O
RCC	O
,	O
the	O
majority	O
of	O
whom	O
were	O
receiving	O
combination	O
cytokine	O
therapy	O
[	O
interleukin	O
(	O
IL	O
)-	O
2	O
,	O
IFN	O
alpha-containing	O
regimens	O
]	O
and	O
37	O
control	O
individuals	O
.	O

In	O
29	O
of	O
these	O
patients	O
,	O
levels	O
of	O
TCRzeta	O
and	O
p56	O
(	O
lck	O
)	O
were	O
determined	O
by	O
Western	O
blots	O
of	O
T-cell	O
lysates	O
and	O
semiquantitated	O
using	O
densitometry	O
.	O

Relative	O
levels	O
were	O
then	O
correlated	O
with	O
a	O
series	O
of	O
clinical	O
variables	O
including	O
response	O
to	O
therapy	O
,	O
performance	O
status	O
,	O
survival	O
,	O
disease	O
sites	O
,	O
age	O
,	O
and	O
others	O
.	O

In	O
another	O
group	O
of	O
28	O
patients	O
(	O
three	O
individuals	O
from	O
the	O
first	O
group	O
)	O
,	O
the	O
frequency	O
of	O
abnormal	O
NFkappaB	O
activation	O
was	O
studied	O
using	O
electrophoretic	O
mobility	O
shift	O
assays	O
after	O
activation	O
of	O
T	O
cells	O
with	O
phorbol	O
myristate	O
acetate	O
/	O
ionomycin	O
or	O
anti-CD3	O
monoclonal	O
antibody	O
.	O

Changes	O
in	O
these	O
signaling	O
molecules	O
during	O
cytokine	O
treatment	O
were	O
also	O
investigated	O
.	O

TCRzeta	O
and	O
p56	O
(	O
lck	O
)	O
were	O
detected	O
in	O
the	O
peripheral	O
blood	O
T	O
cells	O
in	O
27	O
of	O
29	O
patients	O
,	O
and	O
overall	O
,	O
reduced	O
levels	O
were	O
noted	O
visually	O
in	O
12	O
of	O
29	O
(	O
41	O
%)	O
and	O
13	O
of	O
29	O
(	O
45	O
%)	O
individuals	O
,	O
respectively	O
.	O

When	O
levels	O
were	O
semiquantitated	O
using	O
densitometry	O
,	O
significant	O
decreases	O
of	O
TCRzeta	O
(	O
P	O
=	O
0.029	O
)	O
and	O
p56	O
(	O
lck	O
)	O
(	O
P	O
=	O
0.029	O
)	O
but	O
not	B-NEGATION
CD3epsilon	I-NEGATION
(	I-NEGATION
P	I-NEGATION
=	I-NEGATION
0.131	I-NEGATION
)	I-NEGATION
,	O
compared	O
with	O
control	O
levels	O
,	O
were	O
found	O
.	O

In	O
patients	O
treated	O
with	O
IL-2	O
/	O
IFN	O
alpha-based	O
therapy	O
,	O
relative	O
levels	O
of	O
TCRzeta	O
increased	O
significantly	O
(	O
P	O
=	O
0.002	O
)	O
on	O
day	O
15	O
of	O
cycle	O
one	O
compared	O
with	O
the	O
baseline	O
.	O

Correlations	B-NEGATION
of	I-NEGATION
TCRzeta	I-NEGATION
or	I-NEGATION
p56	I-NEGATION
(	I-NEGATION
lck	I-NEGATION
)	I-NEGATION
levels	I-NEGATION
with	I-NEGATION
response	I-NEGATION
or	I-NEGATION
disease	I-NEGATION
variables	I-NEGATION
,	I-NEGATION
except	I-NEGATION
for	I-NEGATION
lower	I-NEGATION
TCRzeta	I-NEGATION
levels	I-NEGATION
(	I-NEGATION
P	I-NEGATION
<	I-NEGATION
0.001	I-NEGATION
)	I-NEGATION
in	I-NEGATION
the	I-NEGATION
presence	I-NEGATION
of	I-NEGATION
bone	I-NEGATION
metastases	I-NEGATION
,	I-NEGATION
were	I-NEGATION
not	I-NEGATION
found	I-NEGATION
.	O

Abnormal	O
NFkappaB	O
activation	O
after	O
stimulation	O
with	O
phorbol	O
myristate	O
acetate	O
/	O
ionomycin	O
and	O
/	O
or	O
anti-CD3	O
monoclonal	O
antibody	O
was	O
found	O
in	O
59	O
%	O
of	O
patients	O
(	O
17	O
of	O
28	O
)	O
and	O
was	B-NEGATION
not	I-NEGATION
accounted	I-NEGATION
for	I-NEGATION
by	I-NEGATION
the	I-NEGATION
advanced	I-NEGATION
age	I-NEGATION
of	I-NEGATION
the	I-NEGATION
study	I-NEGATION
cohort	I-NEGATION
.	O

Activation	O
of	O
NFkappaB	O
in	O
peripheral	O
blood	O
T	O
cells	O
was	O
inducible	O
during	O
cytokine	O
therapy	O
in	O
four	O
of	O
six	O
individuals	O
who	O
displayed	O
impaired	O
NFkappaB	O
activity	O
prior	O
to	O
therapy	O
.	O

Moreover	O
,	O
impaired	B-NEGATION
activation	I-NEGATION
of	I-NEGATION
NFkappaB	I-NEGATION
does	I-NEGATION
not	I-NEGATION
appear	I-SPECULATION
linked	I-SPECULATION
to	I-SPECULATION
a	I-SPECULATION
reduction	I-SPECULATION
of	I-SPECULATION
TCRzeta	I-SPECULATION
expression	I-SPECULATION
,	O
because	O
in	O
five	O
patients	O
,	O
normal	O
TCRzeta	O
levels	O
were	O
present	O
although	O
kappaB	B-NEGATION
binding	I-NEGATION
was	I-NEGATION
not	I-NEGATION
inducible	I-NEGATION
.	O

In	O
the	O
majority	O
of	O
patients	O
with	O
advanced	O
RCC	O
,	O
peripheral	O
blood	O
T	O
cells	O
express	O
TCRzeta	O
and	O
p56	O
(	O
lck	O
)	O
,	O
and	O
in	O
a	O
subset	O
,	O
reduced	O
levels	O
of	O
these	O
TCRzeta	O
associated	O
molecules	O
are	O
seen	O
that	O
may	B-SPECULATION
increase	I-SPECULATION
during	I-SPECULATION
cytokine-based	I-SPECULATION
therapy	I-SPECULATION
.	O

Abnormal	O
activation	O
of	O
NFkappaB	O
is	O
also	O
present	O
in	O
>	O
50	O
%	O
of	O
patients	O
and	O
may	B-SPECULATION
also	I-SPECULATION
revert	I-SPECULATION
to	I-SPECULATION
normal	I-SPECULATION
during	I-SPECULATION
IL-2	I-SPECULATION
/	I-SPECULATION
IFN	I-SPECULATION
alpha-based	I-SPECULATION
treatment	I-SPECULATION
.	O

This	O
alteration	O
in	O
NFkappaB	O
activation	O
occurred	O
in	O
the	O
presence	O
of	O
normal	O
expression	O
of	O
TCRzeta-associated	O
signaling	O
elements	O
.	O

The	B-SPECULATION
clinical	I-SPECULATION
significance	I-SPECULATION
of	I-SPECULATION
these	I-SPECULATION
findings	I-SPECULATION
remains	I-SPECULATION
unclear	I-SPECULATION
.	O

Transcriptional	O
regulation	O
of	O
lysosomal	O
acid	O
lipase	O
in	O
differentiating	O
monocytes	O
is	O
mediated	O
by	O
transcription	O
factors	O
Sp1	O
and	O
AP-2	O
.	O

Human	O
lysosomal	O
acid	O
lipase	O
(	O
LAL	O
)	O
is	O
a	O
hydrolase	O
required	O
for	O
the	O
cleavage	O
of	O
cholesteryl	O
esters	O
and	O
triglycerides	O
derived	O
from	O
plasma	O
lipoproteins	O
.	O

It	O
is	O
shown	O
here	O
that	O
during	O
monocyte	O
to	O
macrophage	O
differentiation	O
,	O
the	O
expression	O
of	O
LAL-mRNA	O
is	O
induced	O
.	O

This	O
induction	O
is	O
dependent	O
on	O
protein	O
kinase	O
C	O
activity	O
and	O
protein	O
synthesis	O
.	O

The	O
cell	O
type-specific	O
increase	O
in	O
LAL	O
expression	O
is	O
further	O
investigated	O
in	O
the	O
THP-1	O
cell	O
line	O
with	O
respect	O
to	O
transcriptional	O
regulation	O
.	O

The	O
human	O
monocytic	O
leukemia	O
cell	O
line	O
THP-1	O
differentiates	O
into	O
macrophage-like	O
cells	O
when	O
treated	O
with	O
phorbol	O
esters	O
.	O

In	O
order	O
to	O
determine	O
the	O
cis-acting	O
elements	O
necessary	O
for	O
both	O
basal	O
and	O
phorbol	O
12-myristate-13	O
acetate	O
(	O
PMA	O
)-	O
enhanced	O
promoter	O
activity	O
,	O
we	O
performed	O
deletion	O
analysis	O
and	O
reporter	O
gene	O
assays	O
.	O

A	O
PMA	O
responsive	O
element	O
has	O
been	O
identified	O
between	O
-	O
182	O
bp	O
and	O
-	O
107	O
bp	O
upstream	O
of	O
the	O
major	O
transcription	O
start	O
site	O
.	O

Gel	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
binding	O
of	O
Sp1	O
and	O
AP-2	O
to	O
the	O
LAL	O
promoter	O
is	O
increased	O
by	O
PMA	O
in	O
THP-1	O
cells	O
.	O

Co-transfections	O
with	O
expression	O
plasmids	O
for	O
Sp1	O
and	O
AP-2	O
further	O
emphasized	O
the	O
important	O
role	O
of	O
these	O
transcription	O
factors	O
in	O
both	O
basal	O
and	O
PMA-enhanced	O
LAL	O
expression	O
.	O

Our	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
differentiation	I-SPECULATION
dependent	I-SPECULATION
increase	I-SPECULATION
of	I-SPECULATION
lysosomal	I-SPECULATION
acid	I-SPECULATION
lipase	I-SPECULATION
(	I-SPECULATION
LAL	I-SPECULATION
)	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
THP-1	I-SPECULATION
cells	I-SPECULATION
is	I-SPECULATION
mediated	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
concerted	I-SPECULATION
action	I-SPECULATION
of	I-SPECULATION
Sp1	I-SPECULATION
and	I-SPECULATION
AP-2	I-SPECULATION
.	O

A	O
nongenomic	O
mechanism	O
for	O
progesterone-mediated	O
immunosuppression	O
:	O
inhibition	O
of	O
K	O
+	O
channels	O
,	O
Ca2	O
+	O
signaling	O
,	O
and	O
gene	O
expression	O
in	O
T	O
lymphocytes	O
.	O

The	B-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
progesterone	I-SPECULATION
causes	I-SPECULATION
localized	I-SPECULATION
suppression	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
immune	I-SPECULATION
response	I-SPECULATION
during	I-SPECULATION
pregnancy	I-SPECULATION
has	I-SPECULATION
remained	I-SPECULATION
elusive	I-SPECULATION
.	O

Using	O
human	O
T	O
lymphocytes	O
and	O
T	O
cell	O
lines	O
,	O
we	O
show	O
that	O
progesterone	O
,	O
at	O
concentrations	O
found	O
in	O
the	O
placenta	O
,	O
rapidly	O
and	O
reversibly	O
blocks	O
voltage-gated	O
and	O
calcium-activated	O
K	O
+	O
channels	O
(	O
KV	O
and	O
KCa	O
,	O
respectively	O
)	O
,	O
resulting	O
in	O
depolarization	O
of	O
the	O
membrane	O
potential	O
.	O

As	O
a	O
result	O
,	O
Ca2	O
+	O
signaling	O
and	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NF-AT	O
)-	O
driven	O
gene	O
expression	O
are	O
inhibited	O
.	O

Progesterone	O
acts	O
distally	O
to	O
the	O
initial	O
steps	O
of	O
T	O
cell	O
receptor	O
(	O
TCR	O
)-	O
mediated	O
signal	O
transduction	O
,	O
since	O
it	O
blocks	O
sustained	O
Ca2	O
+	O
signals	O
after	O
thapsigargin	O
stimulation	O
,	O
as	O
well	O
as	O
oscillatory	O
Ca2	O
+	O
signals	O
,	O
but	O
not	B-NEGATION
the	I-NEGATION
Ca2	I-NEGATION
+	I-NEGATION
transient	I-NEGATION
after	I-NEGATION
TCR	I-NEGATION
stimulation	I-NEGATION
.	O

K	O
+	O
channel	O
blockade	O
by	O
progesterone	O
is	O
specific	O
;	O
other	O
steroid	O
hormones	O
had	O
little	O
or	O
no	B-NEGATION
effect	I-NEGATION
,	O
although	O
the	O
progesterone	O
antagonist	O
RU	O
486	O
also	O
blocked	O
KV	O
and	O
KCa	O
channels	O
.	O

Progesterone	O
effectively	O
blocked	O
a	O
broad	O
spectrum	O
of	O
K	O
+	O
channels	O
,	O
reducing	O
both	O
Kv1.3	O
and	O
charybdotoxin-resistant	O
components	O
of	O
KV	O
current	O
and	O
KCa	O
current	O
in	O
T	O
cells	O
,	O
as	O
well	O
as	O
blocking	O
several	O
cloned	O
KV	O
channels	O
expressed	O
in	O
cell	O
lines	O
.	O

Progesterone	O
had	O
little	O
or	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
a	I-NEGATION
cloned	I-NEGATION
voltage-gated	I-NEGATION
Na	I-NEGATION
+	I-NEGATION
channel	I-NEGATION
,	I-NEGATION
an	I-NEGATION
inward	I-NEGATION
rectifier	I-NEGATION
K	I-NEGATION
+	I-NEGATION
channel	I-NEGATION
,	I-NEGATION
or	I-NEGATION
on	I-NEGATION
lymphocyte	I-NEGATION
Ca2	I-NEGATION
+	I-NEGATION
and	I-NEGATION
Cl	I-NEGATION
-	I-NEGATION
channels	I-NEGATION
.	O

We	O
propose	B-SPECULATION
that	I-SPECULATION
direct	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
K	I-SPECULATION
+	I-SPECULATION
channels	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
by	I-SPECULATION
progesterone	I-SPECULATION
contributes	I-SPECULATION
to	I-SPECULATION
progesterone-induced	I-SPECULATION
immunosuppression	I-SPECULATION
.	O

Role	O
of	O
IKK1	O
and	O
IKK2	O
in	O
lipopolysaccharide	O
signaling	O
in	O
human	O
monocytic	O
cells	O
.	O

Mononuclear	O
phagocytes	O
play	O
a	O
major	O
role	O
in	O
immune	O
and	O
inflammatory	O
responses	O
.	O

Bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
monocytes	O
to	O
express	O
a	O
variety	O
of	O
genes	O
by	O
activating	O
the	O
NF-kappaB	O
/	O
Rel	O
transcription	O
factor	O
family	O
.	O

Recently	O
,	O
we	O
have	O
reported	O
that	O
the	O
tumor	O
necrosis	O
factor	O
and	O
interleukin	O
1	O
signaling	O
pathways	O
activate	O
two	O
kinases	O
,	O
IKK1	O
and	O
IKK2	O
.	O

Phosphorylation	O
of	O
the	O
IkappaB	O
cytoplasmic	O
inhibitors	O
,	O
IkappaBalpha	O
,	O
IkappaBbeta	O
,	O
and	O
IkappaBepsilon	O
,	O
by	O
these	O
kinases	O
triggers	O
proteolytic	O
degradation	O
and	O
the	O
release	O
of	O
NF-kappaB	O
/	O
Rel	O
proteins	O
into	O
the	O
nucleus	O
.	O

At	O
present	O
,	O
the	B-NEGATION
role	I-NEGATION
of	I-NEGATION
the	I-NEGATION
IKKs	I-NEGATION
in	I-NEGATION
LPS	I-NEGATION
signaling	I-NEGATION
has	I-NEGATION
not	I-NEGATION
been	I-NEGATION
investigated	I-NEGATION
.	O

Here	O
,	O
we	O
report	O
that	O
LPS	O
induces	O
IKK	O
activity	O
in	O
human	O
monocytes	O
and	O
THP-1	O
monocytic	O
cells	O
.	O

The	O
kinetics	O
of	O
activation	O
of	O
kinase	O
activity	O
in	O
monocytic	O
cells	O
are	O
relatively	O
slow	O
with	O
maximal	O
activity	O
observed	O
at	O
60	O
min	O
,	O
which	O
coincides	O
with	O
the	O
degradation	O
of	O
IkappaBs	O
and	O
the	O
nuclear	O
translocation	O
of	O
NF-kappaB	O
.	O

In	O
transfection	O
experiments	O
,	O
overexpression	O
of	O
wild	O
type	O
IKK1	O
,	O
a	O
dominant	O
negative	O
mutant	O
IKK1	O
(	O
K44M	O
)	O
,	O
or	O
wild	O
type	O
IKK2	O
did	O
not	B-NEGATION
affect	I-NEGATION
LPS-induced	I-NEGATION
kappaB-dependent	I-NEGATION
transcription	I-NEGATION
in	I-NEGATION
monocytic	I-NEGATION
cells	I-NEGATION
.	O

In	O
contrast	O
,	O
a	O
dominant	O
negative	O
mutant	O
of	O
IKK2	O
inhibited	O
LPS	O
induction	O
of	O
kappaB-dependent	O
transcription	O
in	O
a	O
dose-dependent	O
manner	O
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
LPS	I-SPECULATION
induction	I-SPECULATION
of	I-SPECULATION
kappaB-dependent	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
human	I-SPECULATION
monocytic	I-SPECULATION
cells	I-SPECULATION
requires	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
IKK2	I-SPECULATION
.	O

Effects	O
of	O
overexpression	O
of	O
IL-1	O
receptor-associated	O
kinase	O
on	O
NFkappaB	O
activation	O
,	O
IL-2	O
production	O
and	O
stress-activated	O
protein	O
kinases	O
in	O
the	O
murine	O
T	O
cell	O
line	O
EL4	O
.	O

The	O
association	O
and	O
activation	O
of	O
the	O
IL-1	O
receptor-associated	O
protein	O
kinase	O
(	O
IRAK	O
)	O
to	O
the	O
IL-1	O
receptor	O
complex	O
is	O
one	O
of	O
the	O
earliest	O
events	O
detectable	O
in	O
IL-1	O
signal	O
transduction	O
.	O

We	O
generated	O
permanent	O
clones	O
of	O
the	O
murine	O
T	O
cell	O
line	O
EL4	O
6.1	O
overexpressing	O
human	O
(	O
h	O
)	O
IRAK	O
to	O
evaluate	O
the	O
role	O
of	O
this	O
kinase	O
in	O
IL-1	O
signaling	O
.	O

Overexpression	O
of	O
hIRAK	O
enhanced	O
IL-1-stimulated	O
activation	O
of	O
the	O
transcription	O
factor	O
NFkappaB	O
,	O
whereas	O
a	O
truncated	O
form	O
(	O
N-IRAK	O
)	O
specifically	O
inhibited	O
IL-1-dependent	O
NFkappaB	O
activity	O
.	O

In	O
clones	O
stably	O
overexpressing	O
hIRAK	O
a	O
weak	O
constitutive	O
activation	O
of	O
NFkappaB	O
correlated	O
with	O
a	O
low	O
basal	O
IL-2	O
production	O
which	O
was	O
enhanced	O
in	O
an	O
IL-1-dependent	O
manner	O
.	O

Compared	O
to	O
the	O
parental	O
cell	O
line	O
the	O
dose-response	O
curve	O
of	O
IL-1-induced	O
IL-2	O
production	O
was	O
shifted	O
in	O
both	O
potency	O
and	O
efficacy	O
.	O

These	O
results	O
demonstrate	O
that	O
IRAK	O
directly	O
triggers	O
NFkappaB-mediated	O
gene	O
expression	O
in	O
EL4	O
cells	O
.	O

Qualitatively	O
different	O
effects	O
were	O
observed	O
for	O
the	O
IL-1-induced	O
activation	O
of	O
stress-activated	O
protein	O
(	O
SAP	O
)	O
kinases	O
:	O
permanent	O
overexpression	O
of	O
IRAK	O
did	O
not	B-NEGATION
affect	I-NEGATION
the	I-NEGATION
dose	I-NEGATION
dependence	I-NEGATION
but	O
prolonged	O
the	O
kinetics	O
of	O
IL-1-induced	O
activation	O
of	O
SAP	O
kinases	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
this	I-SPECULATION
signaling	I-SPECULATION
branch	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
regulated	I-SPECULATION
by	I-SPECULATION
distinct	I-SPECULATION
mechanisms	I-SPECULATION
.	O

Decreased	O
IL-12	O
production	O
and	O
Th1	O
cell	O
development	O
by	O
acetyl	O
salicylic	O
acid-mediated	O
inhibition	O
of	O
NF-kappaB	O
.	O

IL-12	O
is	O
a	O
75-kDa	O
heterodimeric	O
cytokine	O
composed	O
of	O
two	O
covalently	O
linked	O
p35	O
and	O
p40	O
chains	O
.	O

This	O
pro-inflammatory	O
cytokine	O
plays	O
a	O
prominent	O
role	O
in	O
the	O
development	O
of	O
Th1	O
cell-mediated	O
immune	O
responses	O
.	O

Th1	O
cell-mediated	O
immune	O
responses	O
have	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
chronic	O
inflammatory	O
autoimmune	O
diseases	O
.	O

Thus	O
,	O
IL-12	B-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
critical	I-SPECULATION
factor	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
generation	I-SPECULATION
and	I-SPECULATION
maintenance	I-SPECULATION
of	I-SPECULATION
chronic	I-SPECULATION
inflammatory	I-SPECULATION
conditions	I-SPECULATION
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
a	O
commonly	O
prescribed	O
anti-inflammatory	O
drug	O
,	O
acetyl	O
salicylic	O
acid	O
(	O
ASA	O
)	O
,	O
on	O
IL-12	O
production	O
and	O
Th1	O
cell	O
development	O
.	O

ASA	O
was	O
found	O
to	O
inhibit	O
secretion	O
of	O
the	O
IL-12	O
heterodimer	O
as	O
well	O
as	O
p40	O
monomer	O
by	O
human	O
monocytic	O
cells	O
.	O

This	O
was	O
associated	O
with	O
the	O
down-regulation	O
of	O
IL-12p40	O
mRNA	O
expression	O
.	O

Analysis	O
of	O
the	O
regulation	O
of	O
the	O
p40	O
gene	O
promoter	O
revealed	O
that	O
ASA	O
inhibited	O
NF-kappaB	O
activation	O
and	O
binding	O
to	O
the	O
p40-kappaB	O
site	O
in	O
the	O
p40	O
promoter	O
,	O
leading	O
to	O
transcriptional	O
repression	O
of	O
the	O
p40	O
gene	O
.	O

Addition	O
of	O
ASA	O
to	O
an	O
in	O
vitro	O
T	O
helper	O
cell	O
differentiation	O
system	O
,	O
at	O
concentrations	O
compatible	O
with	O
plasma	O
levels	O
reached	O
during	O
anti-inflammatory	O
therapy	O
,	O
resulted	O
in	O
reduced	O
development	O
of	O
Th1	O
cells	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
by	I-SPECULATION
ASA	I-SPECULATION
leads	I-SPECULATION
to	I-SPECULATION
down-regulation	I-SPECULATION
of	I-SPECULATION
IL-12	I-SPECULATION
production	I-SPECULATION
and	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
Th1	I-SPECULATION
cell	I-SPECULATION
development	I-SPECULATION
.	O

YM268	O
increases	O
the	O
glucose	O
uptake	O
,	O
cell	O
differentiation	O
,	O
and	O
mRNA	O
expression	O
of	O
glucose	O
transporter	O
in	O
3T3-L1	O
adipocytes	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effects	O
of	O
bis	O
[	O
4	O
-[	O
2,4-dioxo-5-thiazolidinyl	O
)	O
methyl	O
]	O
phenyl	O
]	O
methane	O
(	O
YM-268	O
)	O
,	O
a	O
thiazolidinedione	O
derivative	O
,	O
on	O
glucose	O
uptake	O
,	O
adipocyte	O
differentiation	O
through	O
peroxisome	O
proliferator-activated	O
receptor	O
gamma	O
(	O
PPARgamma	O
)	O
,	O
and	O
phosphatidylinositol	O
3-kinase	O
(	O
PI	O
3-kinase	O
)	O
activity	O
in	O
cultured	O
cells	O
.	O

YM268	O
and	O
pioglitazone	O
dose-dependently	O
increased	O
the	O
2-deoxyglucose	O
uptake	O
in	O
3T3-L1	O
cells	O
.	O

YM268	O
facilitated	O
the	O
insulin-stimulated	O
triglyceride	O
accumulation	O
in	O
3T3-L1	O
adipocytes	O
and	O
increased	O
the	O
mRNA	O
expression	O
of	O
fatty	O
acid-binding	O
protein	O
.	O

YM268	O
,	O
with	O
and	O
without	B-NEGATION
insulin	I-NEGATION
,	O
increased	O
the	O
mRNA	O
expression	O
of	O
glucose	O
transporter	O
isoforms	O
such	O
as	O
GLUT1	O
and	O
GLUT4	O
,	O
indicating	O
enhancement	O
of	O
adipocyte	O
differentiation	O
.	O

Additionally	O
,	O
YM268	O
and	O
pioglitazone	O
showed	O
activity	O
of	O
the	O
PPARgamma	O
ligand	O
,	O
a	O
member	O
of	O
the	O
nuclear	O
receptor	O
superfamily	O
responsible	O
for	O
adipogenesis	O
.	O

To	O
examine	O
the	O
possible	B-SPECULATION
involvement	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
increased	I-SPECULATION
activity	I-SPECULATION
of	I-SPECULATION
PI	I-SPECULATION
3-kinase	I-SPECULATION
in	I-SPECULATION
YM268-stimulated	I-SPECULATION
glucose	I-SPECULATION
uptake	I-SPECULATION
,	O
the	O
enzyme	O
activity	O
was	O
estimated	O
by	O
measuring	O
the	O
phosphatidylinositol-3,4,5-trisphosphate	O
(	O
PI-3,4,5-P3	O
)	O
concentration	O
in	O
human	O
monocytic	O
cells	O
.	O

Insulin	O
dose-dependently	O
increased	O
the	O
PI-3,4,5-P3	O
production	O
but	O
YM268	O
had	O
no	B-NEGATION
significant	I-NEGATION
effect	I-NEGATION
on	I-NEGATION
the	I-NEGATION
insulin-dependent	I-NEGATION
and	I-NEGATION
-	I-NEGATION
independent	I-NEGATION
PI	I-NEGATION
3-kinase	I-NEGATION
activation	I-NEGATION
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
mechanism	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
YM268	I-SPECULATION
increased	I-SPECULATION
glucose	I-SPECULATION
uptake	I-SPECULATION
,	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
accounted	I-SPECULATION
for	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
enhancement	I-SPECULATION
of	I-SPECULATION
GLUT1	I-SPECULATION
and	I-SPECULATION
GLUT4	I-SPECULATION
expression	I-SPECULATION
through	I-SPECULATION
PPARgamma	I-SPECULATION
activation	I-SPECULATION
.	O

Interaction	O
of	O
sickle	O
erythrocytes	O
with	O
endothelial	O
cells	O
in	O
the	O
presence	O
of	O
endothelial	O
cell	O
conditioned	O
medium	O
induces	O
oxidant	O
stress	O
leading	O
to	O
transendothelial	O
migration	O
of	O
monocytes	O
.	O

The	B-SPECULATION
abnormal	I-SPECULATION
adherence	I-SPECULATION
of	I-SPECULATION
sickle	I-SPECULATION
red	I-SPECULATION
blood	I-SPECULATION
cells	I-SPECULATION
(	I-SPECULATION
SS	I-SPECULATION
RBC	I-SPECULATION
)	I-SPECULATION
to	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
has	I-SPECULATION
been	I-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
vascular	I-SPECULATION
occlusion	I-SPECULATION
,	I-SPECULATION
a	I-SPECULATION
major	I-SPECULATION
cause	I-SPECULATION
of	I-SPECULATION
morbidity	I-SPECULATION
in	I-SPECULATION
sickle	I-SPECULATION
cell	I-SPECULATION
disease	I-SPECULATION
(	I-SPECULATION
SCD	I-SPECULATION
)	I-SPECULATION
.	O

We	O
determined	O
whether	B-SPECULATION
the	I-SPECULATION
interaction	I-SPECULATION
of	I-SPECULATION
SS	I-SPECULATION
RBC	I-SPECULATION
with	I-SPECULATION
cultured	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
induced	I-SPECULATION
cellular	I-SPECULATION
oxidant	I-SPECULATION
stress	I-SPECULATION
that	I-SPECULATION
would	B-SPECULATION
culminate	I-SPECULATION
in	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
cell	I-SPECULATION
adhesion	I-SPECULATION
molecules	I-SPECULATION
(	I-SPECULATION
CAMs	I-SPECULATION
)	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
adhesion	I-SPECULATION
and	I-SPECULATION
diapedesis	I-SPECULATION
of	I-SPECULATION
monocytes	I-SPECULATION
and	I-SPECULATION
the	I-SPECULATION
adherence	I-SPECULATION
of	I-SPECULATION
SS	I-SPECULATION
reticulocytes	I-SPECULATION
.	O

We	O
showed	O
that	O
the	O
interaction	O
of	O
SS	O
RBC	O
at	O
2	O
%	O
concentration	O
in	O
the	O
presence	O
of	O
multimers	O
of	O
von	O
Willebrand	O
factor	O
(	O
vWf	O
)	O
,	O
derived	O
from	O
endothelial	O
cell-derived	O
conditioned	O
medium	O
(	O
E-CM	O
)	O
with	O
cultured	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
,	O
resulted	O
in	O
a	O
fivefold	O
increased	O
formation	O
of	O
thiobarbituric	O
acid-reactive	O
substances	O
(	O
TBARS	O
)	O
and	O
activation	O
of	O
the	O
transcription	O
factor	O
NF-kB	O
,	O
both	O
indicators	O
of	O
cellular	O
oxidant	O
stress	O
.	O

Normal	O
RBC	O
show	O
none	B-NEGATION
of	I-NEGATION
these	I-NEGATION
phenomena	I-NEGATION
.	O

The	O
oxidant	O
stress-induced	O
signaling	O
resulted	O
in	O
an	O
increased	O
surface	O
expression	O
of	O
a	O
subset	O
of	O
CAMs	O
,	O
ICAM-1	O
,	O
E-selectin	O
,	O
and	O
VCAM-1	O
in	O
HUVEC	O
.	O

The	O
addition	O
of	O
oxygen	O
radical	O
scavenger	O
enzymes	O
(	O
catalase	O
,	O
superoxide	O
dismutase	O
)	O
and	O
antioxidant	O
(	O
probucol	O
)	O
inhibited	O
these	O
events	O
.	O

Additionally	O
,	O
preincubation	O
of	O
HUVEC	O
with	O
a	O
synthetic	O
peptide	O
Arg-Gly-Asp	O
(	O
RGD	O
)	O
that	O
prevents	O
vWf-mediated	O
adhesion	O
of	O
SS	O
RBC	O
reduced	O
the	O
surface	O
expression	O
of	O
VCAM-1	O
and	O
NF-kB	O
activation	O
.	O

Furthermore	O
,	O
SS	O
RBC-induced	O
oxidant	O
stress	O
resulted	O
in	O
a	O
twofold	O
increase	O
in	O
the	O
transendothelial	O
migration	O
of	O
both	O
monocyte-like	O
HL-60	O
cells	O
and	O
human	O
peripheral	O
blood	O
monocytes	O
,	O
and	O
approximately	O
a	O
sixfold	O
increase	O
in	O
platelet-endothelial	O
cell	O
adhesion	O
molecule-1	O
(	O
PECAM-1	O
)	O
phosphorylation	O
,	O
each	O
of	O
which	O
was	O
blocked	O
by	O
protein	O
kinase	O
C	O
inhibitor	O
and	O
antioxidants	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
adherence	I-SPECULATION
/	I-SPECULATION
contact	I-SPECULATION
of	I-SPECULATION
SS	I-SPECULATION
RBC	I-SPECULATION
to	I-SPECULATION
endothelial	I-SPECULATION
cells	I-SPECULATION
in	I-SPECULATION
large	I-SPECULATION
vessel	I-SPECULATION
can	I-SPECULATION
generate	I-SPECULATION
enhanced	I-SPECULATION
oxidant	I-SPECULATION
stress	I-SPECULATION
leading	I-SPECULATION
to	I-SPECULATION
increased	I-SPECULATION
adhesion	I-SPECULATION
and	I-SPECULATION
diapedesis	I-SPECULATION
of	I-SPECULATION
monocytes	I-SPECULATION
,	I-SPECULATION
as	I-SPECULATION
well	I-SPECULATION
as	I-SPECULATION
heightened	I-SPECULATION
adherence	I-SPECULATION
of	I-SPECULATION
SS	I-SPECULATION
reticulocytes	I-SPECULATION
,	I-SPECULATION
indicating	B-SPECULATION
that	I-SPECULATION
injury	I-SPECULATION
/	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
endothelium	I-SPECULATION
can	I-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
vaso-occlusion	I-SPECULATION
in	I-SPECULATION
SCD	I-SPECULATION
.	O

Tobacco	O
smoke	O
induces	O
coordinate	O
activation	O
of	O
HSF	O
and	O
inhibition	O
of	O
NFkappaB	O
in	O
human	O
monocytes	O
:	O
effects	O
on	O
TNFalpha	O
release	O
.	O

Tobacco	O
smoke	O
(	O
TS	O
)	O
exposure	O
is	O
a	O
major	O
risk	O
factor	O
for	O
human	O
disease	O
,	O
and	O
macrophages	O
of	O
healthy	O
smokers	O
have	O
a	O
depressed	O
capacity	O
to	O
release	O
cytokines	O
,	O
including	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
alpha	O
.	O

TS	O
induces	O
the	O
synthesis	O
of	O
heat	O
shock	O
(	O
HS	O
)/	O
stress	O
proteins	O
(	O
HSP	O
)	O
,	O
and	O
,	O
in	O
particular	O
,	O
of	O
Hsp70	O
.	O

We	O
determined	O
whether	B-SPECULATION
Hsp70	I-SPECULATION
induction	I-SPECULATION
by	I-SPECULATION
TS	I-SPECULATION
was	I-SPECULATION
mediated	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
HS	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
,	I-SPECULATION
HSF	I-SPECULATION
.	O

HSF	O
activation	O
has	O
been	O
shown	O
to	O
inhibit	O
NFkappaB	O
.	O

Thus	O
,	O
we	O
also	O
determined	O
the	O
effects	O
of	O
TS	O
on	O
NFkappaB	O
.	O

U937	O
cells	O
and	O
human	O
peripheral	O
blood	O
monocytes	O
were	O
exposed	O
to	O
TS	O
,	O
binding	O
activities	O
of	O
the	O
respective	O
transcription	O
factors	O
were	O
analyzed	O
,	O
and	O
Hsp70	O
expression	O
and	O
TNFalpha	O
release	O
were	O
determined	O
in	O
parallel	O
.	O

TS	O
activated	O
HSF	O
,	O
which	O
was	O
associated	O
with	O
Hsp70	O
overexpression	O
and	O
inhibition	O
of	O
NFkappaB	O
binding	O
activity	O
and	O
TNFalpha	O
release	O
.	O

The	O
altered	O
cytokine	O
profile	O
observed	O
in	O
smokers	O
may	B-SPECULATION
relate	I-SPECULATION
to	I-SPECULATION
an	I-SPECULATION
HSF	I-SPECULATION
/	I-SPECULATION
Hsp70-mediated	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
NFkappaB	I-SPECULATION
activity	I-SPECULATION
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
beta-casein	O
gene	O
by	O
cytokines	O
:	O
cross-talk	O
between	O
STAT5	O
and	O
other	O
signaling	O
molecules	O
.	O

The	O
beta-casein	O
promoter	O
has	O
been	O
widely	O
used	O
to	O
monitor	O
the	O
activation	O
of	O
STAT	O
(	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
)	O
5	O
since	O
STAT5	O
was	O
originally	O
found	O
as	O
a	O
mediator	O
of	O
PRL-inducible	O
beta-casein	O
expression	O
.	O

However	O
,	O
not	O
only	O
is	O
expression	O
of	O
the	O
beta-casein	O
gene	O
regulated	O
by	O
STAT5	O
but	O
it	O
is	O
also	O
affected	O
by	O
other	O
molecules	O
such	O
as	O
glucocorticoid	O
and	O
Ras	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
the	O
transcriptional	O
regulation	O
of	O
the	O
beta-casein	O
gene	O
by	O
cytokines	O
in	O
T	O
cells	O
.	O

We	O
have	O
found	O
that	O
the	O
beta-casein	O
gene	O
is	O
expressed	O
in	O
a	O
cytotoxic	O
T	O
cell	O
line	O
,	O
CTLL-2	O
,	O
in	O
response	O
to	O
interleukin-2	O
(	O
IL-2	O
)	O
,	O
which	O
activates	O
STAT5	O
.	O

While	O
IL-4	O
does	O
not	B-NEGATION
activate	I-NEGATION
STAT5	I-NEGATION
,	O
it	O
induces	O
expression	O
of	O
STAT5-regulated	O
genes	O
in	O
CTLL-2	O
,	O
i.e.	O
beta-casein	O
,	O
a	O
cytokine-inducible	O
SH2-containing	O
protein	O
(	O
CIS	O
)	O
,	O
and	O
oncostatin	O
M	O
(	O
OSM	O
)	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
STAT6	I-SPECULATION
activated	I-SPECULATION
by	I-SPECULATION
IL-4	I-SPECULATION
substitutes	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
function	I-SPECULATION
of	I-SPECULATION
STAT5	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

IL-2-induced	O
beta-casein	O
expression	O
was	O
enhanced	O
by	O
dexamethasone	O
,	O
and	O
this	O
synergistic	O
effect	O
of	O
Dexamethasone	O
requires	O
the	O
sequence	O
between	O
-	O
155	O
and	O
-	O
193	O
in	O
the	O
beta-casein	O
promoter	O
.	O

Coincidentally	O
,	O
a	O
deletion	O
of	O
this	O
region	O
enhanced	O
the	O
IL-2-induced	O
expression	O
of	O
beta-casein	O
.	O

Expression	O
of	O
an	O
active	O
form	O
of	O
Ras	O
,	O
Ras	O
(	O
G12V	O
)	O
,	O
suppressed	O
the	O
IL-2-induced	O
beta-casein	O
and	O
OSM	O
gene	O
expression	O
,	O
and	O
the	O
negative	O
effect	O
of	O
Ras	O
is	O
mediated	O
by	O
the	O
region	O
between	O
-	O
105	O
and	O
-	O
193	O
in	O
the	O
beta-casein	O
promoter	O
.	O

In	O
apparent	O
contradiction	O
,	O
expression	O
of	O
a	O
dominant	O
negative	O
form	O
of	O
Ras	O
,	O
RasN17	O
,	O
also	O
inhibited	O
IL-2-induced	O
activation	O
of	O
the	O
promoter	O
containing	O
the	O
minimal	O
beta-casein	O
STAT5	O
element	O
as	O
well	O
as	O
the	O
promoters	O
of	O
CIS	O
and	O
OSM	O
.	O

In	O
addition	O
,	O
Ras	O
(	O
G12V	O
)	O
complemented	O
signaling	O
by	O
an	O
erythropoietin	O
receptor	O
mutant	O
defective	O
in	O
Ras	O
activation	O
and	O
augmented	O
the	O
activation	O
of	O
the	O
beta-casein	O
promoter	O
by	O
the	O
mutant	O
erythropoietin	O
receptor	O
signaling	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
possible	B-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
Ras	I-SPECULATION
in	I-SPECULATION
Stat5-mediated	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
.	O

These	O
results	O
collectively	O
reveal	O
a	O
complex	O
interaction	O
of	O
STAT5	O
with	O
other	O
signaling	O
pathways	O
and	O
illustrate	O
that	O
regulation	O
of	O
gene	O
expression	O
requires	O
integration	O
of	O
opposing	O
signals	O
.	O

Transcription	O
factor	O
NF-kappaB	O
regulation	O
of	O
renal	O
fibrosis	O
during	O
ureteral	O
obstruction	O
.	O

Irrespective	O
of	O
the	O
etiology	O
,	O
many	O
kidney	O
diseases	O
result	O
in	O
inflammation	O
and	O
fibrosis	O
of	O
the	O
tubulointerstitium	O
,	O
with	O
the	O
subsequent	O
loss	O
of	O
renal	O
function	O
.	O

To	O
initiate	O
any	O
disease	O
process	O
or	O
for	O
any	O
disease	O
process	O
to	O
progress	O
,	O
there	O
must	O
be	O
changes	O
in	O
the	O
transcription	O
of	O
genes	O
within	O
the	O
affected	O
tissue	O
.	O

The	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappaB	O
)	O
family	O
of	O
transcription	O
factors	O
regulates	O
genes	O
involved	O
in	O
inflammation	O
,	O
cell	O
proliferation	O
,	O
and	O
cell	O
differentiation	O
.	O

This	O
review	O
discusses	O
the	O
NF-kappaB	O
transcription	O
factor	O
family	O
in	O
general	O
and	O
the	O
association	O
of	O
NF-kappaB	O
activation	O
with	O
cellular	O
/	O
molecular	O
events	O
of	O
renal	O
inflammation	O
and	O
fibrosis	O
.	O

TAL1	O
and	O
LIM-only	O
proteins	O
synergistically	O
induce	O
retinaldehyde	O
dehydrogenase	O
2	O
expression	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
by	O
acting	O
as	O
cofactors	O
for	O
GATA3	O
.	O

Previously	O
,	O
we	O
have	O
shown	O
that	O
TAL1	O
and	O
the	O
LIM-only	O
protein	O
gene	O
(	O
LMO	O
)	O
are	O
regularly	O
coactivated	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
)	O
.	O

This	B-SPECULATION
observation	I-SPECULATION
is	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
relate	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
findings	I-SPECULATION
that	I-SPECULATION
TAL1	I-SPECULATION
and	I-SPECULATION
LMO	I-SPECULATION
are	I-SPECULATION
highly	I-SPECULATION
synergistic	I-SPECULATION
in	I-SPECULATION
T-cell	I-SPECULATION
tumorigenesis	I-SPECULATION
in	I-SPECULATION
double-transgenic	I-SPECULATION
mice	I-SPECULATION
.	O

To	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
functional	O
synergy	O
between	O
TAL1	O
and	O
LMO	O
in	O
tumorigenesis	O
and	O
transcriptional	O
regulation	O
,	O
we	O
tried	O
to	O
identify	O
downstream	O
target	O
genes	O
regulated	O
by	O
TAL1	O
and	O
LMO	O
by	O
a	O
subtractive	O
PCR	O
method	O
.	O

One	O
of	O
the	O
isolated	O
genes	O
,	O
that	O
for	O
retinaldehyde	O
dehydrogenase	O
2	O
(	O
RALDH2	O
)	O
,	O
was	O
regularly	O
expressed	O
in	O
most	O
of	O
the	O
T-ALL	O
cell	O
lines	O
that	O
coexpressed	O
TAL1	O
and	O
LMO	O
.	O

Exogenously	O
transfected	O
TAL1	O
and	O
LMO	O
,	O
but	O
not	B-NEGATION
either	I-NEGATION
alone	I-NEGATION
,	O
induced	O
RALDH2	O
expression	O
in	O
a	O
T-ALL	O
cell	O
line	O
,	O
HPB-ALL	O
,	O
not	B-NEGATION
expressing	I-NEGATION
endogeneous	I-NEGATION
TAL1	I-NEGATION
or	I-NEGATION
LMO	I-NEGATION
.	O

The	O
RALDH2	O
transcripts	O
in	O
T-ALL	O
were	O
,	O
however	O
,	O
mostly	O
initiated	O
within	O
the	O
second	O
intron	O
.	O

Promoter	O
analysis	O
revealed	O
that	O
a	O
GATA	O
site	O
in	O
a	O
cryptic	O
promoter	O
in	O
the	O
second	O
intron	O
was	O
essential	O
and	O
sufficient	O
for	O
the	O
TAL1	O
-	O
and	O
LMO-dependent	O
transcriptional	O
activation	O
,	O
and	O
GATA3	O
binds	O
to	O
this	O
site	O
.	O

In	O
addition	O
,	O
forced	O
expression	O
of	O
GATA3	O
potentiated	O
the	O
induction	O
of	O
RALDH2	O
by	O
TAL1	O
and	O
LMO	O
,	O
and	O
these	O
three	O
factors	O
formed	O
a	O
complex	O
in	O
vivo	O
.	O

Furthermore	O
,	O
a	O
TAL1	O
mutant	O
not	B-NEGATION
binding	I-NEGATION
to	I-NEGATION
DNA	I-NEGATION
also	O
activated	O
the	O
transcription	O
of	O
RALDH2	O
in	O
the	O
presence	O
of	O
LMO	O
and	O
GATA3	O
.	O

Collectively	O
,	O
we	O
have	O
identified	O
the	O
RALDH2	O
gene	O
as	O
a	O
first	O
example	O
of	O
direct	O
transcriptional	O
target	O
genes	O
regulated	O
by	O
TAL1	O
and	O
LMO	O
in	O
T-ALL	O
.	O

In	O
this	O
case	O
,	O
TAL1	O
and	O
LMO	O
act	O
as	O
cofactors	O
for	O
GATA3	O
to	O
activate	O
the	O
transcription	O
of	O
RALDH2	O
.	O

Granulocyte	O
colony-stimulating	O
factor	O
activates	O
a	O
72-kDa	O
isoform	O
of	O
STAT3	O
in	O
human	O
neutrophils	O
.	O

Granulocyte	O
colony-stimulating	O
factor	O
(	O
G-CSF	O
)	O
signaling	O
involves	O
activation	O
of	O
STATs	O
,	O
proteins	O
that	O
serve	O
the	O
dual	O
function	O
of	O
signal	O
transduction	O
and	O
activation	O
of	O
transcription	O
.	O

We	O
previously	O
demonstrated	O
that	O
G-CSF	O
activated	O
a	O
distinct	O
Stat3-like	O
protein	O
in	O
immature	O
and	O
mature	O
normal	O
myeloid	O
cells	O
,	O
StatG	O
.	O

StatG	O
in	O
normal	O
immature	O
human	O
myeloid	O
cells	O
,	O
i.e.	O
adult	O
CD34	O
+	O
bone	O
marrow	O
cells	O
,	O
was	O
composed	O
of	O
Stat3beta	O
.	O

This	O
investigation	O
was	O
undertaken	O
to	O
determine	O
the	O
composition	O
of	O
StatG	O
in	O
mature	O
normal	O
human	O
myeloid	O
cells	O
,	O
i.e.	O
polymorphonuclear	O
neutrophilic	O
granulocytes	O
(	O
PMN	O
)	O
.	O

These	O
studies	O
revealed	O
that	O
the	O
major	O
protein	O
in	O
extracts	O
of	O
PMN	O
activated	O
by	O
G-CSF	O
to	O
bind	O
the	O
high-affinity	O
serum-inducible	O
element	O
(	O
hSIE	O
)	O
is	O
a	O
72-kDa	O
protein	O
that	O
cross-reacts	O
with	O
Stat3	O
monoclonal	O
antibody	O
,	O
which	O
we	O
have	O
designated	O
Stat3gamma	O
.	O

Stat3gamma	O
is	O
derived	O
from	O
Stat3alpha	O
by	O
limited	O
proteolysis	O
and	O
lacks	B-NEGATION
the	I-NEGATION
carboxyl-terminal	I-NEGATION
portion	I-NEGATION
of	I-NEGATION
Stat3alpha	I-NEGATION
.	O

Because	O
this	O
region	O
of	O
Stat3alpha	O
is	O
involved	O
in	O
transcriptional	O
activation	O
,	O
our	O
findings	O
suggest	B-SPECULATION
the	I-SPECULATION
possibility	B-SPECULATION
that	I-SPECULATION
Stat3gamma	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
transcriptionally	I-SPECULATION
inactive	I-SPECULATION
and	O
may	B-SPECULATION
compete	I-SPECULATION
with	I-SPECULATION
Stat3alpha	I-SPECULATION
for	I-SPECULATION
Stat3	I-SPECULATION
binding	I-SPECULATION
sites	I-SPECULATION
in	I-SPECULATION
these	I-SPECULATION
terminally	I-SPECULATION
differentiated	I-SPECULATION
myeloid	I-SPECULATION
cells	I-SPECULATION
.	O

Differential	O
effects	O
of	O
protein	O
kinase	O
C	O
inhibitors	O
on	O
fibronectin-induced	O
interleukin-beta	O
gene	O
transcription	O
,	O
protein	O
synthesis	O
and	O
secretion	O
in	O
human	O
monocytic	O
cells	O
.	O

Human	O
monocytic	O
cells	O
express	O
interleukin-1beta	O
(	O
IL-1beta	O
)	O
when	O
stimulated	O
with	O
the	O
extracellular	O
matrix	O
glycoprotein	O
,	O
fibronectin	O
(	O
FN	O
)	O
.	O

Protein	O
kinase	O
C	O
(	O
PKC	O
)	O
activation	O
is	O
considered	O
important	O
for	O
this	O
process	O
;	O
however	O
,	O
the	B-SPECULATION
metabolic	I-SPECULATION
steps	I-SPECULATION
at	I-SPECULATION
which	I-SPECULATION
PKC	I-SPECULATION
acts	I-SPECULATION
upon	I-SPECULATION
to	I-SPECULATION
mediate	I-SPECULATION
the	I-SPECULATION
FN-induced	I-SPECULATION
IL-1beta	I-SPECULATION
response	I-SPECULATION
remain	I-SPECULATION
unclear	I-SPECULATION
.	O

We	O
performed	O
an	O
analysis	O
of	O
the	O
mechanisms	O
by	O
which	O
two	O
PKC	O
inhibitors	O
,	O
Calphostin	O
C	O
and	O
Staurosporine	O
,	O
prevent	O
the	O
FN-induced	O
IL-1beta	O
response	O
.	O

Both	O
inhibitors	O
blocked	O
the	O
secretion	O
of	O
IL-1beta	O
protein	O
into	O
the	O
media	O
of	O
peripheral	O
blood	O
mononuclear	O
cells	O
exposed	O
to	O
FN	O
.	O

Immunoprecipitation	O
analysis	O
revealed	O
that	O
under	O
these	O
circumstances	O
,	O
Calphostin	O
C	O
inhibited	O
the	O
production	O
of	O
IL-1beta	O
protein	O
,	O
whereas	O
Staurosporine	O
allowed	O
protein	O
production	O
,	O
but	O
inhibited	O
its	O
secretion	O
.	O

To	O
determine	O
the	O
mechanisms	O
responsible	O
for	O
these	O
differences	O
,	O
we	O
turned	O
to	O
human	O
U937	O
promonocytic	O
cells	O
.	O

U937	O
cells	O
transfected	O
with	O
the	O
human	O
full-length	O
IL-1beta	O
promoter	O
connected	O
to	O
a	O
luciferase	O
reporter	O
gene	O
were	O
submitted	O
to	O
transcription	O
assays	O
,	O
Northern	O
blotting	O
,	O
and	O
DNA	O
electrophoresis	O
mobility	O
gel	O
shift	O
assays	O
.	O

These	O
studies	O
revealed	O
that	O
Calphostin	O
C	O
inhibited	O
the	O
nuclear	O
translocation	O
of	O
the	O
transcription	O
factor	O
activator	O
protein-1	O
(	O
AP-1	O
)	O
which	O
is	O
considered	O
necessary	O
for	O
FN	O
induction	O
of	O
IL-1beta	O
gene	O
transcription	O
,	O
and	O
prevented	O
the	O
transcription	O
of	O
the	O
IL-1beta	O
gene	O
.	O

In	O
contrast	O
,	O
Staurosporine	O
alone	O
induced	O
AP-1	O
translocation	O
and	O
stimulation	O
of	O
the	O
gene	O
.	O

Overall	O
,	O
our	O
data	O
indicate	B-SPECULATION
that	I-SPECULATION
Calphostin	I-SPECULATION
C	I-SPECULATION
prevents	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
IL-1beta	I-SPECULATION
gene	I-SPECULATION
thereby	I-SPECULATION
inhibiting	I-SPECULATION
protein	I-SPECULATION
synthesis	I-SPECULATION
.	O

Based	O
on	O
the	O
high	O
specificity	O
of	O
this	O
compound	O
for	O
PKC	O
,	O
we	O
conclude	O
that	O
PKC	O
is	O
necessary	O
for	O
FN-induced	O
IL-1beta	O
protein	O
production	O
.	O

In	O
contrast	O
,	O
Staurosporine	O
prevented	O
secretion	O
of	O
IL-1beta	O
by	O
unknown	B-SPECULATION
mechanisms	I-SPECULATION
.	O

Membrane-associated	O
lymphotoxin	O
on	O
natural	O
killer	O
cells	O
activates	O
endothelial	O
cells	O
via	O
an	O
NF-kappaB-dependent	O
pathway	O
.	O

BACKGROUND	O
:	O
Inhibition	O
of	O
complement	O
in	O
small	O
animal	O
models	O
of	O
xenotransplantation	O
has	O
demonstrated	O
graft	O
infiltration	O
with	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
and	O
monocytes	O
associated	O
with	O
endothelial	O
cell	O
(	O
EC	O
)	O
activation	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
human	O
NK	O
cells	O
activate	O
porcine	O
EC	O
in	O
vitro	O
,	O
which	O
results	O
in	O
adhesion	O
molecule	O
expression	O
and	O
cytokine	O
secretion	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
the	O
NK	O
cell	O
line	O
NK92	O
to	O
define	O
the	O
molecular	O
and	O
cellular	O
basis	O
of	O
NK	O
cell-mediated	O
EC	O
activation	O
.	O

METHODS	O
:	O
EC	O
were	O
transfected	O
with	O
either	O
reporter	O
constructs	O
containing	O
the	O
luciferase	O
gene	O
driven	O
either	O
by	O
E-selectin	O
or	O
interleukin	O
(	O
IL	O
)-	O
8	O
promoters	O
or	O
a	O
synthetic	O
NF-kappaB-dependent	O
promoter	O
.	O

In	O
addition	O
,	O
a	O
dominant-negative	O
mutant	O
tumor	O
necrosis	O
factor	O
receptor	O
I	O
(	O
TNFRI	O
)	O
expression	O
vector	O
was	O
co-transfected	O
in	O
inhibition	O
studies	O
.	O

Forty-eight	O
hours	O
after	O
transfection	O
,	O
EC	O
were	O
stimulated	O
with	O
NK	O
cells	O
or	O
NK	O
cell	O
membrane	O
extracts	O
for	O
7	O
hr	O
and	O
activation	O
was	O
measured	O
by	O
a	O
luciferase	O
assay	O
.	O

RESULTS	O
:	O
Co-culture	O
of	O
NK	O
cells	O
with	O
transfected	O
EC	O
enhanced	O
E-selectin	O
,	O
IL-8	O
,	O
and	O
NF-kappaB-dependent	O
promoter	O
activity	O
.	O

NK	O
cell	O
membrane	O
extracts	O
retained	O
the	O
capacity	O
to	O
activate	O
EC	O
and	O
induced	O
nuclear	O
translocation	O
of	O
NF-kappaB	O
(	O
p50	O
and	O
p65	O
)	O
.	O

Western	O
blotting	O
of	O
NK	O
cell	O
and	O
membrane	O
extracts	O
detected	O
the	O
presence	O
of	O
Lymphotoxin-alpha	O
(	O
LTalpha	O
)	O
but	O
not	B-NEGATION
tumor	I-NEGATION
necrosis	I-NEGATION
factor-alpha	I-NEGATION
.	O

Furthermore	O
,	O
LTalpha	O
was	O
secreted	O
in	O
NK	O
:	O
EC	O
co-cultures	O
.	O

Co-transfection	O
with	O
dominant-negative	O
mutant	O
TNFRI	O
inhibited	O
EC	O
activation	O
by	O
NK	O
cell	O
membrane	O
extracts	O
and	O
by	O
NK	O
cells	O
by	O
80	O
%	O
and	O
47	O
%	O
,	O
respectively	O
.	O

The	O
same	O
pattern	O
of	O
inhibition	O
was	O
observed	O
using	O
anti-human	O
LT	O
sera	O
.	O

CONCLUSIONS	O
:	O
Human	O
NK	O
cell	O
membrane-bound	O
LT	O
signals	O
across	O
species	O
via	O
TNFRI	O
,	O
leading	O
to	O
NF-kappaB	O
nuclear	O
translocation	O
and	O
transcription	O
of	O
E-selectin	O
and	O
IL-8	O
,	O
which	O
results	O
in	O
EC	O
activation	O
.	O

The	O
discrepancy	O
in	O
the	O
degree	O
of	O
inhibition	O
by	O
membrane	O
extracts	O
and	O
NK	O
cells	O
with	O
mutant	O
TNFRI	O
suggests	B-SPECULATION
that	I-SPECULATION
additional	I-SPECULATION
pathways	I-SPECULATION
are	I-SPECULATION
utilized	I-SPECULATION
by	I-SPECULATION
NK	I-SPECULATION
cells	I-SPECULATION
to	I-SPECULATION
activate	I-SPECULATION
EC	I-SPECULATION
.	O

Cloning	O
of	O
ARE-containing	O
genes	O
by	O
AU-motif-directed	O
display	O
.	O

A	O
procedure	O
suitable	O
for	O
cloning	O
labile	O
mRNAs	O
that	O
contain	O
AU	O
motifs	O
is	O
presented	O
(	O
AU-DD	O
)	O
.	O

These	O
motifs	O
are	O
regulatory	O
sequences	O
within	O
the	O
so-called	O
AU-rich	O
elements	O
(	O
AREs	O
)	O
often	O
found	O
in	O
3	O
'	O
untranslated	O
regions	O
of	O
genes	O
such	O
as	O
cytokines	O
,	O
proto-oncogenes	O
,	O
and	O
transcription	O
factors	O
.	O

AU-DD	O
is	O
an	O
AU-motif-directed	O
differential	O
display	O
that	O
permits	O
the	O
identification	O
of	O
ARE-containing	O
genes	O
differentially	O
expressed	O
after	O
cell	O
activation	O
.	O

It	O
has	O
been	O
applied	O
to	O
peripheral	O
blood	O
monocytes	O
and	O
a	O
T	O
cell	O
clone	O
to	O
isolate	O
59	O
cDNA	O
fragments	O
associated	O
to	O
activation	O
.	O

Fourteen	O
percent	O
of	O
isolated	O
fragments	O
belong	O
to	O
already	O
known	O
genes	O
that	O
certainly	O
are	O
cytokines	O
and	O
transduction	O
/	O
transcription	O
factors	O
.	O

The	O
remaining	O
86	O
%	O
correspond	O
to	O
unknown	O
genes	O
of	O
which	O
92	O
%	O
have	O
been	O
confirmed	O
to	O
be	O
differentially	O
expressed	O
.	O

These	O
data	O
demonstrate	O
the	O
efficiency	O
of	O
the	O
system	O
and	O
support	O
the	O
notion	B-SPECULATION
that	I-SPECULATION
numerous	I-SPECULATION
genes	I-SPECULATION
falling	I-SPECULATION
into	I-SPECULATION
those	I-SPECULATION
categories	I-SPECULATION
remain	I-SPECULATION
unidentified	I-SPECULATION
and	I-SPECULATION
that	I-SPECULATION
they	I-SPECULATION
can	I-SPECULATION
be	I-SPECULATION
cloned	I-SPECULATION
by	I-SPECULATION
this	I-SPECULATION
method	I-SPECULATION
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Signaling	O
pathways	O
mediated	O
by	O
the	O
TNF	O
-	O
and	O
cytokine-receptor	O
families	O
target	O
a	O
common	O
cis-element	O
of	O
the	O
IFN	O
regulatory	O
factor	O
1	O
promoter	O
.	O

CD40	O
activation	O
of	O
B	O
cells	O
is	O
strongly	O
influenced	O
by	O
the	O
presence	O
of	O
cytokines	O
.	O

However	O
,	O
the	B-SPECULATION
molecular	I-SPECULATION
basis	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
interplay	I-SPECULATION
between	I-SPECULATION
these	I-SPECULATION
distinct	I-SPECULATION
stimuli	I-SPECULATION
is	I-SPECULATION
not	I-SPECULATION
clearly	I-SPECULATION
delineated	I-SPECULATION
.	O

IFN	O
regulatory	O
factor	O
1	O
(	O
IRF-1	O
)	O
is	O
a	O
transcription	O
factor	O
activated	O
by	O
either	O
CD40	O
or	O
cytokines	O
.	O

We	O
have	O
found	O
that	O
these	O
different	O
sets	O
of	O
signals	O
target	O
a	O
common	O
cis-acting	O
element	O
in	O
the	O
promoter	O
of	O
this	O
gene	O
,	O
the	O
IRF-1	O
gamma-activated	O
site	O
(	O
GAS	O
)	O
.	O

Targeting	B-NEGATION
of	I-NEGATION
the	I-NEGATION
IRF-1	I-NEGATION
GAS	I-NEGATION
is	I-NEGATION
not	I-NEGATION
confined	I-NEGATION
to	I-NEGATION
activation	I-NEGATION
via	I-NEGATION
CD40	I-NEGATION
but	O
extends	O
to	O
other	O
stimuli	O
that	O
mimic	O
the	O
CD40	O
signaling	O
cascade	O
,	O
like	O
TNF-alpha	O
and	O
EBV	O
.	O

In	O
contrast	O
to	O
induction	O
of	O
STATs	O
by	O
cytokines	O
,	O
the	O
IRF-1	O
GAS-binding	O
complex	O
activated	O
by	O
CD40	B-SPECULATION
,	I-SPECULATION
TNF-alpha	I-SPECULATION
,	I-SPECULATION
or	I-SPECULATION
EBV	I-SPECULATION
contains	O
Rel	O
proteins	O
,	O
specifically	O
p50	O
and	O
p65	O
.	O

In	O
this	O
system	O
,	O
simultaneous	O
exposure	O
to	O
CD40L	O
together	O
with	O
either	O
IL-4	O
or	O
IFN-gamma	O
does	O
not	B-NEGATION
lead	I-NEGATION
to	I-NEGATION
the	I-NEGATION
activation	I-NEGATION
of	I-NEGATION
novel	I-NEGATION
Rel	I-NEGATION
/	I-NEGATION
STAT	I-NEGATION
complexes	I-NEGATION
.	O

Given	O
the	O
importance	O
of	O
IRF-1	O
in	O
a	O
variety	O
of	O
biologic	O
functions	O
from	O
proliferation	O
to	O
apoptosis	O
,	O
our	O
findings	O
support	O
the	O
notion	B-SPECULATION
that	I-SPECULATION
modulation	I-SPECULATION
of	I-SPECULATION
IRF-1	I-SPECULATION
levels	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
critical	I-SPECULATION
control	I-SPECULATION
point	I-SPECULATION
in	I-SPECULATION
B	I-SPECULATION
cell	I-SPECULATION
activation	I-SPECULATION
.	O

Regulation	O
of	O
NF-kappa	O
B	O
,	O
AP-1	O
,	O
NFAT	O
,	O
and	O
STAT1	O
nuclear	O
import	O
in	O
T	O
lymphocytes	O
by	O
noninvasive	O
delivery	O
of	O
peptide	O
carrying	O
the	O
nuclear	O
localization	O
sequence	O
of	O
NF-kappa	O
B	O
p50	O
.	O

Activation	O
of	O
T	O
lymphocytes	O
by	O
Ags	O
or	O
cytokines	O
results	O
in	O
translocation	O
of	O
the	O
transcription	O
factors	O
NF-kappa	O
B	O
,	O
AP-1	O
,	O
NFAT	O
,	O
and	O
STAT	O
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
.	O

The	O
first	O
step	O
in	O
the	O
nuclear	O
import	O
process	O
is	O
recognition	O
of	O
a	O
nuclear	O
localization	O
sequence	O
(	O
NLS	O
)	O
within	O
the	O
karyophilic	O
protein	O
by	O
a	O
cytoplasmic	O
receptor	O
such	O
as	O
the	O
importin	O
(	O
karyopherin	O
)-	O
alpha	O
subunit	O
.	O

The	O
NLSs	O
of	O
NF-kappa	O
B	O
,	O
AP-1	O
,	O
and	O
NFAT	O
differ	O
and	O
the	B-NEGATION
NLS	I-NEGATION
of	I-NEGATION
STAT1	I-NEGATION
has	I-NEGATION
not	I-NEGATION
yet	I-NEGATION
been	I-NEGATION
identified	I-NEGATION
.	O

Herein	O
we	O
demonstrate	O
that	O
the	O
inducible	O
nuclear	O
import	O
of	O
NF-kappa	O
B	O
,	O
AP-1	O
,	O
NFAT	O
,	O
and	O
STAT1	O
in	O
Jurkat	O
T	O
lymphocytes	O
is	O
significantly	O
inhibited	O
by	O
a	O
cell-permeable	O
peptide	O
carrying	O
the	O
NLS	O
of	O
the	O
NF-kappa	O
B	O
p50	O
subunit	O
.	O

NLS	O
peptide-mediated	O
disruption	O
of	O
the	O
nuclear	O
import	O
of	O
these	O
transcription	O
factors	O
results	O
in	O
inhibition	O
of	O
I	O
kappa	O
B	O
alpha	O
and	O
IL-2	O
gene	O
expression	O
,	O
processes	O
dependent	O
on	O
NF-kappa	O
B	O
or	O
the	O
combination	O
of	O
NF-kappa	O
B	O
,	O
AP-1	O
,	O
and	O
NFAT	O
.	O

Further	O
,	O
we	O
show	O
that	O
inhibitory	O
NLS	O
peptide	O
interacts	O
in	O
vitro	O
with	O
a	O
cytoplasmic	O
NLS	O
receptor	O
complex	O
comprised	O
of	O
the	O
Rch1	O
/	O
importin	O
(	O
karyopherin	O
)-	O
beta	O
heterodimer	O
expressed	O
in	O
Jurkat	O
T	O
cells	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
inducible	I-SPECULATION
nuclear	I-SPECULATION
import	I-SPECULATION
of	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
,	I-SPECULATION
AP-1	I-SPECULATION
,	I-SPECULATION
NFAT	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
STAT1	I-SPECULATION
in	I-SPECULATION
Jurkat	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
can	I-SPECULATION
be	I-SPECULATION
regulated	I-SPECULATION
by	I-SPECULATION
NLS	I-SPECULATION
peptide	I-SPECULATION
delivered	I-SPECULATION
noninvasively	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
cytoplasm	I-SPECULATION
of	I-SPECULATION
Jurkat	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
to	I-SPECULATION
target	I-SPECULATION
members	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
importin	I-SPECULATION
(	I-SPECULATION
karyopherin	I-SPECULATION
)-	I-SPECULATION
alpha	I-SPECULATION
beta	I-SPECULATION
NLS	I-SPECULATION
receptor	I-SPECULATION
complex	I-SPECULATION
.	O

Epithelial	O
cell-initiated	O
inflammation	O
plays	O
a	O
crucial	O
role	O
in	O
early	O
tissue	O
damage	O
in	O
amebic	O
infection	O
of	O
human	O
intestine	O
.	O

BACKGROUND	O
&	O
AIMS	O
:	O
Entamoeba	O
histolytica	O
infection	O
of	O
the	O
intestine	O
can	O
induce	O
severe	O
gut	O
inflammation	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
assess	O
the	O
role	O
of	O
the	O
host	O
inflammatory	O
response	O
in	O
the	O
tissue	O
damage	O
observed	O
with	O
amebiasis	O
and	O
the	O
role	O
of	O
the	O
intestinal	O
epithelial	O
cell	O
in	O
initiating	O
that	O
response	O
.	O

METHODS	O
:	O
E.	O
histolytica	O
infection	O
was	O
established	O
in	O
human	O
intestinal	O
xenografts	O
in	O
severe	O
combined	O
immunodeficient	O
(	O
SCID-HU-INT	O
)	O
mice	O
.	O

Human	O
intestinal	O
epithelial	O
cell	O
inflammatory	O
responses	O
to	O
amebic	O
infection	O
were	O
inhibited	O
by	O
the	O
intraluminal	O
administration	O
of	O
an	O
antisense	O
oligonucleotide	O
to	O
the	O
human	O
p65	O
subunit	O
of	O
nuclear	O
factor	O
kappaB	O
,	O
and	O
the	O
role	O
of	O
neutrophils	O
in	O
tissue	O
damage	O
observed	O
with	O
amebiasis	O
was	O
studied	O
by	O
depleting	O
neutrophils	O
from	O
SCID-HU-INT	O
mice	O
.	O

RESULTS	O
:	O
Administration	O
of	O
the	O
antisense	O
oligonucleotide	O
blocked	O
the	O
production	O
of	O
human	O
interleukin	O
1beta	O
and	O
interleukin	O
8	O
by	O
intestinal	O
epithelial	O
cells	O
and	O
inhibited	O
neutrophil	O
influx	O
into	O
the	O
E.	O
histolytica-infected	O
intestinal	O
xenografts	O
.	O

Inhibition	O
of	O
the	O
gut	O
inflammatory	O
response	O
by	O
the	O
antisense	O
oligonucleotide	O
or	O
the	O
depletion	O
of	O
neutrophils	O
from	O
SCID-HU	O
-	O
INT	O
mice	O
blocked	O
the	O
increase	O
in	O
intestinal	O
permeability	O
observed	O
with	O
amebic	O
infection	O
.	O

CONCLUSIONS	O
:	O
Intestinal	O
epithelial	O
cells	O
initiate	O
an	O
inflammatory	O
response	O
with	O
resulting	O
neutrophil-mediated	O
tissue	O
damage	O
in	O
response	O
to	O
E.	O
histolytica	O
infection	O
;	O
this	O
inflammatory	O
cascade	O
can	O
be	O
blocked	O
by	O
inhibiting	O
the	O
transcription	O
of	O
genes	O
regulated	O
by	O
nuclear	O
factor	O
kappaB	O
.	O

In	O
vitro	O
suppression	O
of	O
programmed	O
cell	O
death	O
of	O
B	O
cells	O
by	O
tissue	O
inhibitor	O
of	O
metalloproteinases-1	O
.	O

Cellular	O
pathways	O
for	O
induction	O
of	O
programmed	O
cell	O
death	O
(	O
PCD	O
)	O
have	O
been	O
identified	O
,	O
but	O
little	O
is	O
known	O
about	O
specific	O
extracellular	O
matrix	O
processes	O
that	O
may	B-SPECULATION
affect	I-SPECULATION
apoptosis	I-SPECULATION
along	I-SPECULATION
those	I-SPECULATION
pathways	I-SPECULATION
.	O

In	O
this	O
study	O
,	O
a	O
series	O
of	O
Burkitt's	O
lymphoma	O
(	O
BL	O
)	O
cell	O
lines	O
were	O
assayed	O
for	O
their	O
expression	O
of	O
tissue	O
inhibitor	O
of	O
metalloproteinases	O
(	O
TIMP	O
)-	O
1	O
.	O

Results	O
indicate	B-SPECULATION
that	I-SPECULATION
TIMP-1-positive	I-SPECULATION
BL	I-SPECULATION
lines	I-SPECULATION
show	I-SPECULATION
resistance	I-SPECULATION
to	I-SPECULATION
cold-shock-induced	I-SPECULATION
apoptosis	I-SPECULATION
.	O

Furthermore	O
,	O
recombinant	O
TIMP-1	O
,	O
but	O
not	B-NEGATION
,	O
confers	O
resistance	O
to	O
apoptosis	O
induced	O
by	O
both	O
CD95-dependent	O
and	O
-	O
independent	O
(	O
cold	O
shock	O
,	O
serum	O
deprivation	O
,	O
and	O
gamma-radiation	O
)	O
pathways	O
in	O
TIMP-1-negative	O
BL	O
lines	O
.	O
TIMP-2	B-SPECULATION
or	I-SPECULATION
a	I-SPECULATION
synthetic	I-SPECULATION
metalloproteinase	I-SPECULATION
inhibitor	I-SPECULATION
(	I-SPECULATION
BB-94	I-SPECULATION
)	I-SPECULATION
.	O

TIMP-1	O
suppression	O
of	O
PCD	O
is	O
not	B-NEGATION
due	I-NEGATION
to	I-NEGATION
metalloproteinase	I-NEGATION
inhibition	I-NEGATION
,	O
as	O
reduction	O
and	O
alkylation	O
of	O
the	O
TIMP-1	O
did	O
not	B-NEGATION
abolish	I-NEGATION
this	I-NEGATION
activity	I-NEGATION
.	O

Retroviral	O
induction	O
of	O
TIMP-1	O
not	O
only	O
resulted	O
in	O
cell	O
survival	O
but	O
also	O
in	O
continued	O
DNA	O
synthesis	O
for	O
up	O
to	O
5	O
d	O
in	O
the	O
absence	O
of	O
serum	O
,	O
while	O
controls	O
underwent	O
apoptosis	O
.	O

This	O
resistance	O
to	O
apoptosis	O
is	O
reversed	O
by	O
anti-TIMP-1	O
antibodies	O
,	O
demonstrating	O
that	O
secreted	O
TIMP-1	O
is	O
active	O
in	O
blocking	O
apoptosis	O
.	O

Furthermore	O
,	O
TIMP-1	O
upregulation	O
induced	O
expression	O
of	O
Bcl-XL	O
but	O
not	B-NEGATION
Bcl-2	I-NEGATION
as	O
well	O
as	O
decreased	O
NF-kappaB	O
activity	O
as	O
compared	O
with	O
controls	O
.	O

These	O
results	O
demonstrate	O
that	O
TIMP-1	O
suppresses	O
apoptosis	O
in	O
B	O
cells	O
and	O
suggests	B-SPECULATION
a	I-SPECULATION
novel	I-SPECULATION
activity	I-SPECULATION
for	I-SPECULATION
TIMP-1	I-SPECULATION
in	I-SPECULATION
tissue	I-SPECULATION
homeostasis	I-SPECULATION
.	O

Interleukin-12	O
expression	O
in	O
B	O
cells	O
by	O
transformation	O
with	O
Epstein-Barr	O
virus	O
.	O

Although	O
interleukin	O
(	O
IL	O
)-	O
12	O
was	O
originally	O
purified	O
from	O
an	O
Epstein-Barr	O
(	O
EBV	O
)-	O
transformed	O
B	O
cell	O
line	O
and	O
the	B-SPECULATION
high	I-SPECULATION
correlation	I-SPECULATION
of	I-SPECULATION
EBV	I-SPECULATION
infection	I-SPECULATION
and	I-SPECULATION
IL-12	I-SPECULATION
expression	I-SPECULATION
has	I-SPECULATION
been	I-SPECULATION
suggested	I-SPECULATION
,	O
no	B-NEGATION
study	I-NEGATION
has	I-NEGATION
reported	I-NEGATION
whether	B-SPECULATION
EBV	I-SPECULATION
infection	I-SPECULATION
is	I-SPECULATION
directly	I-SPECULATION
linked	I-SPECULATION
to	I-SPECULATION
IL-12	I-SPECULATION
expression	I-SPECULATION
.	O

To	O
address	O
this	O
issue	O
,	O
we	O
have	O
investigated	O
IL-12	O
expression	O
in	O
B	O
cells	O
during	O
in	O
vitro	O
transformation	O
with	O
EBV	O
.	O

Human	O
peripheral	O
B	O
cells	O
became	O
capable	O
of	O
constitutively	O
producing	O
p40	O
by	O
in	O
vitro	O
transformation	O
with	O
EBV	O
,	O
coincident	O
with	O
the	O
expression	O
of	O
latent	O
membrane	O
protein	O
1	O
(	O
LMP1	O
)	O
of	O
EBV	O
.	O

These	O
B	O
cells	O
expressed	O
p40	O
and	O
p35	O
mRNA	O
,	O
and	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
stimulation	O
strongly	O
enhanced	O
p40	O
and	O
p70	O
production	O
.	O

Furthermore	O
,	O
transfection	O
with	O
LMP1	O
expression	O
vector	O
into	O
a	O
human	O
B	O
lymphoma	O
cell	O
line	O
,	O
Daudi	O
,	O
led	O
to	O
p40	O
production	O
with	O
nuclear	O
factor	O
(	O
NF	O
)-	O
kappaB	O
activation	O
.	O

These	O
results	O
suggest	B-SPECULATION
that	I-SPECULATION
transformation	I-SPECULATION
of	I-SPECULATION
primary	I-SPECULATION
B	I-SPECULATION
cells	I-SPECULATION
with	I-SPECULATION
EBV	I-SPECULATION
induces	I-SPECULATION
IL-12	I-SPECULATION
expression	I-SPECULATION
potentially	B-SPECULATION
through	I-SPECULATION
LMP1	I-SPECULATION
expression	I-SPECULATION
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Anaphylatoxins	O
C5a	O
and	O
C3a	O
induce	O
nuclear	O
factor	O
kappaB	O
activation	O
in	O
human	O
peripheral	O
blood	O
monocytes	O
.	O

The	O
anaphylatoxins	O
C5a	O
and	O
C3a	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
cytokine	O
production	O
.	O

In	O
this	O
study	O
the	O
capability	O
of	O
C5a	O
and	O
C3a	O
to	O
induce	O
transcription	O
factor	O
activation	O
was	O
examined	O
.	O

C5a	O
and	O
C3a	O
stimulation	O
of	O
human	O
peripheral	O
blood	O
monocytes	O
resulted	O
in	O
nuclear	O
expression	O
of	O
a	O
DNA	O
binding	O
activity	O
with	O
specificity	O
to	O
the	O
kappaB	O
sequence	O
.	O

The	O
p50	O
and	O
p65	O
proteins	O
,	O
constituents	O
of	O
the	O
prototypic	O
nuclear	O
factor	O
kappaB	O
,	O
were	O
identified	O
as	O
components	O
of	O
the	O
DNA-protein	O
complexes	O
by	O
anti-peptide	O
antibodies	O
in	O
gel	O
supershift	O
assays	O
.	O

C5a	O
induced	O
kappaB	O
binding	O
activity	O
was	O
detected	O
15	O
min	O
after	O
agonist	O
stimulation	O
,	O
peaked	O
at	O
30-40	O
min	O
,	O
and	O
remained	O
detectable	O
at	O
2	O
h	O
.	O

Binding	O
to	O
kappaB	O
sequence	O
was	O
accompanied	O
by	O
an	O
initial	O
decrease	O
and	O
subsequent	O
increase	O
in	O
the	O
cytoplasmic	O
IkappaBalpha	O
levels	O
,	O
as	O
detected	O
by	O
Western	O
blotting	O
using	O
an	O
anti-IkappaBalpha	O
antibody	O
.	O

Pertussis	O
toxin	O
treatment	O
markedly	O
decreased	O
kappaB	O
binding	O
activities	O
induced	O
by	O
both	O
C5a	O
and	O
C3a	O
,	O
whereas	O
cholera	O
toxin	O
displayed	O
no	B-NEGATION
inhibitory	I-NEGATION
effect	I-NEGATION
.	O

Neither	B-NEGATION
of	I-NEGATION
the	I-NEGATION
two	I-NEGATION
toxins	I-NEGATION
affected	I-NEGATION
kappaB	I-NEGATION
binding	I-NEGATION
activity	I-NEGATION
induced	I-NEGATION
by	I-NEGATION
TNFalpha	I-NEGATION
in	I-NEGATION
the	I-NEGATION
same	I-NEGATION
cells	I-NEGATION
.	O

These	O
results	O
imply	B-SPECULATION
a	I-SPECULATION
potential	B-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
anaphylatoxins	I-SPECULATION
C5a	I-SPECULATION
and	I-SPECULATION
C3a	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
leukocytes	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
through	I-SPECULATION
G	I-SPECULATION
protein-coupled	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
activation	I-SPECULATION
.	O

Tpl-2	O
induces	O
IL-2	O
expression	O
in	O
T-cell	O
lines	O
by	O
triggering	O
multiple	O
signaling	O
pathways	O
that	O
activate	O
NFAT	O
and	O
NF-kappaB	O
.	O

The	O
Tpl-2	O
kinase	O
activates	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
and	O
induces	O
IL-2	O
expression	O
in	O
T-cell	O
lines	O
.	O

Here	O
we	O
show	O
that	O
the	O
activation	O
of	O
the	O
IL-2	O
promoter	O
by	O
Tpl-2	O
is	O
inhibited	O
by	O
mutant	O
signaling	O
molecules	O
that	O
inhibit	O
the	O
mitogen-activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
or	O
the	O
calcineurin	O
/	O
NFAT	O
pathways	O
and	O
is	O
promoted	O
by	O
combinations	O
of	O
signaling	O
molecules	O
that	O
activate	O
these	O
pathways	O
.	O

We	O
,	O
therefore	O
,	O
conclude	O
that	O
signals	O
generated	O
by	O
the	O
convergence	O
of	O
the	O
MAPK	O
and	O
the	O
calcineurin	O
/	O
NFAT	O
pathway	O
are	O
necessary	O
and	O
sufficient	O
for	O
the	O
activation	O
of	O
the	O
IL-2	O
promoter	O
by	O
Tpl-2	O
.	O

The	O
activation	O
of	O
both	O
the	O
IL-2	O
promoter	O
and	O
an	O
NFAT-driven	O
minimal	O
promoter	O
were	O
shown	O
to	O
depend	O
on	O
signals	O
transduced	O
by	O
Raf1	O
.	O

However	O
,	O
it	O
was	O
only	O
the	O
IL-2	O
promoter	O
whose	O
activation	O
by	O
Tpl-2	O
was	O
fully	O
blocked	O
by	O
the	O
dominant	O
negative	O
mutant	O
MEK1S218	O
/	O
222A	O
and	O
the	O
MEK1	O
/	O
MEK2	O
inhibitor	O
PD098059	O
.	O

Since	O
the	O
activation	O
of	O
NFAT	O
is	O
MAPK-dependent	O
these	O
findings	O
suggested	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
MAPK	I-SPECULATION
by	I-SPECULATION
Tpl-2	I-SPECULATION
is	I-SPECULATION
either	B-SPECULATION
independent	I-SPECULATION
on	O
MEK1	O
and	O
MEK2	O
.	O

In	O
addition	O
,	O
they	O
suggested	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
IL-2	I-SPECULATION
promoter	I-SPECULATION
is	I-SPECULATION
under	I-SPECULATION
the	I-SPECULATION
control	I-SPECULATION
of	I-SPECULATION
not	I-SPECULATION
only	I-SPECULATION
NFAT	I-SPECULATION
but	I-SPECULATION
also	I-SPECULATION
a	I-SPECULATION
second	I-SPECULATION
factor	I-SPECULATION
whose	I-SPECULATION
activation	I-SPECULATION
is	I-SPECULATION
MEK-dependent	I-SPECULATION
.	O

Experiments	O
in	O
COS-1	O
and	O
EL-4	O
cells	O
confirmed	O
both	O
hypotheses	O
and	O
revealed	O
that	O
the	O
second	O
factor	O
activated	O
by	O
Tpl-2	O
is	O
NF-kappaB	O
.	O

While	O
the	O
activation	O
of	O
the	O
IL-2	O
promoter	O
and	O
an	O
NFAT-driven	O
minimal	O
promoter	O
by	O
Tpl-2	O
was	O
fully	O
blocked	O
by	O
the	O
dominant	O
negative	O
mutant	O
NFAT	O
delta418	O
,	O
it	O
was	O
only	O
partially	O
blocked	O
by	O
the	O
calcineurin	O
inhibitor	O
cyclosporin	O
A	O
suggesting	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
Tpl-2-mediated	I-SPECULATION
NFAT	I-SPECULATION
activation	I-SPECULATION
is	I-SPECULATION
under	I-SPECULATION
the	I-SPECULATION
control	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
combination	I-SPECULATION
of	I-SPECULATION
calcineurin-dependent	I-SPECULATION
and	I-SPECULATION
independent	I-SPECULATION
pathways	I-SPECULATION
.	O

Both	O
pathways	O
were	O
fully	O
blocked	O
by	O
Bcl-2	O
or	O
Bcl-X	O
(	O
L	O
)	O
.	O

Activation	O
of	O
human	O
macrophages	O
by	O
mechanical	O
ventilation	O
in	O
vitro	O
.	O

Positive-pressure	O
mechanical	O
ventilation	O
supports	O
gas	O
exchange	O
in	O
patients	O
with	O
respiratory	O
failure	O
but	O
is	O
also	O
responsible	O
for	O
significant	O
lung	O
injury	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
developed	O
an	O
in	O
vitro	O
model	O
in	O
which	O
isolated	O
lung	O
cells	O
can	O
be	O
submitted	O
to	O
a	O
prolonged	O
cyclic	O
pressure-stretching	O
strain	O
resembling	O
that	O
of	O
conventional	O
mechanical	O
ventilation	O
.	O

In	O
this	O
model	O
,	O
cells	O
cultured	O
on	O
a	O
Silastic	O
membrane	O
were	O
elongated	O
up	O
to	O
7	O
%	O
of	O
their	O
initial	O
diameter	O
,	O
corresponding	O
to	O
a	O
12	O
%	O
increase	O
in	O
cell	O
surface	O
.	O

The	O
lung	O
macrophage	O
was	O
identified	O
as	O
the	O
main	O
cellular	O
source	O
for	O
critical	O
inflammatory	O
mediators	O
such	O
as	O
tumor	O
necrosis	O
factor-alpha	O
,	O
the	O
chemokines	O
interleukin	O
(	O
IL	O
)-	O
8	O
and	O
-	O
6	O
,	O
and	O
matrix	O
metalloproteinase-9	O
in	O
this	O
model	O
system	O
of	O
mechanical	O
ventilation	O
.	O

These	O
mediators	O
were	O
measured	O
in	O
supernatants	O
from	O
ventilated	O
alveolar	O
macrophages	O
,	O
monocyte-derived	O
macrophages	O
,	O
and	O
promonocytic	O
THP-1	O
cells	O
.	O

Nuclear	O
factor-kappaB	O
was	O
found	O
to	O
be	O
activated	O
in	O
ventilated	O
macrophages	O
.	O

Synergistic	O
proinflammatory	O
effects	O
of	O
mechanical	O
stress	O
and	O
molecules	O
such	O
as	O
bacterial	O
endotoxin	O
were	O
observed	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
mechanical	I-SPECULATION
ventilation	I-SPECULATION
might	B-SPECULATION
be	I-SPECULATION
particularly	I-SPECULATION
deleterious	I-SPECULATION
in	I-SPECULATION
preinjured	I-SPECULATION
or	I-SPECULATION
infected	I-SPECULATION
lungs	I-SPECULATION
.	O

Dexamethasone	O
prevented	O
IL-8	O
and	O
tumor	O
necrosis	O
factor-alpha	O
secretion	O
in	O
ventilated	O
macrophages	O
.	O

Mechanical	O
ventilation	O
induced	O
low	O
levels	O
of	O
IL-8	O
secretion	O
by	O
alveolar	O
type	O
II-like	O
cells	O
.	O

Other	O
lung	O
cell	O
types	O
such	O
as	O
endothelial	O
cells	O
,	O
bronchial	O
cells	O
,	O
and	O
fibroblasts	O
failed	B-NEGATION
to	I-NEGATION
produce	I-NEGATION
IL-8	I-NEGATION
in	I-NEGATION
response	I-NEGATION
to	I-NEGATION
a	I-NEGATION
prolonged	I-NEGATION
cyclic	I-NEGATION
pressure-stretching	I-NEGATION
load	I-NEGATION
.	O

This	O
model	O
is	O
of	O
particular	O
value	O
for	O
exploring	O
physical	O
stress-induced	O
signaling	O
pathways	O
,	O
as	O
well	O
as	O
for	O
testing	O
the	O
effects	O
of	O
novel	O
ventilatory	O
strategies	O
or	O
adjunctive	O
substances	O
aimed	O
at	O
modulating	O
cell	O
activation	O
induced	O
by	O
mechanical	O
ventilation	O
.	O

Stat6	O
inhibits	O
human	O
interleukin-4	O
promoter	O
activity	O
in	O
T	O
cells	O
.	O

The	O
differentiation	O
of	O
naive	O
T-helper	O
(	O
Th	O
)	O
cells	O
into	O
cytokine-secreting	O
effector	O
Th	O
cells	O
requires	O
exposure	O
to	O
multiple	O
signals	O
,	O
including	O
exogenous	O
cytokines	O
.	O

Interleukin-4	O
(	O
IL-4	O
)	O
plays	O
a	O
major	O
role	O
in	O
this	O
process	O
by	O
promoting	O
the	O
differentiation	O
of	O
IL-4-secreting	O
Th2	O
cells	O
.	O

In	O
Th2	O
cells	O
,	O
IL-4	O
gene	O
expression	O
is	O
tightly	O
controlled	O
at	O
the	O
level	O
of	O
transcription	O
by	O
the	O
coordinated	O
binding	O
of	O
multiple	O
transcription	O
factors	O
to	O
regulatory	O
elements	O
in	O
the	O
proximal	O
promoter	O
region	O
.	O

Nuclear	O
factor	O
of	O
activated	O
T	O
cell	O
(	O
NFAT	O
)	O
family	O
members	O
play	O
a	O
critical	O
role	O
in	O
regulating	O
IL-4	O
transcription	O
and	O
interact	O
with	O
up	O
to	O
five	O
sequences	O
(	O
termed	O
P0	O
through	O
P4	O
)	O
in	O
the	O
IL-4	O
promoter	O
.	O

The	B-SPECULATION
molecular	I-SPECULATION
mechanisms	I-SPECULATION
by	I-SPECULATION
which	I-SPECULATION
IL-4	I-SPECULATION
induces	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
IL-4	I-SPECULATION
gene	I-SPECULATION
are	I-SPECULATION
not	I-SPECULATION
known	I-SPECULATION
,	O
although	O
the	O
IL-4-activated	O
transcription	O
factor	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
6	O
(	O
Stat6	O
)	O
is	O
required	O
for	O
this	O
effect	O
.	O

We	O
report	O
here	O
that	O
Stat6	O
interacts	O
with	O
three	O
binding	O
sites	O
in	O
the	O
human	O
IL-4	O
promoter	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

These	O
sites	O
overlap	O
the	O
P1	O
,	O
P2	O
,	O
and	O
P4	O
NFAT	O
elements	O
.	O

To	O
investigate	O
the	O
role	O
of	O
Stat6	O
in	O
regulating	O
IL-4	O
transcription	O
,	O
we	O
used	O
Stat6-deficient	O
Jurkat	O
T	O
cells	O
with	O
different	O
intact	O
IL-4	O
promoter	O
constructs	O
in	O
cotransfection	O
assays	O
.	O

We	O
show	O
that	O
,	O
whereas	O
a	O
multimerized	O
response	O
element	O
from	O
the	O
germline	O
IgE	O
promoter	O
was	O
highly	O
induced	O
by	O
IL-4	O
in	O
Stat6-expressing	O
Jurkat	O
cells	O
,	O
the	O
intact	O
human	O
IL-4	O
promoter	O
was	O
repressed	O
under	O
similar	O
conditions	O
.	O

We	O
conclude	O
that	O
the	O
function	O
of	O
Stat6	O
is	O
highly	O
dependent	O
on	O
promoter	O
context	O
and	O
that	O
this	O
factor	O
promotes	O
IL-4	O
gene	O
expression	O
in	O
an	O
indirect	O
manner	O
.	O

Interleukin-10	O
and	O
transforming	O
growth	O
factor-beta	O
promoter	O
polymorphisms	O
in	O
allergies	O
and	O
asthma	O
.	O

Interleukin-10	O
(	O
IL-10	O
)	O
and	O
transforming	O
growth	O
factor	O
beta	O
(	O
TGF-beta	O
)	O
are	O
inhibitory	O
for	O
B	O
and	O
T	O
cells	O
,	O
IgE	O
production	O
,	O
and	O
mast	O
cell	O
proliferation	O
,	O
and	O
they	O
induce	O
apoptosis	O
in	O
eosinophils	O
.	O

These	O
cytokines	O
are	O
therefore	O
candidate	O
genes	O
which	O
could	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
development	I-SPECULATION
of	I-SPECULATION
asthma	I-SPECULATION
or	I-SPECULATION
allergies	I-SPECULATION
.	O

We	O
investigated	O
the	O
hypothesis	B-SPECULATION
that	I-SPECULATION
polymorphic	I-SPECULATION
nucleotides	I-SPECULATION
within	I-SPECULATION
the	I-SPECULATION
IL-10	I-SPECULATION
and	I-SPECULATION
TGF-beta	I-SPECULATION
gene	I-SPECULATION
promoters	I-SPECULATION
would	B-SPECULATION
link	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
allergies	I-SPECULATION
and	I-SPECULATION
asthma	I-SPECULATION
.	O

DNA	O
taken	O
from	O
families	O
with	O
an	O
asthmatic	O
proband	O
was	O
examined	O
for	O
base	O
exchanges	O
by	O
single-stranded	O
conformational	O
polymorphism	O
(	O
SSCP	O
)	O
.	O

We	O
demonstrated	O
the	O
presence	O
of	O
a	O
polymorphism	O
in	O
the	O
promoter	O
region	O
of	O
the	O
IL-10	O
gene	O
and	O
four	O
in	O
the	O
TGF-beta	O
gene	O
promoters	O
(	O
3	O
in	O
TGF-beta1	O
and	O
1	O
in	O
TGF-beta2	O
)	O
.	O

The	O
IL-10	O
gene	O
polymorphism	O
was	O
a	O
C-to-A	O
exchange	O
571	O
base	O
pairs	O
upstream	O
from	O
the	O
translation	O
start	O
site	O
and	O
was	O
present	O
between	O
consensus	O
binding	O
sequences	O
for	O
Sp1	O
and	O
elevated	O
total	O
serum	O
.	O

This	O
polymorphism	O
was	O
associated	O
with	O
elevated	O
total	O
serum	O
IgE	O
in	O
subjects	O
heterozygotic	O
or	O
homozygotic	O
for	O
this	O
base	O
exchange	O
(	O
p	O
<	O
0.009	O
)	O
.	O

The	O
base	O
exchange	O
at	O
-	O
509	O
(	O
from	O
the	O
transcription	O
initiation	O
site	O
)	O
in	O
the	O
TGF-beta	O
promoter	O
also	O
linked	O
to	O
elevated	O
total	O
IgE	O
(	O
p	O
<	O
0.01	O
)	O
.	O

This	O
polymorphism	O
represented	O
a	O
C-to-T	O
base	O
exchange	O
which	O
induced	O
a	O
YY1	O
consensus	O
sequence	O
and	O
is	O
present	O
in	O
a	O
region	O
of	O
the	O
promoter	O
associated	O
with	O
negative	O
transcription	O
regulation	O
.	O

The	O
involvement	O
of	O
multiple	O
tumor	O
necrosis	O
factor	O
receptor	O
(	O
TNFR	O
)-	O
associated	O
factors	O
in	O
the	O
signaling	O
mechanisms	O
of	O
receptor	O
activator	O
of	O
NF-kappaB	O
,	O
a	O
member	O
of	O
the	O
TNFR	O
superfamily	O
.	O

Receptor	O
activator	O
of	O
NF-kappaB	O
(	O
RANK	O
)	O
is	O
a	O
recently	O
identified	O
member	O
of	O
the	O
tumor	O
necrosis	O
factor	O
receptor	O
superfamily	O
and	O
is	O
expressed	O
on	O
activated	O
T	O
cells	O
and	O
dendritic	O
cells	O
.	O

Its	O
cognate	O
ligand	O
(	O
RANKL	O
)	O
plays	O
significant	O
roles	O
in	O
the	O
activation	O
of	O
dendritic	O
cell	O
function	O
and	O
osteoclast	O
differentiation	O
.	O

We	O
demonstrate	O
here	O
the	O
interaction	O
of	O
RANK	O
with	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
factors	O
(	O
TRAFs	O
)	O
1	O
,	O
2	O
,	O
3	O
,	O
5	O
,	O
and	O
6	O
both	O
in	O
vitro	O
and	O
in	O
cells	O
.	O

Mapping	O
of	O
the	O
structural	O
requirements	O
for	O
TRAF	O
/	O
RANK	O
interaction	O
revealed	O
multiple	O
TRAF	O
binding	O
sites	O
clustered	O
in	O
two	O
distinct	O
domains	O
in	O
the	O
RANK	O
cytoplasmic	O
tail	O
.	O

These	O
TRAF	O
binding	O
domains	O
were	O
shown	O
to	O
be	O
functionally	O
important	O
for	O
the	O
RANK-dependent	O
induction	O
of	O
NF-kappaB	O
and	O
c-Jun	O
NH2-terminal	O
kinase	O
activities	O
.	O

Site-directed	O
mutagenesis	O
demonstrated	O
that	O
these	O
TRAF	O
binding	O
sites	O
exhibited	O
selective	O
binding	O
for	O
different	O
TRAF	O
proteins	O
.	O

In	O
particular	O
,	O
TRAF6	O
interacted	O
with	O
membrane-proximal	O
determinants	O
distinct	O
from	O
those	O
binding	O
TRAFs	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
5	O
.	O

When	O
this	O
membrane-proximal	O
TRAF6	O
interaction	O
domain	O
was	O
deleted	O
,	O
RANK-mediated	O
NF-kappaB	O
signaling	O
was	O
completely	O
inhibited	O
while	O
c-Jun	O
NH2-terminal	O
kinase	O
activation	O
was	O
partially	O
inhibited	O
.	O

An	O
NH2-terminal	O
truncation	O
mutant	O
of	O
TRAF6	O
inhibited	O
RANKL-mediated	O
NF-kappaB	O
activation	O
,	O
but	O
failed	B-NEGATION
to	I-NEGATION
affect	I-NEGATION
constitutive	I-NEGATION
signaling	I-NEGATION
induced	I-NEGATION
by	I-NEGATION
receptor	I-NEGATION
overexpression	I-NEGATION
,	O
revealing	O
a	O
selective	O
role	O
for	O
TRAF6	O
in	O
ligand-induced	O
activation	O
events	O
.	O

The	O
control	O
of	O
lytic	O
replication	O
of	O
Epstein-Barr	O
virus	O
in	O
B	O
lymphocytes	O
(	O
Review	O
)	O
.	O

Uncontrolled	O
replication	O
of	O
a	O
virus	O
,	O
which	O
is	O
harmful	O
to	O
the	O
host	O
is	O
also	O
disadvantageous	O
to	O
the	O
virus	O
.	O

Most	O
viruses	O
cannot	B-NEGATION
compete	I-NEGATION
with	I-NEGATION
the	I-NEGATION
various	I-NEGATION
immune	I-NEGATION
mechanisms	I-NEGATION
and	O
become	O
eliminated	O
in	O
the	O
course	O
of	O
infection	O
.	O

Therefore	O
,	O
only	O
the	O
time	O
between	O
infection	O
and	O
eradication	O
remains	O
for	O
these	O
viruses	O
to	O
proliferate	O
.	O

A	O
few	O
viruses	O
,	O
like	O
the	O
Herpesviruses	O
or	O
the	O
papillomaviruses	O
,	O
however	O
,	O
have	O
developed	O
a	O
sophisticated	O
strategy	O
for	O
persisting	O
lifelong	O
,	O
usually	O
asymptomatically	O
in	O
the	O
host	O
,	O
hiding	O
from	O
the	O
immune	O
system	O
and	O
producing	O
infectious	O
progeny	O
at	O
the	O
same	O
time	O
.	O

This	O
strategy	O
depends	O
on	O
a	O
separation	O
of	O
latency	O
and	O
the	O
lytic	O
replication	O
,	O
either	O
by	O
time	O
due	O
to	O
differentiation-dependent	O
mechanisms	O
or	O
by	O
spatial	O
separation	O
as	O
the	O
result	O
of	O
different	O
host	O
cell	O
types	O
.	O

Both	O
are	O
true	O
for	O
the	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
.	O

B	O
cells	O
and	O
epithelial	O
cells	O
have	O
a	O
pivotal	O
role	O
in	O
the	O
life	O
cycle	O
of	O
the	O
virus	O
.	O

The	O
former	O
can	O
become	O
latently	O
infected	O
and	O
are	B-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
the	I-SPECULATION
virus	I-SPECULATION
reservoir	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
,	O
whereas	O
the	O
latter	O
were	O
shown	O
to	O
be	O
permissive	O
for	O
lytic	O
replication	O
.	O

However	O
,	O
replication	O
of	O
EBV	O
in	O
vivo	O
is	O
controlled	O
primarily	O
by	O
host	O
immune	O
mechanisms	O
selecting	O
for	O
cells	O
that	O
are	O
not	B-NEGATION
permissive	I-NEGATION
for	I-NEGATION
viral	I-NEGATION
replication	I-NEGATION
as	O
the	O
result	O
of	O
a	O
particular	O
set	O
of	O
transcription	O
factors	O
.	O

These	O
factors	O
control	O
the	O
activity	O
of	O
the	O
regulatory	O
immediate-early	O
genes	O
and	O
,	O
in	O
addition	O
,	O
lytic	O
and	O
latent	O
cycle	O
regulatory	O
genes	O
negatively	O
interfere	O
with	O
each	O
other	O
and	O
thus	O
link	O
cellular	O
and	O
viral	O
gene	O
regulatory	O
mechanisms	O
.	O

Disturbance	O
of	O
both	O
the	O
immune	O
surveillance	O
as	O
well	O
as	O
viral	O
gene	O
regulation	O
may	B-SPECULATION
result	I-SPECULATION
in	I-SPECULATION
EBV-associated	I-SPECULATION
disease	I-SPECULATION
.	O

Human	O
immunodeficiency	O
virus	O
type-1	O
transcription	O
:	O
role	O
of	O
the	O
5	O
'-	O
untranslated	O
leader	O
region	O
(	O
review	O
)	O
.	O

Human	O
immunodeficiency	O
virus	O
type-1	O
(	O
HIV-1	O
)	O
transcription	O
is	O
dependent	O
on	O
the	O
interaction	O
of	O
host-cell	O
transcription	O
factors	O
with	O
cis-regulatory	O
DNA	O
elements	O
within	O
the	O
viral	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

Much	O
attention	O
has	O
focused	O
on	O
the	O
series	O
of	O
sequence	O
elements	O
upstream	O
of	O
the	O
transcriptional	O
initiation	O
site	O
in	O
the	O
U3	O
region	O
of	O
the	O
LTR	O
including	O
the	O
Sp1	O
and	O
NF-kappaB	O
binding	O
sites	O
.	O

Recent	O
studies	O
,	O
however	O
,	O
demonstrate	O
that	O
the	O
transcribed	O
5	O
'-	O
untranslated	O
leader	O
region	O
(	O
5	O
'-	O
UTR	O
)	O
also	O
contains	O
important	O
transcriptional	O
elements	O
.	O

These	O
regulatory	O
elements	O
situated	O
downstream	O
of	O
transcription	O
interact	O
with	O
constitutive	O
and	O
inducible	O
transcription	O
factors	O
,	O
mediate	O
transmission	O
of	O
cellular	O
activation	O
signals	O
,	O
and	O
are	O
important	O
for	O
efficient	O
HIV-1	O
transcription	O
and	O
replication	O
.	O

The	O
5	O
'-	O
UTR	O
contains	O
binding	O
sites	O
for	O
the	O
transcription	O
factors	O
AP-1	O
,	O
NF-kappaB	O
,	O
NF-AT	O
,	O
IRF	O
,	O
and	O
Sp1	O
.	O

Mutations	O
in	O
these	O
binding	O
sites	O
can	O
interfere	O
with	O
the	O
viral	O
response	O
to	O
cell	O
activation	O
signals	O
,	O
decrease	O
LTR	O
transcription	O
,	O
and	O
inhibit	O
viral	O
replication	O
.	O

The	O
5	O
'-	O
UTR	O
also	O
interacts	O
with	O
a	O
specific	O
nucleosome	O
that	O
is	O
rapidly	O
displaced	O
during	O
transcriptional	O
activation	O
of	O
the	O
latent	O
provirus	O
.	O

We	O
propose	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
inducible	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
binding	I-SPECULATION
sites	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
5	I-SPECULATION
'-	I-SPECULATION
UTR	I-SPECULATION
comprise	I-SPECULATION
a	I-SPECULATION
downstream	I-SPECULATION
enhancer	I-SPECULATION
domain	I-SPECULATION
that	I-SPECULATION
can	I-SPECULATION
function	I-SPECULATION
independent	B-SPECULATION
of	I-SPECULATION
,	I-SPECULATION
or	I-SPECULATION
in	I-SPECULATION
concert	I-SPECULATION
with	I-SPECULATION
,	O
the	O
LTR	O
promoter	O
to	O
rapidly	O
increase	O
latent	O
proviral	O
transcription	O
in	O
response	O
to	O
cell	O
activation	O
signals	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
the	O
host-cell	O
transcription	O
factors	O
that	O
interact	O
with	O
the	O
5	O
'-	O
UTR	O
and	O
discuss	O
their	O
role	O
in	O
the	O
transcriptional	O
regulation	O
of	O
HIV-1	O
gene	O
expression	O
.	O

Molecular	O
cloning	O
of	O
FKHRL1P2	O
,	O
a	O
member	O
of	O
the	O
developmentally	O
regulated	O
fork	O
head	O
domain	O
transcription	O
factor	O
family	O
.	O

Here	O
we	O
report	O
the	O
expression	O
of	O
a	O
fork	O
head	O
domain	O
protein	O
in	O
human	O
T	O
helper	O
cells	O
.	O

We	O
cloned	O
and	O
characterized	O
a	O
fork	O
head	O
cDNA	O
from	O
human	O
T	O
helper	O
cell	O
mRNA	O
using	O
differential	O
display	O
RT-PCR	O
.	O

The	O
cDNA	O
contains	O
a	O
546-nucleotide	O
(	O
nt	O
)	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
that	O
codes	O
for	O
the	O
carboxyl-terminal	O
180	O
amino	O
acids	O
(	O
aa	O
)	O
of	O
the	O
recently	O
identified	O
fkhrl1	O
gene	O
.	O

This	O
ORF	O
does	O
not	B-NEGATION
contain	I-NEGATION
the	I-NEGATION
characteristic	I-NEGATION
DNA-binding	I-NEGATION
domain	I-NEGATION
found	I-NEGATION
in	I-NEGATION
members	I-NEGATION
of	I-NEGATION
the	I-NEGATION
forkhead	I-NEGATION
protein	I-NEGATION
family	I-NEGATION
.	O

In-vitro	O
transcription	O
/	O
translation	O
of	O
this	O
cDNA	O
expressed	O
a	O
protein	O
of	O
approximately	O
20	O
kDa	O
.	O

We	O
have	O
generated	O
antibodies	O
that	O
specifically	O
immunoprecipitated	O
the	O
in-vitro-translated	O
20-kDa	O
protein	O
.	O

This	O
antibody	O
also	O
recognizes	O
in	O
human	O
T	O
lymphocytes	O
a	O
70-kDa	O
protein	O
corresponding	O
in	O
size	O
to	O
that	O
predicted	O
for	O
the	O
fkhrl1	O
gene	O
product	O
.	O

The	O
mRNA	O
levels	O
for	O
fkhrl1	O
is	O
elevated	O
in	O
T	O
helper-induced	O
lymphocytes	O
in	O
comparison	O
to	O
PHA-stimulated	O
T	O
lymphocytes	O
.	O

Further	O
characterization	O
of	O
FKHRL1	O
and	O
its	O
related	O
family	O
members	O
should	B-SPECULATION
shed	I-SPECULATION
light	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
transcriptional	I-SPECULATION
mechanisms	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
fork	I-SPECULATION
head	I-SPECULATION
gene	I-SPECULATION
subfamily	I-SPECULATION
and	I-SPECULATION
their	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
T	I-SPECULATION
helper	I-SPECULATION
cell	I-SPECULATION
differentiation	I-SPECULATION
and	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
cell	I-SPECULATION
growth	I-SPECULATION
.	O

Activation	O
of	O
the	O
human	O
delta-globin	O
gene	O
promoter	O
in	O
primary	O
adult	O
erythroid	O
cells	O
.	O

Restoration	O
of	O
the	O
CCAAT	O
box	O
or	O
insertion	O
of	O
an	O
erythroid	O
Kruppel-like	O
factor	O
(	O
EKLF	O
)	O
binding	O
site	O
in	O
the	O
delta	O
promoter	O
activates	O
its	O
expression	O
in	O
several	O
erythroid	O
cell	O
lines	O
.	O

We	O
extended	O
these	O
studies	O
using	O
a	O
novel	O
primary	O
human	O
adult	O
erythroid	O
cell	O
(	O
hAEC	O
)	O
system	O
to	O
investigate	O
these	O
effects	O
at	O
the	O
late	O
erythroblast	O
stage	O
.	O

Restoration	O
of	O
the	O
CCAAT	O
box	O
at	O
-	O
70	O
bp	O
,	O
or	O
insertion	O
of	O
an	O
EKLF	O
binding	O
site	O
at	O
-	O
85	O
bp	O
or	O
-	O
95	O
bp	O
in	O
the	O
promoter	O
significantly	O
increased	O
delta	O
globin	O
gene	O
expression	O
in	O
hAEC	O
.	O

Our	O
results	O
demonstrate	O
that	O
the	O
altered	O
CCAAT	O
box	O
(	O
CCAAC	O
)	O
and	O
the	O
lack	B-NEGATION
of	I-NEGATION
an	I-NEGATION
EKLF	I-NEGATION
binding	I-NEGATION
site	I-NEGATION
in	I-NEGATION
delta-globin	I-NEGATION
contribute	O
to	O
its	O
low	O
level	O
of	O
expression	O
in	O
the	O
hAEC	O
model	O
as	O
well	O
.	O

Interactions	O
between	O
the	O
class	O
II	O
transactivator	O
and	O
CREB	O
binding	O
protein	O
increase	O
transcription	O
of	O
major	O
histocompatibility	O
complex	O
class	O
II	O
genes	O
.	O

Class	O
II	O
major	O
histocompatibility	O
(	O
class	O
II	O
)	O
genes	O
are	O
regulated	O
in	O
a	O
B-cell-specific	O
and	O
gamma	O
interferon-inducible	O
fashion	O
.	O

The	O
master	O
switch	O
for	O
the	O
expression	O
of	O
these	O
genes	O
is	O
the	O
class	O
II	O
transactivator	O
(	O
CIITA	O
)	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
one	O
of	O
the	O
functions	O
of	O
CIITA	O
is	O
to	O
recruit	O
the	O
CREB	O
binding	O
protein	O
(	O
CBP	O
)	O
to	O
class	O
II	O
promoters	O
.	O

Not	O
only	O
functional	O
but	O
also	O
specific	O
binding	O
interactions	O
between	O
CIITA	O
and	O
CBP	O
were	O
demonstrated	O
.	O

Moreover	O
,	O
a	O
dominant	O
negative	O
form	O
of	O
CBP	O
decreased	O
the	O
activity	O
of	O
class	O
II	O
promoters	O
and	O
levels	O
of	O
class	O
II	O
determinants	O
on	O
the	O
surface	O
of	O
cells	O
.	O

Finally	O
,	O
the	O
inhibition	O
of	O
class	O
II	O
gene	O
expression	O
by	O
the	O
glucocorticoid	O
hormone	O
could	O
be	O
attributed	O
to	O
the	O
squelching	O
of	O
CBP	O
by	O
the	O
glucocorticoid	O
receptor	O
.	O

We	O
conclude	O
that	O
CBP	O
,	O
a	O
histone	O
acetyltransferase	O
,	O
plays	O
an	O
important	O
role	O
in	O
the	O
transcription	O
of	O
class	O
II	O
genes	O
.	O

Nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
and	O
AP-1	O
are	O
insufficient	O
for	O
IL-2	O
promoter	O
activation	O
:	O
requirement	O
for	O
CD28	O
up-regulation	O
of	O
RE	O
/	O
AP	O
.	O

IL-2	O
gene	O
transcription	O
in	O
T	O
cells	O
requires	O
both	O
TCR	O
and	O
costimulatory	O
signals	O
.	O

IL-2	O
promoter	O
activation	O
in	O
Jurkat	O
T	O
cells	O
stimulated	O
with	O
superantigen	O
presented	O
by	O
Raji	O
B	O
cells	O
requires	O
CD28	O
activation	O
.	O

The	O
addition	O
of	O
rCTLA4Ig	O
,	O
which	O
blocks	O
CD28	O
binding	O
to	O
its	O
ligand	O
,	O
to	O
the	O
cultures	O
decreased	O
IL-2	O
promoter	O
activation	O
by	O
>	O
80	O
%	O
.	O

Interestingly	O
,	O
CTLA4Ig	O
did	O
not	O
significantly	O
inhibit	O
the	O
activation	O
of	O
either	O
NF	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
or	O
AP-1	O
reporters	O
.	O

Therefore	O
,	O
activation	O
of	O
NFAT	O
and	O
AP-1	O
is	O
insufficient	O
for	O
IL-2	O
promoter	O
activation	O
.	O

In	O
contrast	O
,	O
an	O
RE	O
/	O
AP	O
reporter	O
was	O
blocked	O
by	O
CTLA4Ig	O
by	O
>	O
90	O
%	O
.	O

Thus	O
,	O
the	B-SPECULATION
requirement	I-SPECULATION
for	I-SPECULATION
CD28	I-SPECULATION
in	I-SPECULATION
IL-2	I-SPECULATION
promoter	I-SPECULATION
activation	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
due	I-SPECULATION
to	I-SPECULATION
RE	I-SPECULATION
/	I-SPECULATION
AP	I-SPECULATION
and	I-SPECULATION
not	B-NEGATION
the	I-NEGATION
NFAT	I-NEGATION
or	I-NEGATION
AP-1	I-NEGATION
sites	I-NEGATION
.	O

In	O
addition	O
,	O
these	O
data	O
suggest	B-SPECULATION
that	I-SPECULATION
transcriptional	B-NEGATION
activation	I-NEGATION
of	I-NEGATION
RE	I-NEGATION
/	I-NEGATION
AP	I-NEGATION
is	I-NEGATION
not	I-NEGATION
mediated	I-NEGATION
by	I-NEGATION
NFAT	I-NEGATION
,	O
because	O
activation	B-NEGATION
of	I-NEGATION
a	I-NEGATION
NFAT	I-NEGATION
reporter	I-NEGATION
is	I-NEGATION
not	I-NEGATION
affected	I-NEGATION
by	I-NEGATION
the	I-NEGATION
addition	I-NEGATION
of	I-NEGATION
CTLA4Ig	I-NEGATION
.	O

Phenylarsine	O
oxide	O
inhibits	O
ex	O
vivo	O
HIV-1	O
expression	O
.	O

Phenylarsine	O
oxide	O
(	O
PAO	O
)	O
,	O
which	O
is	O
described	O
as	O
an	O
inhibitor	O
of	O
tyrosine	O
phosphatase	O
activity	O
,	O
inhibits	O
H2O2	O
release	O
from	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
as	O
measured	O
by	O
electrochemistry	O
.	O

Since	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
is	O
known	O
to	O
be	O
favored	O
under	O
oxidative	O
stress	O
conditions	O
,	O
ex	O
vivo	O
experiments	O
using	O
uninfected	O
PBMCs	O
,	O
primary	O
monocytes	O
or	O
a	O
latently	O
infected	O
promonocytic	O
U1	O
cell	O
line	O
show	O
that	O
HIV-1	O
replication	O
and	O
reactivation	O
,	O
monitored	O
by	O
p24	O
antigen	O
measurement	O
,	O
are	O
inhibited	O
by	O
PAO	O
in	O
a	O
time	O
-	O
and	O
concentration-dependent	O
manner	O
.	O

These	O
observations	O
can	O
be	O
linked	O
with	O
the	O
inhibition	O
of	O
NF-kappa	O
B	O
activation	O
when	O
uninfected	O
monocytes	O
are	O
induced	O
by	O
either	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

Interleukin-10	O
stabilizes	O
inhibitory	O
kappaB-alpha	O
in	O
human	O
monocytes	O
.	O

Interleukin-10	O
(	O
IL-10	O
)	O
protects	O
animals	O
from	O
lethal	O
endotoxemia	O
.	O

This	O
beneficial	O
effect	O
is	O
mediated	O
,	O
in	O
part	O
,	O
by	O
inhibition	O
of	O
inflammatory	O
cytokine	O
production	O
,	O
including	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
.	O

Evidence	O
suggests	B-SPECULATION
that	I-SPECULATION
IL-10	I-SPECULATION
may	B-SPECULATION
inhibit	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
nuclear	I-SPECULATION
factor-kappaB	I-SPECULATION
(	I-SPECULATION
NF-kappaB	I-SPECULATION
)	I-SPECULATION
through	I-SPECULATION
an	I-SPECULATION
unknown	B-SPECULATION
mechanism	I-SPECULATION
.	O

NF-kappaB	O
activation	O
in	O
response	O
to	O
inflammatory	O
signals	O
is	O
dependent	O
upon	O
degradation	O
of	O
its	O
associated	O
inhibitory	O
peptide	O
,	O
inhibitory	O
kappaB-alpha	O
(	O
IkappaB-alpha	O
)	O
.	O

We	O
hypothesized	B-SPECULATION
that	I-SPECULATION
IL-10	I-SPECULATION
prevents	I-SPECULATION
human	I-SPECULATION
monocyte	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
and	I-SPECULATION
resultant	I-SPECULATION
TNF-alpha	I-SPECULATION
production	I-SPECULATION
by	I-SPECULATION
stabilization	I-SPECULATION
of	I-SPECULATION
IkappaB-alpha	I-SPECULATION
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effect	O
of	O
IL-10	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
human	O
monocyte	O
TNF-alpha	O
production	O
,	O
NF-kappaB	O
activation	O
,	O
and	O
IkappaB-alpha	O
degradation	O
.	O

Monocytes	O
were	O
isolated	O
from	O
human	O
donors	O
.	O

Cells	O
were	O
stimulated	O
with	O
endotoxin	O
(	O
LPS	O
,	O
100	O
ng	O
/	O
mL	O
)	O
with	O
and	O
without	B-NEGATION
human	I-NEGATION
IL-10	I-NEGATION
(	I-NEGATION
10	I-NEGATION
ng	I-NEGATION
/	I-NEGATION
mL	I-NEGATION
)	I-NEGATION
.	O

Following	O
stimulation	O
,	O
TNF-alpha	O
was	O
measured	O
in	O
cell	O
supernatants	O
by	O
ELISA	O
,	O
NF-kappaB	O
activity	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
and	O
IkappaB-alpha	O
levels	O
by	O
Western	O
blot	O
.	O

We	O
observed	O
that	O
after	O
LPS	O
stimulation	O
of	O
human	O
monocytes	O
,	O
TNF-alpha	O
increased	O
to	O
798	O
+/-	O
67	O
pg	O
/	O
mL	O
(	O
p	O
<	O
.	O
001	O
versus	O
control	O
)	O
.	O

IL-10	O
attenuated	O
LPS-stimulated	O
TNF-alpha	O
production	O
(	O
297	O
+/-	O
54	O
;	O
p	O
<	O
.	O
001	O
versus	O
LPS	O
alone	O
)	O
.	O

After	O
LPS	O
stimulation	O
in	O
human	O
monocytes	O
,	O
IkappaB-alpha	O
protein	O
levels	O
decreased	O
,	O
and	O
NF-kappaB	O
DNA	O
binding	O
increased	O
.	O

IL-10	O
pretreatment	O
prevented	O
LPS-induced	O
decreases	O
in	O
IkappaB-alpha	O
protein	O
levels	O
and	O
attenuated	O
NF-kappaB	O
DNA	O
binding	O
.	O

IL-10	B-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
prevent	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
NF-kappaB	I-SPECULATION
by	I-SPECULATION
preserving	I-SPECULATION
IkappaB-alpha	I-SPECULATION
protein	I-SPECULATION
levels	I-SPECULATION
,	I-SPECULATION
leading	I-SPECULATION
to	I-SPECULATION
a	I-SPECULATION
reduction	I-SPECULATION
in	I-SPECULATION
TNF-alpha	I-SPECULATION
release	I-SPECULATION
.	O

Regulation	O
of	O
fas-ligand	O
expression	O
during	O
activation-induced	O
cell	O
death	O
in	O
T	O
lymphocytes	O
via	O
nuclear	O
factor	O
kappaB	O
.	O

T	O
cell	O
receptor	O
engagement	O
activates	O
transcription	O
factors	O
important	O
for	O
cytokine	O
gene	O
regulation	O
.	O

Additionally	O
,	O
this	O
signaling	O
pathway	O
also	O
leads	O
to	O
activation-induced	O
apoptosis	O
in	O
T	O
lymphocytes	O
that	O
is	O
dependent	O
on	O
FasL	O
transcription	O
and	O
expression	O
.	O

Here	O
we	O
demonstrate	O
that	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)	O
,	O
which	O
is	O
involved	O
in	O
the	O
transcriptional	O
regulation	O
of	O
many	O
cytokine	O
genes	O
expressed	O
in	O
activated	O
lymphocytes	O
,	O
also	O
plays	O
a	O
role	O
in	O
T	O
cell	O
activation-induced	O
FasL	O
expression	O
.	O

Inhibition	O
of	O
NF-kappaB	O
activity	O
in	O
a	O
T	O
cell	O
hybridoma	O
leads	O
to	O
decreased	O
FasL	O
expression	O
and	O
apoptosis	O
upon	O
T	O
cell	O
receptor	O
stimulation	O
.	O

We	O
identified	O
the	O
NF-kappaB	O
site	O
in	O
the	O
FasL	O
promoter	O
that	O
contributes	O
to	O
such	O
regulation	O
.	O

Co-expression	O
of	O
p65	O
(	O
Rel	O
A	O
)	O
with	O
the	O
FasL	O
promoter	O
enhanced	O
its	O
activity	O
,	O
and	O
co-expression	O
of	O
IkappaB	O
dramatically	O
inhibited	O
the	O
inducible	O
promoter	O
activity	O
.	O

In	O
contrast	O
,	O
the	B-NEGATION
transcription	I-NEGATION
factor	I-NEGATION
AP-1	I-NEGATION
is	I-NEGATION
not	I-NEGATION
required	I-NEGATION
for	I-NEGATION
activation-induced	I-NEGATION
FasL	I-NEGATION
promoter	I-NEGATION
activity	I-NEGATION
.	O

These	O
results	O
define	O
a	O
role	O
for	O
NF-kappaB	O
in	O
mediating	O
FasL	O
expression	O
during	O
T	O
cell	O
activation	O
.	O

X-rays-induced	O
secretion	O
of	O
cellular	O
factor	O
(	O
s	O
)	O
that	O
enhance	O
(	O
s	O
)	O
HIV-1	O
promoter	O
transcription	O
in	O
various	O
non-irradiated	O
transfected	O
cell	O
lines	O
.	O

Various	O
cellular	O
stress	O
agents	O
like	O
ionizing	O
radiation	O
exposure	O
could	O
activate	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV	O
-	O
1	O
)	O
replication	O
or	O
reporter	O
gene	O
expression	O
.	O

In	O
addition	O
,	O
extracellular	O
factor	O
(	O
s	O
)	O
released	O
by	O
X-ray-treated	O
human	O
colonic	O
carcinoma	O
cell	O
line	O
(	O
HT29	O
)	O
might	B-SPECULATION
activate	I-SPECULATION
the	I-SPECULATION
long	I-SPECULATION
terminal	I-SPECULATION
repeat	I-SPECULATION
(	I-SPECULATION
LTR	I-SPECULATION
)	I-SPECULATION
of	I-SPECULATION
HIV-1	I-SPECULATION
in	I-SPECULATION
non-irradiated	I-SPECULATION
HT29	I-SPECULATION
cells	I-SPECULATION
.	O

In	O
the	O
present	O
report	O
we	O
show	O
that	O
in	O
various	O
transiently	O
or	O
stably	O
transfected	O
cell	O
lines	O
,	O
X-ray	O
irradiation	O
up-regulates	O
HIV-1	O
LTR	O
transcription	O
through	O
the	O
kappaB	O
regulatory	O
elements	O
.	O

A	O
factor	O
(	O
s	O
)	O
,	O
which	O
is	O
processed	O
by	O
and	O
acts	O
upon	O
a	O
variety	O
of	O
cell	O
types	O
,	O
was	O
detected	O
by	O
addition	O
to	O
non-irradiated	O
cells	O
of	O
either	O
X-ray-treated	O
cells	O
or	O
a	O
conditioned	O
medium	O
taken	O
from	O
irradiated	O
cultures	O
.	O

The	O
magnitude	O
of	O
responsiveness	O
is	O
cell	O
type	O
dependent	O
.	O

In	O
addition	O
,	O
X-ray	O
activation	O
of	O
HIV-1	O
LTR	O
in	O
transiently	O
or	O
stably	O
transfected	O
cell	O
lines	O
is	O
inhibited	O
by	O
a	O
potent	O
antioxidant	O
drug	O
,	O
pyrrolidine	O
dithiocarbamate	O
and	O
by	O
another	O
drug	O
,	O
known	O
for	O
its	O
role	O
in	O
the	O
trapping	O
of	O
growth	O
factors	O
,	O
suramin	O
.	O

The	O
importance	O
of	O
these	O
observations	O
in	O
the	O
pathophysiology	O
of	O
patients	O
with	O
AIDS-related	O
cancers	O
treated	O
by	O
radiotherapy	O
remains	O
to	O
be	O
established	O
.	O

Reactivation	O
of	O
Kaposi's	O
sarcoma-associated	O
herpesvirus	O
infection	O
from	O
latency	O
by	O
expression	O
of	O
the	O
ORF	O
50	O
transactivator	O
,	O
a	O
homolog	O
of	O
the	O
EBV	O
R	O
protein	O
.	O

Kaposi's	O
sarcoma	O
(	O
KS	O
)-	O
associated	O
herpesvirus	O
(	O
KSHV	O
)	O
,	O
or	O
human	O
herpesvirus	O
8	O
,	O
is	O
a	O
lymphotropic	O
virus	O
strongly	O
linked	O
to	O
several	O
AIDS-related	O
neoplasms	O
.	O

The	O
primary	O
reservoir	O
of	O
infection	O
consists	O
of	O
latently	O
infected	O
B	O
lymphocytes	O
and	O
possibly	B-SPECULATION
other	I-SPECULATION
mononuclear	I-SPECULATION
cells	I-SPECULATION
.	O

Viral	B-SPECULATION
reactivation	I-SPECULATION
from	I-SPECULATION
latency	I-SPECULATION
and	I-SPECULATION
spread	I-SPECULATION
from	I-SPECULATION
this	I-SPECULATION
lymphoid	I-SPECULATION
reservoir	I-SPECULATION
is	I-SPECULATION
presumably	I-SPECULATION
required	I-SPECULATION
for	I-SPECULATION
development	I-SPECULATION
of	I-SPECULATION
nonlymphoid	I-SPECULATION
tumors	I-SPECULATION
like	I-SPECULATION
KS	I-SPECULATION
.	O

Here	O
we	O
show	O
that	O
deregulated	O
expression	O
of	O
a	O
single	O
viral	O
gene	O
,	O
ORF	O
50	O
,	O
which	O
encodes	O
a	O
transactivator	O
able	O
to	O
selectively	O
upregulate	O
delayed-early	O
viral	O
genes	O
,	O
suffices	O
to	O
disrupt	O
latency	O
and	O
induce	O
the	O
lytic	O
gene	O
cascade	O
in	O
latently	O
infected	O
B	O
cells	O
.	O

The	O
identification	O
of	O
this	O
gene	O
opens	O
the	O
way	O
to	O
studies	O
of	O
the	O
physiologic	O
mechanisms	O
controlling	O
reactvation	O
of	O
KSHV	O
from	O
latency	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Regulation	O
of	O
interleukin-1beta	O
transcription	O
by	O
Epstein-Barr	O
virus	O
involves	O
a	O
number	O
of	O
latent	O
proteins	O
via	O
their	O
interaction	O
with	O
RBP	O
.	O

Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
infects	O
B	O
cells	O
,	O
resulting	O
in	O
the	O
outgrowth	O
of	O
immortalised	O
lymphoblastoid	O
cell	O
lines	O
(	O
LCLs	O
)	O
.	O

Here	O
,	O
we	O
demonstrate	O
through	O
the	O
use	O
of	O
intracellular	O
staining	O
that	O
interleukin-1beta	O
(	O
IL-1beta	O
)	O
is	O
expressed	O
in	O
LCLs	O
and	O
investigate	O
the	O
influence	O
of	O
the	O
individual	O
latent	O
proteins	O
on	O
the	O
expression	O
of	O
IL-1beta	O
.	O

Using	O
RT-PCR	O
,	O
IL-1beta	O
was	O
shown	O
to	O
be	O
up-regulated	O
in	O
EBV-transformed	O
LCLs	O
as	O
well	O
as	O
in	O
group	O
III	O
Burkitt's	O
lymphoma	O
(	O
BL	O
)	O
cell	O
lines	O
,	O
compared	O
with	O
group	O
I	O
BL	O
cell	O
lines	O
.	O

The	O
up-regulation	O
of	O
IL-1beta	O
message	O
could	O
be	O
mediated	O
by	O
the	O
latent	O
membrane	O
protein-1	O
,	O
EBV	O
nuclear	O
proteins	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
genes	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
demonstrated	O
that	O
the	O
-	O
300	O
region	O
of	O
the	O
IL-1beta	O
promoter	O
,	O
which	O
contains	O
a	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
binding	O
site	O
,	O
contained	O
a	O
functional	O
RBP	O
binding	O
site	O
.	O

Binding	O
of	O
RBP	O
to	O
this	O
site	O
could	O
be	O
inhibited	O
by	O
addition	O
of	O
EBV	O
nuclear	O
proteins	O
3	O
and	O
6	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
these	I-SPECULATION
proteins	I-SPECULATION
displace	I-SPECULATION
RBP	I-SPECULATION
from	I-SPECULATION
its	I-SPECULATION
recognition	I-SPECULATION
sequence	I-SPECULATION
,	I-SPECULATION
removing	I-SPECULATION
transcriptional	I-SPECULATION
repression	I-SPECULATION
and	I-SPECULATION
allowing	I-SPECULATION
gene	I-SPECULATION
transcription	I-SPECULATION
to	I-SPECULATION
occur	I-SPECULATION
.	O

In	O
group	O
I	O
BL	O
cells	O
,	O
containing	O
low	O
levels	O
of	O
NF-kappaB	O
,	O
only	O
RBP	O
binding	O
was	O
observed	O
in	O
EMSAs	O
,	O
whereas	O
NF-kappaB	O
binding	O
could	O
be	O
demonstrated	O
in	O
EBV-transformed	O
B	O
cell	O
lines	O
containing	O
high	O
levels	O
of	O
activated	O
NF-kappaB	O
.	O

In	O
addition	O
,	O
the	O
expression	O
of	O
latent	O
membrane	O
protein-1	O
led	O
to	O
activation	O
of	O
NF-kappaB	O
that	O
was	O
capable	O
of	O
binding	O
the	O
IL-1beta	O
promoter	O
.	O

The	O
study	O
demonstrates	O
that	O
EBV	O
can	O
up-regulate	O
IL-1beta	O
expression	O
,	O
possibly	B-SPECULATION
by	I-SPECULATION
using	I-SPECULATION
RBP	B-SPECULATION
,	I-SPECULATION
NF-kappaB	I-SPECULATION
,	I-SPECULATION
or	I-SPECULATION
both	I-SPECULATION
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Characterization	O
of	O
the	O
human	O
elk-1	O
promoter	O
.	O

Potential	B-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
downstream	I-SPECULATION
intronic	I-SPECULATION
sequence	I-SPECULATION
for	I-SPECULATION
elk-1	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
monocytes	I-SPECULATION
.	O

To	O
characterize	O
the	O
human	O
elk-1	O
promoter	O
,	O
we	O
mapped	O
the	O
transcriptional	O
start	O
site	O
and	O
isolated	O
elk-1-specific	O
genomic	O
phage	O
clones	O
that	O
contained	O
extensive	O
upstream	O
and	O
downstream	O
sequences	O
.	O

A	O
TATA-like	O
motif	O
was	O
identified	O
immediately	O
upstream	O
of	O
the	O
transcriptional	O
start	O
site	O
.	O

Functional	O
analyses	O
of	O
DNA	O
fragments	O
containing	O
the	O
TATA	O
element	O
and	O
the	O
identification	O
of	O
a	O
DNase	O
I-hypersensitive	O
chromatin	O
site	O
(	O
HS	O
1	O
)	O
in	O
close	O
proximity	O
to	O
the	O
TATA	O
box	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
identified	I-SPECULATION
TATA	I-SPECULATION
motif	I-SPECULATION
is	I-SPECULATION
important	I-SPECULATION
for	I-SPECULATION
elk-1	I-SPECULATION
transcription	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
.	O

Sequences	O
upstream	O
and	O
downstream	O
from	O
the	O
TATA	O
box	O
were	O
found	O
to	O
contribute	O
to	O
elk-1	O
promoter	O
activity	O
.	O

A	O
second	O
hypersensitive	O
site	O
(	O
HS	O
2	O
)	O
was	O
identified	O
within	O
the	O
first	O
intron	O
in	O
pre-monocytic	O
cells	O
,	O
which	O
express	O
Elk-1	O
only	O
when	O
differentiating	O
to	O
monocytes	O
.	O

In	O
a	O
variety	O
of	O
other	O
cell	O
types	O
,	O
which	O
display	O
a	O
constitutive	O
Elk-1	O
expression	O
,	O
HS	O
2	O
did	O
not	B-NEGATION
exist	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
inducibility	I-SPECULATION
of	I-SPECULATION
elk-1	I-SPECULATION
expression	I-SPECULATION
is	I-SPECULATION
associated	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
presence	I-SPECULATION
of	I-SPECULATION
HS	I-SPECULATION
2	I-SPECULATION
.	O

Egr-1	O
and	O
the	O
serum	O
response	O
factor	O
were	O
found	O
to	O
interact	O
specifically	O
with	O
the	O
intronic	O
sequence	O
at	O
+	O
265	O
and	O
+	O
448	O
,	O
respectively	O
.	O

Because	O
Egr-1	O
mRNA	O
and	O
protein	O
levels	O
were	O
observed	O
to	O
increase	O
significantly	O
before	O
induction	O
of	O
elk-1	O
expression	O
,	O
we	O
propose	B-SPECULATION
that	I-SPECULATION
Egr-1	I-SPECULATION
is	I-SPECULATION
important	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
regulation	I-SPECULATION
of	I-SPECULATION
elk-1	I-SPECULATION
transcription	I-SPECULATION
in	I-SPECULATION
differentiating	I-SPECULATION
monocytes	I-SPECULATION
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
tax	O
protein	O
abrogates	O
interleukin-2	O
dependence	O
in	O
a	O
mouse	O
T-cell	O
line	O
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
is	O
the	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O

Tax	B-SPECULATION
,	I-SPECULATION
the	I-SPECULATION
viral	I-SPECULATION
protein	I-SPECULATION
,	I-SPECULATION
is	I-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
crucial	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
development	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
disease	I-SPECULATION
,	O
since	O
it	O
transforms	O
healthy	O
T	O
cells	O
in	O
vitro	O
and	O
induces	O
tumors	O
in	O
transgenic	O
animals	O
.	O

We	O
examined	O
the	O
effect	O
of	O
Tax	O
activity	O
on	O
the	O
growth	O
of	O
the	O
interleukin-2	O
(	O
IL-2	O
)-	O
dependent	O
T-cell	O
line	O
CTLL-2	O
.	O

Stable	O
expression	O
of	O
Tax	O
in	O
CTLL-2	O
transformed	O
cell	O
growth	O
from	O
being	O
IL-2	O
dependent	O
to	O
IL-2	O
independent	O
.	O

Tax	O
stimulated	O
transcription	O
through	O
NF-kappaB	O
and	O
the	O
cyclic	O
AMP-responsive	O
element-like	O
sequence	O
in	O
the	O
HTLV-1	O
promoter	O
.	O

The	O
finding	O
of	O
Tax	O
mutants	O
segregating	O
these	O
two	O
pathways	O
suggested	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
NF-kappaB	I-SPECULATION
pathway	I-SPECULATION
was	I-SPECULATION
essential	I-SPECULATION
for	I-SPECULATION
IL-2-independent	I-SPECULATION
growth	I-SPECULATION
of	I-SPECULATION
CTLL-2	I-SPECULATION
cells	I-SPECULATION
while	I-SPECULATION
the	I-SPECULATION
CRE	I-SPECULATION
pathway	I-SPECULATION
was	I-SPECULATION
unnecessary	I-SPECULATION
.	O

However	O
,	O
both	O
pathways	O
were	O
necessary	O
for	O
another	O
transformation-related	O
activity	O
(	O
colony	O
formation	O
in	O
soft	O
agar	O
)	O
of	O
CTLL-2	O
/	O
Tax	O
.	O

Our	O
results	O
show	O
that	O
Tax	O
has	O
at	O
least	O
two	O
distinct	O
activities	O
on	O
T	O
cells	O
,	O
and	O
suggest	B-SPECULATION
that	I-SPECULATION
Tax	I-SPECULATION
plays	I-SPECULATION
a	I-SPECULATION
crucial	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
IL-2-independent	I-SPECULATION
T-cell	I-SPECULATION
transformation	I-SPECULATION
induced	I-SPECULATION
by	I-SPECULATION
HTLV-1	I-SPECULATION
,	I-SPECULATION
in	I-SPECULATION
addition	I-SPECULATION
to	I-SPECULATION
its	I-SPECULATION
well-known	I-SPECULATION
IL-2-dependent	I-SPECULATION
cell	I-SPECULATION
transformation	I-SPECULATION
.	O

Mildly	O
oxidized	O
low-density	O
lipoproteins	O
decrease	O
early	O
production	O
of	O
interleukin	O
2	O
and	O
nuclear	O
factor	O
kappaB	O
binding	O
to	O
DNA	O
in	O
activated	O
T-lymphocytes	O
.	O

Activated	O
T-lymphocytes	O
are	O
found	O
early	O
in	O
atherosclerosis	O
lesions	O
,	O
but	O
little	O
is	O
known	O
about	O
their	O
role	O
.	O

Oxidized	O
low-density	O
lipoproteins	O
(	O
oxLDLs	O
)	O
are	O
considered	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
the	O
lesions	O
,	O
and	O
we	O
have	O
previously	O
demonstrated	O
that	O
oxLDLs	O
inhibit	O
not	O
only	O
interleukin	O
(	O
IL	O
)-	O
2-receptor	O
expression	O
on	O
the	O
surface	O
of	O
in	O
vitro-activated	O
T-lymphocytes	O
but	O
also	O
their	O
proliferation	O
.	O

We	O
have	O
now	O
investigated	O
the	O
effect	O
of	O
oxLDLs	O
on	O
blast	O
differentiation	O
,	O
on	O
IL-2	O
synthesis	O
and	O
on	O
the	O
activation	O
of	O
the	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)	O
system	O
in	O
activated	O
lymphocytes	O
.	O

Mildly	O
oxLDLs	O
(	O
50	O
and	O
100	O
microgram	O
/	O
ml	O
)	O
decreased	O
the	O
number	O
of	O
lymphoblasts	O
and	O
the	O
level	O
of	O
IL-2	O
concentration	O
in	O
the	O
culture	O
supernatants	O
after	O
activation	O
of	O
lymphocytes	O
by	O
phytohaemagglutinin	O
and	O
PMA	O
+	O
ionomycin	O
.	O

The	O
inhibition	O
of	O
IL-2	O
production	O
was	O
observed	O
in	O
the	O
CD3	O
(+)	O
T-lymphocyte	O
cytoplasm	O
as	O
early	O
as	O
4	O
h	O
after	O
activation	O
by	O
PMA	O
+	O
ionomycin	O
.	O

The	O
study	O
of	O
NF-kappaB	O
showed	O
that	O
oxLDLs	O
led	O
to	O
a	O
decrease	O
of	O
activation-induced	O
p65	O
/	O
p50	O
NF-kappaB	O
heterodimer	O
binding	O
to	O
DNA	O
,	O
whereas	O
the	O
presence	O
of	O
the	O
constitutive	O
nuclear	O
form	O
of	O
p50	O
dimer	O
was	O
unchanged	O
.	O

This	O
was	O
correlated	O
with	O
an	O
unchanged	O
level	O
of	O
the	O
active	O
form	O
of	O
the	O
cytosolic	O
inhibitor	O
protein	O
IkappaB-alpha	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
immunosuppressive	I-SPECULATION
effect	I-SPECULATION
of	I-SPECULATION
oxLDLs	I-SPECULATION
might	B-SPECULATION
operate	I-SPECULATION
via	I-SPECULATION
a	I-SPECULATION
dysregulation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
T-lymphocyte	I-SPECULATION
activation	I-SPECULATION
mechanisms	I-SPECULATION
.	O

Binding	O
of	O
HMG-I	O
(	O
Y	O
)	O
elicits	O
structural	O
changes	O
in	O
a	O
silencer	O
of	O
the	O
human	O
beta-globin	O
gene	O
.	O

Proteins	O
involved	O
in	O
repression	O
of	O
the	O
human	O
beta-globin	O
gene	O
may	B-SPECULATION
be	I-SPECULATION
useful	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
treatment	I-SPECULATION
of	I-SPECULATION
sickle	I-SPECULATION
cell	I-SPECULATION
anemia	I-SPECULATION
,	I-SPECULATION
in	I-SPECULATION
conjunction	I-SPECULATION
with	I-SPECULATION
therapy	I-SPECULATION
to	I-SPECULATION
reactivate	I-SPECULATION
fetal	I-SPECULATION
globin	I-SPECULATION
genes	I-SPECULATION
.	O

If	O
there	O
is	O
a	O
reciprocal	O
elevation	O
of	O
gamma-globin	O
expression	O
upon	O
repression	O
,	O
this	O
approach	O
could	B-SPECULATION
be	I-SPECULATION
useful	I-SPECULATION
in	I-SPECULATION
additional	I-SPECULATION
hemoglobinopathies	I-SPECULATION
.	O

We	O
previously	O
showed	O
that	O
repression	B-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
beta-globin	I-SPECULATION
gene	I-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
mediated	I-SPECULATION
through	I-SPECULATION
two	I-SPECULATION
DNA	I-SPECULATION
sequences	I-SPECULATION
,	I-SPECULATION
silencers	I-SPECULATION
I	I-SPECULATION
and	I-SPECULATION
II	I-SPECULATION
,	O
and	O
identified	O
a	O
protein	O
termed	O
BP1	O
which	O
binds	O
to	O
both	O
silencer	O
sequences	O
.	O

In	O
this	O
study	O
,	O
we	O
cloned	O
two	O
cDNAs	O
encoding	O
proteins	O
which	O
bind	O
to	O
an	O
oligonucleotide	O
in	O
silencer	O
I	O
containing	O
a	O
BP1	O
binding	O
site	O
.	O

These	O
cDNAs	O
correspond	O
to	O
HMG-I	O
and	O
HMG-Y	O
,	O
isoforms	O
regarded	O
as	O
architectural	O
proteins	O
.	O

We	O
demonstrate	O
that	O
binding	O
of	O
HMG-I	O
(	O
Y	O
)	O
to	O
this	O
oligonucleotide	O
causes	O
bending	O
/	O
flexure	O
of	O
the	O
DNA	O
.	O

HMG-I	O
(	O
Y	O
)	O
also	O
binds	O
to	O
a	O
second	O
oligonucleotide	O
containing	O
a	O
BP1	O
binding	O
site	O
located	O
in	O
a	O
negative	O
control	O
region	O
upstream	O
of	O
the	O
delta-globin	O
gene	O
,	O
suggesting	B-SPECULATION
a	I-SPECULATION
role	I-SPECULATION
for	I-SPECULATION
HMG-I	I-SPECULATION
(	I-SPECULATION
Y	I-SPECULATION
)	I-SPECULATION
in	I-SPECULATION
repression	I-SPECULATION
of	I-SPECULATION
adult	I-SPECULATION
globin	I-SPECULATION
genes	I-SPECULATION
.	O

Expression	O
studies	O
revealed	O
that	O
HMG-I	O
(	O
Y	O
)	O
is	O
ubiquitously	O
expressed	O
in	O
human	O
tissues	O
that	O
do	O
not	B-NEGATION
express	I-NEGATION
beta-globin	I-NEGATION
,	O
being	O
present	O
in	O
48	O
of	O
50	O
tissues	O
and	O
six	O
hematopoietic	O
cell	O
lines	O
examined	O
.	O

Furthermore	O
,	O
HMG-I	O
(	O
Y	O
)	O
expression	O
is	O
down-regulated	O
during	O
differentiation	O
of	O
primary	O
erythroid	O
cells	O
.	O

We	O
present	O
a	O
model	O
in	O
which	O
HMG-I	O
(	O
Y	O
)	O
alters	O
DNA	O
conformation	O
to	O
allow	O
binding	O
of	O
repressor	O
proteins	O
,	O
and	O
in	O
which	O
the	O
relative	O
amount	O
of	O
HMG-I	O
(	O
Y	O
)	O
helps	O
to	O
determine	O
the	O
repressive	O
state	O
of	O
the	O
beta-globin	O
gene	O
.	O

Regulation	O
of	O
IL-6	O
synthesis	O
in	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
by	O
C3a	O
and	O
C3a	O
(	O
desArg	O
)	O
.	O

The	O
anaphylatoxin	O
C3a	O
has	O
been	O
reported	O
to	O
have	O
immunomodulatory	O
effects	O
on	O
a	O
number	O
of	O
different	O
cell	O
types	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	O
and	O
C3a	O
(	O
desArg	O
)	O
on	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL-6	O
in	O
human	O
PBMCs	O
,	O
either	O
alone	O
or	O
in	O
combination	O
with	O
LPS	O
or	O
IL-1beta	O
.	O

C3a	O
or	O
C3a	O
(	O
desArg	O
)	O
alone	O
exhibited	O
no	B-NEGATION
effect	I-NEGATION
on	I-NEGATION
the	I-NEGATION
expression	I-NEGATION
or	I-NEGATION
secretion	I-NEGATION
of	I-NEGATION
IL-6	I-NEGATION
.	O

However	O
,	O
when	O
PBMC	O
were	O
stimulated	O
with	O
LPS	O
or	O
IL-1beta	O
,	O
both	O
C3a	O
and	O
C3a	O
(	O
desArg	O
)	O
were	O
found	O
to	O
enhance	O
IL-6	O
release	O
by	O
PBMC	O
in	O
a	O
dose-dependent	O
manner	O
.	O

Since	O
C3a	O
has	O
been	O
shown	O
to	O
induce	O
PGE2	O
production	O
by	O
monocytes	O
,	O
and	O
PGE2	O
has	O
been	O
shown	O
to	O
influence	O
cytokine	O
production	O
,	O
we	O
investigated	O
the	O
potential	B-SPECULATION
role	I-SPECULATION
of	I-SPECULATION
PGE2	I-SPECULATION
in	I-SPECULATION
C3a-mediated	I-SPECULATION
enhancement	I-SPECULATION
of	I-SPECULATION
LPS	I-SPECULATION
-	I-SPECULATION
and	I-SPECULATION
IL-1beta-induced	I-SPECULATION
IL-6	I-SPECULATION
production	I-SPECULATION
.	O

Indomethacin	O
blocked	O
PGE2	O
release	O
,	O
but	O
had	O
no	B-NEGATION
influence	I-NEGATION
on	I-NEGATION
the	I-NEGATION
observed	I-NEGATION
effects	I-NEGATION
of	I-NEGATION
C3a	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
effects	I-SPECULATION
of	I-SPECULATION
C3a	I-SPECULATION
on	I-SPECULATION
IL-6	I-SPECULATION
production	I-SPECULATION
are	I-SPECULATION
independent	I-SPECULATION
of	I-SPECULATION
PGE2	I-SPECULATION
formation	I-SPECULATION
by	I-SPECULATION
monocytes	I-SPECULATION
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
C3a	O
as	O
well	O
as	O
C3a	O
(	O
desArg	O
)	O
enhanced	O
LPS-induced	O
mRNA	O
levels	O
for	O
IL-6	O
.	O

Pretreatment	O
of	O
PBMCs	O
with	O
pertussis	O
toxin	O
blocked	O
the	O
functions	O
of	O
C3a	O
and	O
C3a	O
(	O
desArg	O
)	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
actions	I-SPECULATION
of	I-SPECULATION
these	I-SPECULATION
two	I-SPECULATION
molecules	I-SPECULATION
are	I-SPECULATION
mediated	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
G	I-SPECULATION
protein-coupled	I-SPECULATION
pathway	I-SPECULATION
.	O

Furthermore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	O
and	O
C3a	O
(	O
desArg	O
)	O
on	O
induction	O
of	O
NF-kappaB	O
and	O
activating	O
protein-1	O
binding	O
.	O

Both	O
molecules	O
enhanced	O
LPS-induced	O
NF-kappaB	O
and	O
activating	O
protein-1	O
binding	O
activity	O
.	O

These	O
results	O
demonstrate	O
the	O
capacity	O
of	O
intact	O
C3a	O
and	O
its	O
circulating	O
des-Arg	O
form	O
to	O
exert	O
immunmodulatory	O
effects	O
in	O
vitro	O
.	O

Differential	O
monocyte	O
adhesion	O
and	O
adhesion	O
molecule	O
expression	O
in	O
venous	O
and	O
arterial	O
endothelial	O
cells	O
.	O

We	O
compared	O
U-937	O
cell	O
adhesion	O
and	O
adhesion	O
molecule	O
expression	O
in	O
human	O
umbilical	O
venous	O
(	O
HUVECs	O
)	O
and	O
arterial	O
(	O
HUAECs	O
)	O
endothelial	O
cells	O
exposed	O
to	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
,	O
interleukin-1	O
,	O
and	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

TNF	O
and	O
LPS	O
stimulated	O
vascular	O
cell	O
adhesion	O
molecule	O
(	O
VCAM	O
)-	O
1	O
surface	O
expression	O
and	O
adhesion	O
of	O
U-937	O
monocyte-like	O
cells	O
to	O
HUVECs	O
but	O
not	B-NEGATION
to	I-NEGATION
HUAECs	I-NEGATION
.	O

Antibody	O
studies	O
demonstrated	O
that	O
in	O
HUVECs	O
at	O
least	O
75	O
%	O
of	O
the	O
adhesion	O
response	O
is	O
VCAM-1	O
mediated	O
.	O

Interleukin-1	O
stimulated	O
U-937	O
cell	O
adhesion	O
to	O
and	O
VCAM-1	O
surface	O
expression	O
in	O
both	O
HUVECs	O
and	O
HUAECs	O
.	O

Pyrrolidinedithiocarbamate	O
and	O
the	O
proteasome	O
inhibitor	O
MG-132	O
blocked	O
TNF	O
-	O
and	O
LPS-stimulated	O
U-937	O
cell	O
adhesion	O
to	O
HUVECs	O
.	O

These	O
agents	O
also	O
significantly	O
decreased	O
TNF	O
-	O
and	O
LPS-stimulated	O
increases	O
in	O
HUVEC	O
surface	O
VCAM-1	O
.	O

TNF	O
increased	O
VCAM-1	O
protein	O
and	O
mRNA	O
in	O
HUVECs	O
that	O
was	O
blocked	O
by	O
pyrrolidinedithiocarbamate	O
.	O

However	O
,	O
neither	B-NEGATION
TNF	I-NEGATION
.	O

TNF	O
stimulated	O
expression	O
of	O
both	O
intercellular	O
adhesion	O
molecule-1	O
and	O
E-selectin	O
in	O
HUVECs	O
,	O
but	O
in	O
HUAECs	O
,	O
only	O
intercellular	O
adhesion	O
molecule-1	O
was	O
increased	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
no	B-NEGATION
difference	I-NEGATION
in	I-NEGATION
the	I-NEGATION
pattern	I-NEGATION
of	I-NEGATION
TNF-stimulated	I-NEGATION
nuclear	I-NEGATION
factor-kappaB	I-NEGATION
activation	I-NEGATION
between	I-NEGATION
HUVECs	I-NEGATION
and	I-NEGATION
HUAECs	I-NEGATION
.	O

These	O
studies	O
demonstrate	O
a	O
novel	O
and	O
striking	O
insensitivity	O
of	O
arterial	O
endothelium	O
to	O
the	O
effects	O
of	O
TNF	O
and	O
LPS	O
and	O
indicate	B-SPECULATION
a	I-SPECULATION
dissociation	I-SPECULATION
between	I-SPECULATION
the	I-SPECULATION
ability	I-SPECULATION
of	I-SPECULATION
HUAECs	I-SPECULATION
to	I-SPECULATION
upregulate	I-SPECULATION
nuclear	I-SPECULATION
factor-kappaB	I-SPECULATION
and	I-SPECULATION
VCAM-1	I-SPECULATION
.	O

Tissue	O
factor	O
expression	O
of	O
human	O
monocytes	O
is	O
suppressed	O
by	O
lysophosphatidylcholine	O
.	O

The	O
expression	O
of	O
tissue	O
factor	O
(	O
TF	O
)	O
,	O
the	O
principal	O
initiator	O
of	O
coagulation	O
,	O
is	O
increased	O
during	O
inflammation	O
and	O
atherosclerosis	O
.	O

Both	O
conditions	O
are	O
promoted	O
by	O
lysophosphatidylcholine	O
(	O
lysoPC	O
)	O
.	O

We	O
observed	O
in	O
the	O
present	O
study	O
that	O
lysoPC	O
(	O
1	O
to	O
10	O
micromol	O
/	O
L	O
)	O
dose-dependently	O
reduced	O
TF	O
activity	O
in	O
human	O
monocytes	O
,	O
as	O
elicited	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

Lysophosphatidylethanolamine	O
(	O
lysoPE	O
)	O
and	O
other	O
lysophospholipids	O
did	O
not	B-NEGATION
affect	I-NEGATION
LPS-induced	I-NEGATION
TF	I-NEGATION
activity	I-NEGATION
of	I-NEGATION
human	I-NEGATION
monocytes	I-NEGATION
.	O

TF	O
antigen	O
expression	O
as	O
elicited	O
by	O
LPS	O
was	O
also	O
lowered	O
by	O
lysoPC	O
.	O

Phospholipid	O
analyses	O
indicated	O
a	O
selective	O
increase	O
in	O
the	O
lysoPC	O
content	O
of	O
the	O
monocytes	O
after	O
preincubation	O
with	O
the	O
lysophospholipid	O
.	O

LysoPC	O
inhibited	O
the	O
TF	O
activity	O
of	O
Mono	O
Mac-6	O
cells	O
to	O
a	O
similar	O
extent	O
as	O
in	O
the	O
monocytes	O
.	O

LPS	B-NEGATION
binding	I-NEGATION
to	I-NEGATION
plasma	I-NEGATION
membrane	I-NEGATION
receptors	I-NEGATION
and	I-NEGATION
internalization	I-NEGATION
of	I-NEGATION
LPS	I-NEGATION
into	I-NEGATION
monocytes	I-NEGATION
were	I-NEGATION
not	I-NEGATION
affected	I-NEGATION
by	I-NEGATION
lysoPC	I-NEGATION
.	O

In	O
contrast	O
,	O
LPS-mediated	O
nuclear	O
binding	O
of	O
nuclear	O
factor-kappaB	O
/	O
Rel	O
to	O
a	O
TF-specific	O
kappaB	O
site	O
was	O
inhibited	O
by	O
lysoPC	O
.	O

Induction	O
of	O
TF	O
mRNA	O
expression	O
by	O
LPS	O
tended	O
to	O
be	O
partially	O
reduced	O
by	O
the	O
lysophospholipid	O
.	O

Preincubation	O
with	O
lysoPC	O
increased	O
monocytic	O
cAMP	O
levels	O
.	O

Inhibition	O
of	O
adenylyl	O
cyclase	O
by	O
pretreatment	O
with	O
2	O
'-	O
deoxy-3	O
'-	O
adenosine	O
monophosphate	O
partially	O
reversed	O
the	O
inhibition	O
of	O
TF	O
activity	O
promoted	O
by	O
lysoPC	O
.	O

In	O
conclusion	O
,	O
lysoPC	O
markedly	O
decreases	O
LPS-mediated	O
TF	O
expression	O
of	O
human	O
monocytes	O
,	O
the	O
effect	O
probably	B-SPECULATION
being	I-SPECULATION
mediated	I-SPECULATION
by	I-SPECULATION
both	I-SPECULATION
transcriptional	I-SPECULATION
and	I-SPECULATION
posttranscriptional	I-SPECULATION
mechanisms	I-SPECULATION
.	O

LysoPC	O
may	B-SPECULATION
thus	I-SPECULATION
attenuate	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
coagulation	I-SPECULATION
during	I-SPECULATION
inflammation	I-SPECULATION
and	I-SPECULATION
atherosclerosis	I-SPECULATION
.	O

Intranuclear	O
targeted	O
delivery	O
of	O
functional	O
NF-kappaB	O
by	O
70	O
kDa	O
heat	O
shock	O
protein	O
.	O

The	O
70	O
kDa	O
heat	O
shock	O
protein	O
(	O
Hsp70	O
)	O
is	O
a	O
highly	O
conserved	O
,	O
ubiquitous	O
protein	O
involved	O
in	O
chaperoning	O
proteins	O
to	O
various	O
cellular	O
organelles	O
.	O

Here	O
we	O
show	O
that	O
when	O
added	O
exogenously	O
to	O
cells	O
,	O
Hsp70	O
is	O
readily	O
imported	O
into	O
both	O
cytoplasmic	O
and	O
nuclear	O
compartments	O
in	O
a	O
cell-type-specific	O
fashion	O
.	O

We	O
exploited	O
this	O
ability	O
of	O
Hsp70	O
to	O
deliver	O
NF-kappaB	O
,	O
a	O
key	O
transcriptional	O
regulator	O
of	O
inflammatory	O
responses	O
.	O

We	O
demonstrate	O
that	O
a	O
fusion	O
protein	O
composed	O
of	O
a	O
C-terminal	O
Hsp70	O
peptide	O
and	O
the	O
p50	O
subunit	O
of	O
NF-kappaB	O
was	O
directed	O
into	O
the	O
nucleus	O
of	O
cells	O
,	O
could	O
bind	O
DNA	O
specifically	O
,	O
and	O
activated	O
Igkappa	O
expression	O
and	O
TNFalpha	O
production	O
.	O

We	O
therefore	O
propose	B-SPECULATION
that	I-SPECULATION
Hsp70	I-SPECULATION
can	I-SPECULATION
be	I-SPECULATION
used	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
vehicle	I-SPECULATION
for	I-SPECULATION
intracytoplasmic	I-SPECULATION
and	I-SPECULATION
intranuclear	I-SPECULATION
delivery	I-SPECULATION
of	I-SPECULATION
proteins	I-SPECULATION
or	I-SPECULATION
DNA	I-SPECULATION
to	I-SPECULATION
modulate	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
and	I-SPECULATION
thereby	I-SPECULATION
control	I-SPECULATION
immune	I-SPECULATION
responses	I-SPECULATION
.	O

CD2	O
signalling	O
induces	O
phosphorylation	O
of	O
CREB	O
in	O
primary	O
lymphocytes	O
.	O

Promoter	O
sequences	O
responsive	O
to	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
are	O
found	O
in	O
a	O
number	O
of	O
cellular	O
genes	O
,	O
and	O
bind	O
transcription	O
factors	O
of	O
the	O
cAMP	O
response	O
element	O
binding	O
protein	O
(	O
CREB	O
)/	O
activating	O
transcription	O
factor-1	O
(	O
ATF-1	O
)	O
family	O
.	O

We	O
have	O
used	O
a	O
human	O
T-lymphotropic	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
model	O
of	O
cAMP	O
response	O
element	O
(	O
CRE	O
)	O
transcription	O
to	O
investigate	O
the	O
influence	O
of	O
lymphocyte	O
activation	O
on	O
transcription	O
from	O
homologous	O
regions	O
in	O
the	O
viral	O
promoter	O
.	O

We	O
previously	O
demonstrated	O
increased	O
HTLV-1	O
transcription	O
following	O
CD2	O
but	O
not	B-NEGATION
CD3	I-NEGATION
receptor	I-NEGATION
cross-linking	I-NEGATION
.	O

We	O
hypothesized	B-SPECULATION
that	I-SPECULATION
this	I-SPECULATION
increased	I-SPECULATION
viral	I-SPECULATION
transcription	I-SPECULATION
was	I-SPECULATION
mediated	I-SPECULATION
,	I-SPECULATION
in	I-SPECULATION
part	I-SPECULATION
,	I-SPECULATION
through	I-SPECULATION
the	I-SPECULATION
phosphorylation	I-SPECULATION
of	I-SPECULATION
CREB	I-SPECULATION
.	O

Therefore	O
,	O
we	O
investigated	O
CD2	O
and	O
CD3	O
receptor-mediated	O
signalling	O
in	O
primary	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
.	O

CD2	O
,	O
but	O
not	B-NEGATION
CD3	I-NEGATION
,	O
cross-linking	O
increased	O
cAMP	O
detected	O
by	O
competitive	O
enzyme-linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
approximately	O
fourfold	O
.	O

CD2	O
cross-linking	O
concurrently	O
increased	O
phosphorylation	O
of	O
CREB	O
detected	O
by	O
immunoblot	O
assay	O
eightfold	O
.	O

Consistent	O
with	O
post-translational	O
regulation	O
,	O
no	B-NEGATION
change	I-NEGATION
in	I-NEGATION
total	I-NEGATION
level	I-NEGATION
of	I-NEGATION
CREB	I-NEGATION
protein	I-NEGATION
was	I-NEGATION
observed	I-NEGATION
.	O

Phosphorylation	O
of	O
CREB	O
occurred	O
through	O
a	O
herbimycin	O
A	O
and	O
Rp-cAMP-sensitive	O
pathway	O
,	O
suggesting	B-SPECULATION
phosphorylation	I-SPECULATION
required	I-SPECULATION
antecedent	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
both	I-SPECULATION
protein	I-SPECULATION
tyrosine	I-SPECULATION
kinases	I-SPECULATION
(	I-SPECULATION
PTK	I-SPECULATION
)	I-SPECULATION
and	I-SPECULATION
protein	I-SPECULATION
kinase	I-SPECULATION
A	I-SPECULATION
(	I-SPECULATION
PKA	I-SPECULATION
)	I-SPECULATION
.	O

Both	O
CD2	O
and	O
CD3	O
cross-linking	O
increased	O
binding	O
of	O
nuclear	O
proteins	O
to	O
a	O
radiolabelled	O
CRE	O
oligonucleotide	O
probe	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
suggesting	B-SPECULATION
that	I-SPECULATION
lymphocyte	I-SPECULATION
activation	I-SPECULATION
enhances	I-SPECULATION
binding	I-SPECULATION
independently	I-SPECULATION
of	I-SPECULATION
phosphorylation	I-SPECULATION
of	I-SPECULATION
CREB	I-SPECULATION
at	I-SPECULATION
serine	I-SPECULATION
133	I-SPECULATION
.	O

These	O
data	O
indicate	B-SPECULATION
specific	I-SPECULATION
modulation	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
CREB	I-SPECULATION
/	I-SPECULATION
ATF-1	I-SPECULATION
family	I-SPECULATION
of	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
CD2	I-SPECULATION
signalling	I-SPECULATION
pathway	I-SPECULATION
and	O
suggest	B-SPECULATION
CD2	I-SPECULATION
receptor	I-SPECULATION
modulation	I-SPECULATION
of	I-SPECULATION
CRE-mediated	I-SPECULATION
transcription	I-SPECULATION
following	I-SPECULATION
ligand	I-SPECULATION
engagement	I-SPECULATION
(	I-SPECULATION
e.g.	I-SPECULATION
cell-to-cell	I-SPECULATION
contact	I-SPECULATION
)	I-SPECULATION
.	O

Anoxia	O
/	O
reoxygenation-induced	O
tolerance	O
with	O
respect	O
to	O
polymorphonuclear	O
leukocyte	O
adhesion	O
to	O
cultured	O
endothelial	O
cells	O
.	O

A	O
nuclear	O
factor-kappaB-mediated	O
phenomenon	O
.	O

Exposing	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVECs	O
)	O
to	O
anoxia	O
/	O
reoxygenation	O
(	O
A	O
/	O
R	O
)	O
results	O
in	O
an	O
increase	O
in	O
polymorphonuclear	O
leukocyte	O
(	O
PMN	O
)	O
adhesion	O
to	O
HUVECs	O
.	O

This	O
A	O
/	O
R-induced	O
hyperadhesion	O
is	O
completely	O
prevented	O
by	O
a	O
previous	O
(	O
24	O
hours	O
earlier	O
)	O
exposure	O
of	O
HUVECs	O
to	O
A	O
/	O
R	O
.	O

This	O
phenomenon	O
has	O
been	O
termed	O
"	O
A	O
/	O
R	O
tolerance	O
.	O
"	O

Exposing	O
HUVECs	O
to	O
A	O
/	O
R	O
induces	O
an	O
increase	O
in	O
nuclear	O
factor	O
kappaB	O
(	O
NF-kappaB	O
)	O
in	O
HUVEC	O
nuclei	O
within	O
4	O
hours	O
.	O

Interfering	O
with	O
either	O
NF-kappaB	O
activation	O
(	O
proteasome	O
inhibitor	O
)	O
or	O
translocation	O
(	O
double-stranded	O
oligonucleotides	O
containing	O
NF-kappaB	O
binding	O
sequence	O
)	O
prevents	O
the	O
development	O
of	O
A	O
/	O
R	O
tolerance	O
(	O
ie	O
,	O
the	O
increase	O
in	O
A	O
/	O
R-induced	O
PMN	O
adhesion	O
to	O
HUVECs	O
is	O
the	O
same	O
after	O
the	O
first	O
and	O
second	O
A	O
/	O
R	O
challenges	O
)	O
.	O

NO	O
production	O
by	O
HUVECs	O
is	O
increased	O
after	O
the	O
second	O
A	O
/	O
R	O
challenge	O
,	O
but	O
not	B-NEGATION
after	I-NEGATION
the	I-NEGATION
first	I-NEGATION
A	I-NEGATION
/	I-NEGATION
R	I-NEGATION
challenge	I-NEGATION
.	O

Inhibition	O
of	O
NO	O
synthase	O
(	O
NOS	O
)	O
during	O
the	O
second	O
A	O
/	O
R	O
challenge	O
prevents	O
the	O
development	O
of	O
A	O
/	O
R	O
tolerance	O
with	O
respect	O
to	O
PMN	O
adhesion	O
.	O

However	O
,	O
while	O
HUVECs	O
contained	O
endothelial	O
NOS	O
protein	O
,	O
no	B-NEGATION
inducible	I-NEGATION
NOS	I-NEGATION
was	I-NEGATION
detected	I-NEGATION
in	I-NEGATION
either	I-NEGATION
tolerant	I-NEGATION
or	I-NEGATION
nontolerant	I-NEGATION
cells	I-NEGATION
.	O

Further	O
studies	O
indicated	B-SPECULATION
that	I-SPECULATION
inhibition	I-SPECULATION
of	I-SPECULATION
GTP-cyclohydrolase	I-SPECULATION
I	I-SPECULATION
(	I-SPECULATION
an	I-SPECULATION
enzyme	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
de	I-SPECULATION
novo	I-SPECULATION
synthesis	I-SPECULATION
of	I-SPECULATION
an	I-SPECULATION
important	I-SPECULATION
cofactor	I-SPECULATION
for	I-SPECULATION
NOS	I-SPECULATION
activity	I-SPECULATION
,	I-SPECULATION
tetrahydrobiopterin	I-SPECULATION
)	I-SPECULATION
prevented	I-SPECULATION
the	I-SPECULATION
generation	I-SPECULATION
of	I-SPECULATION
NO	I-SPECULATION
in	I-SPECULATION
A	I-SPECULATION
/	I-SPECULATION
R-tolerant	I-SPECULATION
cells	I-SPECULATION
.	O

Extracellular	O
generation	O
of	O
NO	O
(	O
NO	O
donor	O
)	O
did	O
not	B-NEGATION
effect	I-NEGATION
the	I-NEGATION
hyperadhesion	I-NEGATION
response	I-NEGATION
induced	I-NEGATION
by	I-NEGATION
the	I-NEGATION
initial	I-NEGATION
A	I-NEGATION
/	I-NEGATION
R	I-NEGATION
challenge	I-NEGATION
.	O

A	O
/	O
R	O
also	O
induced	O
an	O
oxidant	O
stress	O
in	O
naive	O
HUVECs	O
,	O
but	O
not	B-NEGATION
in	I-NEGATION
A	I-NEGATION
/	I-NEGATION
R-tolerant	I-NEGATION
HUVECs	I-NEGATION
.	O

Inhibition	O
of	O
NOS	O
during	O
the	O
second	O
A	O
/	O
R	O
insult	O
results	O
in	O
the	O
generation	O
of	O
an	O
oxidant	O
stress	O
similar	O
to	O
that	O
observed	O
after	O
the	O
first	O
A	O
/	O
R	O
challenge	O
.	O

Taken	O
together	O
,	O
the	O
findings	O
of	O
the	O
present	O
study	O
are	O
consistent	O
with	O
a	O
role	O
for	O
NF-kappaB	O
in	O
the	O
development	O
of	O
A	O
/	O
R	O
tolerance	O
(	O
with	O
respect	O
to	O
PMN	O
adhesion	O
)	O
,	O
perhaps	O
by	O
transcriptional	O
regulation	O
of	O
GTP-cyclohydrolase	O
.	O

The	O
increased	O
NO	O
production	O
during	O
the	O
second	O
A	O
/	O
R	O
insult	O
reduces	O
PMN	O
adhesion	O
most	O
likely	B-SPECULATION
by	I-SPECULATION
reducing	I-SPECULATION
the	I-SPECULATION
intracellular	I-SPECULATION
oxidant	I-SPECULATION
stress	I-SPECULATION
induced	I-SPECULATION
by	I-SPECULATION
A	I-SPECULATION
/	I-SPECULATION
R	I-SPECULATION
.	O

Role	O
of	O
Egr-2	O
in	O
up-regulation	O
of	O
Fas	O
ligand	O
in	O
normal	O
T	O
cells	O
and	O
aberrant	O
double-negative	O
lpr	O
and	O
gld	O
T	O
cells	O
.	O

We	O
previously	O
identified	O
a	O
Fas	O
ligand	O
regulatory	O
element	O
(	O
FLRE	O
)	O
in	O
the	O
Fas	O
ligand	O
(	O
fasL	O
)	O
promoter	O
that	O
binds	O
Egr	O
family	O
proteins	O
and	O
demonstrated	O
that	O
Egr-3	O
(	O
PILOT	O
)	O
but	O
not	B-NEGATION
Egr-1	I-NEGATION
(	I-NEGATION
NGFI-A	I-NEGATION
,	I-NEGATION
Krox-24	I-NEGATION
,	I-NEGATION
Tis-8	I-NEGATION
,	I-NEGATION
and	I-NEGATION
Zif-268	I-NEGATION
)	I-NEGATION
induces	O
transcription	O
of	O
fasL	O
.	O

The	O
aberrant	O
CD4	O
(-)	O
CD8	O
(-)	O
T	O
cells	O
from	O
lpr	O
/	O
lpr	O
and	O
gld	O
/	O
gld	O
mice	O
,	O
which	O
have	O
mutations	O
in	O
the	O
genes	O
encoding	O
Fas	O
and	O
FasL	O
,	O
respectively	O
,	O
have	O
an	O
activated	O
phenotype	O
and	O
constitutively	O
express	O
high	O
levels	O
of	O
fasL	O
mRNA	O
,	O
prompting	O
us	O
to	O
ask	O
what	O
role	O
if	O
any	O
the	O
FLRE	O
and	O
Egr	O
family	O
proteins	O
have	O
in	O
this	O
aberrant	O
expression	O
of	O
fasL	O
.	O

Unstimulated	O
MRL-lpr	O
/	O
lpr	O
and	O
C3H-gld	O
/	O
gld	O
CD4	O
(-)	O
CD8	O
(-)	O
T	O
cells	O
constitutively	O
contained	O
high	O
levels	O
of	O
two	O
proteins	O
that	O
bound	O
to	O
the	O
FLRE	O
.	O

Supershift	O
analysis	O
revealed	O
these	O
proteins	O
to	O
be	O
Egr-1	O
and	O
Egr-2	O
(	O
Krox-20	O
)	O
;	O
Egr-3	B-NEGATION
was	I-NEGATION
not	I-NEGATION
detected	I-NEGATION
.	O

Activation	O
of	O
normal	O
lymph	O
node	O
cells	O
resulted	O
in	O
increased	O
expression	O
of	O
Egr-1	O
,	O
-	O
2	O
,	O
and	O
-	O
3	O
.	O

As	O
with	O
egr-3	O
,	O
expression	O
of	O
egr-2	O
was	O
blocked	O
by	O
cyclosporin	O
A	O
.	O

Although	O
overexpressed	O
Egr-1	O
was	O
ineffective	O
,	O
overexpressed	O
Egr-2	O
was	O
as	O
potent	O
as	O
Egr-3	O
in	O
inducing	O
fasL	O
promoter-dependent	O
reporter	O
constructs	O
in	O
T	O
cell	O
hybridomas	O
and	O
HeLa	O
cells	O
,	O
and	O
both	O
up-regulated	O
endogenous	O
fasL	O
mRNA	O
in	O
HeLa	O
cells	O
.	O

FasL-dependent	O
reporter	O
constructs	O
in	O
MRL-lpr	O
/	O
lpr	O
and	O
C3H-gld	O
/	O
gld	O
CD4	O
(-)	O
CD8	O
(-)	O
T	O
cells	O
were	O
constitutively	O
active	O
,	O
and	O
this	O
activity	O
was	O
largely	O
prevented	O
by	O
mutation	O
of	O
the	O
critical	O
Egr	O
family	O
binding	O
element	O
.	O

Thus	O
,	O
Egr-2	O
,	O
in	O
addition	O
to	O
Egr-3	O
,	O
regulates	O
FasL	O
expression	O
in	O
activated	O
normal	O
T	O
cells	O
,	O
and	O
Egr-2	B-SPECULATION
is	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
play	I-SPECULATION
a	I-SPECULATION
direct	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
aberrant	I-SPECULATION
fasL	I-SPECULATION
up-regulation	I-SPECULATION
in	I-SPECULATION
lpr	I-SPECULATION
/	I-SPECULATION
lpr	I-SPECULATION
and	I-SPECULATION
gld	I-SPECULATION
/	I-SPECULATION
gld	I-SPECULATION
CD4	I-SPECULATION
(-)	I-SPECULATION
CD8	I-SPECULATION
(-)	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

Involvement	O
of	O
mitogen-activated	O
protein	O
kinase	O
pathways	O
in	O
interleukin-8	O
production	O
by	O
human	O
monocytes	O
and	O
polymorphonuclear	O
cells	O
stimulated	O
with	O
lipopolysaccharide	O
or	O
Mycoplasma	O
fermentans	O
membrane	O
lipoproteins	O
.	O

Interleukin-8	O
(	O
IL-8	O
)	O
is	O
a	O
chemokine	O
that	O
belongs	O
to	O
the	O
alpha-chemokine	O
or	O
CXC	O
subfamily	O
and	O
is	O
produced	O
by	O
a	O
wide	O
variety	O
of	O
human	O
cells	O
,	O
including	O
monocytes	O
and	O
polymorphonuclear	O
cells	O
(	O
PMN	O
)	O
.	O

IL-8	O
is	O
secreted	O
in	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
notably	O
bacterial	O
products	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
by	O
which	O
these	O
agents	O
mediate	O
IL-8	O
induction	O
.	O

In	O
this	O
report	O
,	O
we	O
show	O
that	O
Mycoplasma	O
fermentans	O
lipid-associated	O
membrane	O
proteins	O
(	O
LAMPf	O
)	O
induce	O
the	O
production	O
of	O
high	O
levels	O
of	O
IL-8	O
by	O
THP-1	O
(	O
human	O
monocyte	O
)	O
cells	O
and	O
PMN	O
at	O
the	O
same	O
extent	O
as	O
LPS	O
.	O

It	O
was	O
previously	O
demonstrated	O
that	O
stimulation	O
of	O
monocytic	O
cells	O
with	O
either	O
LPS	O
or	O
LAMPf	O
led	O
to	O
a	O
series	O
of	O
common	O
downstream	O
signaling	O
events	O
,	O
including	O
the	O
activation	O
of	O
protein	O
tyrosine	O
kinase	O
and	O
of	O
mitogen-activated	O
protein	O
kinase	O
cascades	O
.	O

By	O
using	O
PD-98059	O
and	O
SB203580	O
,	O
two	O
potent	O
and	O
selective	O
inhibitors	O
of	O
MEK1	O
(	O
a	O
kinase	O
upstream	O
of	O
ERK1	O
/	O
2	O
)	O
and	O
p38	O
,	O
respectively	O
,	O
we	O
have	O
demonstrated	O
that	O
both	O
ERK1	O
/	O
2	O
and	O
p38	O
cascades	O
play	O
a	O
key	O
role	O
in	O
the	O
production	O
of	O
IL-8	O
by	O
monocytes	O
and	O
PMN	O
stimulated	O
with	O
bacterial	O
fractions	O
.	O

T	O
cell	O
priming	O
enhances	O
IL-4	O
gene	O
expression	O
by	O
increasing	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
.	O

The	O
repetitive	O
activation	O
of	O
T	O
cells	O
(	O
priming	O
)	O
enhances	O
the	O
expression	O
of	O
many	O
cytokines	O
,	O
such	O
as	O
IL-4	O
,	O
but	O
not	B-NEGATION
others	I-NEGATION
,	I-NEGATION
such	I-NEGATION
as	I-NEGATION
IL-2	I-NEGATION
.	O

Molecular	O
mechanisms	O
underlying	O
selective	O
expression	O
of	O
cytokines	O
by	O
T	O
cells	O
remain	O
poorly	O
understood	O
.	O

Here	O
we	O
show	O
that	O
priming	O
of	O
CD4	O
T	O
cells	O
selectively	O
enhances	O
IL-4	O
expression	O
relative	O
to	O
IL-2	O
expression	O
by	O
a	O
transcriptional	O
mechanism	O
involving	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
proteins	O
.	O

As	O
detected	O
by	O
in	O
vivo	O
footprinting	O
,	O
priming	O
markedly	O
increases	O
the	O
activation-dependent	O
engagement	O
of	O
the	O
P0	O
and	O
P1	O
NFAT-binding	O
elements	O
of	O
the	O
IL-4	O
promoter	O
.	O

Moreover	O
,	O
each	O
proximal	O
P	O
element	O
is	O
essential	O
for	O
optimal	O
IL-4	O
promoter	O
activity	O
.	O

Activated	O
primed	O
CD4	O
T	O
cells	O
contain	O
more	O
NFAT1	O
and	O
support	O
greater	O
NFAT-directed	O
transcription	O
than	O
unprimed	O
CD4	O
T	O
cells	O
,	O
while	O
activator	O
protein	O
1	O
binding	O
and	O
activator	O
protein	O
1-mediated	O
transcription	O
by	O
both	O
cell	O
types	O
is	O
similar	O
.	O

Increased	O
expression	O
of	O
wild-type	O
NFAT1	O
substantially	O
increases	O
IL-4	O
promoter	O
activity	O
in	O
unprimed	O
CD4	O
T	O
cells	O
,	O
suggesting	B-SPECULATION
NFAT1	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
limiting	I-SPECULATION
for	I-SPECULATION
IL-4	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
in	I-SPECULATION
this	I-SPECULATION
cell	I-SPECULATION
type	I-SPECULATION
.	O

Furthermore	O
,	O
a	O
truncated	O
form	O
of	O
NFAT1	O
acts	O
as	O
a	O
dominant-negative	O
,	O
reducing	O
IL-4	O
promoter	O
activity	O
in	O
primed	O
CD4	O
T	O
cells	O
and	O
confirming	O
the	O
importance	O
of	O
endogenous	O
NFAT	O
to	O
increased	O
IL-4	O
gene	O
expression	O
by	O
effector	O
T	O
cells	O
.	O

NFAT1	B-SPECULATION
appears	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
the	I-SPECULATION
major	I-SPECULATION
NFAT	I-SPECULATION
family	I-SPECULATION
member	I-SPECULATION
responsible	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
initial	I-SPECULATION
increased	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
IL-4	I-SPECULATION
by	I-SPECULATION
primed	I-SPECULATION
CD4	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
.	O

Inhibition	O
of	O
NF-kappa	O
B	O
activation	O
in	O
vitro	O
and	O
in	O
vivo	O
:	O
role	O
of	O
26S	O
proteasome	O
.	O

It	O
is	O
becoming	O
increasingly	O
apparent	O
that	O
NF-kappa	O
B	O
plays	O
a	O
critical	O
role	O
in	O
regulating	O
the	O
inflammatory	O
response	O
.	O

Data	O
obtained	O
from	O
studies	O
in	O
our	O
laboratories	O
demonstrate	O
that	O
the	O
proteasome	O
plays	O
an	O
important	O
role	O
in	O
the	O
inflammatory	O
cascade	O
by	O
regulating	O
the	O
activation	O
of	O
NF-kappa	O
B	O
.	O

Indeed	O
,	O
the	O
availability	O
of	O
selective	O
and	O
orally	O
active	O
proteasome	O
inhibitors	O
should	B-SPECULATION
prove	I-SPECULATION
useful	I-SPECULATION
in	I-SPECULATION
delineating	I-SPECULATION
the	I-SPECULATION
roles	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
proteasome	I-SPECULATION
and	I-SPECULATION
NF-kappa	I-SPECULATION
B	I-SPECULATION
in	I-SPECULATION
other	I-SPECULATION
pathophysiological	I-SPECULATION
conditions	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
cancer	I-SPECULATION
and	I-SPECULATION
heart	I-SPECULATION
disease	I-SPECULATION
.	O

Comparison	O
of	O
HTLV-I	O
basal	O
transcription	O
and	O
expression	O
of	O
CREB	O
/	O
ATF-1	O
/	O
CREM	O
family	O
members	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
and	O
Jurkat	O
T	O
cells	O
.	O

HTLV-I	O
is	O
the	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
/	O
lymphoma	O
and	O
is	O
associated	O
with	O
tropical	O
spastic	O
paraparesis	O
/	O
HTLV-I-associated	O
myelopathy	O
.	O

Following	O
integration	O
into	O
the	O
host	O
cell	O
genome	O
,	O
HTLV-I	O
replication	O
is	O
regulated	O
by	O
both	O
host	O
and	O
viral	O
mechanisms	O
that	O
control	O
transcription	O
.	O

Low	O
levels	O
of	O
viral	O
transcription	O
(	O
basal	O
transcription	O
)	O
occur	O
before	O
expression	O
of	O
the	O
virally	O
encoded	O
Tax	O
protein	O
(	O
Tax-mediated	O
transcription	O
)	O
.	O

Members	O
of	O
the	O
cyclic	O
adenosine	O
monophosphate	O
(	O
cAMP	O
)	O
response	O
element	O
binding	O
(	O
CREB	O
)/	O
activating	O
transcription	O
factor	O
1	O
(	O
ATF-1	O
)	O
family	O
of	O
transcription	O
factors	O
bind	O
three	O
21-bp	O
repeats	O
(	O
Tax-responsive	O
element-1	O
,	O
or	O
TRE-1	O
)	O
within	O
the	O
viral	O
promoter	O
and	O
are	O
important	O
for	O
basal	O
and	O
Tax-mediated	O
transcription	O
.	O

Using	O
mitogen	O
stimulated	O
and	O
quiescent	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
and	O
Jurkat	O
cells	O
,	O
we	O
compared	O
differences	O
in	O
basal	O
transcription	O
and	O
amounts	O
and	O
binding	O
of	O
transcription	O
factors	O
with	O
TRE-1	O
.	O

We	O
demonstrate	O
that	O
amounts	O
of	O
transcriptionally	O
active	O
phosphorylated	O
CREB	O
protein	O
(	O
P-CREB	O
)	O
differ	O
between	O
activated	O
PBMC	O
and	O
Jurkat	O
cells	O
.	O

Following	O
stimulation	O
,	O
P-CREB	O
levels	O
remain	O
elevated	O
in	O
PBMC	O
for	O
up	O
to	O
24	O
hours	O
whereas	O
CREB	O
is	O
dephosphorylated	O
in	O
Jurkat	O
cells	O
within	O
4	O
hours	O
following	O
stimulation	O
.	O

The	O
differences	O
in	O
P-CREB	O
levels	O
between	O
PBMC	O
and	O
Jurkat	O
cells	O
were	O
directly	O
correlated	O
with	O
basal	O
transcription	O
of	O
HTLV-I	O
in	O
the	O
two	O
cell	O
types	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
determined	O
that	O
the	O
pattern	O
of	O
band	O
migration	O
differed	O
between	O
the	O
two	O
cell	O
types	O
.	O

These	O
data	O
demonstrate	O
that	O
PBMC	O
differentially	O
regulate	O
basal	O
HTLV-I	O
transcription	O
compared	O
with	O
Jurkat	O
T	O
cells	O
,	O
and	O
this	O
differential	O
regulation	O
is	O
due	O
,	O
in	O
part	O
to	O
differential	O
phosphorylation	O
and	O
binding	O
of	O
CREB	O
/	O
ATF-1	O
to	O
TRE-1	O
in	O
the	O
HTLV-I	O
promoter	O
.	O

We	O
demonstrate	O
the	O
utility	O
of	O
using	O
primary	O
lymphocyte	O
models	O
to	O
study	O
HTLV-I	O
transcription	O
in	O
the	O
context	O
of	O
cell	O
signaling	O
and	O
suggest	B-SPECULATION
that	I-SPECULATION
activated	I-SPECULATION
PBMC	I-SPECULATION
maintain	I-SPECULATION
elevated	I-SPECULATION
levels	I-SPECULATION
of	I-SPECULATION
P-CREB	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
promote	I-SPECULATION
basal	I-SPECULATION
HTLV-I	I-SPECULATION
transcription	I-SPECULATION
and	I-SPECULATION
enhance	I-SPECULATION
viral	I-SPECULATION
persistence	I-SPECULATION
in	I-SPECULATION
vivo	I-SPECULATION
.	O

NF-kappaB	O
activation	O
is	O
a	O
critical	O
regulator	O
of	O
human	O
granulocyte	O
apoptosis	O
in	O
vitro	O
.	O

During	O
beneficial	O
inflammation	O
,	O
potentially	B-SPECULATION
tissue-damaging	I-SPECULATION
granulocytes	O
undergo	O
apoptosis	O
before	O
being	O
cleared	O
by	O
phagocytes	O
in	O
a	O
non-phlogistic	O
manner	O
.	O

Here	O
we	O
show	O
that	O
the	O
rate	O
of	O
constitutive	O
apoptosis	O
in	O
human	O
neutrophils	O
and	O
eosinophils	O
is	O
greatly	O
accelerated	O
in	O
both	O
a	O
rapid	O
and	O
concentration-dependent	O
manner	O
by	O
the	O
fungal	O
metabolite	O
gliotoxin	O
,	O
but	O
not	B-NEGATION
by	I-NEGATION
its	I-NEGATION
inactive	I-NEGATION
analog	I-NEGATION
methylthiogliotoxin	I-NEGATION
.	O

This	O
induction	O
of	O
apoptosis	O
was	O
abolished	O
by	O
the	O
caspase	O
inhibitor	O
zVAD-fmk	O
,	O
correlated	O
with	O
the	O
inhibition	O
of	O
nuclear	O
factor-kappa	O
B	O
(	O
NF-kappaB	O
)	O
,	O
and	O
was	O
mimicked	O
by	O
a	O
cell	O
permeable	O
inhibitory	O
peptide	O
of	O
NF-kappaB	O
,	O
SN-50	O
;	O
other	O
NF-kappaB	O
inhibitors	O
,	O
curcumin	O
and	O
pyrrolidine	O
dithiocarbamate	O
;	O
and	O
the	O
proteasome	O
inhibitor	O
,	O
MG-132	O
.	O

Gliotoxin	O
also	O
augmented	O
dramatically	O
the	O
early	O
(	O
2-6	O
h	O
)	O
pro-apoptotic	O
effects	O
of	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF-alpha	O
)	O
in	O
neutrophils	O
and	O
unmasked	O
the	O
ability	O
of	O
TNF-alpha	O
to	O
induce	O
eosinophil	O
apoptosis	O
.	O

In	O
neutrophils	O
,	O
TNF-alpha	O
caused	O
a	O
gliotoxin-inhibitable	O
activation	O
of	O
an	O
inducible	O
form	O
of	O
NF-kappaB	O
,	O
a	O
response	O
that	O
may	B-SPECULATION
underlie	I-SPECULATION
the	I-SPECULATION
ability	I-SPECULATION
of	I-SPECULATION
TNF-alpha	I-SPECULATION
to	I-SPECULATION
delay	I-SPECULATION
apoptosis	I-SPECULATION
at	I-SPECULATION
later	I-SPECULATION
times	I-SPECULATION
(	I-SPECULATION
12-24	I-SPECULATION
h	I-SPECULATION
)	I-SPECULATION
and	I-SPECULATION
limit	I-SPECULATION
its	I-SPECULATION
early	I-SPECULATION
killing	I-SPECULATION
effect	I-SPECULATION
.	O

Furthermore	O
,	O
cycloheximide	O
displayed	O
a	O
similar	O
capacity	O
to	O
enhance	O
TNF-alpha	O
induced	O
neutrophil	O
apoptosis	O
even	O
at	O
time	O
points	O
when	O
cycloheximide	O
alone	O
had	O
no	B-NEGATION
pro-apoptotic	I-NEGATION
effect	I-NEGATION
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
NF-kappaB	I-SPECULATION
may	B-SPECULATION
regulate	I-SPECULATION
the	I-SPECULATION
production	I-SPECULATION
of	I-SPECULATION
protein	I-SPECULATION
(	I-SPECULATION
s	I-SPECULATION
)	I-SPECULATION
which	I-SPECULATION
protect	I-SPECULATION
neutrophils	I-SPECULATION
from	I-SPECULATION
the	I-SPECULATION
cytotoxic	I-SPECULATION
effects	I-SPECULATION
of	I-SPECULATION
TNF-alpha	I-SPECULATION
.	O

These	O
data	O
shed	O
light	O
on	O
the	O
biochemical	O
and	O
molecular	O
mechanisms	O
regulating	O
human	O
granulocyte	O
apoptosis	O
and	O
,	O
in	O
particular	O
,	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
transcription	I-SPECULATION
factor	I-SPECULATION
NF-kappaB	I-SPECULATION
plays	I-SPECULATION
a	I-SPECULATION
crucial	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
regulating	I-SPECULATION
the	I-SPECULATION
physiological	I-SPECULATION
cell	I-SPECULATION
death	I-SPECULATION
pathway	I-SPECULATION
in	I-SPECULATION
granulocytes	I-SPECULATION
.	O

Lactobacilli	O
and	O
vaginal	O
host	O
defense	O
:	O
activation	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
long	O
terminal	O
repeat	O
,	O
cytokine	O
production	O
,	O
and	O
NF-kappaB	O
.	O

Lactobacilli	O
,	O
a	O
component	O
of	O
the	O
normal	O
vaginal	O
flora	O
,	O
can	O
activate	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)-	O
1	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
in	O
the	O
Jurkat	O
T	O
lymphocyte	O
and	O
THP-1	O
macrophage	O
cell	O
lines	O
.	O

Activation	O
of	O
the	O
LTR	O
in	O
Jurkat	O
cells	O
was	O
strongly	O
enhanced	O
by	O
vanadate	O
and	O
inhibited	O
by	O
catalase	O
,	O
implicating	O
H2O2	O
.	O

In	O
contrast	O
,	O
activation	O
in	O
THP-1	O
cells	O
occurred	O
in	O
the	O
absence	B-NEGATION
of	I-NEGATION
vanadate	I-NEGATION
and	O
was	O
unaffected	O
by	O
catalase	O
.	O

The	O
active	O
material	O
partitioned	O
into	O
the	O
phenol	O
layer	O
on	O
hot	O
aqueous	O
phenol	O
extraction	O
.	O

Lactobacilli	O
also	O
increased	O
tumor	O
necrosis	O
factor-alphaand	O
interleukin-1betaproduction	O
and	O
activated	O
NF-kappaB	O
in	O
THP-1	O
cells	O
and	O
increased	O
tumor	O
necrosis	O
factor-alphaproduction	O
by	O
human	O
monocytes	O
.	O

Human	O
vaginal	O
fluid	O
specimens	O
had	O
comparable	O
properties	O
,	O
which	O
correlated	O
with	O
their	O
bacterial	O
content	O
.	O

These	O
findings	O
suggest	B-SPECULATION
the	I-SPECULATION
presence	I-SPECULATION
in	I-SPECULATION
vaginal	I-SPECULATION
fluid	I-SPECULATION
of	I-SPECULATION
agent	I-SPECULATION
(	I-SPECULATION
s	I-SPECULATION
)	I-SPECULATION
derived	I-SPECULATION
from	I-SPECULATION
indigenous	I-SPECULATION
bacteria	I-SPECULATION
that	I-SPECULATION
can	I-SPECULATION
activate	I-SPECULATION
the	I-SPECULATION
HIV-1	I-SPECULATION
LTR	I-SPECULATION
,	I-SPECULATION
cytokine	I-SPECULATION
production	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
NF-kappaB	I-SPECULATION
in	I-SPECULATION
cells	I-SPECULATION
of	I-SPECULATION
macrophage	I-SPECULATION
lineage	I-SPECULATION
,	I-SPECULATION
with	I-SPECULATION
possible	B-SPECULATION
influence	I-SPECULATION
on	I-SPECULATION
vaginal	I-SPECULATION
physiology	I-SPECULATION
and	I-SPECULATION
host	I-SPECULATION
defense	I-SPECULATION
.	O

High-level	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
in	O
thymocytes	O
requires	O
NF-kappaB	O
activation	O
through	O
interaction	O
with	O
thymic	O
epithelial	O
cells	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
interaction	O
of	O
infected	O
thymocytes	O
with	O
autologous	O
thymic	O
epithelial	O
cells	O
(	O
TEC	O
)	O
is	O
a	O
prerequisite	O
for	O
a	O
high	O
level	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
replication	O
in	O
thymocytes	O
(	O
M.Rothe	O
,	O
L.Chene	O
,	O
M.Nugeyre	O
,	O
F.Barre-Sinoussi	O
,	O
and	O
N.Israel	O
,	O
J.Virol.72:5852-5861	O
,	O
1998	O
)	O
.	O

We	O
report	O
here	O
that	O
this	O
activation	O
of	O
HIV	O
replication	O
takes	O
place	O
at	O
the	O
transcriptional	O
level	O
through	O
activation	O
of	O
the	O
Rel	O
/	O
NF-kappaB	O
transcription	O
factors	O
.	O

We	O
first	O
demonstrate	O
that	O
an	O
HIV-1	O
provirus	O
(	O
SF-2	O
strain	O
)	O
very	O
effectively	O
replicates	O
in	O
thymocytes	O
cocultured	O
with	O
TEC	O
whereas	O
this	O
provirus	O
,	O
with	O
kappaB	O
sites	O
deleted	O
,	O
fails	B-NEGATION
to	I-NEGATION
replicate	I-NEGATION
.	O

We	O
provide	O
evidence	O
that	O
several	O
NF-kappaB	O
complexes	O
are	O
constitutively	O
found	O
in	O
the	O
nuclei	O
of	O
thymocytes	O
either	O
freshly	O
isolated	O
from	O
the	O
thymus	O
or	O
maintained	O
in	O
coculture	O
with	O
autologous	O
or	O
heterologous	O
TEC	O
.	O

The	O
prevalent	O
complex	O
is	O
the	O
heterodimer	O
p50-p65	O
.	O

NF-kappaB	O
activity	O
is	O
tightly	O
correlated	O
with	O
the	O
transcriptional	O
activity	O
of	O
a	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
of	O
HIV-1	O
transfected	O
in	O
thymocytes	O
.	O

The	O
cotransfection	O
of	O
this	O
LTR	O
with	O
a	O
mutated	O
IkappaBalpha	O
molecule	O
formally	O
demonstrates	O
that	O
LTR	O
transactivation	O
is	O
regulated	O
by	O
members	O
of	O
the	O
Rel	O
/	O
NF-kappaB	O
family	O
in	O
thymocytes	O
.	O

We	O
also	O
showed	O
that	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
and	O
to	O
a	O
lesser	O
extent	O
interleukin-1	O
(	O
IL-1	O
)	O
,	O
secreted	O
within	O
the	O
coculture	O
,	O
induce	O
NF-kappaB	O
activity	O
and	O
a	O
correlative	O
LTR	O
transactivation	O
.	O

However	O
IL-7	O
,	O
a	O
crucial	O
factor	O
for	O
thymopoiesis	O
that	O
is	O
secreted	O
mainly	O
by	O
TEC	O
,	O
is	O
a	O
necessary	O
cofactor	O
for	O
NF-kappaB	O
activation	O
elicited	O
by	O
TNF	O
or	O
IL-1	O
.	O

Together	O
,	O
these	O
data	O
indicate	B-SPECULATION
that	I-SPECULATION
NF-kappaB	I-SPECULATION
activation	I-SPECULATION
,	I-SPECULATION
required	I-SPECULATION
for	I-SPECULATION
a	I-SPECULATION
high	I-SPECULATION
level	I-SPECULATION
of	I-SPECULATION
HIV	I-SPECULATION
replication	I-SPECULATION
in	I-SPECULATION
thymocytes	I-SPECULATION
,	I-SPECULATION
is	I-SPECULATION
regulated	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
specific	I-SPECULATION
manner	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
thymic	I-SPECULATION
microenvironment	I-SPECULATION
which	I-SPECULATION
provides	I-SPECULATION
the	I-SPECULATION
necessary	I-SPECULATION
cytokines	I-SPECULATION
:	I-SPECULATION
TNF	I-SPECULATION
,	I-SPECULATION
IL-1	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
IL-7	I-SPECULATION
.	O

Cross-linking	O
of	O
CD44	O
on	O
rheumatoid	O
synovial	O
cells	O
up-regulates	O
VCAM-1	O
.	O

CD44	O
is	O
a	O
ubiquitous	O
molecule	O
also	O
known	O
as	O
hyaluronic	O
acid	O
or	O
homing	O
receptor	O
.	O

However	O
,	O
the	B-SPECULATION
cellular	I-SPECULATION
functions	I-SPECULATION
and	I-SPECULATION
its	I-SPECULATION
role	I-SPECULATION
in	I-SPECULATION
inflammation	I-SPECULATION
,	I-SPECULATION
for	I-SPECULATION
example	I-SPECULATION
,	I-SPECULATION
rheumatoid	I-SPECULATION
synovitis	I-SPECULATION
,	I-SPECULATION
are	I-SPECULATION
currently	I-SPECULATION
unknown	I-SPECULATION
.	O

In	O
this	O
study	O
,	O
we	O
propose	O
a	O
novel	O
function	O
for	O
CD44	O
.	O

Using	O
synovial	O
cells	O
from	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
patients	O
,	O
we	O
demonstrated	O
that	O
CD44	O
cross-linking	O
and	O
binding	O
to	O
hyaluronan	O
augmented	O
VCAM-1	O
expression	O
and	O
subsequently	O
VCAM-1-mediated	O
cell	O
adhesion	O
.	O

Briefly	O
,	O
we	O
found	O
that	O
1	O
)	O
rheumatoid	O
synovial	O
cells	O
highly	O
expressed	O
CD44	O
;	O
2	O
)	O
cross-linking	O
of	O
CD44	O
markedly	O
but	O
transiently	O
augmented	O
VCAM-1	O
expression	O
and	O
its	O
mRNA	O
transcription	O
much	O
more	O
than	O
did	O
IL-1beta	O
and	O
TNF-alpha	O
;	O
3	O
)	O
hyaluronan	O
,	O
especially	O
when	O
fragmented	O
,	O
also	O
up-regulated	O
VCAM-1	O
;	O
4	O
)	O
CD44	O
activated	O
the	O
transcription	O
factor	O
AP-1	O
;	O
and	O
5	O
)	O
the	O
integrin-dependent	O
adhesive	O
function	O
of	O
RA	O
synovial	O
cells	O
to	O
T	O
cells	O
was	O
also	O
amplified	O
by	O
CD44	O
cross-linking	O
.	O

These	O
results	O
indicate	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
adhesion	I-SPECULATION
of	I-SPECULATION
RA	I-SPECULATION
synovial	I-SPECULATION
cells	I-SPECULATION
to	I-SPECULATION
matrices	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
hyaluronic	I-SPECULATION
acid	I-SPECULATION
through	I-SPECULATION
CD44	I-SPECULATION
could	I-SPECULATION
up-regulate	I-SPECULATION
VCAM-1	I-SPECULATION
expression	I-SPECULATION
and	I-SPECULATION
VCAM-1-mediated	I-SPECULATION
adhesion	I-SPECULATION
to	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
might	B-SPECULATION
in	I-SPECULATION
turn	I-SPECULATION
cause	I-SPECULATION
activation	I-SPECULATION
of	I-SPECULATION
T	I-SPECULATION
cells	I-SPECULATION
and	I-SPECULATION
synovial	I-SPECULATION
cells	I-SPECULATION
in	I-SPECULATION
RA	I-SPECULATION
synovitis	I-SPECULATION
.	O

We	O
therefore	O
propose	B-SPECULATION
that	I-SPECULATION
such	I-SPECULATION
cross-talking	I-SPECULATION
among	I-SPECULATION
distinct	I-SPECULATION
adhesion	I-SPECULATION
molecules	I-SPECULATION
may	B-SPECULATION
be	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
pathogenesis	I-SPECULATION
of	I-SPECULATION
inflammation	I-SPECULATION
,	I-SPECULATION
including	I-SPECULATION
RA	I-SPECULATION
synovitis	I-SPECULATION
.	O

Oleic	O
acid	O
inhibits	O
endothelial	O
activation	O
:	O
A	O
direct	O
vascular	O
antiatherogenic	O
mechanism	O
of	O
a	O
nutritional	O
component	O
in	O
the	O
mediterranean	O
diet	O
.	O

Because	O
oleic	O
acid	O
is	O
implicated	O
in	O
the	O
antiatherogenic	O
effects	O
attributed	O
to	O
the	O
Mediterranean	O
diet	O
,	O
we	O
investigated	O
whether	B-SPECULATION
this	I-SPECULATION
fatty	I-SPECULATION
acid	I-SPECULATION
can	I-SPECULATION
modulate	I-SPECULATION
endothelial	I-SPECULATION
activation	I-SPECULATION
,	I-SPECULATION
ie	I-SPECULATION
,	I-SPECULATION
the	I-SPECULATION
concerted	I-SPECULATION
expression	I-SPECULATION
of	I-SPECULATION
gene	I-SPECULATION
products	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
leukocyte	I-SPECULATION
recruitment	I-SPECULATION
and	I-SPECULATION
early	I-SPECULATION
atherogenesis	I-SPECULATION
.	O

We	O
incubated	O
sodium	O
oleate	O
with	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
for	O
0	O
to	O
72	O
hours	O
,	O
followed	O
by	O
coincubation	O
of	O
oleate	O
with	O
human	O
recombinant	O
tumor	O
necrosis	O
factor	O
,	O
interleukin	O
(	O
IL	O
)-	O
1alpha	O
,	O
IL-1beta	O
,	O
IL-4	O
,	O
Escherichia	O
coli	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
or	O
phorbol	O
12-myristate	O
13-acetate	O
for	O
a	O
further	O
6	O
to	O
24	O
hours	O
.	O

The	O
endothelial	O
expression	O
of	O
vascular	O
cell	O
adhesion	O
molecule-1	O
(	O
VCAM-1	O
)	O
,	O
E-selectin	O
,	O
and	O
intercellular	O
adhesion	O
molecule-1	O
was	O
monitored	O
by	O
cell	O
surface	O
enzyme	O
immunoassays	O
or	O
flow	O
cytometry	O
,	O
and	O
steady-state	O
levels	O
of	O
VCAM-1	O
mRNA	O
were	O
assessed	O
by	O
Northern	O
blot	O
analysis	O
.	O

At	O
10	O
to	O
100	O
micromol	O
/	O
L	O
for	O
>	O
24	O
hours	O
,	O
oleate	O
inhibited	O
the	O
expression	O
of	O
all	O
adhesion	O
molecules	O
tested	O
.	O

After	O
a	O
72-hour	O
incubation	O
with	O
oleate	O
and	O
a	O
further	O
16-hour	O
incubation	O
with	O
oleate	O
plus	O
1	O
microg	O
/	O
mL	O
LPS	O
,	O
VCAM-1	O
expression	O
was	O
reduced	O
by	O
>	O
40	O
%	O
compared	O
with	O
control	O
.	O

Adhesion	O
of	O
monocytoid	O
U937	O
cells	O
to	O
LPS-treated	O
endothelial	O
cells	O
was	O
reduced	O
concomitantly	O
.	O

Oleate	O
also	O
produced	O
a	O
quantitatively	O
similar	O
reduction	O
of	O
VCAM-1	O
mRNA	O
levels	O
on	O
Northern	O
blot	O
analysis	O
and	O
inhibited	O
nuclear	O
factor-kappaB	O
activation	O
on	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

Incubation	O
of	O
endothelial	O
cells	O
with	O
oleate	O
for	O
72	O
hours	O
decreased	O
the	O
relative	O
proportions	O
of	O
saturated	O
(	O
palmitic	O
and	O
stearic	O
)	O
acids	O
in	O
total	O
cell	O
lipids	O
and	O
increased	O
the	O
proportions	O
of	O
oleate	O
in	O
total	O
cell	O
lipids	O
without	B-NEGATION
significantly	I-NEGATION
changing	I-NEGATION
the	I-NEGATION
relative	I-NEGATION
proportions	I-NEGATION
of	I-NEGATION
polyunsaturated	I-NEGATION
fatty	I-NEGATION
acids	I-NEGATION
.	O

Although	O
less	O
potent	O
than	O
polyunsaturated	O
fatty	O
acids	O
in	O
inhibiting	O
endothelial	O
activation	O
,	O
oleic	O
acid	O
may	B-SPECULATION
contribute	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
prevention	I-SPECULATION
of	I-SPECULATION
atherogenesis	I-SPECULATION
through	I-SPECULATION
selective	I-SPECULATION
displacement	I-SPECULATION
of	I-SPECULATION
saturated	I-SPECULATION
fatty	I-SPECULATION
acids	I-SPECULATION
in	I-SPECULATION
cell	I-SPECULATION
membrane	I-SPECULATION
phospholipids	I-SPECULATION
and	I-SPECULATION
a	I-SPECULATION
consequent	I-SPECULATION
modulation	I-SPECULATION
of	I-SPECULATION
gene	I-SPECULATION
expression	I-SPECULATION
for	I-SPECULATION
molecules	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
monocyte	I-SPECULATION
recruitment	I-SPECULATION
.	O

Functional	O
association	O
of	O
Nmi	O
with	O
Stat5	O
and	O
Stat1	O
in	O
IL-2	O
-	O
and	O
IFNgamma-mediated	O
signaling	O
.	O

Using	O
the	O
coiled-coil	O
region	O
of	O
Stat5b	O
as	O
the	O
bait	O
in	O
a	O
yeast	O
two-hybrid	O
screen	O
,	O
we	O
identified	O
the	O
association	O
of	O
Nmi	O
,	O
a	O
protein	O
of	O
unknown	B-SPECULATION
function	I-SPECULATION
previously	O
reported	O
as	O
an	O
N-Myc	O
interactor	O
.	O

We	O
further	O
show	O
that	O
Nmi	O
interacts	O
with	O
all	O
STATs	O
except	O
Stat2	O
.	O

We	O
evaluated	O
two	O
cytokine	O
systems	O
,	O
IL-2	O
and	O
IFNgamma	O
,	O
and	O
demonstrate	O
that	O
Nmi	O
augments	O
STAT-mediated	O
transcription	O
in	O
response	O
to	O
these	O
cytokines	O
.	O

Interestingly	O
,	O
Nmi	O
lacks	B-NEGATION
an	I-NEGATION
intrinsic	I-NEGATION
transcriptional	I-NEGATION
activation	I-NEGATION
domain	I-NEGATION
;	O
instead	O
,	O
Nmi	O
enhances	O
the	O
association	O
of	O
CBP	O
/	O
p300	O
coactivator	O
proteins	O
with	O
Stat1	O
and	O
Stat5	O
,	O
and	O
together	O
with	O
CBP	O
/	O
p300	O
can	O
augment	O
IL-2	O
-	O
and	O
IFNgamma-dependent	O
transcription	O
.	O

Therefore	O
,	O
our	O
data	O
not	O
only	O
reveal	O
that	O
Nmi	O
can	O
potentiate	O
STAT-dependent	O
transcription	O
,	O
but	O
also	O
suggest	B-SPECULATION
that	I-SPECULATION
it	I-SPECULATION
can	I-SPECULATION
augment	I-SPECULATION
coactivator	I-SPECULATION
protein	I-SPECULATION
recruitment	I-SPECULATION
to	I-SPECULATION
at	I-SPECULATION
least	I-SPECULATION
some	I-SPECULATION
members	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
group	I-SPECULATION
of	I-SPECULATION
sequence-specific	I-SPECULATION
transcription	I-SPECULATION
factors	I-SPECULATION
.	O

Mining	O
prokaryotic	O
genomes	O
for	O
unknown	O
amino	O
acids	O
:	O
a	O
stop-codon-based	O
approach	O

Abstract	O

Background	O

Selenocysteine	O
and	O
pyrrolysine	O
are	O
the	O
21st	O
and	O
22nd	O
amino	O
acids	O
,	O
which	O
are	O
genetically	O
encoded	O
by	O
stop	O
codons	O
.	O

Since	O
a	O
number	O
of	O
microbial	O
genomes	O
have	O
been	O
completely	O
sequenced	O
to	O
date	O
,	O
it	O
is	O
tempting	O
to	O
ask	O
whether	B-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
is	I-SPECULATION
left	I-SPECULATION
undiscovered	I-SPECULATION
in	I-SPECULATION
these	I-SPECULATION
genomes	I-SPECULATION
.	O

Recently	O
,	O
a	O
computational	O
study	O
addressed	O
this	O
question	O
and	O
reported	O
that	O
no	B-NEGATION
tRNA	I-NEGATION
gene	I-NEGATION
for	I-NEGATION
unknown	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
was	I-NEGATION
found	I-NEGATION
in	I-NEGATION
genome	I-NEGATION
sequences	I-NEGATION
available	I-NEGATION
.	O

However	O
,	O
performance	B-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
tRNA	I-SPECULATION
prediction	I-SPECULATION
program	I-SPECULATION
on	I-SPECULATION
an	I-SPECULATION
unknown	I-SPECULATION
tRNA	I-SPECULATION
family	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
unclear	I-SPECULATION
,	O
thereby	O
rendering	O
their	O
result	O
inconclusive	O
.	O
may	B-SPECULATION
have	I-SPECULATION
atypical	I-SPECULATION
sequence	I-SPECULATION
and	I-SPECULATION
structure	I-SPECULATION
,	O
is	O
.	O

A	O
protein-level	O
study	O
will	O
provide	O
independent	O
insight	O
into	O
the	O
novel	O
amino	O
acid	O
.	O

Results	O

Assuming	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
is	I-SPECULATION
also	I-SPECULATION
encoded	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
stop	I-SPECULATION
codon	I-SPECULATION
,	O
we	O
systematically	O
predicted	O
proteins	O
that	O
contain	O
stop-codon-encoded	O
amino	O
acids	O
from	O
191	O
prokaryotic	O
genomes	O
.	O

Since	O
our	O
prediction	O
method	O
relies	O
only	O
on	O
the	O
conservation	O
patterns	O
of	O
primary	O
sequences	O
,	O
it	O
also	O
provides	O
an	O
opportunity	O
to	O
search	O
novel	O
selenoproteins	O
and	O
other	O
readthrough	O
proteins	O
.	O

It	O
successfully	O
recovered	O
many	O
of	O
currently	O
known	O
selenoproteins	O
and	O
pyrrolysine	O
proteins	O
.	O

However	O
,	O
no	B-NEGATION
promising	I-NEGATION
candidate	I-NEGATION
for	I-NEGATION
the	I-NEGATION
23rd	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
was	I-NEGATION
detected	I-NEGATION
,	O
and	O
only	O
one	O
novel	O
selenoprotein	O
was	O
predicted	O
.	O

Conclusion	O

Our	O
result	O
suggests	B-SPECULATION
that	I-SPECULATION
,	O
which	O
is	O
in	O
agreement	O
with	O
the	O
previous	O
study	O
on	O
tRNA	O
.	O
the	B-SPECULATION
unknown	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
encoded	I-SPECULATION
by	I-SPECULATION
stop	I-SPECULATION
codons	I-SPECULATION
does	I-SPECULATION
or	I-SPECULATION
its	I-SPECULATION
phylogenetic	I-SPECULATION
distribution	I-SPECULATION
is	I-SPECULATION
rather	I-SPECULATION
limited	I-SPECULATION
not	B-NEGATION
exist	I-NEGATION
,	O
.	O

The	O
method	O
described	O
here	O
can	O
be	O
used	O
in	O
future	O
studies	O
to	O
explore	O
novel	O
readthrough	O
events	O
from	O
complete	O
genomes	O
,	O
which	O
are	O
rapidly	O
growing	O
.	O

Background	O

Stop	O
codon	O
readthrough	O
is	O
a	O
phenomenon	O
in	O
which	O
the	O
translation	O
process	O
does	O
not	B-NEGATION
terminate	I-NEGATION
at	I-NEGATION
a	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
,	O
and	O
an	O
amino	O
acid	O
is	O
inserted	O
there	O
instead	O
12	O
.	O

In	O
some	O
cases	O
,	O
the	O
inserted	O
amino	O
acid	O
is	O
not	B-NEGATION
one	I-NEGATION
of	I-NEGATION
the	I-NEGATION
20	I-NEGATION
amino	I-NEGATION
acids	I-NEGATION
but	O
a	O
noncanonical	O
one	O
.	O

Two	O
such	O
amino	O
acids	O
have	O
been	O
discovered	O
to	O
date	O
:	O
selenocysteine	O
34	O
and	O
pyrrolysine	O
56	O
.	O

Because	O
each	O
of	O
them	O
have	O
specialized	O
tRNA	O
genes	O
for	O
decoding	O
and	O
can	O
be	O
considered	O
extensions	O
of	O
the	O
standard	O
genetic	O
code	O
,	O
they	O
are	O
called	O
the	O
21st	O
and	O
22nd	O
amino	O
acids	O
,	O
respectively	O
.	O

Selenocysteine	O
,	O
the	O
21st	O
amino	O
acid	O
,	O
is	O
encoded	O
by	O
stop	O
codon	O
UGA	O
,	O
and	O
organisms	O
that	O
use	O
selenocysteine	O
have	O
been	O
found	O
from	O
all	O
three	O
domains	O
of	O
life	O
.	O

Its	O
insertion	O
into	O
UGA	O
is	O
directed	O
by	O
SECIS	O
(	O
selenocysteine	O
insertion	O
sequence	O
)	O
elements	O
,	O
a	O
stem-loop	O
structure	O
on	O
the	O
selenoprotein	O
mRNA	O
.	O

Along	O
with	O
the	O
progress	O
of	O
genome	O
sequencing	O
projects	O
,	O
computational	O
prediction	O
methods	O
of	O
selenocysteine-containing	O
proteins	O
(	O
selenoproteins	O
)	O
have	O
been	O
developed	O
by	O
several	O
research	O
groups	O
78910	O
,	O
and	O
the	O
repertoire	O
of	O
selenoproteins	O
has	O
been	O
greatly	O
expanded	O
1112	O
.	O

Pyrrolysine	O
,	O
the	O
22nd	O
amino	O
acid	O
encoded	O
by	O
stop	O
codon	O
UAG	O
,	O
was	O
recently	O
discovered	O
from	O
a	O
methanogenic	O
archaea	O
56	O
.	O

Currently	O
,	O
only	O
methanogenic	O
archaea	O
of	O
the	O
order	O
Methanosarcinales	O
and	O
one	O
bacterium	O
are	O
considered	O
to	O
utilize	O
pyrrolysine	O
13	O
.	O

The	O
limited	O
phylogenetic	O
distribution	O
of	O
pyrrolysine	O
suggests	B-SPECULATION
that	I-SPECULATION
its	I-SPECULATION
incorporation	I-SPECULATION
into	I-SPECULATION
the	I-SPECULATION
genetic	I-SPECULATION
code	I-SPECULATION
of	I-SPECULATION
methanogen	I-SPECULATION
is	I-SPECULATION
relatively	I-SPECULATION
recent	I-SPECULATION
,	I-SPECULATION
and	I-SPECULATION
the	I-SPECULATION
insertion	I-SPECULATION
mechanism	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
novel	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
can	B-SPECULATION
evolve	I-SPECULATION
in	I-SPECULATION
a	I-SPECULATION
shorter	I-SPECULATION
period	I-SPECULATION
of	I-SPECULATION
time	I-SPECULATION
than	I-SPECULATION
anticipated	I-SPECULATION
.	O

This	O
raises	B-SPECULATION
an	I-SPECULATION
interesting	I-SPECULATION
question	I-SPECULATION
:	I-SPECULATION
:	I-SPECULATION
""	I-SPECULATION
Is	I-SPECULATION
there	I-SPECULATION
a	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
"	I-SPECULATION
?"	O
.	O

If	O
such	O
an	O
amino	O
acid	O
is	O
discovered	O
,	O
it	O
will	O
deepen	O
our	O
understanding	O
of	O
the	O
evolution	O
and	O
diversity	O
of	O
the	O
genetic	O
code	O
.	O

Because	O
genome	O
sequences	O
of	O
various	O
prokaryotes	O
are	O
available	O
today	O
,	O
there	O
will	O
be	O
a	O
chance	O
to	O
discover	O
the	O
novel	O
amino	O
acid	O
via	O
analysis	O
of	O
these	O
genomes	O
.	O

Since	O
both	O
the	O
21st	O
and	O
22nd	O
amino	O
acids	O
are	O
encoded	O
by	O
stop	O
codons	O
,	O
the	O
prime	O
suspect	O
is	O
other	O
stop	O
codons	O
(	O
e.g.	O
stop	O
codon	O
UAA	O
)	O
,	O
although	O
the	O
possibility	O
of	O
sense	O
codons	O
certainly	O
remains	O
.	O

Using	O
this	O
clue	O
,	O
computational	O
screening	O
methods	O
of	O
the	O
23rd	O
amino	O
acid	O
can	O
be	O
designed	O
.	O

Recently	O
,	O
Lobanov	O
et	O
al.	O
addressed	O
this	O
problem	O
by	O
searching	O
tRNAs	O
with	O
anticodons	O
corresponding	O
to	O
stop	O
codons	O
14	O
.	O

They	O
analyzed	O
146	O
prokaryotic	O
genomes	O
,	O
but	O
no	B-NEGATION
likely	I-NEGATION
tRNA	I-NEGATION
of	I-NEGATION
the	I-NEGATION
novel	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
was	I-NEGATION
detected	I-NEGATION
.	O

They	O
concluded	O
that	O
the	O
23rd	O
amino	O
acid	O
would	B-SPECULATION
have	I-SPECULATION
a	I-SPECULATION
limited	I-SPECULATION
phylogenetic	I-SPECULATION
distribution	I-SPECULATION
,	I-SPECULATION
if	I-SPECULATION
it	I-SPECULATION
exists	I-SPECULATION
.	O

However	O
,	O
programs	O
for	O
tRNA	O
identification	O
are	O
based	O
on	O
the	O
features	O
of	O
known	O
tRNAs	O
and	O
do	O
not	O
necessarily	O
perform	O
well	O
on	O
unknown	O
ones	O
.	O

Actually	O
,	O
tRNASec	O
and	O
tRNAPyl	O
have	O
unusual	O
secondary	O
structures	O
515	O
and	O
often	O
escape	O
detection	O
by	O
programs	O
without	B-NEGATION
special	I-NEGATION
consideration	I-NEGATION
.	O

Lobanov	O
et	O
al.	O
thus	O
developed	O
a	O
sensitive	O
search	O
method	O
to	O
deal	O
with	O
this	O
problem	O
,	O
but	O
they	O
also	O
admitted	O
that	O
it	O
would	B-SPECULATION
fail	B-NEGATION
to	I-NEGATION
identify	I-NEGATION
highly	I-NEGATION
unusual	I-NEGATION
tRNAs	I-NEGATION
.	O

There	O
is	O
another	O
approach	O
to	O
searching	O
for	O
the	O
23rd	O
amino	O
acid	O
.	O

By	O
enumerating	O
ORFs	O
that	O
have	O
an	O
inframe	O
stop	O
codon	O
from	O
genomes	O
and	O
examining	O
their	O
evolutionary	O
conservation	O
,	O
candidate	O
proteins	O
can	O
be	O
predicted	O
.	O

Because	O
such	O
an	O
ORF-based	O
study	O
is	O
independent	O
from	O
the	O
tRNA	O
analysis	O
,	O
it	O
can	O
either	B-SPECULATION
identify	I-SPECULATION
candidate	I-SPECULATION
organisms	I-SPECULATION
missed	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
previous	I-SPECULATION
study	I-SPECULATION
.	O

Here	O
we	O
report	O
a	O
comprehensive	O
analysis	O
of	O
prokaryotic	O
ORFs	O
that	O
contain	O
an	O
inframe	O
stop	O
codon	O
.	O

Through	O
enumeration	O
of	O
theoretical	O
ORFs	O
and	O
inspection	O
of	O
their	O
evolutionary	O
conservation	O
,	O
candidates	O
of	O
readthrough	O
proteins	O
were	O
predicted	O
.	O

They	O
contained	O
many	O
of	O
the	O
known	O
proteins	O
with	O
stop-codon-encoded	O
amino	O
acids	O
,	O
but	O
almost	O
no	O
novel	O
candidates	O
were	O
identified	O
.	O

Therefore	O
,	O
the	B-SPECULATION
unknown	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
,	I-SPECULATION
if	I-SPECULATION
it	I-SPECULATION
is	I-SPECULATION
encoded	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
stop	I-SPECULATION
codon	I-SPECULATION
,	I-SPECULATION
is	I-SPECULATION
unlikely	I-SPECULATION
to	I-SPECULATION
exist	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
current	I-SPECULATION
databases	I-SPECULATION
of	I-SPECULATION
microbial	I-SPECULATION
genomes	I-SPECULATION
.	O

The	O
consequences	O
for	O
selenoproteins	O
and	O
other	O
readthrough	O
genes	O
are	O
also	O
discussed	O
.	O

Results	O

Basic	O
ideas	O

In	O
this	O
study	O
,	O
we	O
focus	O
on	O
theoretical	O
ORFs	O
with	O
one	O
inframe	O
stop	O
codon	O
,	O
termed	O
"	O
interrupted	O
ORFs	O
"	O
(	O
iORFs	O
)	O
(	O
Figure	O
1a	O
)	O
.	O

If	O
we	O
enumerate	O
all	O
iORFs	O
from	O
microbial	O
genomes	O
,	O
most	O
of	O
the	O
readthrough	O
genes	O
will	O
be	O
included	O
in	O
them	O
.	O

However	O
,	O
the	O
vast	O
majority	O
of	O
the	O
enumerated	O
iORFs	O
will	O
be	O
biologically	O
meaningless	O
.	O

To	O
filter	O
out	O
such	O
meaningless	O
iORFs	O
,	O
we	O
required	O
the	O
iORFs	O
to	O
have	O
at	O
least	O
one	O
homolog	O
in	O
other	O
genomes	O
,	O
because	O
evolutionary	O
conservation	O
of	O
primary	O
sequence	O
is	O
a	O
strong	O
indicator	O
of	O
functional	O
importance	O
.	O

However	O
,	O
this	O
condition	O
is	O
not	B-NEGATION
sufficient	I-NEGATION
,	O
since	O
two	O
major	O
problems	O
remain	O
:	O
:	O
pseudogenes	O
and	O
two	O
adjacent	O
genes	O
.	O

The	O
first	O
problem	O
is	O
that	O
even	O
if	O
an	O
iORF	O
has	O
homologs	O
in	O
other	O
species	O
,	O
it	O
could	B-SPECULATION
be	I-SPECULATION
a	B-SPECULATION
pseudogene	I-SPECULATION
or	I-SPECULATION
a	I-SPECULATION
product	I-SPECULATION
of	I-SPECULATION
sequencing	I-SPECULATION
error	I-SPECULATION
.	O

The	O
second	O
problem	O
is	O
that	O
adjacent	O
genes	O
on	O
the	O
same	O
reading	O
frame	O
may	B-SPECULATION
satisfy	I-SPECULATION
the	I-SPECULATION
condition	I-SPECULATION
of	I-SPECULATION
conserved	I-SPECULATION
iORFs	I-SPECULATION
.	O

In	O
particular	O
,	O
gene	O
pairs	O
within	O
an	O
operon	O
are	O
problematic	O
because	O
their	O
gene	O
arrangement	O
is	O
often	O
conserved	O
.	O

If	O
the	B-SPECULATION
intergenic	I-SPECULATION
distance	I-SPECULATION
between	I-SPECULATION
two	I-SPECULATION
genes	I-SPECULATION
in	I-SPECULATION
an	I-SPECULATION
operon	I-SPECULATION
happens	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
a	I-SPECULATION
multiple	I-SPECULATION
of	I-SPECULATION
three	I-SPECULATION
,	O
they	O
look	B-SPECULATION
like	I-SPECULATION
a	I-SPECULATION
conserved	I-SPECULATION
readthrough	I-SPECULATION
gene	I-SPECULATION
.	O

Basic	O
ideas	O
of	O
the	O
prediction	O
method	O

Basic	O
ideas	O
of	O
the	O
prediction	O
method	O
.	O

(	O
a	O
)	O
Schematic	O
illustration	O
of	O
an	O
interrupted	O
ORF	O
(	O
iORF	O
)	O
.	O

(	O
b	O
)	O
Readthrough	O
genes	O
can	O
be	O
distinguished	O
from	O
two	O
adjacent	O
genes	O
based	O
on	O
the	O
results	O
of	O
BLAST	O
searches	O
.	O

Boxes	O
denote	O
iORFs	O
,	O
and	O
×	O
indicates	O
the	O
inframe	O
stop	O
codon	O
.	O

Shaded	O
regions	O
represent	O
actual	O
protein-coding	O
regions	O
.	O

If	O
an	O
iORF	O
codes	O
a	O
readthrough	O
protein	O
,	O
BLAST	O
hits	O
from	O
other	O
organisms	O
will	O
cover	O
the	O
inframe	O
stop	O
codon	O
.	O

In	O
contrast	O
,	O
if	O
the	O
iORF	O
consists	O
of	O
two	O
adjacent	O
genes	O
,	O
many	O
hits	O
that	O
do	O
not	B-NEGATION
cover	I-NEGATION
the	I-NEGATION
inframe	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
will	O
be	O
found	O
.	O

To	O
discriminate	O
them	O
from	O
true	O
readthrough	O
genes	O
,	O
evolutionary	O
information	O
was	O
exploited	O
.	O

In	O
order	O
to	O
eliminate	O
pseudogenes	O
and	O
sequencing	O
errors	O
,	O
conservation	O
of	O
iORFs	O
and	O
their	O
inframe	O
stop	O
codons	O
was	O
examined	O
.	O

Since	O
pseudogenes	O
are	O
less	O
conserved	O
,	O
and	O
sequencing	O
errors	O
are	O
relatively	O
rare	O
events	O
,	O
they	O
will	O
not	B-NEGATION
have	I-NEGATION
homologous	I-NEGATION
iORFs	I-NEGATION
in	I-NEGATION
other	I-NEGATION
species	I-NEGATION
.	O

Even	O
if	O
they	O
do	O
,	O
the	O
position	O
or	O
type	O
(	O
UAA	O
,	O
UAG	O
or	O
UGA	O
)	O
of	O
their	O
inframe	O
stop	O
codons	O
will	O
not	B-NEGATION
coincide	I-NEGATION
.	O

In	O
this	O
way	O
,	O
they	O
can	O
be	O
eliminated	O
as	O
candidates	O
.	O

A	O
drawback	O
of	O
this	O
criterion	O
is	O
that	O
it	O
limits	O
the	O
target	O
of	O
our	O
study	O
to	O
readthrough	O
genes	O
conserved	O
across	O
two	O
or	O
more	O
species	O
.	O

In	O
other	O
words	O
,	O
species-specific	O
readthrough	O
genes	O
are	O
not	B-NEGATION
in	I-NEGATION
the	I-NEGATION
scope	I-NEGATION
of	I-NEGATION
this	I-NEGATION
study	I-NEGATION
.	O

To	O
address	O
the	O
second	O
problem	O
,	O
adjacent	O
gene	O
pairs	O
were	O
filtered	O
out	O
by	O
examining	O
boundaries	O
of	O
sequence	O
alignments	O
between	O
iORFs	O
and	O
its	O
homologs	O
(	O
Figure	O
1b	O
)	O
.	O

The	O
stop-codon-encoded	O
amino	O
acids	O
of	O
prokaryotes	O
are	O
usually	O
located	O
inside	O
domains	O
,	O
the	O
units	O
of	O
evolutionary	O
sequence	O
conservation	O
.	O

Therefore	O
,	O
the	O
aligned	O
regions	O
of	O
readthrough	O
proteins	O
contain	O
their	O
inframe	O
stop	O
codon	O
.	O

Based	O
on	O
this	O
observation	O
,	O
each	O
iORF	O
was	O
required	O
to	O
have	O
:	O
:	O
(	O
i	O
)	O
at	O
least	O
one	O
homolog	O
from	O
other	O
organisms	O
that	O
covers	O
the	O
inframe	O
stop	O
codon	O
and	O
(	O
ii	O
)	O
no	B-NEGATION
homolog	I-NEGATION
that	I-NEGATION
does	I-NEGATION
not	B-NEGATION
cover	I-NEGATION
the	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
.	O

Note	O
that	O
,	O
however	O
,	O
if	O
the	O
whole	O
length	O
of	O
an	O
iORF	O
was	O
used	O
as	O
a	O
query	O
sequence	O
,	O
this	O
procedure	O
will	O
erroneously	O
discard	O
multidomain	O
readthrough	O
proteins	O
.	O

To	O
avoid	O
this	O
problem	O
,	O
a	O
partial	O
sequence	O
around	O
the	O
inframe	O
stop	O
codon	O
was	O
used	O
as	O
a	O
query	O
.	O

Prediction	O
procedure	O

The	O
prediction	O
schema	O
is	O
shown	O
in	O
Figure	O
2	O
.	O

A	O
total	O
of	O
191	O
prokaryotes	O
were	O
analyzed	O
in	O
this	O
study	O
,	O
of	O
which	O
166	O
are	O
bacteria	O
and	O
25	O
are	O
archaea	O
.	O

They	O
were	O
selected	O
from	O
328	O
prokaryotes	O
with	O
completely	O
sequenced	O
genomes	O
by	O
excluding	O
closely	O
related	O
species	O
.	O

From	O
the	O
genome	O
sequences	O
of	O
the	O
191	O
organisms	O
,	O
all	O
possible	O
iORFs	O
were	O
enumerated	O
.	O

Two	O
conditions	O
were	O
imposed	O
on	O
the	O
geometry	O
of	O
the	O
iORFs	O
(	O
Figure	O
1a	O
)	O
.	O

First	O
,	O
only	O
iORFs	O
longer	O
than	O
80	O
codons	O
were	O
extracted	O
.	O

Secondly	O
,	O
margins	O
between	O
the	O
inframe	O
stop	O
codon	O
and	O
both	O
termini	O
of	O
the	O
iORF	O
must	O
be	O
longer	O
than	O
10	O
codons	O
.	O

The	O
total	O
number	O
of	O
iORFs	O
extracted	O
under	O
these	O
conditions	O
was	O
2,969,958	O
.	O

Next	O
,	O
iORFs	O
that	O
overlap	O
RNA	O
genes	O
or	O
protein-coding	O
genes	O
in	O
different	O
reading	O
frames	O
were	O
discarded	O
.	O

This	O
test	O
significantly	O
reduced	O
the	O
number	O
of	O
iORFs	O
to	O
390,926	O
.	O

A	O
flowchart	O
of	O
the	O
prediction	O
procedure	O

A	O
flowchart	O
of	O
the	O
prediction	O
procedure	O
.	O

Several	O
steps	O
are	O
omitted	O
for	O
simplicity	O
.	O

Detailed	O
explanation	O
is	O
given	O
in	O
the	O
text	O
.	O

As	O
noted	O
above	O
,	O
the	O
target	O
of	O
this	O
study	O
is	O
evolutionarily	O
conserved	O
iORFs	O
.	O

Thus	O
,	O
it	O
was	O
examined	O
whether	B-SPECULATION
the	I-SPECULATION
iORFs	I-SPECULATION
have	I-SPECULATION
homologous	I-SPECULATION
regions	I-SPECULATION
in	I-SPECULATION
other	I-SPECULATION
genomes	I-SPECULATION
.	O

The	O
390,926	O
iORFs	O
were	O
translated	O
into	O
amino	O
acid	O
sequences	O
and	O
subjected	O
to	O
TBLASTN	O
16	O
against	O
the	O
191	O
genome	O
sequences	O
.	O

Instead	B-NEGATION
of	I-NEGATION
the	I-NEGATION
whole	I-NEGATION
length	I-NEGATION
of	I-NEGATION
the	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
sequence	I-NEGATION
,	O
a	O
window	O
of	O
101	O
residues	O
centered	O
at	O
the	O
inframe	O
stop	O
codon	O
was	O
used	O
as	O
a	O
BLAST	O
query	O
.	O

After	O
the	O
BLAST	O
searches	O
,	O
iORFs	O
that	O
have	O
at	O
least	O
one	O
interspecific	O
hit	O
that	O
contains	O
the	O
inframe	O
stop	O
codon	O
were	O
collected	O
.	O

Whether	B-SPECULATION
the	I-SPECULATION
codon	I-SPECULATION
aligned	I-SPECULATION
to	I-SPECULATION
the	I-SPECULATION
inframe	I-SPECULATION
stop	I-SPECULATION
codon	I-SPECULATION
is	I-SPECULATION
was	O
neglected	O
at	O
this	O
stage	O
.	O
a	B-SPECULATION
nonsense	I-SPECULATION
codon	I-SPECULATION
or	I-SPECULATION
not	B-NEGATION
.	O

There	O
were	O
94,690	O
iORFs	O
that	O
have	O
interspecific	O
hits	O
.	O

The	O
result	O
of	O
the	O
above	O
homology	O
searches	O
was	O
also	O
used	O
for	O
the	O
boundary	O
analysis	O
(	O
Figure	O
1b	O
)	O
.	O

An	O
iORF	O
was	O
discarded	O
if	O
there	O
were	O
any	O
BLAST	O
hits	O
that	O
do	O
not	B-NEGATION
cover	I-NEGATION
the	I-NEGATION
inframe	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
.	O

A	O
total	O
of	O
26,003	O
iORF	O
satisfied	O
the	O
above	O
criteria	O
.	O

To	O
examine	O
intrafamily	O
conservation	O
of	O
the	O
inframe	O
stop	O
codons	O
,	O
these	O
iORFs	O
were	O
clustered	O
into	O
protein	O
families	O
based	O
on	O
sequence	O
similarity	O
.	O

After	O
removal	O
of	O
singletons	O
,	O
679	O
clusters	O
with	O
two	O
or	O
more	O
members	O
were	O
obtained	O
.	O

A	O
cluster	O
was	O
discarded	O
unless	O
all	O
members	O
of	O
the	O
cluster	O
had	O
the	O
same	O
type	O
of	O
inframe	O
stop	O
codons	O
(	O
UAA	O
,	O
UAG	O
or	O
UGA	O
)	O
.	O

The	O
locations	O
of	O
the	O
inframe	O
stop	O
codons	O
were	O
also	O
required	O
to	O
be	O
identical	O
in	O
the	O
multiple	O
sequence	O
alignment	O
of	O
the	O
cluster	O
members	O
.	O

These	O
conditions	O
reduced	O
the	O
number	O
of	O
clusters	O
to	O
273	O
.	O

Manual	O
inspection	O
of	O
these	O
273	O
clusters	O
revealed	O
that	O
they	O
still	O
contain	O
many	O
false	O
positives	O
that	O
are	O
unrelated	O
to	O
stop-codon-encoded	O
amino	O
acids	O
.	O

Hence	O
,	O
three-step	O
filtering	O
procedures	O
were	O
applied	O
to	O
remove	O
the	O
false	O
positives	O
.	O

Briefly	O
,	O
the	O
first	O
filter	O
assesses	O
protein-likeliness	O
based	O
on	O
the	O
signal	O
of	O
purifying	O
selection	O
,	O
while	O
the	O
second	O
and	O
third	O
filters	O
try	O
to	O
remove	O
adjacent	O
gene	O
pairs	O
using	O
the	O
pattern	O
of	O
BLAST	O
alignments	O
(	O
for	O
details	O
,	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

As	O
a	O
result	O
of	O
the	O
filtering	O
,	O
the	O
number	O
of	O
candidate	O
clusters	O
was	O
reduced	O
to	O
32	O
.	O

Through	O
manual	O
inspection	O
of	O
the	O
BLAST	O
alignments	O
,	O
11	O
clusters	O
were	O
discarded	O
because	O
they	B-SPECULATION
are	I-SPECULATION
highly	I-SPECULATION
unlikely	I-SPECULATION
to	I-SPECULATION
code	I-SPECULATION
readthrough	I-SPECULATION
proteins	I-SPECULATION
.	O

Known	O
proteins	O
in	O
the	O
predicted	O
clusters	O

The	O
clusters	O
predicted	O
by	O
our	O
method	O
are	O
summarized	O
in	O
Table	O
1	O
.	O

Of	O
the	O
21	O
clusters	O
,	O
15	O
were	O
known	O
selenoproteins	O
,	O
and	O
four	O
were	O
known	O
pyrrolysine	O
proteins	O
.	O

To	O
assess	O
the	O
sensitivity	O
of	O
our	O
method	O
,	O
the	O
result	O
was	O
compared	O
with	O
a	O
list	O
of	O
prokaryotic	O
selenoproteins	O
reported	O
by	O
Kryukov	O
and	O
Gladyshev	O
12	O
.	O

Since	O
our	O
target	O
is	O
readthrough	O
genes	O
conserved	O
across	O
two	O
or	O
more	O
species	O
,	O
such	O
selenoprotein	O
families	O
were	O
selected	O
from	O
their	O
list	O
.	O

There	O
were	O
15	O
families	O
satisfying	O
this	O
criterion	O
,	O
but	O
one	O
family	O
,	O
proline	O
reductase	O
,	O
was	O
excluded	O
because	O
it	O
was	O
found	O
in	O
only	O
one	O
organism	O
in	O
our	O
dataset	O
.	O

Of	O
the	O
14	O
families	O
,	O
11	O
were	O
found	O
in	O
our	O
prediction	O
result	O
.	O

The	O
three	O
families	O
we	O
failed	B-NEGATION
to	I-NEGATION
find	I-NEGATION
were	O
SelW-like	O
protein	O
,	O
peroxiredoxin	O
and	O
thiol	O
:	O
protein	O
disulphide	O
oxidoreductase	O
.	O

SelW-like	O
protein	O
was	O
below	O
the	O
threshold	O
of	O
detection	O
,	O
because	O
its	O
stop	O
codon	O
is	O
near	O
the	O
N-terminus	O
and	O
the	O
amino	O
acid	O
sequences	O
of	O
its	O
members	O
are	O
too	O
divergent	O
.	O

The	O
reason	O
why	O
the	B-NEGATION
two	I-NEGATION
other	I-NEGATION
families	I-NEGATION
were	I-NEGATION
not	I-NEGATION
detected	I-NEGATION
is	O
more	O
complex	O
.	O

Since	O
these	O
two	O
families	O
are	O
homologous	O
,	O
they	O
were	O
grouped	O
into	O
an	O
identical	O
cluster	O
at	O
the	O
clustering	O
stage	O
of	O
our	O
method	O
.	O

However	O
,	O
the	O
positions	O
of	O
selenocysteine	O
were	O
different	O
between	O
the	O
two	O
families	O
(	O
Figure	O
3	O
)	O
.	O

The	O
cluster	O
was	O
thus	O
discarded	O
because	O
of	O
an	O
apparent	B-SPECULATION
lack	B-NEGATION
of	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
conservation	I-NEGATION
.	O

To	O
deal	O
with	O
a	O
situation	O
like	O
this	O
,	O
a	O
reexamination	O
of	O
the	O
clustering	O
threshold	O
and	O
subdivision	O
of	O
clusters	O
will	O
be	O
required	O
.	O

Predicted	O
clusters	O
of	O
readthrough	O
proteins	O

A	O
plus	O
sign	O
in	O
a	O
locus	O
indicates	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
genomic	I-SPECULATION
coordinates	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
iORF	I-SPECULATION
can	I-SPECULATION
be	I-SPECULATION
described	I-SPECULATION
by	I-SPECULATION
a	I-SPECULATION
concatenation	I-SPECULATION
of	I-SPECULATION
two	I-SPECULATION
genes	B-SPECULATION
or	I-SPECULATION
regions	I-SPECULATION
.	O

For	O
example	O
,	O
"	O
GSU2293	O
+	O
downstream	O
"	O
means	O
that	O
the	O
iORF	O
consists	O
of	O
the	O
gene	O
GSU2293	O
and	O
its	O
downstream	O
sequence	O
.	O

HesB	B-NEGATION
family	I-NEGATION
was	I-NEGATION
not	I-NEGATION
clustered	I-NEGATION
into	I-NEGATION
one	I-NEGATION
family	I-NEGATION
,	O
because	O
their	O
sequences	O
were	O
too	O
short	O
and	O
diverged	O
.	O

Selenoprotein	B-NEGATION
families	I-NEGATION
we	I-NEGATION
failed	I-NEGATION
to	I-NEGATION
detect	I-NEGATION
because	O
of	O
nonconserved	O
location	O
of	O
stop	O
codons	O
.	O

Selenoprotein	B-NEGATION
families	I-NEGATION
we	I-NEGATION
failed	I-NEGATION
to	I-NEGATION
detect	I-NEGATION
because	O
of	O
nonconserved	O
location	O
of	O
stop	O
codons	O
.	O

Selenocysteine	O
residues	O
of	O
Peroxiredoxin-like	O
protein	O
families	O
constitute	O
homologous	O
redox	O
motifs	O
(	O
TXXU	O
and	O
UXXC	O
)	O
,	O
but	O
their	O
positions	O
are	O
different	O
between	O
two	O
families	O
.	O

Columns	O
are	O
colored	O
according	O
to	O
sequence	O
conservation	O
.	O

Selenocysteine	O
residues	O
are	O
shown	O
in	O
red	O
,	O
and	O
the	O
other	O
residues	O
in	O
the	O
redox	O
motifs	O
are	O
shown	O
in	O
yellow	O
.	O

Prx	O
;	O
Peroxiredoxin	O
,	O
TPO	O
;	O
thiol	O
:	O
protein	O
disulphide	O
oxidereductase	O
,	O
Adeh	O
;	O
Anaeromyxobacter	O
dehalogenans	O
,	O
Gmet	O
;	O
Geobacter	O
metallireducens	O
,	O
Gsul	O
;	O
G.	O
sulfurreducens	O
,	O
Dpsy	O
;	O
Desulfotalea	O
psychrophila	O
.	O

The	O
alignments	O
were	O
computed	O
using	O
ClustalW	O
,	O
and	O
the	O
figures	O
were	O
generated	O
using	O
Jalview	O
.	O

Of	O
the	O
four	O
pyrrolysine	O
proteins	O
detected	O
,	O
three	O
methylamine	O
methyltransferases	O
have	O
been	O
experimentally	O
confirmed	O
to	O
contain	O
pyrrolysine	O
617	O
.	O

The	O
rest	O
is	O
a	O
cluster	O
of	O
TetR-like	O
transcriptional	O
regulators	O
from	O
Methanosarcina	O
acetivorans	O
and	O
M.	O
barkeri	O
.	O

Since	O
the	O
genome	O
annotation	O
of	O
M.	O
acetivorans	O
describes	O
this	O
protein	O
as	O
a	O
gene	O
containing	O
an	O
inframe	O
amber	O
codon	O
,	O
we	O
classified	O
it	O
as	O
a	O
''	O
known	O
''	O
candidate	O
,	O
although	O
it	O
is	O
still	O
unclear	B-SPECULATION
whether	B-SPECULATION
it	I-SPECULATION
really	I-SPECULATION
contains	I-SPECULATION
pyrrolysine	I-SPECULATION
.	O

The	O
genome	O
annotation	O
of	O
M.	O
acetivorans	O
also	O
includes	O
several	O
amber-containing	O
genes	O
that	B-NEGATION
were	I-NEGATION
absent	I-NEGATION
from	I-NEGATION
our	I-NEGATION
prediction	I-NEGATION
result	I-NEGATION
.	O

They	O
are	O
a	O
methlycobamide	O
:	O
CoM	O
methylase	O
and	O
four	O
transposases	O
18	O
.	O

The	O
reason	O
why	O
they	B-NEGATION
were	I-NEGATION
not	I-NEGATION
detected	I-NEGATION
is	O
that	O
only	O
one	O
species	O
in	O
our	O
dataset	O
had	O
an	O
amber-containing	O
form	O
of	O
these	O
proteins	O
.	O

This	O
is	O
unavoidable	O
because	O
of	O
the	O
inability	O
of	O
our	O
method	O
to	O
detect	O
species-specific	O
readthrough	O
events	O
.	O

It	O
is	O
the	O
price	O
for	O
reliably	O
excluding	O
pseudogenes	O
and	O
sequencing	O
errors	O
.	O

Unknown	O
candidates	O
in	O
the	O
predicted	O
clusters	O

The	O
successful	O
detection	O
of	O
many	O
known	O
proteins	O
is	O
encouraging	O
,	O
because	O
our	O
method	O
relies	O
only	O
on	O
general	O
properties	O
of	O
proteins	O
that	O
contain	O
stop-codon-encoded	O
amino	O
acids	O
,	O
but	O
not	B-NEGATION
on	I-NEGATION
specific	I-NEGATION
features	I-NEGATION
of	I-NEGATION
selenocysteine	I-NEGATION
or	I-NEGATION
pyrrolysine	I-NEGATION
.	O

Therefore	O
,	O
unknown	O
clusters	O
in	O
our	O
candidates	O
have	O
possibilities	O
for	O
the	O
23rd	O
amino	O
acid	O
or	O
novel	O
readthrough	O
proteins	O
.	O

There	O
were	O
two	O
such	O
clusters	O
(	O
Table	O
1	O
)	O
.	O

The	O
first	O
cluster	O
is	O
comprised	O
of	O
c-type	O
cytochromes	O
from	O
δ-proteobacteria	O
Geobacter	O
sulfurreducens	O
and	O
G.	O
metallireducens	O
.	O

The	O
N-terminal	O
part	O
of	O
the	O
sequence	O
contains	O
five	O
CXXCH	O
heme-biding	O
motifs	O
,	O
while	O
the	O
C-terminal	O
part	O
has	O
no	B-NEGATION
similarity	I-NEGATION
with	I-NEGATION
any	I-NEGATION
characterized	I-NEGATION
proteins	I-NEGATION
.	O

Homology	O
search	O
against	O
unfinished	O
microbial	O
genomes	O
identified	O
seven	O
homologous	O
proteins	O
from	O
four	O
other	O
δ-proteobacteria	O
species	O
.	O

Multiple	O
sequence	O
alignment	O
of	O
these	O
sequences	O
is	O
shown	O
in	O
Figure	O
4a	O
.	O

Multiple	O
sequence	O
alignments	O
of	O
novel	O
candidate	O
proteins	O

Multiple	O
sequence	O
alignments	O
of	O
novel	O
candidate	O
proteins	O
.	O

(	O
a	O
)	O
A	O
selenoprotein	O
candidate	O
from	O
Geobacter	O
sulfurreducens	O
and	O
its	O
homologs	O
.	O

The	O
possible	B-SPECULATION
selenocysteine	I-SPECULATION
residues	I-SPECULATION
are	O
shown	O
in	O
red	O
,	O
and	O
putative	B-SPECULATION
heme-binding	I-SPECULATION
motifs	I-SPECULATION
are	O
underlined	O
.	O

Note	O
that	O
sequence	O
conservation	O
near	O
the	O
selenocysteine	O
is	O
comparable	O
to	O
that	O
of	O
the	O
N-terminal	O
cytochrome	O
domain	O
.	O

A	O
protein	O
Dpro	O
_	O
2	O
contains	O
yet	O
another	O
inframe	O
stop	O
codon	O
(	O
TAG	O
)	O
at	O
the	O
column	O
189	O
.	O

It	O
will	O
be	O
either	B-SPECULATION
a	I-SPECULATION
sequencing	I-SPECULATION
error	I-SPECULATION
.	O

Gsul	O
;	O
G.	O
sulfurreducens	O
,	O
Gmet	O
;	O
G.	O
metallireducens	O
,	O
Gura	O
;	O
G.	O
uraniumreducens	O
,	O
Gfrc	O
;	O
Geobacter	O
sp.	O
FRC-32	O
,	O
Dace	O
;	O
Desulfuromonas	O
acetoxidans	O
,	O
Dpro	O
;	O
Delta	O
proteobacterium	O
MLMS-1	O
.	O

(	O
b	O
)	O
Hypothetical	O
proteins	O
from	O
Geobacter	O
species	O
.	O

The	O
inframe	O
stop	O
codons	O
(	O
TAG	O
)	O
are	O
shown	O
in	O
red	O
.	O

This	O
cluster	O
is	O
probably	B-SPECULATION
an	I-SPECULATION
artifact	I-SPECULATION
of	I-SPECULATION
close	I-SPECULATION
phylogenetic	I-SPECULATION
relationship	I-SPECULATION
.	O

We	O
expect	B-SPECULATION
that	I-SPECULATION
this	I-SPECULATION
cluster	I-SPECULATION
may	B-SPECULATION
represent	I-SPECULATION
a	I-SPECULATION
novel	I-SPECULATION
selenoprotein	I-SPECULATION
family	I-SPECULATION
.	O

This	O
is	O
because	O
the	O
inframe	O
stop	O
codons	O
of	O
these	O
proteins	O
are	O
exclusively	O
TGA	O
,	O
and	O
all	O
of	O
the	O
above	O
organisms	O
possess	O
selenocysteine	O
insertion	O
machinery	O
(	B-NEGATION
data	I-NEGATION
not	I-NEGATION
shown	I-NEGATION
)	I-NEGATION
.	O

High	O
conservation	O
of	O
residues	O
near	O
the	O
inframe	O
stop	O
codon	O
also	O
suggests	B-SPECULATION
the	I-SPECULATION
importance	I-SPECULATION
of	I-SPECULATION
this	I-SPECULATION
region	I-SPECULATION
.	O

If	O
they	O
are	O
true	O
selenoproteins	O
,	O
this	O
protein	O
family	O
becomes	O
a	O
rare	O
instance	O
of	O
selenoprotein	O
that	O
lacks	B-NEGATION
non-selenocysteine	I-NEGATION
homologs	I-NEGATION
.	O

However	O
,	O
computational	O
analysis	O
of	O
sequences	O
immediately	O
downstream	O
of	O
the	O
inframe	O
stop	O
codons	O
failed	B-NEGATION
to	I-NEGATION
identify	I-NEGATION
SECIS	I-NEGATION
elements	I-NEGATION
,	O
which	O
is	O
a	O
hallmark	O
of	O
selenocysteine-containing	O
genes	O
.	O

Therefore	O
,	O
yet	O
another	O
possibility	B-SPECULATION
is	I-SPECULATION
that	I-SPECULATION
they	I-SPECULATION
are	I-SPECULATION
a	I-SPECULATION
highly	I-SPECULATION
conserved	I-SPECULATION
operon	I-SPECULATION
.	O

An	O
experimental	O
verification	O
is	O
necessary	O
to	O
distinguish	O
these	O
two	O
possibilities	O
.	O

The	O
second	O
cluster	O
consists	O
of	O
two	O
hypothetical	O
proteins	O
,	O
again	O
from	O
G.	O
sulfurreducens	O
and	O
G.	O
metallireducens	O
(	O
Figure	O
4b	O
)	O
.	O

In	O
contrast	O
to	O
the	O
first	O
cluster	O
,	O
no	B-NEGATION
homolog	I-NEGATION
was	I-NEGATION
identified	I-NEGATION
from	I-NEGATION
other	I-NEGATION
species	I-NEGATION
.	O

This	O
cluster	O
is	O
probably	B-SPECULATION
a	I-SPECULATION
false	I-SPECULATION
positive	I-SPECULATION
and	I-SPECULATION
not	B-NEGATION
readthrough	I-NEGATION
proteins	I-NEGATION
.	O

This	O
is	O
because	O
the	O
residues	O
near	O
the	O
inframe	O
stop	O
codons	O
are	O
poorly	O
conserved	O
.	O

Moreover	O
,	O
the	O
C-terminal	O
extensions	O
are	O
quite	O
short	O
(	O
about	O
20	O
aa	O
)	O
.	O

The	O
sequence	O
conservation	O
in	O
this	O
region	O
can	O
be	O
easily	O
explained	O
by	O
the	O
close	O
phylogenetic	O
relationship	O
between	O
the	O
two	O
species	O
.	O

In	O
summary	O
,	O
although	O
a	O
possible	O
selenoprotein	O
was	O
newly	O
identified	O
,	O
there	O
was	O
no	B-NEGATION
promising	I-NEGATION
candidate	I-NEGATION
for	I-NEGATION
an	I-NEGATION
unknown	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
encoded	I-NEGATION
by	I-NEGATION
a	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
.	O

Stop	O
codon	O
usage	O
in	O
the	O
pre-filtering	O
clusters	O

The	B-SPECULATION
above	I-SPECULATION
negative	I-SPECULATION
result	I-SPECULATION
could	I-SPECULATION
be	I-SPECULATION
explained	I-SPECULATION
if	I-SPECULATION
the	I-SPECULATION
filtering	I-SPECULATION
process	I-SPECULATION
,	I-SPECULATION
which	I-SPECULATION
is	I-SPECULATION
the	I-SPECULATION
final	I-SPECULATION
step	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
prediction	I-SPECULATION
method	I-SPECULATION
(	I-SPECULATION
Figure	I-SPECULATION
2	I-SPECULATION
)	I-SPECULATION
,	I-SPECULATION
was	I-SPECULATION
too	I-SPECULATION
strict	I-SPECULATION
.	O

Although	O
the	O
raw	O
output	O
of	O
the	O
search	O
for	O
evolutionarily	O
conserved	O
iORFs	O
was	O
273	O
clusters	O
,	O
most	O
of	O
them	O
were	O
discarded	O
at	O
the	O
subsequent	O
filtering	O
stage	O
.	O

Because	O
we	O
have	O
no	B-NEGATION
a	I-NEGATION
priori	I-NEGATION
knowledge	I-NEGATION
about	I-NEGATION
the	I-NEGATION
23rd	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
,	O
cutoff	O
thresholds	O
for	O
the	O
filtering	O
procedures	O
were	O
determined	O
based	O
on	O
the	O
known	O
readthrough	O
proteins	O
.	O

This	O
is	O
practically	O
indispensable	O
for	O
objective	O
classification	O
of	O
candidates	O
,	O
but	O
there	O
is	O
no	B-SPECULATION
guarantee	I-SPECULATION
that	I-SPECULATION
unknown	I-SPECULATION
proteins	I-SPECULATION
with	I-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
will	I-SPECULATION
score	I-SPECULATION
higher	I-SPECULATION
than	I-SPECULATION
the	I-SPECULATION
thresholds	I-SPECULATION
.	O

To	O
explore	O
whether	B-SPECULATION
a	I-SPECULATION
number	I-SPECULATION
of	I-SPECULATION
good	I-SPECULATION
candidates	I-SPECULATION
lie	I-SPECULATION
below	I-SPECULATION
the	I-SPECULATION
thresholds	I-SPECULATION
,	O
the	O
273	O
clusters	O
were	O
analyzed	O
in	O
a	O
way	O
independent	O
from	O
filtering	O
.	O

If	O
an	O
organism	O
has	O
many	O
readthrough	O
proteins	O
,	O
proteins	O
from	O
the	O
organism	O
will	O
frequently	O
appear	O
in	O
the	O
273	O
clusters	O
.	O

Moreover	O
,	O
relative	O
usage	O
of	O
the	O
inframe	O
stop	O
codons	O
will	O
deviate	O
from	O
that	O
of	O
usual	O
termination	O
signals	O
in	O
the	O
proteome	O
.	O

Figure	O
5	O
shows	O
the	O
discrepancies	O
between	O
relative	O
usage	O
of	O
the	O
inframe	O
and	O
C-terminal	O
stop	O
codons	O
of	O
127	O
organisms	O
in	O
the	O
pre-filtering	O
clusters	O
.	O

Only	O
seven	O
organisms	O
had	O
statistically	O
significant	O
discrepancies	O
(	O
P	O
<	O
0.05	O
)	O
,	O
and	O
all	O
of	O
them	O
are	O
known	O
to	O
utilize	O
selenocysteine	O
or	O
pyrrolysine	O
.	O

Discrepancies	O
of	O
stop	O
codon	O
usages	O
between	O
the	O
inframe	O
and	O
C-terminal	O
stop	O
codons	O

Discrepancies	O
of	O
stop	O
codon	O
usages	O
between	O
the	O
inframe	O
and	O
C-terminal	O
stop	O
codons	O
.	O

The	O
inframe	O
stop	O
codon	O
usage	O
is	O
taken	O
from	O
the	O
pre-filtering	O
clusters	O
,	O
and	O
the	O
C-terminal	O
usage	O
is	O
computed	O
based	O
on	O
the	O
annotated	O
proteins	O
of	O
the	O
organism	O
.	O

Red	O
circle	O
:	O
an	O
organism	O
with	O
pyrrolysine	O
,	O
blue	O
;	O
selenocysteine	O
,	O
yellow	O
;	O
both	O
pyrrolysine	O
and	O
selenocysteine	O
,	O
white	O
;	O
neither	B-NEGATION
pyrrolysine	I-NEGATION
.	O

The	O
organisms	O
are	O
ordered	O
by	O
their	O
discrepancy	O
scores	O
.	O

The	O
discrepancy	O
score	O
is	O
the	O
negative	O
logarithm	O
of	O
a	O
p-value	O
of	O
Fisher's	O
exact	O
test	O
.	O

The	O
dotted	O
line	O
indicates	O
significance	O
level	O
0.05	O
after	O
a	O
correction	O
for	O
multiple	O
testing	O
.	O

When	O
top	O
ten	O
organisms	O
were	O
examined	O
,	O
only	O
Gluconobacter	O
oxydans	O
was	O
an	O
organism	O
not	B-NEGATION
known	I-NEGATION
to	I-NEGATION
have	I-NEGATION
stop-codon-encoded	I-NEGATION
amino	I-NEGATION
acids	I-NEGATION
.	O

An	O
inspection	O
of	O
the	O
G.	O
oxydans	O
iORFs	O
in	O
the	O
273	O
clusters	O
revealed	O
that	O
their	O
inframe	O
stop	O
codons	O
are	O
dominated	O
by	O
TAA	O
,	O
but	O
all	O
of	O
them	O
belong	O
to	O
a	O
single	O
protein	O
cluster	O
associated	O
with	O
transposable	O
elements	O
.	O

Because	O
it	O
seems	B-SPECULATION
unlikely	I-SPECULATION
that	I-SPECULATION
an	I-SPECULATION
insertion	I-SPECULATION
system	I-SPECULATION
of	I-SPECULATION
novel	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
evolves	I-SPECULATION
solely	I-SPECULATION
for	I-SPECULATION
transposable	I-SPECULATION
elements	I-SPECULATION
,	O
this	B-NEGATION
organism	I-NEGATION
cannot	I-NEGATION
be	O
considered	B-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
good	I-SPECULATION
candidate	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
.	O

Sensitivity	O
of	O
this	O
test	O
is	O
not	O
high	O
because	O
many	O
organisms	O
that	O
utilize	O
selenocysteine	O
were	O
below	O
the	O
defined	O
threshold	O
.	O

However	O
,	O
the	O
result	O
agrees	O
with	O
the	O
filtering-dependent	O
analysis	O
that	O
no	B-NEGATION
candidate	I-NEGATION
of	I-NEGATION
the	I-NEGATION
novel	I-NEGATION
stop-codon-encoded	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
is	I-NEGATION
detectable	I-NEGATION
in	I-NEGATION
the	I-NEGATION
current	I-NEGATION
dataset	I-NEGATION
.	O

Discussion	O

As	O
the	O
number	O
of	O
completely	O
sequenced	O
genomes	O
increases	O
,	O
several	O
research	O
groups	O
started	O
to	O
predict	O
proteins	O
that	O
contain	O
stop-codon-encoded	O
amino	O
acids	O
through	O
computational	O
analyses	O
.	O

Most	O
of	O
them	O
are	O
aimed	O
at	O
identification	O
of	O
selenoproteins	O
,	O
reflecting	O
concerns	O
from	O
the	O
scientific	O
community	O
and	O
accumulated	O
knowledge	O
on	O
selenocysteine	O
.	O

In	O
order	O
to	O
improve	O
prediction	O
specificity	O
,	O
they	O
have	O
fully	O
exploited	O
the	O
known	O
features	O
of	O
selenocysteine	O
,	O
such	O
as	O
the	O
SECIS	O
elements	O
or	O
cysteine	O
homologs	O
,	O
which	O
have	O
cysteine	O
in	O
place	O
of	O
selenocysteine	O
.	O

However	O
,	O
since	O
the	O
target	O
of	O
this	O
study	O
is	O
the	O
23rd	O
amino	O
acid	O
,	O
and	O
there	O
is	O
no	B-NEGATION
a	I-NEGATION
priori	I-NEGATION
knowledge	I-NEGATION
,	O
only	O
general	O
properties	O
of	O
stop-codon-encoded	O
amino	O
acids	O
can	O
be	O
used	O
for	O
prediction	O
.	O

Such	O
general-purpose	O
algorithms	O
have	O
also	O
been	O
developed	O
to	O
date	O
.	O

The	O
method	O
of	O
Chaudhuri	O
and	O
Yeates	O
10	O
extracts	O
iORFs	O
from	O
microbial	O
genomes	O
and	O
analyzes	O
sequence	O
conservation	O
around	O
the	O
inframe	O
stop	O
codon	O
.	O

Their	O
method	O
is	O
thus	O
similar	O
to	O
ours	O
and	O
applicable	O
to	O
both	O
selenocysteine	O
and	O
pyrrolysine	O
.	O

Perrodou	O
et	O
al.	O
19	O
constructed	O
a	O
database	O
of	O
predicted	O
recoding	O
events	O
in	O
microbes	O
.	O

Their	O
method	O
is	O
applicable	O
not	O
only	O
to	O
stop	O
codon	O
readthrough	O
but	O
also	O
to	O
frameshift	O
.	O

However	O
,	O
both	O
of	O
them	O
did	O
not	B-NEGATION
apply	I-NEGATION
their	I-NEGATION
methods	I-NEGATION
to	I-NEGATION
search	I-NEGATION
for	I-NEGATION
novel	I-NEGATION
amino	I-NEGATION
acids	I-NEGATION
.	O

Therefore	O
,	O
the	B-NEGATION
question	I-NEGATION
of	I-NEGATION
the	I-NEGATION
23rd	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
has	I-NEGATION
not	I-NEGATION
been	I-NEGATION
investigated	I-NEGATION
from	I-NEGATION
the	I-NEGATION
viewpoint	I-NEGATION
of	I-NEGATION
coding	I-NEGATION
sequences	I-NEGATION
.	O

Additionally	O
,	O
the	O
previous	O
methods	O
cannot	B-NEGATION
effectively	I-NEGATION
discriminate	I-NEGATION
pseudogenes	I-NEGATION
from	I-NEGATION
readthrough	I-NEGATION
genes	I-NEGATION
.	O

For	O
instance	O
,	O
Chaudhuri	O
and	O
Yeates	O
reported	O
a	O
homolog	O
of	O
cobalamin	O
biosynthesis	O
protein	O
CobN	O
as	O
a	O
novel	O
candidate	O
of	O
pyrrolysine	O
protein	O
.	O

However	O
,	O
the	O
gene	O
is	O
probably	B-SPECULATION
a	I-SPECULATION
pseudogene	I-SPECULATION
because	O
it	O
contains	O
an	O
inframe	O
TAA	O
codon	O
in	O
addition	O
to	O
the	O
TAG	O
codon	O
,	O
and	O
only	O
one	B-SPECULATION
species	I-SPECULATION
seems	I-SPECULATION
to	I-SPECULATION
have	I-SPECULATION
the	I-SPECULATION
amber-containing	I-SPECULATION
form	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
gene	I-SPECULATION
.	O

The	O
previous	O
methods	O
also	O
assume	B-SPECULATION
that	I-SPECULATION
proteins	I-SPECULATION
with	I-SPECULATION
stop-codon-encoded	I-SPECULATION
amino	I-SPECULATION
acids	I-SPECULATION
will	I-SPECULATION
have	I-SPECULATION
non-readthrough	I-SPECULATION
homologs	I-SPECULATION
(	I-SPECULATION
i.e.	I-SPECULATION
,	I-SPECULATION
homologous	I-SPECULATION
proteins	I-SPECULATION
that	I-SPECULATION
do	I-SPECULATION
not	B-NEGATION
have	I-NEGATION
inframe	I-NEGATION
stop	I-NEGATION
codons	I-NEGATION
)	I-NEGATION
.	O

However	O
,	O
that	O
is	O
not	O
necessarily	O
true	O
.	O

For	O
example	O
,	O
pyrrolysine-containing	O
monomethylamine	O
methyltransferases	O
adopt	O
TIM	O
barrel	O
fold	O
6	O
,	O
but	O
their	O
primary	O
sequences	O
do	O
not	B-NEGATION
exhibit	I-NEGATION
detectable	I-NEGATION
similarity	I-NEGATION
to	I-NEGATION
other	I-NEGATION
TIM	I-NEGATION
barrel	I-NEGATION
proteins	I-NEGATION
because	O
of	O
evolutionary	O
divergence	O
.	O

Dimethylamine	O
methyltransferases	O
also	O
lack	B-NEGATION
non-readthrough	I-NEGATION
homologs	I-NEGATION
.	O

Yet	O
another	O
example	O
is	O
glycine	O
reductase	O
selenoprotein	O
A	O
.	O

Only	O
the	O
selenocysteine-containing	O
form	O
of	O
the	O
enzyme	O
is	O
currently	O
known	O
20	O
.	O

Therefore	O
,	O
it	O
is	O
important	O
not	B-NEGATION
to	I-NEGATION
assume	I-NEGATION
non-readthrough	I-NEGATION
homologs	I-NEGATION
for	I-NEGATION
exploring	I-NEGATION
novel	I-NEGATION
candidates	I-NEGATION
.	O

If	O
any	O
non-readthrough	O
homologs	O
are	O
registered	O
in	O
public	O
sequence	O
databases	O
,	O
a	O
careful	O
annotation	O
process	O
of	O
a	O
newly	O
sequenced	O
genome	O
will	O
be	O
able	O
to	O
detect	O
readthrough	O
genes	O
,	O
even	O
though	O
they	B-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
annotated	I-SPECULATION
as	I-SPECULATION
pseudogenes	I-SPECULATION
.	O

However	O
,	O
if	O
all	O
members	O
of	O
a	O
gene	O
family	O
have	O
stop	O
codon	O
readthrough	O
,	O
correct	O
annotation	O
of	O
their	O
gene	O
structure	O
will	O
be	O
extremely	O
difficult	O
,	O
and	O
all	O
of	O
them	O
will	O
be	O
split	O
into	O
two	O
distinct	O
genes	O
.	O

The	O
method	O
reported	O
here	O
is	O
unique	O
in	O
that	O
it	O
does	O
not	B-NEGATION
assume	I-NEGATION
non-readthrough	I-NEGATION
homologs	I-NEGATION
.	O

Using	O
this	O
method	O
,	O
a	O
systematic	O
screening	O
of	O
the	O
23rd	O
amino	O
acid	O
and	O
other	O
readthrough	O
genes	O
was	O
carried	O
out	O
.	O

Many	O
of	O
the	O
currently	O
known	O
selenoproteins	O
and	O
pyrrolysine	O
proteins	O
were	O
recovered	O
,	O
indicating	O
the	O
effectiveness	O
of	O
this	O
approach	O
.	O

In	O
particular	O
,	O
successful	O
detection	O
of	O
pyrrolysine-containing	O
methyltransferases	O
and	O
selenoprotein	O
A	O
should	O
be	O
noted	O
.	O

However	O
,	O
almost	O
no	O
novel	O
candidates	O
for	O
readthrough	O
genes	O
were	O
predicted	O
.	O

What	O
can	O
be	O
concluded	O
from	O
this	O
result	O
?	O

The	O
most	O
likely	B-SPECULATION
explanation	I-SPECULATION
is	O
that	O
the	B-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
does	I-SPECULATION
or	I-SPECULATION
its	I-SPECULATION
distribution	I-SPECULATION
on	I-SPECULATION
the	I-SPECULATION
tree	I-SPECULATION
of	I-SPECULATION
life	I-SPECULATION
is	I-SPECULATION
rather	I-SPECULATION
limited	I-SPECULATION
not	B-NEGATION
exist	I-NEGATION
,	O
.	O

Although	O
a	O
broad	O
spectrum	O
of	O
taxonomic	O
groups	O
has	O
been	O
subjected	O
to	O
genome	O
sequencing	O
,	O
the	O
genomes	O
of	O
most	O
microbial	O
species	O
on	O
the	O
earth	O
have	O
yet	O
to	O
be	O
determined	O
.	O

The	B-SPECULATION
unknown	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
used	I-SPECULATION
by	I-SPECULATION
these	I-SPECULATION
species	I-SPECULATION
.	O

Alternatively	O
,	O
only	O
one	O
organism	O
in	O
our	O
dataset	O
may	B-SPECULATION
have	I-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
.	O

This	O
is	O
because	O
our	O
method	O
is	O
limited	O
to	O
readthrough	O
genes	O
conserved	O
across	O
two	O
or	O
more	O
species	O
.	O

If	O
the	O
novel	O
amino	O
acid	O
appears	O
in	O
younger	O
,	O
non-conserved	O
sequences	O
,	O
our	O
technique	O
will	O
miss	O
them	O
.	O

In	O
either	O
case	O
,	O
the	O
distribution	O
of	O
the	O
23rd	O
amino	O
acid	O
will	O
be	O
significantly	O
narrower	O
than	O
that	O
of	O
selenocysteine	O
,	O
which	O
has	O
scattered	O
but	O
wide	O
distribution	O
21	O
.	O

This	O
conclusion	O
coincides	O
with	O
and	O
strengthens	O
that	O
of	O
the	O
previous	O
research	O
on	O
tRNA	O
14	O
.	O

Yet	O
another	O
possibility	B-SPECULATION
is	I-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
23rd	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
exists	I-SPECULATION
but	I-SPECULATION
is	I-SPECULATION
not	B-NEGATION
encoded	I-NEGATION
by	I-NEGATION
stop	I-NEGATION
codons	I-NEGATION
.	O

It	O
is	O
well	O
known	O
that	O
the	O
genetic	O
code	O
varies	O
in	O
several	O
organisms	O
22	O
.	O

Thus	O
,	O
certain	O
organisms	O
may	B-SPECULATION
use	I-SPECULATION
one	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
sense	I-SPECULATION
codons	I-SPECULATION
for	I-SPECULATION
the	I-SPECULATION
novel	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
.	O

Because	O
codons	O
for	O
most	O
amino	O
acids	O
are	O
degenerate	O
,	O
redefinition	O
of	O
one	B-SPECULATION
of	I-SPECULATION
them	I-SPECULATION
is	I-SPECULATION
feasible	I-SPECULATION
.	O

However	O
,	O
that	O
possibility	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
study	O
and	O
is	O
left	O
as	O
an	O
open	O
problem	O
.	O

Bioinformatics	O
analysis	O
of	O
unusual	O
tRNA	O
genes	O
and	O
codon	O
usage	O
may	B-SPECULATION
provide	I-SPECULATION
insights	I-SPECULATION
into	I-SPECULATION
this	I-SPECULATION
problem	I-SPECULATION
.	O

In	O
addition	O
to	O
the	O
23rd	O
amino	O
acid	O
,	O
our	O
method	O
can	O
simultaneously	O
explore	O
selenoproteins	O
and	O
other	O
readthrough	O
proteins	O
.	O

A	O
common	O
assumption	B-SPECULATION
in	I-SPECULATION
microbial	I-SPECULATION
selenoprotein	I-SPECULATION
predictions	I-SPECULATION
is	I-SPECULATION
that	I-SPECULATION
selenoproteins	I-SPECULATION
will	I-SPECULATION
have	I-SPECULATION
cysteine	I-SPECULATION
homologs	I-SPECULATION
.	O

Zhang	O
et	O
al.	O
20	O
examined	O
the	O
validity	O
of	O
this	O
assumption	O
using	O
a	O
SECIS-based	O
method	O
and	O
concluded	O
that	O
selenoproteins	O
without	B-NEGATION
cysteine	I-NEGATION
homologs	I-NEGATION
will	O
be	O
extremely	O
rare	O
.	O

Our	O
method	O
can	O
reassess	O
this	O
assumption	O
in	O
a	O
SECIS-independent	O
way	O
.	O

Such	O
selenoproteins	O
identified	O
through	O
our	O
screening	O
of	O
nearly	O
200	O
microbial	O
genomes	O
were	O
selenoprotein	O
A	O
and	O
only	O
one	O
uncertain	O
candidate	O
.	O

Therefore	O
,	O
selenoproteins	O
that	O
lack	B-NEGATION
cysteine	I-NEGATION
homologs	I-NEGATION
will	O
be	O
scarce	O
,	O
as	O
previously	O
reported	O
.	O

Other	O
readthrough	O
proteins	O
with	O
canonical	O
amino	O
acids	O
(	O
i.e.	O
,	O
proteins	O
that	O
have	O
canonical	O
amino	O
acids	O
at	O
their	O
inframe	O
stop	O
codons	O
)	O
are	O
quite	O
rare	O
in	O
prokaryotes	O
1	O
.	O

The	O
result	O
reported	O
here	O
is	O
in	O
agreement	O
,	O
but	O
it	O
is	O
not	B-NEGATION
conclusive	I-NEGATION
.	O

This	O
is	O
because	O
our	O
method	O
assumes	B-SPECULATION
that	I-SPECULATION
stop-codon-encoded	I-SPECULATION
amino	I-SPECULATION
acid	I-SPECULATION
is	I-SPECULATION
located	I-SPECULATION
inside	I-SPECULATION
a	I-SPECULATION
domain	I-SPECULATION
,	O
but	O
it	O
is	O
unclear	B-SPECULATION
whether	B-SPECULATION
it	I-SPECULATION
holds	I-SPECULATION
true	I-SPECULATION
in	I-SPECULATION
prokaryotic	I-SPECULATION
readthrough	I-SPECULATION
with	I-SPECULATION
canonical	I-SPECULATION
amino	I-SPECULATION
acids	I-SPECULATION
.	O

At	O
least	O
,	O
only	O
one	O
experimentally-confirmed	O
example	O
from	O
a	O
pathogenic	O
strain	O
of	O
Escherichia	O
coli	O
23	O
,	O
whose	B-NEGATION
genome	I-NEGATION
is	I-NEGATION
not	I-NEGATION
yet	I-NEGATION
determined	I-NEGATION
,	O
does	O
not	B-NEGATION
obey	I-NEGATION
this	I-NEGATION
rule	I-NEGATION
.	O

What	O
can	O
be	O
concluded	O
from	O
our	O
result	O
is	O
that	O
this	O
type	O
of	O
readthrough	O
will	O
be	O
located	O
outside	O
of	O
domains	O
,	O
such	O
as	O
a	O
linker	O
between	O
two	O
domains	O
.	O

Such	O
a	O
stop	O
codon	O
may	B-SPECULATION
behave	I-SPECULATION
as	I-SPECULATION
a	I-SPECULATION
switch	I-SPECULATION
that	I-SPECULATION
regulates	I-SPECULATION
production	I-SPECULATION
of	I-SPECULATION
short	I-SPECULATION
and	I-SPECULATION
long	I-SPECULATION
isoforms	I-SPECULATION
from	I-SPECULATION
a	I-SPECULATION
single	I-SPECULATION
mRNA	I-SPECULATION
,	I-SPECULATION
as	I-SPECULATION
in	I-SPECULATION
readthrough	I-SPECULATION
genes	I-SPECULATION
from	I-SPECULATION
viruses	I-SPECULATION
24	O
.	O

Conclusion	O

To	O
explore	O
the	O
possibility	O
of	O
a	O
23rd	O
amino	O
acid	O
,	O
ORFs	O
in	O
prokaryotic	O
genomes	O
were	O
investigated	O
in	O
a	O
comprehensive	O
way	O
.	O

Although	O
many	O
of	O
the	O
currently	O
known	O
selenoproteins	O
and	O
pyrrolysine	O
proteins	O
were	O
successfully	O
detected	O
,	O
no	B-NEGATION
candidate	I-NEGATION
for	I-NEGATION
the	I-NEGATION
23rd	I-NEGATION
amino	I-NEGATION
acid	I-NEGATION
was	I-NEGATION
discovered	I-NEGATION
.	O

Therefore	O
,	O
if	O
such	O
an	O
amino	O
acid	O
exists	O
,	O
it	O
will	O
have	O
limited	O
distribution	O
in	O
the	O
tree	O
of	O
life	O
.	O

Alternatively	O
,	O
it	B-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
encoded	I-SPECULATION
by	I-SPECULATION
one	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
sense	I-SPECULATION
codons	I-SPECULATION
.	O

From	O
the	O
viewpoint	O
of	O
selenoprotein	O
prediction	O
,	O
the	O
sensitivity	O
of	O
our	O
method	O
was	O
lower	O
than	O
an	O
existing	O
method	O
.	O

However	O
,	O
our	O
method	O
has	O
several	O
unique	O
features	O
.	O

It	O
is	O
applicable	O
to	O
general	O
readthrough	O
genes	O
and	O
rigorously	O
excludes	O
pseudogenes	O
and	O
sequencing	O
errors	O
.	O

Moreover	O
,	O
it	O
does	O
not	B-NEGATION
assume	I-NEGATION
the	I-NEGATION
occurrence	I-NEGATION
of	I-NEGATION
non-readthrough	I-NEGATION
homologs	I-NEGATION
in	I-NEGATION
the	I-NEGATION
public	I-NEGATION
databases	I-NEGATION
.	O

It	O
will	O
help	O
in	O
identification	O
of	O
novel	O
readthrough	O
genes	O
from	O
the	O
rapidly	O
expanding	O
collection	O
of	O
complete	O
microbial	O
genomes	O
.	O

Methods	O

Enumeration	O
of	O
iORFs	O
from	O
prokaryotic	O
genomes	O

A	O
total	O
of	O
328	O
complete	O
genome	O
sequences	O
of	O
prokaryotes	O
were	O
downloaded	O
from	O
the	O
KEGG	O
FTP	O
site	O
25	O
in	O
April	O
2006	O
.	O

From	O
them	O
,	O
191	O
representative	O
organisms	O
were	O
selected	O
by	O
excluding	O
close	O
relatives	O
.	O

The	O
threshold	O
was	O
set	O
to	O
average	O
sequence	O
identity	O
90	O
%	O
of	O
two	O
house-keeping	O
genes	O
,	O
DNA	O
polymerase	O
III	O
α	O
subunit	O
and	O
alanyl-tRNA	O
synthetase	O
.	O

From	O
these	O
191	O
genomes	O
,	O
iORFs	O
longer	O
than	O
80	O
codons	O
were	O
enumerated	O
using	O
inhouse	O
software	O
,	O
which	O
is	O
available	O
from	O
the	O
author's	O
web	O
site	O
26	O
.	O

Both	O
upstream	O
and	O
downstream	O
regions	O
of	O
its	O
inframe	O
stop	O
codon	O
were	O
required	O
to	O
be	O
longer	O
than	O
10	O
codons	O
.	O

Two	O
stop	O
codons	O
of	O
an	O
iORF	O
(	O
i.e.	O
the	O
inframe	O
and	O
C-terminal	O
stops	O
)	O
can	O
be	O
any	O
combination	O
of	O
canonical	O
stop	O
codons	O
(	O
TAA	O
,	O
TAG	O
,	O
TGA	O
)	O
.	O

However	O
,	O
for	O
Mycoplasma	O
,	O
only	O
TAA	O
and	O
TAG	O
were	O
used	O
.	O

Three	O
codons	O
ATG	O
,	O
TTG	O
and	O
GTG	O
were	O
allowed	O
to	O
be	O
start	O
signals	O
.	O

The	O
iORFs	O
of	O
each	O
organism	O
were	O
compared	O
with	O
protein-coding	O
genes	O
of	O
the	O
organism	O
using	O
BLASTX	O
.	O

If	O
an	O
iORF	O
matched	O
any	O
protein-coding	O
genes	O
(	O
E-value	O
<	O
10-3	O
)	O
and	O
their	O
reading	O
frames	O
did	O
not	B-NEGATION
coincide	I-NEGATION
,	O
the	O
iORF	O
was	O
discarded	O
.	O

Similarly	O
,	O
iORFs	O
were	O
compared	O
with	O
RNA	O
genes	O
using	O
BLASTN	O
,	O
and	O
those	O
matched	O
with	O
the	O
RNAs	O
were	O
removed	O
.	O

Remaining	O
iORFs	O
were	O
translated	O
into	O
amino	O
acid	O
sequences	O
.	O

We	O
translated	O
all	O
three	O
types	O
of	O
nonsense	O
codons	O
into	O
the	O
one-letter	O
code	O
U	O
,	O
so	O
as	O
to	O
simplify	O
visual	O
inspection	O
of	O
sequence	O
alignments	O
.	O

Although	O
the	O
code	O
U	O
is	O
usually	O
for	O
selenocysteine	O
,	O
it	O
will	O
be	O
harmless	O
because	O
U	O
is	O
automatically	O
converted	O
into	O
×	O
inside	O
the	O
BLAST	O
programs	O
.	O

Construction	O
of	O
clusters	O
of	O
conserved	O
iORFs	O

To	O
examine	O
evolutionary	O
conservation	O
of	O
the	O
iORFs	O
,	O
a	O
window	O
of	O
101	O
residues	O
around	O
the	O
inframe	O
stop	O
codon	O
was	O
extracted	O
and	O
subjected	O
to	O
TBLASTN	O
searches	O
against	O
the	O
above	O
191	O
genome	O
sequences	O
.	O

If	O
there	O
were	O
any	O
hits	O
(	O
E-value	O
<	O
0.01	O
)	O
in	O
other	O
organisms	O
,	O
and	O
if	O
the	O
hit	O
includes	O
10	O
upstream	O
and	O
10	O
downstream	O
residues	O
of	O
the	O
inframe	O
stop	O
codon	O
,	O
then	O
the	O
iORF	O
was	O
retained	O
.	O

However	O
,	O
if	O
there	O
were	O
any	O
hits	O
(	O
E-value	O
<	O
10-5	O
)	O
that	O
did	O
not	B-NEGATION
cover	I-NEGATION
the	I-NEGATION
inframe	I-NEGATION
stop	I-NEGATION
codon	I-NEGATION
,	O
the	O
iORF	O
was	O
discarded	O
.	O

Eligible	O
iORFs	O
were	O
then	O
clustered	O
using	O
BLASTCLUST	O
with	O
score	O
density	O
0.5	O
and	O
minimum	O
length	O
coverage	O
0.6	O
.	O

After	O
removing	O
singleton	O
clusters	O
,	O
multiple	O
sequence	O
alignments	O
of	O
the	O
remaining	O
clusters	O
were	O
computed	O
using	O
MAFFT	O
27	O
with	O
the	O
L-INS-i	O
option	O
.	O

Subsequently	O
,	O
conservation	O
of	O
the	O
inframe	O
stop	O
codons	O
in	O
each	O
cluster	O
was	O
examined	O
.	O

If	O
the	O
location	O
or	O
type	O
of	O
stop	O
codons	O
was	O
not	B-NEGATION
identical	I-NEGATION
,	O
the	O
cluster	O
was	O
discarded	O
.	O

Three-step	O
filtering	O
of	O
the	O
candidate	O
clusters	O

The	O
first	O
filter	O
examines	O
protein-likeliness	O
of	O
the	O
iORFs	O
.	O

This	O
filter	O
is	O
mainly	O
designed	O
to	O
remove	O
conserved	O
non-coding	O
sequences	O
(	O
CNS	O
)	O
immediately	O
downstream	O
of	O
non-readthrough	O
genes	O
.	O

If	O
we	O
measure	O
purifying	O
selection	O
for	O
amino	O
acid	O
sequences	O
by	O
the	O
ratio	O
of	O
nonsynonymous	O
to	O
synonymous	O
substitution	O
rates	O
(	O
dN	O
/	O
dS	O
)	O
,	O
a	O
protein	O
with	O
a	O
stop-codon-encoded	O
amino	O
acid	O
will	O
indicate	O
the	O
sign	O
of	O
selection	O
,	O
while	O
CNS	O
will	O
not	B-NEGATION
.	O

The	O
dN	O
/	O
dS	O
was	O
calculated	O
for	O
each	O
of	O
the	O
two	O
parts	O
flanking	O
the	O
inframe	O
stop	O
codon	O
in	O
an	O
iORF	O
using	O
codeml	O
program	O
in	O
the	O
PAML	O
package	O
28	O
.	O

Statistical	O
significance	O
was	O
estimated	O
by	O
likelihood	O
ratio	O
test	O
29	O
.	O

The	O
observed	O
alignment	O
was	O
fitted	O
to	O
two	O
distinct	O
substitution	O
models	O
,	O
one	O
of	O
which	O
estimates	O
dN	O
/	O
dS	O
from	O
the	O
data	O
,	O
and	O
the	O
other	O
fixes	O
it	O
to	O
1.0	O
.	O

Let	O
lfree	O
and	O
lfix	O
denote	O
log	O
likelihood	O
of	O
these	O
models	O
.	O

Then	O
,	O
2Δl	O
=	O
2	O
(	O
lfree	O
–	O
lfix	O
)	O
approximately	O
follows	O
the	O
χ2	O
distribution	O
with	O
one	O
degree	O
of	O
freedom	O
.	O

If	O
dN	O
/	O
dS	O
was	O
less	O
than	O
1.0	O
,	O
and	O
the	O
statistics	O
2Δl	O
was	O
larger	O
than	O
a	O
threshold	O
,	O
we	O
regard	O
it	O
as	O
a	O
sign	O
of	O
purifying	O
selection	O
.	O

In	O
this	O
study	O
,	O
the	O
threshold	O
was	O
set	O
to	O
5.0	O
(	O
corresponds	O
to	O
P	O
<	O
0.025	O
)	O
so	O
that	O
the	O
known	O
readthrough	O
proteins	O
score	O
higher	O
than	O
the	O
threshold	O
.	O

For	O
each	O
of	O
the	O
above	O
clusters	O
,	O
an	O
all-against-all	O
comparison	O
of	O
cluster	O
members	O
was	O
performed	O
.	O

If	O
any	O
pair	O
exhibits	O
such	O
signals	O
in	O
both	O
the	O
N	O
-	O
and	O
C-terminal	O
parts	O
,	O
the	O
cluster	O
was	O
retained	O
.	O

Even	O
if	O
both	O
the	O
upstream	O
and	O
downstream	O
regions	O
of	O
the	O
inframe	O
stop	O
codon	O
code	O
proteins	O
,	O
they	O
may	B-SPECULATION
be	I-SPECULATION
two	I-SPECULATION
adjacent	I-SPECULATION
genes	I-SPECULATION
instead	B-NEGATION
of	I-NEGATION
a	I-NEGATION
readthrough	I-NEGATION
protein	I-NEGATION
.	O

The	O
second	O
and	O
third	O
filtering	O
processes	O
remove	O
such	O
genes	O
based	O
on	O
BLAST	O
alignment	O
patterns	O
.	O

Although	O
the	O
boundary	O
analysis	O
applied	O
previously	O
has	O
the	O
same	O
goal	O
(	O
Figure	O
1b	O
)	O
,	O
some	O
gene	O
pairs	O
escaped	O
elimination	O
.	O

To	O
enhance	O
sensitivity	O
of	O
the	O
filters	O
,	O
the	O
whole	O
length	O
of	O
an	O
iORF	O
was	O
used	O
as	O
a	O
BLAST	O
query	O
instead	B-NEGATION
of	I-NEGATION
the	I-NEGATION
partial	I-NEGATION
sequence	I-NEGATION
,	O
and	O
the	O
size	O
of	O
the	O
BLAST	O
database	O
was	O
increased	O
from	O
the	O
191	O
nonredundant	O
genomes	O
to	O
the	O
328	O
complete	O
genomes	O
in	O
GenomeNet	O
and	O
246	O
draft	O
genome	O
sequences	O
downloaded	O
from	O
GenBank	O
in	O
May	O
2006	O
.	O

The	O
second	O
filter	O
inspects	O
synteny	O
of	O
iORFs	O
.	O

If	O
the	O
N	O
-	O
and	O
C-terminal	O
parts	O
of	O
an	O
iORF	O
have	O
distinct	O
but	O
closely	O
arranged	O
BLAST	O
hits	O
in	O
other	O
genomes	O
,	O
it	O
strongly	O
suggests	B-SPECULATION
the	I-SPECULATION
iORF	I-SPECULATION
is	I-SPECULATION
actually	I-SPECULATION
two	I-SPECULATION
adjacent	I-SPECULATION
genes	I-SPECULATION
.	O

Translated	O
sequences	O
of	O
iORFs	O
in	O
the	O
pre-filtering	O
clusters	O
were	O
subjected	O
to	O
TBLASTN	O
searches	O
against	O
the	O
genome	O
database	O
.	O

If	O
both	O
the	O
best	O
hits	O
of	O
the	O
N	O
-	O
and	O
C-terminal	O
parts	O
are	O
statistically	O
significant	O
(	O
E-value	O
<	O
10-5	O
)	O
,	O
and	O
distance	O
between	O
them	O
is	O
less	O
than	O
1	O
kbp	O
,	O
we	O
call	O
these	O
hits	O
'	O
syntenic	O
hits	O
'	O
.	O

If	O
any	O
syntenic	O
hits	O
with	O
non-coinciding	O
reading	O
frames	O
were	O
found	O
,	O
the	O
cluster	O
was	O
removed	O
.	O

The	O
third	O
filter	O
uses	O
co-occurrence	O
of	O
residues	O
around	O
the	O
inframe	O
stop	O
codon	O
as	O
another	O
source	O
of	O
information	O
for	O
screening	O
stop	O
codon	O
readthrough	O
.	O

Suppose	O
a	O
window	O
of	O
21	O
residues	O
centered	O
at	O
the	O
inframe	O
stop	O
codon	O
.	O

In	O
prokaryotes	O
,	O
most	O
stop-codon-encoded	O
amino	O
acids	O
are	O
located	O
inside	O
a	O
domain	O
,	O
the	O
unit	O
of	O
evolutionary	O
sequence	O
conservation	O
.	O

Therefore	O
,	O
in	O
an	O
ideal	O
situation	O
the	O
presence	O
or	O
absence	B-NEGATION
of	I-NEGATION
the	I-NEGATION
21	I-NEGATION
residues	I-NEGATION
in	I-NEGATION
alignments	I-NEGATION
will	O
be	O
synchronized	O
.	O

In	O
contrast	O
,	O
if	O
the	O
iORF	O
is	O
actually	O
two	O
adjacent	O
genes	O
,	O
then	O
upstream	O
and	O
downstream	O
residues	O
of	O
the	O
stop	O
codon	O
will	O
appear	O
separately	O
in	O
many	O
alignments	O
.	O

We	O
defined	O
a	O
co-occurrence	O
matrix	O
as	O
a	O
21	O
×	O
21	O
matrix	O
whose	O
(	O
i,j	O
)-	O
th	O
element	O
represents	O
how	O
often	O
residue	O
i	O
and	O
j	O
appeared	O
simultaneously	O
in	O
N	O
alignments	O
.	O

The	O
matrix	O
elements	O
were	O
subsequently	O
normalized	O
to	O
the	O
number	O
of	O
alignments	O
N	O
.	O

By	O
definition	O
,	O
the	O
more	O
often	O
the	O
upstream	O
and	O
downstream	O
residues	O
of	O
the	O
inframe	O
stop	O
codon	O
co-occur	O
in	O
the	O
alignments	O
,	O
the	O
higher	O
the	O
density	O
in	O
the	O
upper	O
right	O
quarter	O
of	O
the	O
matrix	O
.	O

If	O
average	O
density	O
in	O
the	O
quarter	O
was	O
lower	O
than	O
0.85	O
,	O
the	O
cluster	O
was	O
filtered	O
out	O
.	O

Stop	O
codon	O
usage	O

For	O
each	O
organism	O
,	O
its	O
iORFs	O
were	O
extracted	O
from	O
the	O
pre-filtering	O
clusters	O
,	O
and	O
codon	O
usage	O
at	O
the	O
inframe	O
stop	O
positions	O
was	O
counted	O
.	O

Codon	O
usage	O
at	O
the	O
C-terminal	O
stop	O
codons	O
in	O
its	O
proteome	O
was	O
also	O
computed	O
using	O
data	O
of	O
coding	O
sequences	O
downloaded	O
from	O
KEGG	O
GENES	O
25	O
.	O

These	O
data	O
were	O
combined	O
into	O
a	O
3	O
×	O
2	O
matrix	O
,	O
and	O
Fisher's	O
exact	O
test	O
was	O
applied	O
.	O

The	O
p-value	O
was	O
corrected	O
for	O
multiple	O
testing	O
using	O
the	O
Bonferroni	O
correction	O
because	O
there	O
were	O
127	O
organisms	O
in	O
the	O
pre-filtering	O
clusters	O
.	O

Probabilistic	O
prediction	O
and	O
ranking	O
of	O
human	O
protein-protein	O
interactions	O

Abstract	O

Background	O

Although	O
the	O
prediction	O
of	O
protein-protein	O
interactions	O
has	O
been	O
extensively	O
investigated	O
for	O
yeast	O
,	O
few	O
such	O
datasets	O
exist	O
for	O
the	O
far	O
larger	O
proteome	O
in	O
human	O
.	O

Furthermore	O
,	O
it	O
has	O
recently	O
been	O
estimated	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
overall	I-SPECULATION
average	I-SPECULATION
false	I-SPECULATION
positive	I-SPECULATION
rate	I-SPECULATION
of	I-SPECULATION
available	I-SPECULATION
computational	I-SPECULATION
and	I-SPECULATION
high-throughput	I-SPECULATION
experimental	I-SPECULATION
interaction	I-SPECULATION
datasets	I-SPECULATION
is	I-SPECULATION
as	I-SPECULATION
high	I-SPECULATION
as	I-SPECULATION
90	I-SPECULATION
%	I-SPECULATION
.	O

Results	O

The	O
prediction	O
of	O
human	O
protein-protein	O
interactions	O
was	O
investigated	O
by	O
combining	O
orthogonal	O
protein	O
features	O
within	O
a	O
probabilistic	O
framework	O
.	O

The	O
features	O
include	O
co-expression	O
,	O
orthology	O
to	O
known	O
interacting	O
proteins	O
and	O
the	O
full-Bayesian	O
combination	O
of	O
subcellular	O
localization	O
,	O
co-occurrence	O
of	O
domains	O
and	O
post-translational	O
modifications	O
.	O

A	O
novel	O
scoring	O
function	O
for	O
local	O
network	O
topology	O
was	O
also	O
investigated	O
.	O

This	O
topology	O
feature	O
greatly	O
enhanced	O
the	O
predictions	O
and	O
together	O
with	O
the	O
full-Bayes	O
combined	O
features	O
,	O
made	O
the	O
largest	O
contribution	O
to	O
the	O
predictions	O
.	O

Using	O
a	O
conservative	O
threshold	O
,	O
our	O
most	O
accurate	O
predictor	O
identifies	O
37606	O
human	O
interactions	O
,	O
32892	O
(	O
80	O
%)	O
of	O
which	O
are	O
not	B-NEGATION
present	I-NEGATION
in	I-NEGATION
other	I-NEGATION
publicly	I-NEGATION
available	I-NEGATION
large	I-NEGATION
human	I-NEGATION
interaction	I-NEGATION
datasets	I-NEGATION
,	O
thus	O
substantially	O
increasing	O
the	O
coverage	O
of	O
the	O
human	O
interaction	O
map	O
.	O

A	O
subset	O
of	O
the	O
32892	O
novel	O
predicted	O
interactions	O
have	O
been	O
independently	O
validated	O
.	O

Comparison	O
of	O
the	O
prediction	O
dataset	O
to	O
other	O
available	O
human	O
interaction	O
datasets	O
estimates	B-SPECULATION
the	I-SPECULATION
false	I-SPECULATION
positive	I-SPECULATION
rate	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
new	I-SPECULATION
method	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
below	I-SPECULATION
80	I-SPECULATION
%	I-SPECULATION
which	I-SPECULATION
is	I-SPECULATION
competitive	I-SPECULATION
with	I-SPECULATION
other	I-SPECULATION
methods	I-SPECULATION
.	O

Since	O
the	O
new	O
method	O
scores	O
and	O
ranks	O
all	O
human	O
protein	O
pairs	O
,	O
smaller	O
subsets	O
of	O
higher	O
quality	O
can	O
be	O
generated	O
thus	O
leading	O
to	O
even	O
lower	O
false	O
positive	O
prediction	O
rates	O
.	O

Conclusion	O

The	O
set	O
of	O
interactions	O
predicted	O
in	O
this	O
work	O
increases	O
the	O
coverage	O
of	O
the	O
human	O
interaction	O
map	O
and	O
will	O
help	O
determine	O
the	O
highest	O
confidence	O
human	O
interactions	O
.	O

Background	O

Protein-protein	O
interactions	O
perform	O
and	O
regulate	O
fundamental	O
cellular	O
processes	O
.	O

The	O
comprehensive	O
study	O
of	O
such	O
interactions	O
on	O
a	O
genome-wide	O
scale	O
will	O
lead	O
to	O
a	O
clearer	O
understanding	O
of	O
diverse	O
cellular	O
processes	O
and	O
of	O
the	O
molecular	O
mechanisms	O
of	O
disease	O
.	O

Although	O
the	O
determination	O
of	O
interactions	O
by	O
small-scale	O
laboratory	O
techniques	O
is	O
impractical	O
for	O
a	O
complete	O
proteome	O
on	O
the	O
grounds	O
of	O
cost	O
and	O
time	O
,	O
several	O
experimental	O
techniques	O
now	O
exist	O
to	O
determine	O
protein-protein	O
interactions	O
in	O
a	O
high-throughput	O
manner	O
1	O
.	O

High-throughput	O
datasets	O
have	O
been	O
generated	O
for	O
model	O
organisms	O
such	O
as	O
yeast	O
23456	O
,	O
worm	O
7	O
and	O
fly	O
89	O
as	O
well	O
as	O
Escherichia	O
coli	O
10	O
.	O

In	O
addition	O
,	O
the	O
first	O
broad-focus	O
experimental	O
datasets	O
for	O
the	O
human	O
interactome	O
have	O
recently	O
been	O
published	O
1112	O
.	O

Interactions	B-SPECULATION
determined	I-SPECULATION
by	I-SPECULATION
high-throughput	I-SPECULATION
methods	I-SPECULATION
are	I-SPECULATION
generally	I-SPECULATION
considered	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
less	I-SPECULATION
reliable	I-SPECULATION
than	I-SPECULATION
those	I-SPECULATION
obtained	I-SPECULATION
by	I-SPECULATION
low-throughput	I-SPECULATION
studies	I-SPECULATION
1314	O
and	O
as	O
a	O
consequence	O
efforts	O
are	O
also	O
underway	O
to	O
extract	O
evidence	O
for	O
interactions	O
from	O
the	O
literature	O
151617	O
.	O

Analysis	O
of	O
the	O
high-throughput	O
datasets	O
has	O
shown	O
that	O
they	O
overlap	O
very	O
little	O
with	O
each	O
other	O
,	O
suggesting	B-SPECULATION
that	I-SPECULATION
their	I-SPECULATION
coverage	I-SPECULATION
is	I-SPECULATION
low	I-SPECULATION
.	O

Indeed	O
,	O
it	O
has	O
been	O
estimated	B-SPECULATION
recently	I-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
current	I-SPECULATION
yeast	I-SPECULATION
and	I-SPECULATION
human	I-SPECULATION
protein	I-SPECULATION
interaction	I-SPECULATION
maps	I-SPECULATION
are	I-SPECULATION
only	I-SPECULATION
50	I-SPECULATION
%	I-SPECULATION
and	I-SPECULATION
10	I-SPECULATION
%	I-SPECULATION
complete	I-SPECULATION
,	I-SPECULATION
respectively	I-SPECULATION
18	O
.	O

The	O
low	O
coverage	O
and	O
variable	O
quality	O
of	O
the	O
experimental	O
interaction	O
datasets	O
have	O
prompted	O
many	O
groups	O
to	O
investigate	O
computational	O
methods	O
to	O
predict	O
interactions	O
or	O
to	O
determine	O
the	O
most	O
likely	O
interactions	O
seen	O
in	O
the	O
high-throughput	O
datasets	O
.	O

The	O
different	O
approaches	O
to	O
predict	O
interactions	O
can	O
be	O
grouped	O
into	O
five	O
main	O
categories	O
:	O

1	O
)	O
Predictors	O
based	O
on	O
sequence	O
and	O
structure	O
exploit	O
the	O
observation	O
that	O
some	O
pairs	O
of	O
sequence	O
motifs	O
,	O
domains	O
and	O
structural	O
families	O
tend	O
to	O
interact	O
preferentially	O
.	O

Some	O
methods	O
predict	O
interaction	O
from	O
sequence-motifs	O
found	O
to	O
be	O
over-represented	O
in	O
interacting	O
protein	O
pairs	O
19	O
,	O
or	O
by	O
considering	O
the	O
physico-chemical	O
properties	O
and	O
the	O
location	O
of	O
groups	O
of	O
amino	O
acids	O
in	O
the	O
sequence	O
2021	O
.	O

Others	O
investigate	O
the	O
co-occurrence	O
in	O
interacting	O
proteins	O
of	O
specific	O
protein	O
domains	O
or	O
their	O
structural	O
family	O
classification	O
2223	O
.	O

When	O
three-dimensional	O
structures	O
are	O
available	O
for	O
both	B-SPECULATION
proteins	I-SPECULATION
thought	I-SPECULATION
to	I-SPECULATION
interact	I-SPECULATION
,	O
high	B-SPECULATION
quality	I-SPECULATION
predictions	I-SPECULATION
and	I-SPECULATION
additional	I-SPECULATION
information	I-SPECULATION
such	I-SPECULATION
as	I-SPECULATION
the	I-SPECULATION
residues	I-SPECULATION
involved	I-SPECULATION
in	I-SPECULATION
the	I-SPECULATION
interaction	I-SPECULATION
and	I-SPECULATION
their	I-SPECULATION
binding	I-SPECULATION
affinity	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
estimated	I-SPECULATION
(	O
reviewed	O
in	O
24	O
)	O
.	O

Similarly	O
,	O
when	O
two	O
proteins	O
show	O
clear	O
sequence	O
similarity	O
to	O
proteins	O
that	O
exist	O
in	O
a	O
complex	O
for	O
which	O
the	O
three-dimensional	O
structure	O
is	O
known	O
,	O
detailed	B-SPECULATION
predictions	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
atomic-level	I-SPECULATION
interactions	I-SPECULATION
may	I-SPECULATION
be	I-SPECULATION
made	I-SPECULATION
.	O

For	O
example	O
,	O
the	O
major	O
complexes	O
in	O
yeast	O
have	O
been	O
predicted	O
by	O
this	O
strategy	O
25	O
.	O

2	O
)	O
Predictors	O
based	O
on	O
comparative	O
genomics	O
have	O
been	O
exploited	O
primarily	O
in	O
prokaryotes	O
.	O

They	O
consider	O
the	O
physical	O
location	O
of	O
genes	O
,	O
as	O
well	O
as	O
their	O
pattern	O
of	O
occurrence	O
and	O
evolutionary	O
rate	O
,	O
to	O
predict	O
interactions	O
or	O
functional	O
relationships	O
between	O
protein	O
pairs	O
.	O

Some	O
predictors	O
make	O
use	O
of	O
the	O
observation	O
that	O
neighboring	B-SPECULATION
genes	I-SPECULATION
whose	I-SPECULATION
relative	I-SPECULATION
location	I-SPECULATION
is	I-SPECULATION
conserved	I-SPECULATION
across	I-SPECULATION
several	I-SPECULATION
prokaryotic	I-SPECULATION
organisms	I-SPECULATION
are	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
interact	I-SPECULATION
26	O
.	O

Other	O
predictors	O
exploit	O
the	O
observation	O
that	O
gene	B-SPECULATION
pairs	I-SPECULATION
that	I-SPECULATION
co-occur	I-SPECULATION
in	I-SPECULATION
related	I-SPECULATION
species	I-SPECULATION
or	I-SPECULATION
that	I-SPECULATION
co-evolve	I-SPECULATION
also	I-SPECULATION
tend	I-SPECULATION
to	I-SPECULATION
be	I-SPECULATION
more	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
interact	I-SPECULATION
27282930	O
.	O

In	O
addition	O
,	O
domains	O
that	O
exist	O
as	O
separate	O
proteins	O
in	O
some	O
genomes	O
but	O
are	O
also	O
seen	O
fused	O
in	O
a	O
single	O
protein	O
in	O
other	O
genomes	O
have	O
been	O
used	O
to	O
suggest	B-SPECULATION
the	I-SPECULATION
isolated	I-SPECULATION
domains	I-SPECULATION
3132	O
.	O
may	B-SPECULATION
interact	I-SPECULATION
.	O

3	O
)	O
Predictors	O
based	O
on	O
orthology	O
work	O
on	O
the	O
assumption	B-SPECULATION
that	I-SPECULATION
the	I-SPECULATION
orthologs	I-SPECULATION
of	I-SPECULATION
a	I-SPECULATION
protein	I-SPECULATION
pair	I-SPECULATION
that	I-SPECULATION
are	I-SPECULATION
known	I-SPECULATION
to	I-SPECULATION
interact	I-SPECULATION
in	I-SPECULATION
one	I-SPECULATION
organism	I-SPECULATION
will	I-SPECULATION
also	I-SPECULATION
interact	I-SPECULATION
.	O

Such	O
relationships	O
are	O
often	O
referred	O
to	O
as	O
interologs	O
33	O
.	O

For	O
example	O
,	O
at	O
BLAST	O
e-values	O
below	O
10-10	O
,	O
it	O
has	O
been	O
shown	O
that	O
16	O
–	O
30	O
%	O
of	O
yeast	O
interactions	O
can	O
be	O
transferred	O
to	O
the	O
worm	O
34	O
while	O
further	O
studies	O
have	O
estimated	B-SPECULATION
that	I-SPECULATION
a	I-SPECULATION
joint	I-SPECULATION
e-value	I-SPECULATION
below	I-SPECULATION
10-70	I-SPECULATION
is	I-SPECULATION
required	I-SPECULATION
to	I-SPECULATION
transfer	I-SPECULATION
interactions	I-SPECULATION
reliably	I-SPECULATION
between	I-SPECULATION
organisms	I-SPECULATION
35	O
.	O

Interologs	O
have	O
been	O
used	O
to	O
predict	O
protein-protein	O
interactions	O
in	O
human	O
36	O
.	O

4	O
)	O
Predictors	O
based	O
on	O
functional	O
features	O
exploit	O
non-sequence	O
information	O
to	O
infer	O
interactions	O
.	O

Some	O
predictors	O
exploit	O
the	O
observation	O
that	O
there	O
is	O
a	O
significant	O
correlation	O
in	O
the	O
expression	O
levels	O
of	O
transcripts	O
encoding	O
proteins	O
that	O
interact	O
37	O
.	O

Since	O
proteins	O
must	O
be	O
co-localized	O
in	O
order	O
to	O
interact	O
,	O
protein	O
subcellular	O
localization	O
has	O
often	O
been	O
used	O
to	O
assess	O
the	O
quality	O
of	O
interaction	O
datasets	O
3839	O
.	O

Similarly	O
,	O
interacting	O
proteins	O
are	O
also	O
often	O
involved	O
in	O
similar	O
cellular	O
processes	O
,	O
so	O
Gene	O
Ontology	O
"	O
process	O
"	O
and	O
"	O
function	O
"	O
annotations	O
have	O
been	O
exploited	O
to	O
predict	O
interactions	O
and	O
validate	O
high-throughput	O
datasets	O
163638	O
.	O

5	O
)	O
Predictors	O
have	O
exploited	O
similarities	O
in	O
the	O
network	O
topology	O
of	O
known	O
interaction	O
datasets	O
to	O
predict	O
novel	O
interactions	O
.	O

In	O
one	O
study	O
,	O
the	O
local	O
topology	O
of	O
small-world	O
networks	O
has	O
been	O
used	O
to	O
assess	O
the	O
quality	O
of	O
interaction	O
datasets	O
and	O
predict	O
novel	O
interactions	O
40	O
while	O
Gerstein	O
and	O
colleagues	O
have	O
investigated	O
the	O
prediction	O
of	O
interactions	O
by	O
the	O
identification	O
of	O
missing	O
edges	O
in	O
almost	O
fully	O
connected	O
complexes	O
41	O
.	O

In	O
addition	O
to	O
these	O
diverse	O
approaches	O
,	O
some	O
groups	O
have	O
combined	O
concepts	O
from	O
several	O
of	O
the	O
above	O
categories	O
in	O
integrative	O
frameworks	O
.	O

The	O
first	O
such	O
predictor	O
integrated	O
co-expression	O
data	O
,	O
co-essentiality	O
as	O
well	O
as	O
biological	O
function	O
in	O
a	O
naïve	O
Bayes	O
network	O
to	O
provide	O
proteome-wide	O
de	O
novo	O
prediction	O
of	O
yeast	O
protein	O
interactions	O
37	O
.	O

Subsequently	O
,	O
the	O
combination	O
of	O
many	O
more	O
diverse	O
features	O
was	O
investigated	O
using	O
different	O
frameworks	O
to	O
predict	O
yeast	O
protein-protein	O
interactions	O
,	O
increasing	O
the	O
prediction	O
accuracy	O
and	O
allowing	O
an	O
assessment	O
of	O
the	O
limits	O
of	O
genomic	O
integration	O
424344	O
.	O

The	O
integration	O
of	O
diverse	O
genomic	O
features	O
has	O
also	O
been	O
useful	O
in	O
the	O
investigation	O
of	O
the	O
related	O
but	O
broader	O
problem	O
of	O
predicting	O
protein-protein	O
associations	O
as	O
well	O
as	O
complex	O
and	O
pathway	O
membership	O
(	O
see	O
for	O
example	O
45	O
)	O
.	O

Although	O
,	O
many	O
computational	O
methods	O
have	O
investigated	O
the	O
prediction	O
of	O
protein-protein	O
interactions	O
,	O
few	O
have	O
so	O
far	O
been	O
applied	O
to	O
the	O
human	O
proteome	O
.	O

The	O
first	O
large-scale	O
prediction	O
of	O
the	O
human	O
interactome	O
map	O
involved	O
transferring	O
interactions	O
from	O
model	O
organisms	O
36	O
.	O

This	O
resulted	O
in	O
over	O
70000	O
predicted	O
physical	O
interactions	O
involving	O
approximately	O
6200	O
human	O
proteins	O
.	O

A	O
second	O
method	O
integrated	O
expression	O
data	O
,	O
orthology	O
,	O
protein	O
domain	O
data	O
and	O
functional	O
annotations	O
into	O
a	O
probabilistic	O
framework	O
and	O
resulted	O
in	O
the	O
prediction	B-SPECULATION
of	I-SPECULATION
nearly	I-SPECULATION
40000	I-SPECULATION
human	I-SPECULATION
protein	I-SPECULATION
interactions	I-SPECULATION
46	O
.	O

It	O
has	O
recently	O
been	O
estimated	O
that	O
the	O
false-positive	O
rates	O
of	O
these	O
computational	O
datasets	O
as	O
well	O
as	O
of	O
available	O
high-throughput	O
human	O
interaction	O
datasets	O
are	O
,	O
on	O
average	O
,	O
as	O
high	O
as	O
90	O
%	O
and	O
their	O
coverage	O
is	O
only	O
approximately	O
10	O
%	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
more	I-SPECULATION
such	I-SPECULATION
efforts	I-SPECULATION
are	I-SPECULATION
needed	I-SPECULATION
to	I-SPECULATION
increase	I-SPECULATION
the	I-SPECULATION
coverage	I-SPECULATION
and	I-SPECULATION
confidence	I-SPECULATION
we	I-SPECULATION
have	I-SPECULATION
in	I-SPECULATION
current	I-SPECULATION
maps	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
human	I-SPECULATION
interactome	I-SPECULATION
18	O
.	O

In	O
this	O
paper	O
,	O
the	O
prediction	O
of	O
physical	O
interactions	O
between	O
human	O
proteins	O
has	O
been	O
investigated	O
by	O
integrating	O
in	O
a	O
Bayesian	O
framework	O
several	O
different	O
pieces	O
of	O
evidence	O
including	O
orthology	O
,	O
functional	O
features	O
and	O
local	O
network	O
topology	O
.	O

In	O
order	O
to	O
increase	O
the	O
accuracy	O
and	O
coverage	O
of	O
the	O
predictions	O
,	O
different	O
types	O
of	O
negative	O
data	O
(	O
non-interacting	O
protein	O
pairs	O
)	O
were	O
explored	O
to	O
train	O
the	O
predictor	O
.	O

The	O
most	O
accurate	O
of	O
the	O
predictors	O
was	O
then	O
used	O
to	O
assess	O
the	O
likelihood	O
of	O
pair-wise	O
interaction	O
for	O
over	O
20000	O
human	O
proteins	O
from	O
the	O
IPI	O
(	O
International	O
Protein	O
Index	O
)	O
database	O
.	O

These	O
predictions	O
provide	O
a	O
likelihood	B-SPECULATION
of	I-SPECULATION
interaction	I-SPECULATION
for	I-SPECULATION
over	I-SPECULATION
260	I-SPECULATION
million	I-SPECULATION
human	I-SPECULATION
protein	I-SPECULATION
pairs	I-SPECULATION
and	O
lead	O
to	O
the	O
prediction	B-SPECULATION
of	I-SPECULATION
over	I-SPECULATION
37000	I-SPECULATION
human	I-SPECULATION
interactions	I-SPECULATION
.	O

They	O
should	B-SPECULATION
thus	I-SPECULATION
augment	I-SPECULATION
current	I-SPECULATION
knowledge	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
human	I-SPECULATION
interactome	I-SPECULATION
as	I-SPECULATION
well	I-SPECULATION
as	I-SPECULATION
the	I-SPECULATION
understanding	I-SPECULATION
of	I-SPECULATION
the	I-SPECULATION
relationship	I-SPECULATION
between	I-SPECULATION
distinct	I-SPECULATION
cellular	I-SPECULATION
processes	I-SPECULATION
.	O

Results	O
and	O
discussion	O

Architecture	O
of	O
the	O
predictor	O
and	O
training	O
of	O
the	O
modules	O

The	O
prediction	O
of	O
human	O
protein-protein	O
interactions	O
was	O
investigated	O
in	O
a	O
Bayesian	O
framework	O
by	O
considering	O
combinations	O
of	O
individual	O
protein	O
features	O
known	O
to	O
be	O
indicative	O
of	O
interaction	O
.	O

The	O
seven	O
individual	O
features	O
considered	O
are	O
summarized	O
in	O
Table	O
1	O
and	O
detailed	O
in	O
the	O
Methods	O
section	O
.	O

As	O
indicated	O
in	O
Table	O
1	O
,	O
the	O
different	O
features	O
were	O
grouped	O
into	O
five	O
distinct	O
modules	O
:	O
Expression	O
(	O
E	O
)	O
,	O
Orthology	O
(	O
O	O
)	O
,	O
Combined	O
(	O
C	O
)	O
,	O
Disorder	O
(	O
D	O
)	O
and	O
Transitive	O
(	O
T	O
)	O
.	O

Figure	O
1	O
illustrates	O
the	O
training	O
scheme	O
and	O
architecture	O
of	O
the	O
method	O
.	O

The	O
Expression	O
,	O
Orthology	O
,	O
Combined	O
and	O
Disorder	O
modules	O
can	O
calculate	O
likelihood	O
ratios	O
(	O
LR	O
)	O
of	O
interaction	O
independently	O
and	O
are	O
referred	O
to	O
as	O
the	O
Group	O
A	O
modules	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
product	O
of	O
their	O
likelihood	O
ratios	O
is	O
referred	O
to	O
as	O
the	O
Preliminary	O
Score	O
.	O

The	O
Transitive	O
module	O
considers	O
the	O
local	O
topology	O
of	O
the	O
network	O
predicted	O
by	O
the	O
group	O
A	O
modules	O
and	O
thus	O
requires	O
the	O
completion	O
of	O
their	O
analysis	O
to	O
calculate	O
its	O
own	O
likelihood	O
ratios	O
of	O
interaction	O
(	O
Figure	O
1B	O
)	O
.	O

As	O
such	O
,	O
all	O
combinations	O
of	O
the	O
Group	O
A	O
modules	O
can	O
be	O
used	O
to	O
predict	O
interaction	O
in	O
the	O
presence	O
or	O
absence	B-NEGATION
of	I-NEGATION
the	I-NEGATION
Transitive	I-NEGATION
module	I-NEGATION
.	O

In	O
the	O
absence	B-NEGATION
of	I-NEGATION
the	I-NEGATION
Transitive	I-NEGATION
module	I-NEGATION
,	O
the	O
Preliminary	O
Score	O
is	O
used	O
as	O
the	O
final	O
likelihood	O
ratio	O
output	O
by	O
the	O
predictor	O
.	O

Features	O
considered	O
in	O
the	O
prediction	O
of	O
interactions	O
for	O
each	O
module	O

Architecture	O
of	O
the	O
predictor	O
and	O
likelihoods	O
of	O
the	O
modules	O

Architecture	O
of	O
the	O
predictor	O
and	O
likelihoods	O
of	O
the	O
modules	O
.	O

The	O
predictor	O
consists	O
of	O
two	O
different	O
parts	O
(	O
A	O
and	O
B	O
)	O
which	O
are	O
trained	O
consecutively	O
.	O

The	O
Group	O
A	O
modules	O
(	O
shown	O
in	O
panel	O
A	O
)	O
are	O
trained	O
in	O
parallel	O
.	O

The	O
likelihood	O
ratios	O
(	O
LR	O
)	O
for	O
most	O
of	O
their	O
states	O
are	O
shown	O
in	O
panel	O
A	O
(	O
their	O
complete	O
likelihood	O
ratios	O
are	O
available	O
in	O
Additional	O
File	O
4	O
)	O
.	O

The	O
product	O
of	O
the	O
likelihood	O
ratios	O
of	O
all	O
Group	O
A	O
modules	O
considered	O
in	O
a	O
given	O
prediction	O
is	O
referred	O
to	O
as	O
the	O
preliminary	O
score	O
(	O
PS	O
)	O
and	O
can	O
be	O
calculated	O
for	O
all	O
human	O
protein	O
pairs	O
.	O

If	O
the	B-NEGATION
Transitive	I-NEGATION
module	I-NEGATION
is	I-NEGATION
not	I-NEGATION
considered	I-NEGATION
,	O
the	O
final	O
likelihood	O
ratios	O
assigned	O
to	O
all	O
protein	O
pairs	O
is	O
the	O
preliminary	O
score	O
(	O
PS	O
)	O
.	O

If	O
the	O
Transitive	O
module	O
is	O
considered	O
,	O
the	O
local	O
topology	O
of	O
the	O
network	O
determined	O
by	O
the	O
assignment	O
of	O
preliminary	O
scores	O
to	O
all	O
protein	O
pairs	O
considered	O
in	O
the	O
training	O
set	O
is	O
used	O
to	O
calculate	O
the	O
likelihood	O
ratios	O
for	O
the	O
transitive	O
module	O
(	O
shown	O
in	O
panel	O
B	O
)	O
for	O
every	O
protein	O
pair	O
in	O
the	O
training	O
set	O
.	O

The	O
final	O
likelihood	O
ratio	O
is	O
then	O
the	O
product	O
of	O
the	O
preliminary	O
score	O
calculated	O
in	O
panel	O
A	O
and	O
the	O
likelihood	O
ratio	O
output	O
by	O
the	O
transitive	O
module	O
in	O
panel	O
B	O
.	O

For	O
the	O
Orthology	O
module	O
:	O
YL	O
,	O
YM	O
,	O
YH	O
:	O
yeast	O
low	O
,	O
medium	O
and	O
high	O
scoring	O
bins	O
;	O
FL	O
,	O
FM	O
,	O
FH	O
:	O
fly	O
low	O
,	O
medium	O
and	O
high	O
scoring	O
bins	O
;	O
WL	O
,	O
WM	O
,	O
WH	O
:	O
worm	O
low	O
,	O
medium	O
and	O
high	O
scoring	O
bins	O
;	O
HM	O
and	O
HL	O
:	O
medium	O
and	O
low	O
scoring	O
bins	O
for	O
human	O
protein	O
pairs	O
that	O
have	O
human	O
paralogs	O
;	O
>	O
1	O
organism	O
:	O
bin	O
for	O
human	O
protein	O
pairs	O
that	O
have	O
interologs	O
in	O
more	O
than	O
one	O
organism	O
.	O

For	O
the	O
Combined	O
module	O
,	O
–—	O
refers	O
to	O
the	O
lowest	O
scoring	O
bin	O
(	O
for	O
the	O
domain	O
(	O
Dom	O
)	O
,	O
post-translational	O
modification	O
(	O
PTM	O
)	O
and	O
subcellular	O
localization	O
(	O
Loc	O
)	O
features	O
)	O
,	O
–	O
refers	O
to	O
the	O
second	O
lowest	O
scoring	O
bin	O
and	O
+	O
,	O
++	O
,	O
+++	O
refer	O
respectively	O
to	O
the	O
third	O
highest	O
,	O
second	O
highest	O
and	O
highest	O
scoring	O
bins	O
.	O

The	O
likelihood	O
ratios	O
of	O
interaction	O
are	O
evaluated	O
for	O
each	O
module	O
by	O
considering	O
the	O
relative	O
proportions	O
of	O
positive	O
and	O
negative	O
training	O
examples	O
that	O
have	O
a	O
specific	O
state	O
(	O
i.e.	O
that	O
fall	O
in	O
a	O
particular	O
bin	O
of	O
a	O
module	O
)	O
.	O

The	O
datasets	O
used	O
to	O
train	O
the	O
predictor	O
consisted	O
of	O
26896	O
known	O
human	O
protein	O
interactions	O
extracted	O
from	O
the	O
Human	O
Protein	O
Reference	O
Database	O
(	O
HPRD	O
)	O
15	O
and	O
approximately	O
100	O
times	O
more	O
randomly	O
chosen	O
protein	O
pairs	O
used	O
as	O
negative	O
examples	O
.	O

The	O
composition	O
of	O
the	O
datasets	O
and	O
likelihood	O
ratio	O
calculations	O
are	O
explained	O
in	O
greater	O
detail	O
in	O
the	O
Methods	O
section	O
.	O

Once	O
the	O
final	O
likelihood	O
ratio	O
of	O
interaction	O
(	O
LRfinal	O
)	O
is	O
calculated	O
for	O
a	O
given	O
protein	O
pair	O
as	O
shown	O
in	O
Figure	O
1B	O
,	O
it	O
is	O
possible	B-SPECULATION
to	I-SPECULATION
estimate	I-SPECULATION
the	I-SPECULATION
posterior	I-SPECULATION
odds	I-SPECULATION
ratio	I-SPECULATION
of	I-SPECULATION
interaction	I-SPECULATION
by	I-SPECULATION
multiplying	I-SPECULATION
the	I-SPECULATION
final	I-SPECULATION
likelihood	I-SPECULATION
ratio	I-SPECULATION
by	I-SPECULATION
the	I-SPECULATION
prior	I-SPECULATION
odds	I-SPECULATION
ratio	I-SPECULATION
of	I-SPECULATION
interaction	I-SPECULATION
.	O

Protein	B-SPECULATION
pairs	I-SPECULATION
that	I-SPECULATION
have	I-SPECULATION
a	I-SPECULATION
posterior	I-SPECULATION
odds	I-SPECULATION
of	I-SPECULATION
interaction	I-SPECULATION
above	I-SPECULATION
1	I-SPECULATION
are	I-SPECULATION
more	I-SPECULATION
likely	I-SPECULATION
to	I-SPECULATION
interact	I-SPECULATION
than	I-SPECULATION
,	O
thus	O
providing	O
an	O
obvious	O
threshold	O
to	O
predict	O
interacting	O
proteins	O
.	O
not	B-NEGATION
to	I-NEGATION
interact	I-NEGATION
.	O

Estimates	O
for	O
the	O
prior	O
odds	O
ratio	O
of	O
interaction	O
vary	O
.	O

Previous	O
interaction	O
studies	O
on	O
yeast	O
and	O
human	O
use	O
prior	O
odds	O
ratios	O
that	O
range	O
from	O
1	O
/	O
600	O
to	O
>	O
1	O
/	O
400	O
37434647	O
.	O

The	O
evaluation	O
of	O
this	O
ratio	O
is	O
difficult	O
because	O
not	O
all	O
true	O
interactions	O
are	O
known	O
.	O

As	O
detailed	O
in	O
Methods	O
,	O
the	O
prior	O
odds	O
ratio	O
for	O
human	O
protein	O
interaction	O
was	O
explored	O
by	O
considering	O
different	O
versions	O
and	O
subsets	O
of	O
human	O
interaction	O
datasets	O
.	O

This	O
suggested	B-SPECULATION
that	I-SPECULATION
there	I-SPECULATION
is	I-SPECULATION
insufficient	I-SPECULATION
data	I-SPECULATION
currently	I-SPECULATION
available	I-SPECULATION
to	I-SPECULATION
determine	I-SPECULATION
a	I-SPECULATION
reliable	I-SPECULATION
ratio	I-SPECULATION
for	I-SPECULATION
human	I-SPECULATION
.	O

Accordingly	O
,	O
we	O
selected	O
a	O
prior	O
odds	O
ratio	O
of	O
interaction	O
of	O
1	O
/	O
400	O
which	O
is	O
similar	O
to	O
current	O
estimates	O
for	O
yeast	O
and	O
is	O
probably	B-SPECULATION
still	I-SPECULATION
quite	I-SPECULATION
conservative	I-SPECULATION
.	O

Thus	O
,	O
the	O
likelihood	O
ratio	O
threshold	O
to	O
predict	O
interactions	O
is	O
400	O
.	O

Likelihood	O
ratios	O
of	O
the	O
modules	O

Figure	O
1	O
summarizes	O
the	O
likelihood	O
ratios	O
computed	O
for	O
the	O
five	O
modules	O
.	O

The	O
different	O
modules	O
differ	O
in	O
the	O
range	O
of	O
likelihood	O
ratio	O
values	O
achieved	O
by	O
their	O
different	O
states	O
.	O

The	O
Orthology	O
and	O
Combined	O
modules	O
both	O
have	O
states	O
that	O
achieve	O
likelihood	O
ratios	O
above	O
400	O
(	O
as	O
high	O
as	O
1207	O
for	O
the	O
Orthology	O
module	O
and	O
613	O
for	O
the	O
Combined	O
module	O
)	O
,	O
indicating	B-SPECULATION
that	I-SPECULATION
both	I-SPECULATION
these	I-SPECULATION
modules	I-SPECULATION
can	B-SPECULATION
,	I-SPECULATION
on	I-SPECULATION
their	I-SPECULATION
own	I-SPECULATION
,	I-SPECULATION
predict	I-SPECULATION
some	I-SPECULATION
interacting	I-SPECULATION
protein	I-SPECULATION
pairs	I-SPECULATION
with	I-SPECULATION
a	I-SPECULATION
posterior	I-SPECULATION
odds	I-SPECULATION
ratio	I-SPECULATION
above	I-SPECULATION
1	I-SPECULATION
.	O

The	O
Expression	O
module	O
follows	O
trends	O
seen	O
in	O
previous	O
studies	O
with	O
increasing	O
likelihood	O
ratios	O
of	O
interaction	O
reflecting	O
increasing	O
expression	O
correlation	O
3746	O
.	O

However	O
,	O
since	O
the	O
highest	O
likelihood	O
ratio	O
for	O
the	O
expression	O
datasets	O
that	O
we	O
consider	O
is	O
33	O
,	O
they	O
are	O
not	B-NEGATION
sufficient	I-NEGATION
on	I-NEGATION
their	I-NEGATION
own	I-NEGATION
to	I-NEGATION
predict	I-NEGATION
interacting	I-NEGATION
protein	I-NEGATION
pairs	I-NEGATION
with	I-NEGATION
a	I-NEGATION
posterior	I-NEGATION
odds	I-NEGATION
ratio	I-NEGATION
above	I-NEGATION
1	I-NEGATION
.	O

Similarly	O
,	O
but	O
in	O
a	O
much	O
more	O
pronounced	O
way	O
,	O
the	O
Disorder	O
module	O
is	O
only	O
slightly	O
predictive	O
of	O
interaction	O
,	O
with	O
a	O
maximum	O
likelihood	O
ratio	O
of	O
1.8	O
.	O

Most	O
states	O
of	O
the	O
Orthology	O
module	O
achieve	O
higher	O
likelihood	O
ratios	O
than	O
the	O
highest	O
obtained	O
by	O
the	O
Expression	O
and	O
Disorder	O
modules	O
.	O

This	O
is	O
not	B-NEGATION
surprising	I-NEGATION
as	O
the	O
transfer	O
of	O
interacting	O
orthologs	O
(	O
known	O
as	O
interologs	O
33	O
)	O
from	O
one	O
organism	O
to	O
another	O
is	O
a	O
popular	O
method	O
to	O
predict	O
interactions	O
(	O
see	O
for	O
example	O
3448	O
)	O
,	O
particularly	O
in	O
the	O
case	O
of	O
organisms	O
like	O
human	O
for	O
which	O
only	O
a	O
small	O
proportion	O
of	O
interactions	O
are	O
known	O
.	O

The	O
direct	O
transfer	O
of	O
interactions	O
to	O
human	O
from	O
either	O
yeast	O
,	O
fly	O
or	O
worm	O
does	O
not	O
alone	O
result	O
in	O
a	O
posterior	O
odds	O
ratio	O
above	O
1	O
(	O
as	O
the	O
likelihood	O
ratios	O
of	O
interaction	O
for	O
all	O
yeast	O
,	O
fly	O
and	O
worm	O
bins	O
in	O
the	O
Orthology	O
module	O
are	O
below	O
400	O
)	O
.	O

This	O
is	O
not	B-NEGATION
surprising	I-NEGATION
as	O
previous	O
studies	O
have	O
indicated	B-SPECULATION
that	I-SPECULATION
quite	I-SPECULATION
stringent	I-SPECULATION
joint	I-SPECULATION
E-values	I-SPECULATION
must	I-SPECULATION
be	I-SPECULATION
used	I-SPECULATION
to	I-SPECULATION
transfer	I-SPECULATION
interactions	I-SPECULATION
safely	I-SPECULATION
between	I-SPECULATION
organisms	I-SPECULATION
3435	O
.	O

In	O
contrast	O
,	O
the	O
consideration	O
of	O
human	O
interactions	O
paralogous	O
to	O
the	O
human	O
protein	O
pairs	O
under	O
investigation	O
results	O
in	O
likelihood	O
ratios	O
of	O
431	O
and	O
1034	O
(	O
depending	O
on	O
how	O
close	O
the	O
paralogs	O
are	O
as	O
described	O
in	O
Methods	O
)	O
which	O
is	O
much	O
higher	O
than	O
those	O
obtained	O
for	O
any	O
single	O
model	O
organism	O
.	O

This	O
agrees	O
with	O
a	O
recent	O
report	O
that	O
suggested	B-SPECULATION
protein-protein	I-SPECULATION
interactions	I-SPECULATION
are	I-SPECULATION
more	I-SPECULATION
conserved	I-SPECULATION
within	I-SPECULATION
species	I-SPECULATION
than	I-SPECULATION
across	I-SPECULATION
species	I-SPECULATION
49	O
.	O

The	O
Combined	O
module	O
uses	O
domain	O
co-occurrence	O
,	O
post-translational	O
modification	O
(	O
PTM	O
)	O
co-occurrence	O
and	O
subcellular	O
localization	O
information	O
to	O
predict	O
interaction	O
.	O

These	O
features	O
were	O
originally	O
investigated	O
separately	O
,	O
as	O
shown	O
in	O
Figure	O
3	O
,	O
but	O
their	O
combination	O
into	O
one	O
module	O
that	O
considers	O
all	O
dependencies	O
between	O
them	O
achieves	O
higher	O
accuracy	O
(	B-NEGATION
data	I-NEGATION
not	I-NEGATION
shown	I-NEGATION
)	I-NEGATION
and	O
higher	O
likelihood	O
ratios	O
(	O
as	O
can	O
be	O
seen	O
by	O
comparing	O
to	O
Figure	O
1	O
)	O
while	O
still	O
being	O
computationally	O
feasible	O
.	O

Additionally	O
,	O
this	O
combination	O
circumvents	O
possible	B-SPECULATION
problems	I-SPECULATION
of	I-SPECULATION
dependence	I-SPECULATION
between	I-SPECULATION
these	I-SPECULATION
features	I-SPECULATION
.	O

Likelihood	O
ratios	O
of	O
the	O
features	O
that	O
form	O
the	O
Combined	O
module	O
,	O
considered	O
separately	O

Likelihood	O
ratios	O
of	O
the	O
features	O
that	O
form	O
the	O
Combined	O
module	O
,	O
considered	O
separately	O
.	O

The	O
Combined	O
module	O
considers	O
simultaneously	O
three	O
distinct	O
features	O
:	O
the	O
co-occurrence	O
of	O
both	O
domains	O
and	O
PTMs	O
as	O
well	O
as	O
the	O
subcellular	O
co-localization	O
of	O
proteins	O
.	O

Here	O
the	O
likelihood	O
ratios	O
of	O
these	O
features	O
considered	O
separately	O
are	O
shown	O
.	O

In	O
panel	O
A	O
,	O
all	O
domain	O
pairs	O
considered	O
were	O
given	O
scores	O
and	O
likelihood	O
ratios	O
were	O
estimated	O
for	O
different	O
values	O
of	O
these	O
scores	O
.	O

Similarly	O
,	O
shown	O
in	O
panel	O
B	O
are	O
the	O
likelihood	O
ratios	O
for	O
different	O
values	O
of	O
PTM	O
co-occurrence	O
scores	O
.	O

Panel	O
C	O
shows	O
the	O
likelihood	O
ratios	O
for	O
protein	O
pairs	O
localized	O
to	O
different	O
sets	O
of	O
cellular	O
compartments	O
.	O

Previous	O
methods	O
have	O
investigated	O
the	O
use	O
of	O
co-occurring	O
domains	O
to	O
predict	O
interaction	O
(	O
see	O
for	O
example	O
2346	O
)	O
.	O

Many	O
pairs	O
of	O
domains	O
co-occur	O
in	O
proteins	O
known	O
to	O
interact	O
.	O

When	O
investigated	O
as	O
a	O
separate	O
feature	O
,	O
the	O
chi-square	O
score	O
of	O
co-occurrence	O
of	O
domain	O
pairs	O
correlates	O
well	O
with	O
the	O
likelihood	O
of	O
interaction	O
of	O
protein	O
pairs	O
that	O
contain	O
these	O
domains	O
,	O
with	O
the	O
highest	O
chi-square	O
score	O
bin	O
obtaining	O
a	O
likelihood	O
ratio	O
of	O
14	O
,	O
as	O
shown	O
in	O
Figure	O
3A	O
.	O

Similarly	O
,	O
the	O
co-occurrence	O
of	O
PTMs	O
is	O
also	O
predictive	O
of	O
interaction	O
,	O
with	O
its	O
highest	O
scoring	O
bin	O
obtaining	O
a	O
likelihood	O
ratio	O
of	O
6	O
as	O
shown	O
in	O
Figure	O
3B	O
.	O

Lists	O
of	O
high	O
scoring	O
domain	O
pairs	O
and	O
PTM	O
pairs	O
are	O
shown	O
in	O
Additional	O
Files	O
1	O
and	O
2	O
.	O

Subcellular	O
localization	O
has	O
been	O
extensively	O
used	O
both	O
to	O
assess	O
the	O
quality	O
of	O
interaction	O
datasets	O
115051	O
and	O
to	O
generate	O
examples	O
of	O
non-interacting	O
protein	O
pairs	O
to	O
use	O
as	O
negative	O
datasets	O
when	O
training	O
and	O
testing	O
predictors	O
3746	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
use	O
of	O
localization	O
was	O
investigated	O
as	O
a	O
feature	O
predictive	O
of	O
interaction	O
.	O

Four	O
possible	B-SPECULATION
localization	I-SPECULATION
states	I-SPECULATION
were	O
considered	O
for	O
protein	O
pairs	O
:	O
:	O
same	O
compartment	O
,	O
neighboring	O
compartments	O
,	O
different	O
non-neighboring	O
compartments	O
and	O
absence	B-NEGATION
of	I-NEGATION
localization	I-NEGATION
annotation	I-NEGATION
(	O
more	O
details	O
are	O
given	O
in	O
the	O
Methods	O
section	O
)	O
.	O

As	O
shown	O
in	O
Figure	O
3C	O
,	O
the	O
likelihood	O
ratio	O
of	O
same	O
compartment	O
protein	O
pairs	O
was	O
found	O
to	O
be	O
twice	O
as	O
high	O
as	O
that	O
of	O
randomly	O
chosen	O
or	O
non-annotated	O
protein	O
pairs	O
whereas	O
different	O
non-neighboring	O
protein	O
pairs	O
are	O
more	O
than	O
three	O
times	O
less	O
likely	O
to	O
interact	O
than	O
random	O
protein	O
pairs	O
.	O

Individual	O
localization	O
features	O
achieve	O
low	O
interaction	O
likelihood	O
ratios	O
.	O

However	O
,	O
when	O
integrated	O
into	O
the	O
Combined	O
module	O
,	O
domain	O
,	O
PTM	O
and	O
localization	O
information	O
together	O
achieve	O
likelihood	O
ratios	O
that	O
are	O
high	O
enough	O
to	O
predict	O
interaction	O
on	O
their	O
own	O
(	O
i.e.	O
above	O
400	O
)	O
.	O

As	O
expected	O
,	O
the	O
highest	O
likelihood	O
ratio	O
bins	O
for	O
the	O
Combined	O
module	O
are	O
those	O
representing	O
the	O
highest	O
combinations	O
of	O
the	O
three	O
features	O
separately	O
.	O